Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 C20140605_SFK031_02 C20140605_SFK031_02 TB295066.[MT7]-VMDALEPADWC[CAM]QFAALIVR.2b3_1.heavy 1175.1 / 490.245 2845.0 54.46070098876953 31 8 10 3 10 0.46875419137110375 98.36451232901075 0.05860137939453125 3 0.7717255546424124 2.532228689050122 2845.0 8.966978868943583 0.0 - - - - - - - 117.0 5 18 IRAK1 interleukin-1 receptor-associated kinase 1 3 1 C20140605_SFK031_02 C20140605_SFK031_02 TB295066.[MT7]-VMDALEPADWC[CAM]QFAALIVR.2b4_1.heavy 1175.1 / 561.282 3742.0 54.46070098876953 31 8 10 3 10 0.46875419137110375 98.36451232901075 0.05860137939453125 3 0.7717255546424124 2.532228689050122 3742.0 32.862435897435894 0.0 - - - - - - - 148.2 7 15 IRAK1 interleukin-1 receptor-associated kinase 1 5 1 C20140605_SFK031_02 C20140605_SFK031_02 TB295066.[MT7]-VMDALEPADWC[CAM]QFAALIVR.2b6_1.heavy 1175.1 / 803.409 6197.0 54.46070098876953 31 8 10 3 10 0.46875419137110375 98.36451232901075 0.05860137939453125 3 0.7717255546424124 2.532228689050122 6197.0 4.089151873767259 1.0 - - - - - - - 147.0 12 13 IRAK1 interleukin-1 receptor-associated kinase 1 7 1 C20140605_SFK031_02 C20140605_SFK031_02 TB295066.[MT7]-VMDALEPADWC[CAM]QFAALIVR.2b5_1.heavy 1175.1 / 674.366 2845.0 54.46070098876953 31 8 10 3 10 0.46875419137110375 98.36451232901075 0.05860137939453125 3 0.7717255546424124 2.532228689050122 2845.0 22.14514652014652 0.0 - - - - - - - 133.71428571428572 5 14 IRAK1 interleukin-1 receptor-associated kinase 1 9 2 C20140605_SFK031_02 C20140605_SFK031_02 TB558215.[MT7]-VFLLLQK[MT7].2y4_1.heavy 574.886 / 645.442 90703.0 42.06990051269531 48 18 10 10 10 5.327866327208333 18.769239665289703 0.0 3 0.9886679807918456 11.582378272886038 90703.0 118.36796491667135 0.0 - - - - - - - 816.4285714285714 181 7 CDK19 cyclin-dependent kinase 19 11 2 C20140605_SFK031_02 C20140605_SFK031_02 TB558215.[MT7]-VFLLLQK[MT7].2b3_1.heavy 574.886 / 504.33 105669.0 42.06990051269531 48 18 10 10 10 5.327866327208333 18.769239665289703 0.0 3 0.9886679807918456 11.582378272886038 105669.0 113.54120955066006 0.0 - - - - - - - 771.25 211 4 CDK19 cyclin-dependent kinase 19 13 2 C20140605_SFK031_02 C20140605_SFK031_02 TB558215.[MT7]-VFLLLQK[MT7].2y3_1.heavy 574.886 / 532.357 113107.0 42.06990051269531 48 18 10 10 10 5.327866327208333 18.769239665289703 0.0 3 0.9886679807918456 11.582378272886038 113107.0 117.42522995481553 0.0 - - - - - - - 393.3333333333333 226 3 CDK19 cyclin-dependent kinase 19 15 2 C20140605_SFK031_02 C20140605_SFK031_02 TB558215.[MT7]-VFLLLQK[MT7].2y6_1.heavy 574.886 / 905.594 98775.0 42.06990051269531 48 18 10 10 10 5.327866327208333 18.769239665289703 0.0 3 0.9886679807918456 11.582378272886038 98775.0 101.12676018982293 0.0 - - - - - - - 655.1111111111111 197 9 CDK19 cyclin-dependent kinase 19 17 3 C20140605_SFK031_02 C20140605_SFK031_02 TB557356.[MT7]-EIVSGLK[MT7].2y4_1.heavy 517.328 / 548.352 153703.0 27.722700119018555 50 20 10 10 10 108.89895481613259 0.9182824588981797 0.0 3 0.9999569441143478 188.08083663891085 153703.0 173.57849658718828 0.0 - - - - - - - 1179.25 307 8 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 19 3 C20140605_SFK031_02 C20140605_SFK031_02 TB557356.[MT7]-EIVSGLK[MT7].2y5_1.heavy 517.328 / 647.421 99384.0 27.722700119018555 50 20 10 10 10 108.89895481613259 0.9182824588981797 0.0 3 0.9999569441143478 188.08083663891085 99384.0 89.48168656166312 0.0 - - - - - - - 1682.375 198 8 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 21 3 C20140605_SFK031_02 C20140605_SFK031_02 TB557356.[MT7]-EIVSGLK[MT7].2y6_1.heavy 517.328 / 760.505 61349.0 27.722700119018555 50 20 10 10 10 108.89895481613259 0.9182824588981797 0.0 3 0.9999569441143478 188.08083663891085 61349.0 59.59784611339373 0.0 - - - - - - - 827.6666666666666 122 9 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 23 3 C20140605_SFK031_02 C20140605_SFK031_02 TB557356.[MT7]-EIVSGLK[MT7].2b5_1.heavy 517.328 / 630.358 16464.0 27.722700119018555 50 20 10 10 10 108.89895481613259 0.9182824588981797 0.0 3 0.9999569441143478 188.08083663891085 16464.0 13.357051330596912 1.0 - - - - - - - 1277.0 32 8 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 25 4 C20140605_SFK031_02 C20140605_SFK031_02 TB561640.[MT7]-LNQLK[MT7]PGLQYK[MT7].4b7_2.heavy 434.271 / 520.329 71096.0 29.36555051803589 39 13 10 6 10 1.4003057033363402 56.817512172567405 0.03259849548339844 3 0.922189684096432 4.395281303071105 71096.0 47.61837569439682 0.0 - - - - - - - 391.0 142 1 ILF3 interleukin enhancer binding factor 3, 90kDa 27 4 C20140605_SFK031_02 C20140605_SFK031_02 TB561640.[MT7]-LNQLK[MT7]PGLQYK[MT7].4b4_1.heavy 434.271 / 613.379 10092.0 29.36555051803589 39 13 10 6 10 1.4003057033363402 56.817512172567405 0.03259849548339844 3 0.922189684096432 4.395281303071105 10092.0 12.699869638985149 0.0 - - - - - - - 1199.857142857143 20 7 ILF3 interleukin enhancer binding factor 3, 90kDa 29 4 C20140605_SFK031_02 C20140605_SFK031_02 TB561640.[MT7]-LNQLK[MT7]PGLQYK[MT7].4b5_2.heavy 434.271 / 443.292 198380.0 29.36555051803589 39 13 10 6 10 1.4003057033363402 56.817512172567405 0.03259849548339844 3 0.922189684096432 4.395281303071105 198380.0 134.57335515207856 0.0 - - - - - - - 1367.0 396 7 ILF3 interleukin enhancer binding factor 3, 90kDa 31 4 C20140605_SFK031_02 C20140605_SFK031_02 TB561640.[MT7]-LNQLK[MT7]PGLQYK[MT7].4b3_1.heavy 434.271 / 500.295 36134.0 29.36555051803589 39 13 10 6 10 1.4003057033363402 56.817512172567405 0.03259849548339844 3 0.922189684096432 4.395281303071105 36134.0 22.938553837838313 0.0 - - - - - - - 1766.125 72 8 ILF3 interleukin enhancer binding factor 3, 90kDa 33 5 C20140605_SFK031_02 C20140605_SFK031_02 TB561509.[MT7]-EELNIIQGALELR.3y7_1.heavy 547.981 / 786.447 199892.0 46.07109832763672 46 16 10 10 10 4.003473747989236 24.978307913277934 0.0 3 0.9648075639547575 6.559273649247604 199892.0 405.2487206388088 0.0 - - - - - - - 674.7142857142857 399 7 CNNM1;CNNM2 cyclin M1;cyclin M2 35 5 C20140605_SFK031_02 C20140605_SFK031_02 TB561509.[MT7]-EELNIIQGALELR.3y6_1.heavy 547.981 / 658.388 190013.0 46.07109832763672 46 16 10 10 10 4.003473747989236 24.978307913277934 0.0 3 0.9648075639547575 6.559273649247604 190013.0 477.3242614180903 0.0 - - - - - - - 322.5 380 4 CNNM1;CNNM2 cyclin M1;cyclin M2 37 5 C20140605_SFK031_02 C20140605_SFK031_02 TB561509.[MT7]-EELNIIQGALELR.3b4_1.heavy 547.981 / 630.321 279608.0 46.07109832763672 46 16 10 10 10 4.003473747989236 24.978307913277934 0.0 3 0.9648075639547575 6.559273649247604 279608.0 432.9961735078059 0.0 - - - - - - - 365.5 559 4 CNNM1;CNNM2 cyclin M1;cyclin M2 39 5 C20140605_SFK031_02 C20140605_SFK031_02 TB561509.[MT7]-EELNIIQGALELR.3b5_1.heavy 547.981 / 743.406 191559.0 46.07109832763672 46 16 10 10 10 4.003473747989236 24.978307913277934 0.0 3 0.9648075639547575 6.559273649247604 191559.0 635.2301033591732 0.0 - - - - - - - 723.8571428571429 383 7 CNNM1;CNNM2 cyclin M1;cyclin M2 41 6 C20140605_SFK031_02 C20140605_SFK031_02 TB558018.[MT7]-LDVPEDLR.2y5_1.heavy 550.807 / 629.325 70157.0 32.77690029144287 37 11 10 6 10 1.1040824338908473 52.51413672251503 0.037998199462890625 3 0.8718643403320545 3.410177821403195 70157.0 66.63432850137025 0.0 - - - - - - - 1179.0 140 3 FMR1 fragile X mental retardation 1 43 6 C20140605_SFK031_02 C20140605_SFK031_02 TB558018.[MT7]-LDVPEDLR.2b6_1.heavy 550.807 / 813.411 99931.0 32.77690029144287 37 11 10 6 10 1.1040824338908473 52.51413672251503 0.037998199462890625 3 0.8718643403320545 3.410177821403195 99931.0 138.6289361637426 0.0 - - - - - - - 730.7142857142857 199 7 FMR1 fragile X mental retardation 1 45 6 C20140605_SFK031_02 C20140605_SFK031_02 TB558018.[MT7]-LDVPEDLR.2y6_1.heavy 550.807 / 728.394 46151.0 32.77690029144287 37 11 10 6 10 1.1040824338908473 52.51413672251503 0.037998199462890625 3 0.8718643403320545 3.410177821403195 46151.0 44.242862832314614 0.0 - - - - - - - 465.0 92 2 FMR1 fragile X mental retardation 1 47 6 C20140605_SFK031_02 C20140605_SFK031_02 TB558018.[MT7]-LDVPEDLR.2y7_1.heavy 550.807 / 843.421 48570.0 32.77690029144287 37 11 10 6 10 1.1040824338908473 52.51413672251503 0.037998199462890625 3 0.8718643403320545 3.410177821403195 48570.0 61.44427748707547 0.0 - - - - - - - 1289.7142857142858 97 7 FMR1 fragile X mental retardation 1 49 7 C20140605_SFK031_02 C20140605_SFK031_02 TB557059.[MT7]-FMATEVEPFK[MT7].3b6_1.heavy 496.267 / 823.414 10907.0 37.376399993896484 50 20 10 10 10 11.073410619902269 9.030641365386536 0.0 3 0.9987266245963987 34.58103963095618 10907.0 64.43099127589967 0.0 - - - - - - - 162.1818181818182 21 11 CNNM1 cyclin M1 51 7 C20140605_SFK031_02 C20140605_SFK031_02 TB557059.[MT7]-FMATEVEPFK[MT7].3y3_1.heavy 496.267 / 535.336 77395.0 37.376399993896484 50 20 10 10 10 11.073410619902269 9.030641365386536 0.0 3 0.9987266245963987 34.58103963095618 77395.0 92.38685184613834 0.0 - - - - - - - 262.25 154 4 CNNM1 cyclin M1 53 7 C20140605_SFK031_02 C20140605_SFK031_02 TB557059.[MT7]-FMATEVEPFK[MT7].3b4_1.heavy 496.267 / 595.303 17723.0 37.376399993896484 50 20 10 10 10 11.073410619902269 9.030641365386536 0.0 3 0.9987266245963987 34.58103963095618 17723.0 44.67544478281776 0.0 - - - - - - - 667.1818181818181 35 11 CNNM1 cyclin M1 55 7 C20140605_SFK031_02 C20140605_SFK031_02 TB557059.[MT7]-FMATEVEPFK[MT7].3b5_1.heavy 496.267 / 724.346 47926.0 37.376399993896484 50 20 10 10 10 11.073410619902269 9.030641365386536 0.0 3 0.9987266245963987 34.58103963095618 47926.0 163.50062308521623 0.0 - - - - - - - 268.22222222222223 95 9 CNNM1 cyclin M1 57 8 C20140605_SFK031_02 C20140605_SFK031_02 TB295061.[MT7]-DAMWVPC[CAM]LVSIPGLNVTLR.3b4_1.heavy 762.414 / 648.293 9815.0 52.36280059814453 50 20 10 10 10 8.723133190881525 11.463770850653995 0.0 3 0.9953070567689319 18.008176135823625 9815.0 50.11806228235199 0.0 - - - - - - - 272.0 19 14 FLT4 fms-related tyrosine kinase 4 59 8 C20140605_SFK031_02 C20140605_SFK031_02 TB295061.[MT7]-DAMWVPC[CAM]LVSIPGLNVTLR.3b5_1.heavy 762.414 / 747.362 15239.0 52.36280059814453 50 20 10 10 10 8.723133190881525 11.463770850653995 0.0 3 0.9953070567689319 18.008176135823625 15239.0 37.72264395685415 0.0 - - - - - - - 258.27272727272725 30 11 FLT4 fms-related tyrosine kinase 4 61 8 C20140605_SFK031_02 C20140605_SFK031_02 TB295061.[MT7]-DAMWVPC[CAM]LVSIPGLNVTLR.3y8_1.heavy 762.414 / 869.52 18855.0 52.36280059814453 50 20 10 10 10 8.723133190881525 11.463770850653995 0.0 3 0.9953070567689319 18.008176135823625 18855.0 324.80479764915935 0.0 - - - - - - - 180.8 37 10 FLT4 fms-related tyrosine kinase 4 63 8 C20140605_SFK031_02 C20140605_SFK031_02 TB295061.[MT7]-DAMWVPC[CAM]LVSIPGLNVTLR.3y10_1.heavy 762.414 / 1069.64 4520.0 52.36280059814453 50 20 10 10 10 8.723133190881525 11.463770850653995 0.0 3 0.9953070567689319 18.008176135823625 4520.0 16.85676893401754 0.0 - - - - - - - 298.5625 9 16 FLT4 fms-related tyrosine kinase 4 65 9 C20140605_SFK031_02 C20140605_SFK031_02 TB561091.[MT7]-EDITQSAQHALR.3y7_1.heavy 504.934 / 782.427 25281.0 25.286300659179688 47 17 10 10 10 2.0303970482237466 39.154188595119706 0.0 3 0.9707107067254627 7.193531839717131 25281.0 71.16831359297707 0.0 - - - - - - - 702.7142857142857 50 7 ILF3 interleukin enhancer binding factor 3, 90kDa 67 9 C20140605_SFK031_02 C20140605_SFK031_02 TB561091.[MT7]-EDITQSAQHALR.3y6_1.heavy 504.934 / 695.395 24240.0 25.286300659179688 47 17 10 10 10 2.0303970482237466 39.154188595119706 0.0 3 0.9707107067254627 7.193531839717131 24240.0 55.2779288323589 0.0 - - - - - - - 642.4 48 10 ILF3 interleukin enhancer binding factor 3, 90kDa 69 9 C20140605_SFK031_02 C20140605_SFK031_02 TB561091.[MT7]-EDITQSAQHALR.3b3_1.heavy 504.934 / 502.263 48364.0 25.286300659179688 47 17 10 10 10 2.0303970482237466 39.154188595119706 0.0 3 0.9707107067254627 7.193531839717131 48364.0 41.09614544422669 0.0 - - - - - - - 1251.125 96 8 ILF3 interleukin enhancer binding factor 3, 90kDa 71 9 C20140605_SFK031_02 C20140605_SFK031_02 TB561091.[MT7]-EDITQSAQHALR.3y5_1.heavy 504.934 / 624.358 38645.0 25.286300659179688 47 17 10 10 10 2.0303970482237466 39.154188595119706 0.0 3 0.9707107067254627 7.193531839717131 38645.0 78.60134733219755 0.0 - - - - - - - 1239.7142857142858 77 7 ILF3 interleukin enhancer binding factor 3, 90kDa 73 10 C20140605_SFK031_02 C20140605_SFK031_02 TB399822.[MT7]-QLPQEIIFLVWSPK[MT7].3b6_1.heavy 662.727 / 853.49 30217.0 52.16925048828125 41 16 10 5 10 2.9070247273944516 34.39943219527733 0.04070281982421875 3 0.9653069343927826 6.606590429624467 30217.0 220.16390266414336 0.0 - - - - - - - 189.375 60 8 ANAPC4 anaphase promoting complex subunit 4 75 10 C20140605_SFK031_02 C20140605_SFK031_02 TB399822.[MT7]-QLPQEIIFLVWSPK[MT7].3b4_1.heavy 662.727 / 611.363 6689.0 52.16925048828125 41 16 10 5 10 2.9070247273944516 34.39943219527733 0.04070281982421875 3 0.9653069343927826 6.606590429624467 6689.0 29.780041835357622 0.0 - - - - - - - 189.53846153846155 13 13 ANAPC4 anaphase promoting complex subunit 4 77 10 C20140605_SFK031_02 C20140605_SFK031_02 TB399822.[MT7]-QLPQEIIFLVWSPK[MT7].3b5_1.heavy 662.727 / 740.406 32494.0 52.16925048828125 41 16 10 5 10 2.9070247273944516 34.39943219527733 0.04070281982421875 3 0.9653069343927826 6.606590429624467 32494.0 85.21833346676512 0.0 - - - - - - - 205.55555555555554 64 9 ANAPC4 anaphase promoting complex subunit 4 79 10 C20140605_SFK031_02 C20140605_SFK031_02 TB399822.[MT7]-QLPQEIIFLVWSPK[MT7].3b7_1.heavy 662.727 / 966.574 27560.0 52.16925048828125 41 16 10 5 10 2.9070247273944516 34.39943219527733 0.04070281982421875 3 0.9653069343927826 6.606590429624467 27560.0 107.39113043992782 0.0 - - - - - - - 189.75 55 4 ANAPC4 anaphase promoting complex subunit 4 81 11 C20140605_SFK031_02 C20140605_SFK031_02 TB561503.[MT7]-DVLLLGNDYIVPR.3y6_1.heavy 544.314 / 762.414 46014.0 43.10649871826172 50 20 10 10 10 8.185740388554246 12.216365930664686 0.0 3 0.9967543592685446 21.656816347266194 46014.0 73.02909304269087 0.0 - - - - - - - 315.42857142857144 92 7 HNF4A hepatocyte nuclear factor 4, alpha 83 11 C20140605_SFK031_02 C20140605_SFK031_02 TB561503.[MT7]-DVLLLGNDYIVPR.3b4_1.heavy 544.314 / 585.373 263292.0 43.10649871826172 50 20 10 10 10 8.185740388554246 12.216365930664686 0.0 3 0.9967543592685446 21.656816347266194 263292.0 48.05342544539195 1.0 - - - - - - - 322.0 547 4 HNF4A hepatocyte nuclear factor 4, alpha 85 11 C20140605_SFK031_02 C20140605_SFK031_02 TB561503.[MT7]-DVLLLGNDYIVPR.3b3_1.heavy 544.314 / 472.289 395813.0 43.10649871826172 50 20 10 10 10 8.185740388554246 12.216365930664686 0.0 3 0.9967543592685446 21.656816347266194 395813.0 149.95076701094774 0.0 - - - - - - - 674.6666666666666 791 3 HNF4A hepatocyte nuclear factor 4, alpha 87 11 C20140605_SFK031_02 C20140605_SFK031_02 TB561503.[MT7]-DVLLLGNDYIVPR.3y5_1.heavy 544.314 / 647.388 147521.0 43.10649871826172 50 20 10 10 10 8.185740388554246 12.216365930664686 0.0 3 0.9967543592685446 21.656816347266194 147521.0 103.86819774025449 0.0 - - - - - - - 276.0 295 3 HNF4A hepatocyte nuclear factor 4, alpha 89 12 C20140605_SFK031_02 C20140605_SFK031_02 TB555863.[MT7]-HPNVIALQK[MT7].3y3_1.heavy 436.606 / 532.357 159650.0 25.58679962158203 47 17 10 10 10 11.494262304221103 8.699992861940904 0.0 3 0.9790896640611766 8.519658293884477 159650.0 71.25209129366813 0.0 - - - - - - - 1468.0 319 2 CDK19 cyclin-dependent kinase 19 91 12 C20140605_SFK031_02 C20140605_SFK031_02 TB555863.[MT7]-HPNVIALQK[MT7].3b4_1.heavy 436.606 / 592.332 269978.0 25.58679962158203 47 17 10 10 10 11.494262304221103 8.699992861940904 0.0 3 0.9790896640611766 8.519658293884477 269978.0 348.7088106515274 0.0 - - - - - - - 1252.6666666666667 539 9 CDK19 cyclin-dependent kinase 19 93 12 C20140605_SFK031_02 C20140605_SFK031_02 TB555863.[MT7]-HPNVIALQK[MT7].3b3_1.heavy 436.606 / 493.264 128060.0 25.58679962158203 47 17 10 10 10 11.494262304221103 8.699992861940904 0.0 3 0.9790896640611766 8.519658293884477 128060.0 124.97472739433472 0.0 - - - - - - - 1225.75 256 8 CDK19 cyclin-dependent kinase 19 95 12 C20140605_SFK031_02 C20140605_SFK031_02 TB555863.[MT7]-HPNVIALQK[MT7].3y4_1.heavy 436.606 / 603.395 257178.0 25.58679962158203 47 17 10 10 10 11.494262304221103 8.699992861940904 0.0 3 0.9790896640611766 8.519658293884477 257178.0 139.5129423396053 0.0 - - - - - - - 470.0 514 1 CDK19 cyclin-dependent kinase 19 97 13 C20140605_SFK031_02 C20140605_SFK031_02 TB561902.[MT7]-ERVEDLFEYEGC[CAM]K[MT7].4b8_2.heavy 491.243 / 581.797 322363.0 34.328399658203125 35 5 10 10 10 0.37679919385890387 115.88507089612062 0.0 3 0.6980193618135931 2.1866676062000083 322363.0 330.3853314969605 0.0 - - - - - - - 800.5 644 10 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 99 13 C20140605_SFK031_02 C20140605_SFK031_02 TB561902.[MT7]-ERVEDLFEYEGC[CAM]K[MT7].4b5_1.heavy 491.243 / 773.391 67017.0 34.328399658203125 35 5 10 10 10 0.37679919385890387 115.88507089612062 0.0 3 0.6980193618135931 2.1866676062000083 67017.0 119.5485546875 0.0 - - - - - - - 250.71428571428572 134 7 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 101 13 C20140605_SFK031_02 C20140605_SFK031_02 TB561902.[MT7]-ERVEDLFEYEGC[CAM]K[MT7].4y3_1.heavy 491.243 / 508.267 353843.0 34.328399658203125 35 5 10 10 10 0.37679919385890387 115.88507089612062 0.0 3 0.6980193618135931 2.1866676062000083 353843.0 427.10866122285023 0.0 - - - - - - - 877.25 707 8 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 103 13 C20140605_SFK031_02 C20140605_SFK031_02 TB561902.[MT7]-ERVEDLFEYEGC[CAM]K[MT7].4b6_1.heavy 491.243 / 886.475 43764.0 34.328399658203125 35 5 10 10 10 0.37679919385890387 115.88507089612062 0.0 3 0.6980193618135931 2.1866676062000083 43764.0 452.2473603185136 0.0 - - - - - - - 205.625 87 8 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 105 14 C20140605_SFK031_02 C20140605_SFK031_02 TB557880.[MT7]-EVTAAQVAR.2y8_1.heavy 544.813 / 815.473 38485.0 20.768549919128418 32 18 2 6 6 12.915547297596893 7.742606464582908 0.030500411987304688 5 0.985264604730104 10.154223925206855 38485.0 150.76012065074212 2.0 - - - - - - - 243.9047619047619 198 21 CNOT1 CCR4-NOT transcription complex, subunit 1 107 14 C20140605_SFK031_02 C20140605_SFK031_02 TB557880.[MT7]-EVTAAQVAR.2y6_1.heavy 544.813 / 615.357 16382.0 20.768549919128418 32 18 2 6 6 12.915547297596893 7.742606464582908 0.030500411987304688 5 0.985264604730104 10.154223925206855 16382.0 41.93555314757482 0.0 - - - - - - - 709.9230769230769 32 13 CNOT1 CCR4-NOT transcription complex, subunit 1 109 14 C20140605_SFK031_02 C20140605_SFK031_02 TB557880.[MT7]-EVTAAQVAR.2b5_1.heavy 544.813 / 616.342 9414.0 20.768549919128418 32 18 2 6 6 12.915547297596893 7.742606464582908 0.030500411987304688 5 0.985264604730104 10.154223925206855 9414.0 28.887725631768955 0.0 - - - - - - - 692.2727272727273 18 11 CNOT1 CCR4-NOT transcription complex, subunit 1 111 14 C20140605_SFK031_02 C20140605_SFK031_02 TB557880.[MT7]-EVTAAQVAR.2y7_1.heavy 544.813 / 716.405 36224.0 20.768549919128418 32 18 2 6 6 12.915547297596893 7.742606464582908 0.030500411987304688 5 0.985264604730104 10.154223925206855 36224.0 128.45480555310968 0.0 - - - - - - - 245.0625 72 16 CNOT1 CCR4-NOT transcription complex, subunit 1 113 15 C20140605_SFK031_02 C20140605_SFK031_02 TB558200.[MT7]-DQVFVLK[MT7].2y4_1.heavy 568.849 / 650.436 101551.0 33.76449966430664 50 20 10 10 10 8.580687090915143 11.654078390281313 0.0 3 0.9940121605647336 15.940808746108326 101551.0 80.48251458814117 0.0 - - - - - - - 746.0 203 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 115 15 C20140605_SFK031_02 C20140605_SFK031_02 TB558200.[MT7]-DQVFVLK[MT7].2y5_1.heavy 568.849 / 749.504 24722.0 33.76449966430664 50 20 10 10 10 8.580687090915143 11.654078390281313 0.0 3 0.9940121605647336 15.940808746108326 24722.0 37.541107268785616 0.0 - - - - - - - 298.4 49 5 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 117 15 C20140605_SFK031_02 C20140605_SFK031_02 TB558200.[MT7]-DQVFVLK[MT7].2b4_1.heavy 568.849 / 634.332 49337.0 33.76449966430664 50 20 10 10 10 8.580687090915143 11.654078390281313 0.0 3 0.9940121605647336 15.940808746108326 49337.0 28.475241673367677 0.0 - - - - - - - 1781.0 98 7 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 119 15 C20140605_SFK031_02 C20140605_SFK031_02 TB558200.[MT7]-DQVFVLK[MT7].2y3_1.heavy 568.849 / 503.367 48165.0 33.76449966430664 50 20 10 10 10 8.580687090915143 11.654078390281313 0.0 3 0.9940121605647336 15.940808746108326 48165.0 34.92997609605519 0.0 - - - - - - - 426.0 96 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 121 16 C20140605_SFK031_02 C20140605_SFK031_02 TB559497.[MT7]-NLSWLEEK[MT7].3y3_1.heavy 436.246 / 549.3 120815.0 36.291099548339844 50 20 10 10 10 47.66992604937302 2.0977586559800265 0.0 3 0.9997848672401427 84.13976780887992 120815.0 1087.397891723061 0.0 - - - - - - - 209.85714285714286 241 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 123 16 C20140605_SFK031_02 C20140605_SFK031_02 TB559497.[MT7]-NLSWLEEK[MT7].3b4_1.heavy 436.246 / 645.348 37748.0 36.291099548339844 50 20 10 10 10 47.66992604937302 2.0977586559800265 0.0 3 0.9997848672401427 84.13976780887992 37748.0 84.34840707964602 0.0 - - - - - - - 282.5 75 10 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 125 16 C20140605_SFK031_02 C20140605_SFK031_02 TB559497.[MT7]-NLSWLEEK[MT7].3y4_1.heavy 436.246 / 662.384 22038.0 36.291099548339844 50 20 10 10 10 47.66992604937302 2.0977586559800265 0.0 3 0.9997848672401427 84.13976780887992 22038.0 230.61889380530974 0.0 - - - - - - - 251.11111111111111 44 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 127 16 C20140605_SFK031_02 C20140605_SFK031_02 TB559497.[MT7]-NLSWLEEK[MT7].3b3_1.heavy 436.246 / 459.268 107479.0 36.291099548339844 50 20 10 10 10 47.66992604937302 2.0977586559800265 0.0 3 0.9997848672401427 84.13976780887992 107479.0 91.09009870660313 0.0 - - - - - - - 263.6666666666667 214 3 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 129 17 C20140605_SFK031_02 C20140605_SFK031_02 TB561900.[MT7]-VADNLAIQLAAVTEDK[MT7].3b6_1.heavy 653.705 / 728.406 50236.0 43.58039855957031 43 13 10 10 10 1.6852214985889113 46.35121788916887 0.0 3 0.911886584125628 4.126668827539187 50236.0 62.12962350937646 0.0 - - - - - - - 328.5 100 8 ILF3 interleukin enhancer binding factor 3, 90kDa 131 17 C20140605_SFK031_02 C20140605_SFK031_02 TB561900.[MT7]-VADNLAIQLAAVTEDK[MT7].3b4_1.heavy 653.705 / 544.285 11925.0 43.58039855957031 43 13 10 10 10 1.6852214985889113 46.35121788916887 0.0 3 0.911886584125628 4.126668827539187 11925.0 13.026436691578233 0.0 - - - - - - - 774.5 23 8 ILF3 interleukin enhancer binding factor 3, 90kDa 133 17 C20140605_SFK031_02 C20140605_SFK031_02 TB561900.[MT7]-VADNLAIQLAAVTEDK[MT7].3b5_1.heavy 653.705 / 657.369 23099.0 43.58039855957031 43 13 10 10 10 1.6852214985889113 46.35121788916887 0.0 3 0.911886584125628 4.126668827539187 23099.0 27.28882172887841 0.0 - - - - - - - 352.25 46 8 ILF3 interleukin enhancer binding factor 3, 90kDa 135 17 C20140605_SFK031_02 C20140605_SFK031_02 TB561900.[MT7]-VADNLAIQLAAVTEDK[MT7].3y4_1.heavy 653.705 / 636.332 32395.0 43.58039855957031 43 13 10 10 10 1.6852214985889113 46.35121788916887 0.0 3 0.911886584125628 4.126668827539187 32395.0 20.08574642772559 0.0 - - - - - - - 1180.5714285714287 64 7 ILF3 interleukin enhancer binding factor 3, 90kDa 137 18 C20140605_SFK031_02 C20140605_SFK031_02 TB399601.[MT7]-EAAGAAGSGK[MT7].2y8_1.heavy 553.806 / 762.423 2093.0 14.24120044708252 46 20 6 10 10 5.869680736263321 17.036701737829215 0.0 3 0.9926621362719035 14.398313471717483 2093.0 42.696890040725656 0.0 - - - - - - - 119.375 4 8 FOXA2 forkhead box A2 139 18 C20140605_SFK031_02 C20140605_SFK031_02 TB399601.[MT7]-EAAGAAGSGK[MT7].2b4_1.heavy 553.806 / 473.248 N/A 14.24120044708252 46 20 6 10 10 5.869680736263321 17.036701737829215 0.0 3 0.9926621362719035 14.398313471717483 1689.0 2.9376331470560992 5.0 - - - - - - - 667.8125 6 16 FOXA2 forkhead box A2 141 18 C20140605_SFK031_02 C20140605_SFK031_02 TB399601.[MT7]-EAAGAAGSGK[MT7].2y9_1.heavy 553.806 / 833.46 2240.0 14.24120044708252 46 20 6 10 10 5.869680736263321 17.036701737829215 0.0 3 0.9926621362719035 14.398313471717483 2240.0 36.99504290816054 0.0 - - - - - - - 125.3529411764706 4 17 FOXA2 forkhead box A2 143 18 C20140605_SFK031_02 C20140605_SFK031_02 TB399601.[MT7]-EAAGAAGSGK[MT7].2y7_1.heavy 553.806 / 691.385 2350.0 14.24120044708252 46 20 6 10 10 5.869680736263321 17.036701737829215 0.0 3 0.9926621362719035 14.398313471717483 2350.0 35.36716056285528 0.0 - - - - - - - 118.88235294117646 4 17 FOXA2 forkhead box A2 145 19 C20140605_SFK031_02 C20140605_SFK031_02 TB294960.[MT7]-QIEGTGISMSAC[CAM]R.2b3_1.heavy 777.38 / 515.295 8837.0 27.907899856567383 47 17 10 10 10 3.350715476208727 23.57905720809604 0.0 3 0.9786154788071495 8.424334845061265 8837.0 17.381423316337234 0.0 - - - - - - - 291.4375 17 16 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 147 19 C20140605_SFK031_02 C20140605_SFK031_02 TB294960.[MT7]-QIEGTGISMSAC[CAM]R.2y6_1.heavy 777.38 / 711.291 4600.0 27.907899856567383 47 17 10 10 10 3.350715476208727 23.57905720809604 0.0 3 0.9786154788071495 8.424334845061265 4600.0 31.617776163230708 0.0 - - - - - - - 192.35294117647058 9 17 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 149 19 C20140605_SFK031_02 C20140605_SFK031_02 TB294960.[MT7]-QIEGTGISMSAC[CAM]R.2y10_1.heavy 777.38 / 1039.47 17129.0 27.907899856567383 47 17 10 10 10 3.350715476208727 23.57905720809604 0.0 3 0.9786154788071495 8.424334845061265 17129.0 133.0682644628099 0.0 - - - - - - - 228.77777777777777 34 18 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 151 19 C20140605_SFK031_02 C20140605_SFK031_02 TB294960.[MT7]-QIEGTGISMSAC[CAM]R.2y11_1.heavy 777.38 / 1168.51 8777.0 27.907899856567383 47 17 10 10 10 3.350715476208727 23.57905720809604 0.0 3 0.9786154788071495 8.424334845061265 8777.0 36.57737720827963 0.0 - - - - - - - 181.72222222222223 17 18 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 153 20 C20140605_SFK031_02 C20140605_SFK031_02 TB294961.[MT7]-ENADLEWTAVK[MT7].2y5_1.heavy 782.417 / 748.447 7860.0 33.465301513671875 47 17 10 10 10 1.5438130897188422 40.864922383863814 0.0 3 0.972311420591695 7.399541725412564 7860.0 17.313532245862255 0.0 - - - - - - - 724.875 15 8 IRAK1 interleukin-1 receptor-associated kinase 1 155 20 C20140605_SFK031_02 C20140605_SFK031_02 TB294961.[MT7]-ENADLEWTAVK[MT7].2b4_1.heavy 782.417 / 574.259 16016.0 33.465301513671875 47 17 10 10 10 1.5438130897188422 40.864922383863814 0.0 3 0.972311420591695 7.399541725412564 16016.0 57.158062707551636 0.0 - - - - - - - 716.0 32 7 IRAK1 interleukin-1 receptor-associated kinase 1 157 20 C20140605_SFK031_02 C20140605_SFK031_02 TB294961.[MT7]-ENADLEWTAVK[MT7].2b6_1.heavy 782.417 / 816.386 6780.0 33.465301513671875 47 17 10 10 10 1.5438130897188422 40.864922383863814 0.0 3 0.972311420591695 7.399541725412564 6780.0 29.626205201190317 0.0 - - - - - - - 302.9166666666667 13 12 IRAK1 interleukin-1 receptor-associated kinase 1 159 20 C20140605_SFK031_02 C20140605_SFK031_02 TB294961.[MT7]-ENADLEWTAVK[MT7].2b5_1.heavy 782.417 / 687.343 4028.0 33.465301513671875 47 17 10 10 10 1.5438130897188422 40.864922383863814 0.0 3 0.972311420591695 7.399541725412564 4028.0 8.354401767862779 0.0 - - - - - - - 347.61538461538464 8 13 IRAK1 interleukin-1 receptor-associated kinase 1 161 21 C20140605_SFK031_02 C20140605_SFK031_02 TB555769.[MT7]-LALC[CAM]AR.2b3_1.heavy 424.251 / 442.315 88117.0 26.679899215698242 50 20 10 10 10 8.481260982023452 11.790699544791286 0.0 3 0.9971036827439693 22.926324068246778 88117.0 93.02703453712823 0.0 - - - - - - - 1272.375 176 8 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 163 21 C20140605_SFK031_02 C20140605_SFK031_02 TB555769.[MT7]-LALC[CAM]AR.2y4_1.heavy 424.251 / 519.271 109981.0 26.679899215698242 50 20 10 10 10 8.481260982023452 11.790699544791286 0.0 3 0.9971036827439693 22.926324068246778 109981.0 162.65947257297518 0.0 - - - - - - - 803.0 219 3 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 165 21 C20140605_SFK031_02 C20140605_SFK031_02 TB555769.[MT7]-LALC[CAM]AR.2y5_1.heavy 424.251 / 590.308 614265.0 26.679899215698242 50 20 10 10 10 8.481260982023452 11.790699544791286 0.0 3 0.9971036827439693 22.926324068246778 614265.0 175.57777237352732 0.0 - - - - - - - 1626.0 1228 2 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 167 21 C20140605_SFK031_02 C20140605_SFK031_02 TB555769.[MT7]-LALC[CAM]AR.2b4_1.heavy 424.251 / 602.345 58183.0 26.679899215698242 50 20 10 10 10 8.481260982023452 11.790699544791286 0.0 3 0.9971036827439693 22.926324068246778 58183.0 89.03375199604537 0.0 - - - - - - - 807.3 116 10 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 169 22 C20140605_SFK031_02 C20140605_SFK031_02 TB557167.[MT7]-IQTLLVGN.2b3_1.heavy 501.309 / 487.3 174241.0 38.6869010925293 41 11 10 10 10 0.8297616515061512 73.72110861240625 0.0 3 0.8657541075279866 3.329884276064209 174241.0 113.59268736337941 0.0 - - - - - - - 1237.2 348 5 ETV3 ets variant 3 171 22 C20140605_SFK031_02 C20140605_SFK031_02 TB557167.[MT7]-IQTLLVGN.2y5_1.heavy 501.309 / 515.319 4312.0 38.6869010925293 41 11 10 10 10 0.8297616515061512 73.72110861240625 0.0 3 0.8657541075279866 3.329884276064209 4312.0 3.217181265597967 3.0 - - - - - - - 1166.3333333333333 9 9 ETV3 ets variant 3 173 22 C20140605_SFK031_02 C20140605_SFK031_02 TB557167.[MT7]-IQTLLVGN.2b4_1.heavy 501.309 / 600.384 430495.0 38.6869010925293 41 11 10 10 10 0.8297616515061512 73.72110861240625 0.0 3 0.8657541075279866 3.329884276064209 430495.0 378.2371069512195 0.0 - - - - - - - 1231.7142857142858 860 7 ETV3 ets variant 3 175 22 C20140605_SFK031_02 C20140605_SFK031_02 TB557167.[MT7]-IQTLLVGN.2b5_1.heavy 501.309 / 713.468 595611.0 38.6869010925293 41 11 10 10 10 0.8297616515061512 73.72110861240625 0.0 3 0.8657541075279866 3.329884276064209 595611.0 1154.6016082317074 0.0 - - - - - - - 318.8 1191 10 ETV3 ets variant 3 177 23 C20140605_SFK031_02 C20140605_SFK031_02 TB294968.[MT7]-VLQDMGLPTGAEGR.2y9_1.heavy 794.418 / 857.448 9525.0 35.90700149536133 47 17 10 10 10 2.65225886480109 30.187700746400665 0.0 3 0.9740641670881446 7.646613258239319 9525.0 20.059973860643307 0.0 - - - - - - - 309.3636363636364 19 11 ILF3 interleukin enhancer binding factor 3, 90kDa 179 23 C20140605_SFK031_02 C20140605_SFK031_02 TB294968.[MT7]-VLQDMGLPTGAEGR.2b4_1.heavy 794.418 / 600.347 23246.0 35.90700149536133 47 17 10 10 10 2.65225886480109 30.187700746400665 0.0 3 0.9740641670881446 7.646613258239319 23246.0 36.007657482891375 0.0 - - - - - - - 283.5 46 8 ILF3 interleukin enhancer binding factor 3, 90kDa 181 23 C20140605_SFK031_02 C20140605_SFK031_02 TB294968.[MT7]-VLQDMGLPTGAEGR.2y10_1.heavy 794.418 / 988.488 18710.0 35.90700149536133 47 17 10 10 10 2.65225886480109 30.187700746400665 0.0 3 0.9740641670881446 7.646613258239319 18710.0 37.62567209160928 0.0 - - - - - - - 272.1 37 10 ILF3 interleukin enhancer binding factor 3, 90kDa 183 23 C20140605_SFK031_02 C20140605_SFK031_02 TB294968.[MT7]-VLQDMGLPTGAEGR.2y7_1.heavy 794.418 / 687.342 16556.0 35.90700149536133 47 17 10 10 10 2.65225886480109 30.187700746400665 0.0 3 0.9740641670881446 7.646613258239319 16556.0 13.591537544461195 1.0 - - - - - - - 368.75 50 8 ILF3 interleukin enhancer binding factor 3, 90kDa 185 24 C20140605_SFK031_02 C20140605_SFK031_02 TB294969.[MT7]-IEIPEVLLWAK[MT7].2b3_1.heavy 799.992 / 500.32 19419.0 50.00550079345703 42 12 10 10 10 1.4042277111308301 60.655868595983605 0.0 3 0.8885222603456179 3.6614127823036133 19419.0 72.45009174311926 0.0 - - - - - - - 654.5555555555555 38 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 187 24 C20140605_SFK031_02 C20140605_SFK031_02 TB294969.[MT7]-IEIPEVLLWAK[MT7].2y8_1.heavy 799.992 / 1099.66 32219.0 50.00550079345703 42 12 10 10 10 1.4042277111308301 60.655868595983605 0.0 3 0.8885222603456179 3.6614127823036133 32219.0 103.46373673577281 0.0 - - - - - - - 644.1428571428571 64 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 189 24 C20140605_SFK031_02 C20140605_SFK031_02 TB294969.[MT7]-IEIPEVLLWAK[MT7].2y5_1.heavy 799.992 / 774.499 2618.0 50.00550079345703 42 12 10 10 10 1.4042277111308301 60.655868595983605 0.0 3 0.8885222603456179 3.6614127823036133 2618.0 8.993847211935245 0.0 - - - - - - - 627.25 5 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 191 24 C20140605_SFK031_02 C20140605_SFK031_02 TB294969.[MT7]-IEIPEVLLWAK[MT7].2y3_1.heavy 799.992 / 548.331 6909.0 50.00550079345703 42 12 10 10 10 1.4042277111308301 60.655868595983605 0.0 3 0.8885222603456179 3.6614127823036133 6909.0 20.670202583675866 0.0 - - - - - - - 601.6363636363636 13 11 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 193 25 C20140605_SFK031_02 C20140605_SFK031_02 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 3754380.0 29.98430061340332 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 3754380.0 5692.557408120329 0.0 - - - - - - - 806.2 7508 5 195 25 C20140605_SFK031_02 C20140605_SFK031_02 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 1249170.0 29.98430061340332 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1249170.0 1894.0554470195007 0.0 - - - - - - - 1214.75 2498 8 197 25 C20140605_SFK031_02 C20140605_SFK031_02 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 1102750.0 29.98430061340332 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1102750.0 323.87477115384513 0.0 - - - - - - - 2738.5714285714284 2205 7 199 26 C20140605_SFK031_02 C20140605_SFK031_02 TB557165.[MT7]-IFSVMGFPADK[MT7].3b6_1.heavy 500.611 / 779.424 13701.0 43.006248474121094 41 20 10 1 10 25.918106086634104 3.858306608736729 0.12030029296875 3 0.9987300324713522 34.62741636568804 13701.0 14.073743915654372 1.0 - - - - - - - 213.16666666666666 27 6 CDK19 cyclin-dependent kinase 19 201 26 C20140605_SFK031_02 C20140605_SFK031_02 TB557165.[MT7]-IFSVMGFPADK[MT7].3b4_1.heavy 500.611 / 591.362 13335.0 43.006248474121094 41 20 10 1 10 25.918106086634104 3.858306608736729 0.12030029296875 3 0.9987300324713522 34.62741636568804 13335.0 23.335154485511495 1.0 - - - - - - - 353.875 26 8 CDK19 cyclin-dependent kinase 19 203 26 C20140605_SFK031_02 C20140605_SFK031_02 TB557165.[MT7]-IFSVMGFPADK[MT7].3b5_1.heavy 500.611 / 722.403 5480.0 43.006248474121094 41 20 10 1 10 25.918106086634104 3.858306608736729 0.12030029296875 3 0.9987300324713522 34.62741636568804 5480.0 1.9833480254601832 1.0 - - - - - - - 171.125 10 8 CDK19 cyclin-dependent kinase 19 205 26 C20140605_SFK031_02 C20140605_SFK031_02 TB557165.[MT7]-IFSVMGFPADK[MT7].3y4_1.heavy 500.611 / 574.332 42015.0 43.006248474121094 41 20 10 1 10 25.918106086634104 3.858306608736729 0.12030029296875 3 0.9987300324713522 34.62741636568804 42015.0 82.45786893266897 0.0 - - - - - - - 121.66666666666667 84 3 CDK19 cyclin-dependent kinase 19 207 27 C20140605_SFK031_02 C20140605_SFK031_02 TB555865.[MT7]-SLLEIR.2y4_1.heavy 437.778 / 530.33 143531.0 33.549800872802734 44 14 10 10 10 2.684988176431732 37.244111865288346 0.0 3 0.9314788595088662 4.6874695672330375 143531.0 137.41536607744152 0.0 - - - - - - - 712.5 287 2 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 209 27 C20140605_SFK031_02 C20140605_SFK031_02 TB555865.[MT7]-SLLEIR.2b3_1.heavy 437.778 / 458.31 289913.0 33.549800872802734 44 14 10 10 10 2.684988176431732 37.244111865288346 0.0 3 0.9314788595088662 4.6874695672330375 289913.0 314.89218723590375 0.0 - - - - - - - 560.0 579 2 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 211 27 C20140605_SFK031_02 C20140605_SFK031_02 TB555865.[MT7]-SLLEIR.2y5_1.heavy 437.778 / 643.414 298769.0 33.549800872802734 44 14 10 10 10 2.684988176431732 37.244111865288346 0.0 3 0.9314788595088662 4.6874695672330375 298769.0 244.73002577411944 0.0 - - - - - - - 237.33333333333334 597 6 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 213 27 C20140605_SFK031_02 C20140605_SFK031_02 TB555865.[MT7]-SLLEIR.2b4_1.heavy 437.778 / 587.352 851993.0 33.549800872802734 44 14 10 10 10 2.684988176431732 37.244111865288346 0.0 3 0.9314788595088662 4.6874695672330375 851993.0 959.8015379647974 0.0 - - - - - - - 839.5 1703 4 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 215 28 C20140605_SFK031_02 C20140605_SFK031_02 TB559809.[MT7]-LLAFALADTK[MT7].3y3_1.heavy 450.946 / 507.289 123799.0 43.7056999206543 44 14 10 10 10 2.2184608253157805 30.20092583762092 0.0 3 0.9365506911386594 4.873325572406803 123799.0 661.2693478545964 0.0 - - - - - - - 280.1111111111111 247 9 ANAPC4 anaphase promoting complex subunit 4 217 28 C20140605_SFK031_02 C20140605_SFK031_02 TB559809.[MT7]-LLAFALADTK[MT7].3b4_1.heavy 450.946 / 589.383 111092.0 43.7056999206543 44 14 10 10 10 2.2184608253157805 30.20092583762092 0.0 3 0.9365506911386594 4.873325572406803 111092.0 392.09768047269523 0.0 - - - - - - - 327.0 222 8 ANAPC4 anaphase promoting complex subunit 4 219 28 C20140605_SFK031_02 C20140605_SFK031_02 TB559809.[MT7]-LLAFALADTK[MT7].3b5_1.heavy 450.946 / 660.42 85118.0 43.7056999206543 44 14 10 10 10 2.2184608253157805 30.20092583762092 0.0 3 0.9365506911386594 4.873325572406803 85118.0 588.2261785714286 0.0 - - - - - - - 213.42857142857142 170 7 ANAPC4 anaphase promoting complex subunit 4 221 28 C20140605_SFK031_02 C20140605_SFK031_02 TB559809.[MT7]-LLAFALADTK[MT7].3y4_1.heavy 450.946 / 578.327 113334.0 43.7056999206543 44 14 10 10 10 2.2184608253157805 30.20092583762092 0.0 3 0.9365506911386594 4.873325572406803 113334.0 398.9122161023257 0.0 - - - - - - - 263.1818181818182 226 11 ANAPC4 anaphase promoting complex subunit 4 223 29 C20140605_SFK031_02 C20140605_SFK031_02 TB295075.[MT7]-VWLLFDYAEHDLWHIIK[MT7].3b6_1.heavy 829.454 / 918.521 963.0 54.70212650299072 40 16 9 7 8 2.7606512719410556 28.83553094525254 0.027698516845703125 4 0.9684955930345468 6.934735314371093 963.0 8.214563106796117 2.0 - - - - - - - 0.0 1 0 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 225 29 C20140605_SFK031_02 C20140605_SFK031_02 TB295075.[MT7]-VWLLFDYAEHDLWHIIK[MT7].3y3_1.heavy 829.454 / 517.383 1582.0 54.70212650299072 40 16 9 7 8 2.7606512719410556 28.83553094525254 0.027698516845703125 4 0.9684955930345468 6.934735314371093 1582.0 4.598837209302325 1.0 - - - - - - - 121.03448275862068 5 29 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 227 29 C20140605_SFK031_02 C20140605_SFK031_02 TB295075.[MT7]-VWLLFDYAEHDLWHIIK[MT7].3b4_1.heavy 829.454 / 656.425 1342.0 54.70212650299072 40 16 9 7 8 2.7606512719410556 28.83553094525254 0.027698516845703125 4 0.9684955930345468 6.934735314371093 1342.0 3.619212953986289 1.0 - - - - - - - 137.57692307692307 2 26 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 229 29 C20140605_SFK031_02 C20140605_SFK031_02 TB295075.[MT7]-VWLLFDYAEHDLWHIIK[MT7].3y4_1.heavy 829.454 / 654.442 2271.0 54.70212650299072 40 16 9 7 8 2.7606512719410556 28.83553094525254 0.027698516845703125 4 0.9684955930345468 6.934735314371093 2271.0 16.2928482727478 0.0 - - - - - - - 140.8095238095238 4 21 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 231 30 C20140605_SFK031_02 C20140605_SFK031_02 TB561499.[MT7]-LVMPNYPFINIR.2y4_1.heavy 810.956 / 515.33 1295.0 45.990501403808594 39 17 10 10 2 2.340174168964855 42.731862152052415 0.0 11 0.9705192964639202 7.170025362248168 1295.0 1.1785714285714286 16.0 - - - - - - - 738.7777777777778 3 9 ETV3 ets variant 3 233 30 C20140605_SFK031_02 C20140605_SFK031_02 TB561499.[MT7]-LVMPNYPFINIR.2y5_1.heavy 810.956 / 662.398 518.0 45.990501403808594 39 17 10 10 2 2.340174168964855 42.731862152052415 0.0 11 0.9705192964639202 7.170025362248168 518.0 -0.1813185116566311 34.0 - - - - - - - 669.0833333333334 4 12 ETV3 ets variant 3 235 30 C20140605_SFK031_02 C20140605_SFK031_02 TB561499.[MT7]-LVMPNYPFINIR.2y9_1.heavy 810.956 / 1133.61 97482.0 45.990501403808594 39 17 10 10 2 2.340174168964855 42.731862152052415 0.0 11 0.9705192964639202 7.170025362248168 97482.0 93.52247881477639 1.0 - - - - - - - 259.0 215 2 ETV3 ets variant 3 237 30 C20140605_SFK031_02 C20140605_SFK031_02 TB561499.[MT7]-LVMPNYPFINIR.2y6_1.heavy 810.956 / 759.451 13038.0 45.990501403808594 39 17 10 10 2 2.340174168964855 42.731862152052415 0.0 11 0.9705192964639202 7.170025362248168 13038.0 20.325881959010875 0.0 - - - - - - - 220.66666666666666 26 9 ETV3 ets variant 3 239 31 C20140605_SFK031_02 C20140605_SFK031_02 TB294966.[MT7]-QSFLTEVEQLSR.2y8_1.heavy 790.924 / 961.495 38936.0 44.0447998046875 44 14 10 10 10 1.1170324403305625 58.57122642990719 0.0 3 0.9338774399297186 4.772708768763269 38936.0 119.96415296078895 0.0 - - - - - - - 697.25 77 8 IRAK1 interleukin-1 receptor-associated kinase 1 241 31 C20140605_SFK031_02 C20140605_SFK031_02 TB294966.[MT7]-QSFLTEVEQLSR.2b4_1.heavy 790.924 / 620.352 31848.0 44.0447998046875 44 14 10 10 10 1.1170324403305625 58.57122642990719 0.0 3 0.9338774399297186 4.772708768763269 31848.0 55.36438627352216 0.0 - - - - - - - 773.4545454545455 63 11 IRAK1 interleukin-1 receptor-associated kinase 1 243 31 C20140605_SFK031_02 C20140605_SFK031_02 TB294966.[MT7]-QSFLTEVEQLSR.2y6_1.heavy 790.924 / 731.405 12286.0 44.0447998046875 44 14 10 10 10 1.1170324403305625 58.57122642990719 0.0 3 0.9338774399297186 4.772708768763269 12286.0 17.595226212433545 0.0 - - - - - - - 796.5714285714286 24 7 IRAK1 interleukin-1 receptor-associated kinase 1 245 31 C20140605_SFK031_02 C20140605_SFK031_02 TB294966.[MT7]-QSFLTEVEQLSR.2y10_1.heavy 790.924 / 1221.65 10773.0 44.0447998046875 44 14 10 10 10 1.1170324403305625 58.57122642990719 0.0 3 0.9338774399297186 4.772708768763269 10773.0 38.43648648648649 0.0 - - - - - - - 714.2222222222222 21 9 IRAK1 interleukin-1 receptor-associated kinase 1 247 32 C20140605_SFK031_02 C20140605_SFK031_02 TB555867.[MT7]-LSLIMR.2y4_1.heavy 438.776 / 532.328 12683.0 36.63240051269531 43 18 10 5 10 2.587779555939008 38.643167950878166 0.0446014404296875 3 0.9835302084237498 9.603298947192574 12683.0 23.432539567350887 0.0 - - - - - - - 222.71428571428572 25 7 FMR1 fragile X mental retardation 1 249 32 C20140605_SFK031_02 C20140605_SFK031_02 TB555867.[MT7]-LSLIMR.2b3_1.heavy 438.776 / 458.31 34822.0 36.63240051269531 43 18 10 5 10 2.587779555939008 38.643167950878166 0.0446014404296875 3 0.9835302084237498 9.603298947192574 34822.0 60.07029649595687 0.0 - - - - - - - 389.5 69 4 FMR1 fragile X mental retardation 1 251 32 C20140605_SFK031_02 C20140605_SFK031_02 TB555867.[MT7]-LSLIMR.2y5_1.heavy 438.776 / 619.36 100015.0 36.63240051269531 43 18 10 5 10 2.587779555939008 38.643167950878166 0.0446014404296875 3 0.9835302084237498 9.603298947192574 100015.0 472.83326231168735 0.0 - - - - - - - 222.625 200 8 FMR1 fragile X mental retardation 1 253 32 C20140605_SFK031_02 C20140605_SFK031_02 TB555867.[MT7]-LSLIMR.2b4_1.heavy 438.776 / 571.394 31595.0 36.63240051269531 43 18 10 5 10 2.587779555939008 38.643167950878166 0.0446014404296875 3 0.9835302084237498 9.603298947192574 31595.0 87.28275179856115 0.0 - - - - - - - 222.71428571428572 63 7 FMR1 fragile X mental retardation 1 255 33 C20140605_SFK031_02 C20140605_SFK031_02 TB295074.[MT7]-VWLLFDYAEHDLWHIIK[MT7].4y4_1.heavy 622.342 / 654.442 4985.0 54.6952018737793 48 18 10 10 10 10.829130154575514 9.234352027595502 0.0 3 0.9833081170647482 9.539019751873532 4985.0 68.84047619047618 0.0 - - - - - - - 119.64285714285714 9 14 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 257 33 C20140605_SFK031_02 C20140605_SFK031_02 TB295074.[MT7]-VWLLFDYAEHDLWHIIK[MT7].4b4_1.heavy 622.342 / 656.425 9830.0 54.6952018737793 48 18 10 10 10 10.829130154575514 9.234352027595502 0.0 3 0.9833081170647482 9.539019751873532 9830.0 105.67502569373073 0.0 - - - - - - - 102.95 19 20 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 259 33 C20140605_SFK031_02 C20140605_SFK031_02 TB295074.[MT7]-VWLLFDYAEHDLWHIIK[MT7].4y3_1.heavy 622.342 / 517.383 11608.0 54.6952018737793 48 18 10 10 10 10.829130154575514 9.234352027595502 0.0 3 0.9833081170647482 9.539019751873532 11608.0 91.29486943164362 0.0 - - - - - - - 143.33333333333334 23 27 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 261 33 C20140605_SFK031_02 C20140605_SFK031_02 TB295074.[MT7]-VWLLFDYAEHDLWHIIK[MT7].4b6_1.heavy 622.342 / 918.521 8226.0 54.6952018737793 48 18 10 10 10 10.829130154575514 9.234352027595502 0.0 3 0.9833081170647482 9.539019751873532 8226.0 77.96443864229765 0.0 - - - - - - - 131.23076923076923 16 13 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 263 34 C20140605_SFK031_02 C20140605_SFK031_02 TB560507.[MT7]-AIIFFDPDAK[MT7].3b6_1.heavy 475.606 / 851.478 29727.0 41.69894981384277 46 20 10 6 10 7.393874999933817 13.524707950958748 0.03459930419921875 3 0.9957428297208689 18.90809024629128 29727.0 149.1916069730586 0.0 - - - - - - - 231.42857142857142 59 7 HNF4A hepatocyte nuclear factor 4, alpha 265 34 C20140605_SFK031_02 C20140605_SFK031_02 TB560507.[MT7]-AIIFFDPDAK[MT7].3b4_1.heavy 475.606 / 589.383 203407.0 41.69894981384277 46 20 10 6 10 7.393874999933817 13.524707950958748 0.03459930419921875 3 0.9957428297208689 18.90809024629128 203407.0 313.0615395873161 0.0 - - - - - - - 210.0 406 6 HNF4A hepatocyte nuclear factor 4, alpha 267 34 C20140605_SFK031_02 C20140605_SFK031_02 TB560507.[MT7]-AIIFFDPDAK[MT7].3b3_1.heavy 475.606 / 442.315 417444.0 41.69894981384277 46 20 10 6 10 7.393874999933817 13.524707950958748 0.03459930419921875 3 0.9957428297208689 18.90809024629128 417444.0 559.0579783993054 0.0 - - - - - - - 315.0 834 4 HNF4A hepatocyte nuclear factor 4, alpha 269 34 C20140605_SFK031_02 C20140605_SFK031_02 TB560507.[MT7]-AIIFFDPDAK[MT7].3y4_1.heavy 475.606 / 574.332 204938.0 41.69894981384277 46 20 10 6 10 7.393874999933817 13.524707950958748 0.03459930419921875 3 0.9957428297208689 18.90809024629128 204938.0 409.2273988703866 0.0 - - - - - - - 340.0 409 9 HNF4A hepatocyte nuclear factor 4, alpha 271 35 C20140605_SFK031_02 C20140605_SFK031_02 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 2428830.0 15.873900413513184 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2428830.0 3783.8765205245104 0.0 - - - - - - - 1181.142857142857 4857 7 273 35 C20140605_SFK031_02 C20140605_SFK031_02 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 3470200.0 15.873900413513184 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 3470200.0 9440.341415982424 0.0 - - - - - - - 1262.0 6940 7 275 35 C20140605_SFK031_02 C20140605_SFK031_02 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 1921810.0 15.873900413513184 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1921810.0 3470.860737294216 0.0 - - - - - - - 1203.2857142857142 3843 7 277 36 C20140605_SFK031_02 C20140605_SFK031_02 TB557898.[MT7]-ALLEEVK[MT7].2y4_1.heavy 545.342 / 648.369 66495.0 31.44070053100586 50 20 10 10 10 9.242003908668877 10.820164218519896 0.0 3 0.9970412785817463 22.683141090565943 66495.0 55.36723356621087 0.0 - - - - - - - 462.0 132 2 KIAA1279 KIAA1279 279 36 C20140605_SFK031_02 C20140605_SFK031_02 TB557898.[MT7]-ALLEEVK[MT7].2y5_1.heavy 545.342 / 761.453 51488.0 31.44070053100586 50 20 10 10 10 9.242003908668877 10.820164218519896 0.0 3 0.9970412785817463 22.683141090565943 51488.0 41.05086885004184 0.0 - - - - - - - 1183.125 102 8 KIAA1279 KIAA1279 281 36 C20140605_SFK031_02 C20140605_SFK031_02 TB557898.[MT7]-ALLEEVK[MT7].2y3_1.heavy 545.342 / 519.326 N/A 31.44070053100586 50 20 10 10 10 9.242003908668877 10.820164218519896 0.0 3 0.9970412785817463 22.683141090565943 44253.0 14.876164074193682 0.0 - - - - - - - 6201.0 88 7 KIAA1279 KIAA1279 283 36 C20140605_SFK031_02 C20140605_SFK031_02 TB557898.[MT7]-ALLEEVK[MT7].2y6_1.heavy 545.342 / 874.537 46562.0 31.44070053100586 50 20 10 10 10 9.242003908668877 10.820164218519896 0.0 3 0.9970412785817463 22.683141090565943 46562.0 51.40211519643548 0.0 - - - - - - - 735.7777777777778 93 9 KIAA1279 KIAA1279 285 37 C20140605_SFK031_02 C20140605_SFK031_02 TB558429.[MT7]-LIEPEEVAR.2b3_1.heavy 600.341 / 500.32 75336.0 30.421774864196777 37 14 10 3 10 1.3167767362138163 54.14956343651652 0.0605010986328125 3 0.9357153085176064 4.841212338163516 75336.0 63.54491267568328 0.0 - - - - - - - 1200.5 150 4 ETV1;ETV4;ETV5 ets variant 1;ets variant 4;ets variant 5 287 37 C20140605_SFK031_02 C20140605_SFK031_02 TB558429.[MT7]-LIEPEEVAR.2y8_1.heavy 600.341 / 942.489 69476.0 30.421774864196777 37 14 10 3 10 1.3167767362138163 54.14956343651652 0.0605010986328125 3 0.9357153085176064 4.841212338163516 69476.0 56.855161703694776 1.0 - - - - - - - 393.42857142857144 138 7 ETV1;ETV4;ETV5 ets variant 1;ets variant 4;ets variant 5 289 37 C20140605_SFK031_02 C20140605_SFK031_02 TB558429.[MT7]-LIEPEEVAR.2y6_1.heavy 600.341 / 700.362 79996.0 30.421774864196777 37 14 10 3 10 1.3167767362138163 54.14956343651652 0.0605010986328125 3 0.9357153085176064 4.841212338163516 79996.0 33.277750171552164 0.0 - - - - - - - 847.0 159 3 ETV1;ETV4;ETV5 ets variant 1;ets variant 4;ets variant 5 291 37 C20140605_SFK031_02 C20140605_SFK031_02 TB558429.[MT7]-LIEPEEVAR.2y7_1.heavy 600.341 / 829.405 36079.0 30.421774864196777 37 14 10 3 10 1.3167767362138163 54.14956343651652 0.0605010986328125 3 0.9357153085176064 4.841212338163516 36079.0 35.34685741308692 0.0 - - - - - - - 381.4 72 5 ETV1;ETV4;ETV5 ets variant 1;ets variant 4;ets variant 5 293 38 C20140605_SFK031_02 C20140605_SFK031_02 TB558428.[MT7]-SGTNDTYTIIQLGK[MT7].3b6_1.heavy 600.331 / 720.328 9992.0 35.433101654052734 34 12 4 10 8 0.9812146491842153 67.94299975249405 0.0 4 0.8977625605442996 3.826360781385171 9992.0 8.504355641194138 0.0 - - - - - - - 230.0 19 1 RAB11FIP2 RAB11 family interacting protein 2 (class I) 295 38 C20140605_SFK031_02 C20140605_SFK031_02 TB558428.[MT7]-SGTNDTYTIIQLGK[MT7].3b4_1.heavy 600.331 / 504.253 6202.0 35.433101654052734 34 12 4 10 8 0.9812146491842153 67.94299975249405 0.0 4 0.8977625605442996 3.826360781385171 6202.0 5.2965960007344 2.0 - - - - - - - 1263.4 12 5 RAB11FIP2 RAB11 family interacting protein 2 (class I) 297 38 C20140605_SFK031_02 C20140605_SFK031_02 TB558428.[MT7]-SGTNDTYTIIQLGK[MT7].3b5_1.heavy 600.331 / 619.28 7466.0 35.433101654052734 34 12 4 10 8 0.9812146491842153 67.94299975249405 0.0 4 0.8977625605442996 3.826360781385171 7466.0 2.339833282199292 4.0 - - - - - - - 230.0 37 1 RAB11FIP2 RAB11 family interacting protein 2 (class I) 299 38 C20140605_SFK031_02 C20140605_SFK031_02 TB558428.[MT7]-SGTNDTYTIIQLGK[MT7].3b8_1.heavy 600.331 / 984.439 11026.0 35.433101654052734 34 12 4 10 8 0.9812146491842153 67.94299975249405 0.0 4 0.8977625605442996 3.826360781385171 11026.0 9.5450912757821 0.0 - - - - - - - 230.0 22 5 RAB11FIP2 RAB11 family interacting protein 2 (class I) 301 39 C20140605_SFK031_02 C20140605_SFK031_02 TB561621.[MT7]-VLEAILPLVQNDPR.3b6_1.heavy 574.341 / 783.51 58156.0 46.71782398223877 43 17 10 6 10 4.060026670128646 24.630380075023353 0.038501739501953125 3 0.9710938068095041 7.241277330676781 58156.0 150.77520904569937 0.0 - - - - - - - 618.25 116 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 303 39 C20140605_SFK031_02 C20140605_SFK031_02 TB561621.[MT7]-VLEAILPLVQNDPR.3b4_1.heavy 574.341 / 557.341 290863.0 46.71782398223877 43 17 10 6 10 4.060026670128646 24.630380075023353 0.038501739501953125 3 0.9710938068095041 7.241277330676781 290863.0 311.3799353600786 0.0 - - - - - - - 838.0 581 1 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 305 39 C20140605_SFK031_02 C20140605_SFK031_02 TB561621.[MT7]-VLEAILPLVQNDPR.3b5_1.heavy 574.341 / 670.426 201702.0 46.71782398223877 43 17 10 6 10 4.060026670128646 24.630380075023353 0.038501739501953125 3 0.9710938068095041 7.241277330676781 201702.0 252.76098618090452 0.0 - - - - - - - 670.5 403 2 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 307 39 C20140605_SFK031_02 C20140605_SFK031_02 TB561621.[MT7]-VLEAILPLVQNDPR.3y8_1.heavy 574.341 / 938.505 112038.0 46.71782398223877 43 17 10 6 10 4.060026670128646 24.630380075023353 0.038501739501953125 3 0.9710938068095041 7.241277330676781 112038.0 189.78062827695965 0.0 - - - - - - - 335.0 224 2 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 309 40 C20140605_SFK031_02 C20140605_SFK031_02 TB560768.[MT7]-QVEELFERK[MT7].3y7_1.heavy 489.28 / 1094.6 N/A 31.25589942932129 36 14 6 10 6 1.9110216744340436 42.846839981902576 0.0 5 0.9342949643527737 4.788019637245208 0.0 -0.0 0.0 - - - - - - - 0.0 0 0 GTF2I general transcription factor IIi 311 40 C20140605_SFK031_02 C20140605_SFK031_02 TB560768.[MT7]-QVEELFERK[MT7].3b4_1.heavy 489.28 / 630.321 26135.0 31.25589942932129 36 14 6 10 6 1.9110216744340436 42.846839981902576 0.0 5 0.9342949643527737 4.788019637245208 26135.0 27.350895347635937 0.0 - - - - - - - 1233.7142857142858 52 7 GTF2I general transcription factor IIi 313 40 C20140605_SFK031_02 C20140605_SFK031_02 TB560768.[MT7]-QVEELFERK[MT7].3b3_1.heavy 489.28 / 501.279 11439.0 31.25589942932129 36 14 6 10 6 1.9110216744340436 42.846839981902576 0.0 5 0.9342949643527737 4.788019637245208 11439.0 3.5322879740498365 1.0 - - - - - - - 2673.1428571428573 118 7 GTF2I general transcription factor IIi 315 40 C20140605_SFK031_02 C20140605_SFK031_02 TB560768.[MT7]-QVEELFERK[MT7].3y8_2.heavy 489.28 / 597.336 45982.0 31.25589942932129 36 14 6 10 6 1.9110216744340436 42.846839981902576 0.0 5 0.9342949643527737 4.788019637245208 45982.0 30.05649625384084 1.0 - - - - - - - 379.0 134 1 GTF2I general transcription factor IIi 317 41 C20140605_SFK031_02 C20140605_SFK031_02 TB294974.[MT7]-EQLLVLVEWAK[MT7].2b3_1.heavy 808.487 / 515.295 53880.0 48.301998138427734 45 15 10 10 10 2.539465722402226 33.310767721810485 0.0 3 0.9552544805327535 5.812390008210632 53880.0 210.83478260869563 0.0 - - - - - - - 796.2222222222222 107 9 HNF4A hepatocyte nuclear factor 4, alpha 319 41 C20140605_SFK031_02 C20140605_SFK031_02 TB294974.[MT7]-EQLLVLVEWAK[MT7].2b4_1.heavy 808.487 / 628.379 60967.0 48.301998138427734 45 15 10 10 10 2.539465722402226 33.310767721810485 0.0 3 0.9552544805327535 5.812390008210632 60967.0 91.21199779641154 0.0 - - - - - - - 358.6363636363636 121 11 HNF4A hepatocyte nuclear factor 4, alpha 321 41 C20140605_SFK031_02 C20140605_SFK031_02 TB294974.[MT7]-EQLLVLVEWAK[MT7].2y6_1.heavy 808.487 / 889.526 37289.0 48.301998138427734 45 15 10 10 10 2.539465722402226 33.310767721810485 0.0 3 0.9552544805327535 5.812390008210632 37289.0 183.05862298420516 0.0 - - - - - - - 228.33333333333334 74 12 HNF4A hepatocyte nuclear factor 4, alpha 323 41 C20140605_SFK031_02 C20140605_SFK031_02 TB294974.[MT7]-EQLLVLVEWAK[MT7].2b5_1.heavy 808.487 / 727.447 44054.0 48.301998138427734 45 15 10 10 10 2.539465722402226 33.310767721810485 0.0 3 0.9552544805327535 5.812390008210632 44054.0 65.31434255881828 0.0 - - - - - - - 662.1111111111111 88 9 HNF4A hepatocyte nuclear factor 4, alpha 325 42 C20140605_SFK031_02 C20140605_SFK031_02 TB399708.[MT7]-STVVPVPYEK[MT7].2y4_1.heavy 703.91 / 680.374 27012.0 29.819700241088867 35 5 10 10 10 0.4034016548020069 123.94594668814742 0.0 3 0.6400400638196724 1.9918258265576663 27012.0 44.65075245664174 0.0 - - - - - - - 693.9166666666666 54 12 GTF2I general transcription factor IIi 327 42 C20140605_SFK031_02 C20140605_SFK031_02 TB399708.[MT7]-STVVPVPYEK[MT7].2b4_1.heavy 703.91 / 531.326 52779.0 29.819700241088867 35 5 10 10 10 0.4034016548020069 123.94594668814742 0.0 3 0.6400400638196724 1.9918258265576663 52779.0 141.75601417522745 0.0 - - - - - - - 703.8666666666667 105 15 GTF2I general transcription factor IIi 329 42 C20140605_SFK031_02 C20140605_SFK031_02 TB399708.[MT7]-STVVPVPYEK[MT7].2y3_1.heavy 703.91 / 583.321 1508.0 29.819700241088867 35 5 10 10 10 0.4034016548020069 123.94594668814742 0.0 3 0.6400400638196724 1.9918258265576663 1508.0 2.0691945331143273 20.0 - - - - - - - 669.8571428571429 3 14 GTF2I general transcription factor IIi 331 42 C20140605_SFK031_02 C20140605_SFK031_02 TB399708.[MT7]-STVVPVPYEK[MT7].2y6_1.heavy 703.91 / 876.495 37372.0 29.819700241088867 35 5 10 10 10 0.4034016548020069 123.94594668814742 0.0 3 0.6400400638196724 1.9918258265576663 37372.0 117.548334661778 0.0 - - - - - - - 330.9047619047619 74 21 GTF2I general transcription factor IIi 333 43 C20140605_SFK031_02 C20140605_SFK031_02 TB560767.[MT7]-VY[MT7]QSLANLIR.3y7_1.heavy 488.964 / 786.483 11692.0 36.74319839477539 46 16 10 10 10 2.4453030455597 35.179404051766085 0.0 3 0.961671760727411 6.283562489725863 11692.0 51.57441108545035 0.0 - - - - - - - 336.8888888888889 23 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 335 43 C20140605_SFK031_02 C20140605_SFK031_02 TB560767.[MT7]-VY[MT7]QSLANLIR.3y6_1.heavy 488.964 / 699.451 12341.0 36.74319839477539 46 16 10 10 10 2.4453030455597 35.179404051766085 0.0 3 0.961671760727411 6.283562489725863 12341.0 27.15300497194403 0.0 - - - - - - - 288.8666666666667 24 15 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 337 43 C20140605_SFK031_02 C20140605_SFK031_02 TB560767.[MT7]-VY[MT7]QSLANLIR.3y9_2.heavy 488.964 / 611.357 N/A 36.74319839477539 46 16 10 10 10 2.4453030455597 35.179404051766085 0.0 3 0.961671760727411 6.283562489725863 47199.0 27.116181433417182 1.0 - - - - - - - 162.5 137 2 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 339 43 C20140605_SFK031_02 C20140605_SFK031_02 TB560767.[MT7]-VY[MT7]QSLANLIR.3y5_1.heavy 488.964 / 586.367 28471.0 36.74319839477539 46 16 10 10 10 2.4453030455597 35.179404051766085 0.0 3 0.961671760727411 6.283562489725863 28471.0 22.20524564826727 0.0 - - - - - - - 379.0 56 2 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 341 44 C20140605_SFK031_02 C20140605_SFK031_02 TB399801.[MT7]-SLTYEEVLQELVK[MT7].2y9_1.heavy 920.021 / 1230.71 3737.0 47.30424976348877 44 18 10 6 10 5.156597169286469 19.392633691771827 0.035800933837890625 3 0.9871626589206115 10.88075755440376 3737.0 7.1738206913916285 0.0 - - - - - - - 638.5 7 10 RAB11FIP2 RAB11 family interacting protein 2 (class I) 343 44 C20140605_SFK031_02 C20140605_SFK031_02 TB399801.[MT7]-SLTYEEVLQELVK[MT7].2b4_1.heavy 920.021 / 609.336 3737.0 47.30424976348877 44 18 10 6 10 5.156597169286469 19.392633691771827 0.035800933837890625 3 0.9871626589206115 10.88075755440376 3737.0 4.967016178389552 0.0 - - - - - - - 249.2 7 20 RAB11FIP2 RAB11 family interacting protein 2 (class I) 345 44 C20140605_SFK031_02 C20140605_SFK031_02 TB399801.[MT7]-SLTYEEVLQELVK[MT7].2b6_1.heavy 920.021 / 867.422 9265.0 47.30424976348877 44 18 10 6 10 5.156597169286469 19.392633691771827 0.035800933837890625 3 0.9871626589206115 10.88075755440376 9265.0 26.780642398286936 0.0 - - - - - - - 265.6470588235294 18 17 RAB11FIP2 RAB11 family interacting protein 2 (class I) 347 44 C20140605_SFK031_02 C20140605_SFK031_02 TB399801.[MT7]-SLTYEEVLQELVK[MT7].2y6_1.heavy 920.021 / 873.553 5761.0 47.30424976348877 44 18 10 6 10 5.156597169286469 19.392633691771827 0.035800933837890625 3 0.9871626589206115 10.88075755440376 5761.0 13.974057244565433 0.0 - - - - - - - 216.85714285714286 11 14 RAB11FIP2 RAB11 family interacting protein 2 (class I) 349 45 C20140605_SFK031_02 C20140605_SFK031_02 TB559095.[MT7]-LIQEIVDK[MT7].2y4_1.heavy 623.386 / 618.394 52724.0 37.21009826660156 44 14 10 10 10 1.8513582743120742 38.53247159814102 0.0 3 0.9386187149794486 4.955614199315134 52724.0 16.120136234814694 0.0 - - - - - - - 638.0 105 1 FMR1 fragile X mental retardation 1 351 45 C20140605_SFK031_02 C20140605_SFK031_02 TB559095.[MT7]-LIQEIVDK[MT7].2b4_1.heavy 623.386 / 628.379 58889.0 37.21009826660156 44 14 10 10 10 1.8513582743120742 38.53247159814102 0.0 3 0.9386187149794486 4.955614199315134 58889.0 70.88920007976697 0.0 - - - - - - - 354.3333333333333 117 3 FMR1 fragile X mental retardation 1 353 45 C20140605_SFK031_02 C20140605_SFK031_02 TB559095.[MT7]-LIQEIVDK[MT7].2y3_1.heavy 623.386 / 505.31 44113.0 37.21009826660156 44 14 10 10 10 1.8513582743120742 38.53247159814102 0.0 3 0.9386187149794486 4.955614199315134 44113.0 18.281676331982375 1.0 - - - - - - - 1199.7142857142858 106 7 FMR1 fragile X mental retardation 1 355 45 C20140605_SFK031_02 C20140605_SFK031_02 TB559095.[MT7]-LIQEIVDK[MT7].2y7_1.heavy 623.386 / 988.58 78873.0 37.21009826660156 44 14 10 10 10 1.8513582743120742 38.53247159814102 0.0 3 0.9386187149794486 4.955614199315134 78873.0 83.74273616942013 0.0 - - - - - - - 1315.5 157 8 FMR1 fragile X mental retardation 1 357 46 C20140605_SFK031_02 C20140605_SFK031_02 TB560118.[MT7]-LDTVLEEFK[MT7].3y3_1.heavy 461.265 / 567.326 20427.0 42.89747619628906 40 14 10 6 10 1.278944073170729 52.12633457957877 0.0381011962890625 3 0.9424879715983809 5.1212891460447985 20427.0 247.93451904260124 0.0 - - - - - - - 221.42857142857142 40 7 CNNM1 cyclin M1 359 46 C20140605_SFK031_02 C20140605_SFK031_02 TB560118.[MT7]-LDTVLEEFK[MT7].3b4_1.heavy 461.265 / 573.336 14135.0 42.89747619628906 40 14 10 6 10 1.278944073170729 52.12633457957877 0.0381011962890625 3 0.9424879715983809 5.1212891460447985 14135.0 212.025 0.0 - - - - - - - 159.41666666666666 28 12 CNNM1 cyclin M1 361 46 C20140605_SFK031_02 C20140605_SFK031_02 TB560118.[MT7]-LDTVLEEFK[MT7].3y4_1.heavy 461.265 / 696.369 9211.0 42.89747619628906 40 14 10 6 10 1.278944073170729 52.12633457957877 0.0381011962890625 3 0.9424879715983809 5.1212891460447985 9211.0 57.345539104405646 0.0 - - - - - - - 260.42857142857144 18 7 CNNM1 cyclin M1 363 46 C20140605_SFK031_02 C20140605_SFK031_02 TB560118.[MT7]-LDTVLEEFK[MT7].3b3_1.heavy 461.265 / 474.268 19607.0 42.89747619628906 40 14 10 6 10 1.278944073170729 52.12633457957877 0.0381011962890625 3 0.9424879715983809 5.1212891460447985 19607.0 125.28084024750386 0.0 - - - - - - - 164.0 39 10 CNNM1 cyclin M1 365 47 C20140605_SFK031_02 C20140605_SFK031_02 TB295055.[MT7]-VQEVIFGLALLNSSSSDLR.3b4_1.heavy 731.406 / 600.347 6552.0 52.275299072265625 47 17 10 10 10 4.127316986269557 24.228815071067324 0.0 3 0.9728209121014946 7.468894901337428 6552.0 12.951557272466392 0.0 - - - - - - - 735.0 13 9 CNOT1 CCR4-NOT transcription complex, subunit 1 367 47 C20140605_SFK031_02 C20140605_SFK031_02 TB295055.[MT7]-VQEVIFGLALLNSSSSDLR.3b5_1.heavy 731.406 / 713.431 2735.0 52.275299072265625 47 17 10 10 10 4.127316986269557 24.228815071067324 0.0 3 0.9728209121014946 7.468894901337428 2735.0 1.5836146805982612 1.0 - - - - - - - 739.375 8 8 CNOT1 CCR4-NOT transcription complex, subunit 1 369 47 C20140605_SFK031_02 C20140605_SFK031_02 TB295055.[MT7]-VQEVIFGLALLNSSSSDLR.3b3_1.heavy 731.406 / 501.279 5025.0 52.275299072265625 47 17 10 10 10 4.127316986269557 24.228815071067324 0.0 3 0.9728209121014946 7.468894901337428 5025.0 16.842868464932444 0.0 - - - - - - - 654.1428571428571 10 7 CNOT1 CCR4-NOT transcription complex, subunit 1 371 47 C20140605_SFK031_02 C20140605_SFK031_02 TB295055.[MT7]-VQEVIFGLALLNSSSSDLR.3b7_1.heavy 731.406 / 917.521 5279.0 52.275299072265625 47 17 10 10 10 4.127316986269557 24.228815071067324 0.0 3 0.9728209121014946 7.468894901337428 5279.0 17.559231153522312 0.0 - - - - - - - 264.15384615384613 10 13 CNOT1 CCR4-NOT transcription complex, subunit 1 373 48 C20140605_SFK031_02 C20140605_SFK031_02 TB561921.[MT7]-RDLIALANTAGEVLLHR.4y4_1.heavy 502.296 / 538.346 121120.0 44.560699462890625 38 8 10 10 10 0.6554821154814532 83.3239177683955 0.0 3 0.7964033253711127 2.6873055244946427 121120.0 365.9370212765957 0.0 - - - - - - - 792.2857142857143 242 7 ANAPC4 anaphase promoting complex subunit 4 375 48 C20140605_SFK031_02 C20140605_SFK031_02 TB561921.[MT7]-RDLIALANTAGEVLLHR.4b5_1.heavy 502.296 / 713.443 49652.0 44.560699462890625 38 8 10 10 10 0.6554821154814532 83.3239177683955 0.0 3 0.7964033253711127 2.6873055244946427 49652.0 160.04846808510638 0.0 - - - - - - - 335.7142857142857 99 7 ANAPC4 anaphase promoting complex subunit 4 377 48 C20140605_SFK031_02 C20140605_SFK031_02 TB561921.[MT7]-RDLIALANTAGEVLLHR.4y7_1.heavy 502.296 / 823.479 70904.0 44.560699462890625 38 8 10 10 10 0.6554821154814532 83.3239177683955 0.0 3 0.7964033253711127 2.6873055244946427 70904.0 724.1259574468086 0.0 - - - - - - - 125.33333333333333 141 3 ANAPC4 anaphase promoting complex subunit 4 379 48 C20140605_SFK031_02 C20140605_SFK031_02 TB561921.[MT7]-RDLIALANTAGEVLLHR.4b6_1.heavy 502.296 / 826.527 25672.0 44.560699462890625 38 8 10 10 10 0.6554821154814532 83.3239177683955 0.0 3 0.7964033253711127 2.6873055244946427 25672.0 216.66439716312055 0.0 - - - - - - - 219.33333333333334 51 9 ANAPC4 anaphase promoting complex subunit 4 381 49 C20140605_SFK031_02 C20140605_SFK031_02 TB561922.[MT7]-RDLIALANTAGEVLLHR.3y7_1.heavy 669.392 / 823.479 58236.0 44.560699462890625 46 16 10 10 10 2.179968421552217 36.49746315088919 0.0 3 0.9614648154126131 6.266557865815423 58236.0 68.04011875637408 0.0 - - - - - - - 282.0 116 4 ANAPC4 anaphase promoting complex subunit 4 383 49 C20140605_SFK031_02 C20140605_SFK031_02 TB561922.[MT7]-RDLIALANTAGEVLLHR.3b6_1.heavy 669.392 / 826.527 20570.0 44.560699462890625 46 16 10 10 10 2.179968421552217 36.49746315088919 0.0 3 0.9614648154126131 6.266557865815423 20570.0 56.19545051043053 0.0 - - - - - - - 289.2307692307692 41 13 ANAPC4 anaphase promoting complex subunit 4 385 49 C20140605_SFK031_02 C20140605_SFK031_02 TB561922.[MT7]-RDLIALANTAGEVLLHR.3b5_1.heavy 669.392 / 713.443 29494.0 44.560699462890625 46 16 10 10 10 2.179968421552217 36.49746315088919 0.0 3 0.9614648154126131 6.266557865815423 29494.0 31.913070716249248 1.0 - - - - - - - 338.4 59 10 ANAPC4 anaphase promoting complex subunit 4 387 49 C20140605_SFK031_02 C20140605_SFK031_02 TB561922.[MT7]-RDLIALANTAGEVLLHR.3y8_1.heavy 669.392 / 894.516 38135.0 44.560699462890625 46 16 10 10 10 2.179968421552217 36.49746315088919 0.0 3 0.9614648154126131 6.266557865815423 38135.0 44.64383682126881 0.0 - - - - - - - 387.75 76 8 ANAPC4 anaphase promoting complex subunit 4 389 50 C20140605_SFK031_02 C20140605_SFK031_02 TB556881.[MT7]-NEEASK[MT7].2y4_1.heavy 483.261 / 578.327 2119.0 13.21637487411499 22 5 10 1 6 0.8728055634761548 72.78695598923873 0.09729957580566406 6 0.6307153925428547 1.964749356808572 2119.0 6.421212121212122 2.0 - - - - - - - 177.5909090909091 4 22 FMR1 fragile X mental retardation 1 391 50 C20140605_SFK031_02 C20140605_SFK031_02 TB556881.[MT7]-NEEASK[MT7].2b3_1.heavy 483.261 / 517.237 10856.0 13.21637487411499 22 5 10 1 6 0.8728055634761548 72.78695598923873 0.09729957580566406 6 0.6307153925428547 1.964749356808572 10856.0 73.76326208691538 0.0 - - - - - - - 192.54545454545453 21 22 FMR1 fragile X mental retardation 1 393 50 C20140605_SFK031_02 C20140605_SFK031_02 TB556881.[MT7]-NEEASK[MT7].2y5_1.heavy 483.261 / 707.369 297.0 13.21637487411499 22 5 10 1 6 0.8728055634761548 72.78695598923873 0.09729957580566406 6 0.6307153925428547 1.964749356808572 297.0 0.6853846153846154 14.0 - - - - - - - 138.94736842105263 2 19 FMR1 fragile X mental retardation 1 395 50 C20140605_SFK031_02 C20140605_SFK031_02 TB556881.[MT7]-NEEASK[MT7].2b4_1.heavy 483.261 / 588.275 1301.0 13.21637487411499 22 5 10 1 6 0.8728055634761548 72.78695598923873 0.09729957580566406 6 0.6307153925428547 1.964749356808572 1301.0 5.823662716207559 6.0 - - - - - - - 172.45454545454547 3 22 FMR1 fragile X mental retardation 1 397 51 C20140605_SFK031_02 C20140605_SFK031_02 TB561893.[MT7]-RTAFTSEQLLELEK[MT7].4b8_1.heavy 489.028 / 1065.54 114.0 34.995201110839844 28 3 10 5 10 0.3962065768280123 109.46469030095805 0.0446014404296875 3 0.5099718220165068 1.685259370424609 114.0 0.0 1.0 - - - - - - - 0.0 1 0 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 399 51 C20140605_SFK031_02 C20140605_SFK031_02 TB561893.[MT7]-RTAFTSEQLLELEK[MT7].4y4_1.heavy 489.028 / 662.384 42758.0 34.995201110839844 28 3 10 5 10 0.3962065768280123 109.46469030095805 0.0446014404296875 3 0.5099718220165068 1.685259370424609 42758.0 58.27915688457128 0.0 - - - - - - - 857.75 85 8 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 401 51 C20140605_SFK031_02 C20140605_SFK031_02 TB561893.[MT7]-RTAFTSEQLLELEK[MT7].4b7_1.heavy 489.028 / 937.486 6631.0 34.995201110839844 28 3 10 5 10 0.3962065768280123 109.46469030095805 0.0446014404296875 3 0.5099718220165068 1.685259370424609 6631.0 61.99922254616132 0.0 - - - - - - - 228.55555555555554 13 9 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 403 51 C20140605_SFK031_02 C20140605_SFK031_02 TB561893.[MT7]-RTAFTSEQLLELEK[MT7].4b4_1.heavy 489.028 / 620.364 5716.0 34.995201110839844 28 3 10 5 10 0.3962065768280123 109.46469030095805 0.0446014404296875 3 0.5099718220165068 1.685259370424609 5716.0 12.1942027696793 0.0 - - - - - - - 326.57142857142856 11 7 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 405 52 C20140605_SFK031_02 C20140605_SFK031_02 TB560378.[MT7]-QVEEIFNLK[MT7].3y3_1.heavy 469.941 / 518.342 72853.0 38.652198791503906 46 16 10 10 10 1.8803117291823352 42.100854134654455 0.0 3 0.9689362576611866 6.984008992558748 72853.0 103.18406256211489 0.0 - - - - - - - 290.875 145 8 GTF2I general transcription factor IIi 407 52 C20140605_SFK031_02 C20140605_SFK031_02 TB560378.[MT7]-QVEEIFNLK[MT7].3b4_1.heavy 469.941 / 630.321 120365.0 38.652198791503906 46 16 10 10 10 1.8803117291823352 42.100854134654455 0.0 3 0.9689362576611866 6.984008992558748 120365.0 266.9618417319763 0.0 - - - - - - - 665.4285714285714 240 7 GTF2I general transcription factor IIi 409 52 C20140605_SFK031_02 C20140605_SFK031_02 TB560378.[MT7]-QVEEIFNLK[MT7].3b5_1.heavy 469.941 / 743.406 29253.0 38.652198791503906 46 16 10 10 10 1.8803117291823352 42.100854134654455 0.0 3 0.9689362576611866 6.984008992558748 29253.0 86.34425255638448 0.0 - - - - - - - 209.41666666666666 58 12 GTF2I general transcription factor IIi 411 52 C20140605_SFK031_02 C20140605_SFK031_02 TB560378.[MT7]-QVEEIFNLK[MT7].3b3_1.heavy 469.941 / 501.279 61953.0 38.652198791503906 46 16 10 10 10 1.8803117291823352 42.100854134654455 0.0 3 0.9689362576611866 6.984008992558748 61953.0 43.80173172402397 0.0 - - - - - - - 239.42857142857142 123 7 GTF2I general transcription factor IIi 413 53 C20140605_SFK031_02 C20140605_SFK031_02 TB294801.[MT7]-FQAALALSR.2y8_1.heavy 560.833 / 829.489 103290.0 34.71009826660156 50 20 10 10 10 8.267589634753715 12.09542374716315 0.0 3 0.9922860893472912 14.042534392882633 103290.0 185.94567484040567 0.0 - - - - - - - 870.8571428571429 206 7 KIAA1279 KIAA1279 415 53 C20140605_SFK031_02 C20140605_SFK031_02 TB294801.[MT7]-FQAALALSR.2b6_1.heavy 560.833 / 746.432 30477.0 34.71009826660156 50 20 10 10 10 8.267589634753715 12.09542374716315 0.0 3 0.9922860893472912 14.042534392882633 30477.0 46.27756323120988 0.0 - - - - - - - 712.4285714285714 60 7 KIAA1279 KIAA1279 417 53 C20140605_SFK031_02 C20140605_SFK031_02 TB294801.[MT7]-FQAALALSR.2y6_1.heavy 560.833 / 630.393 40673.0 34.71009826660156 50 20 10 10 10 8.267589634753715 12.09542374716315 0.0 3 0.9922860893472912 14.042534392882633 40673.0 22.195049927857223 0.0 - - - - - - - 942.0 81 2 KIAA1279 KIAA1279 419 53 C20140605_SFK031_02 C20140605_SFK031_02 TB294801.[MT7]-FQAALALSR.2y7_1.heavy 560.833 / 701.43 61509.0 34.71009826660156 50 20 10 10 10 8.267589634753715 12.09542374716315 0.0 3 0.9922860893472912 14.042534392882633 61509.0 61.8941778817733 0.0 - - - - - - - 1203.142857142857 123 7 KIAA1279 KIAA1279 421 54 C20140605_SFK031_02 C20140605_SFK031_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 3330020.0 18.671899795532227 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 3330020.0 3389.2714513344845 0.0 - - - - - - - 720.375 6660 16 423 54 C20140605_SFK031_02 C20140605_SFK031_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 2082650.0 18.671899795532227 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2082650.0 5567.269436999302 0.0 - - - - - - - 624.75 4165 12 425 54 C20140605_SFK031_02 C20140605_SFK031_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 2470000.0 18.671899795532227 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2470000.0 24153.60346996742 0.0 - - - - - - - 663.0 4940 10 427 55 C20140605_SFK031_02 C20140605_SFK031_02 TB558631.[MT7]-VTRAPEGAK[MT7].3y3_1.heavy 406.247 / 419.273 18623.0 16.235450267791748 43 17 10 6 10 4.955658212610194 20.17895417919248 0.031000137329101562 3 0.9748812287827298 7.770516380701287 18623.0 19.301515629978738 0.0 - - - - - - - 1278.6 37 10 RBM20 RNA binding motif protein 20 429 55 C20140605_SFK031_02 C20140605_SFK031_02 TB558631.[MT7]-VTRAPEGAK[MT7].3b3_1.heavy 406.247 / 501.327 1379.0 16.235450267791748 43 17 10 6 10 4.955658212610194 20.17895417919248 0.031000137329101562 3 0.9748812287827298 7.770516380701287 1379.0 0.19246336357292387 32.0 - - - - - - - 1306.5 19 8 RBM20 RNA binding motif protein 20 431 55 C20140605_SFK031_02 C20140605_SFK031_02 TB558631.[MT7]-VTRAPEGAK[MT7].3y4_1.heavy 406.247 / 548.316 5359.0 16.235450267791748 43 17 10 6 10 4.955658212610194 20.17895417919248 0.031000137329101562 3 0.9748812287827298 7.770516380701287 5359.0 9.953543890640148 0.0 - - - - - - - 270.14285714285717 10 21 RBM20 RNA binding motif protein 20 433 55 C20140605_SFK031_02 C20140605_SFK031_02 TB558631.[MT7]-VTRAPEGAK[MT7].3y5_1.heavy 406.247 / 645.369 6685.0 16.235450267791748 43 17 10 6 10 4.955658212610194 20.17895417919248 0.031000137329101562 3 0.9748812287827298 7.770516380701287 6685.0 30.24531064971974 0.0 - - - - - - - 240.83333333333334 13 24 RBM20 RNA binding motif protein 20 435 56 C20140605_SFK031_02 C20140605_SFK031_02 TB399628.[MT7]-YSTSVAEK[MT7].2y4_1.heavy 586.824 / 590.363 3360.0 21.135950565338135 41 15 10 6 10 3.6295952328459835 27.551281502425134 0.03380012512207031 3 0.957800982167364 5.986486536182575 3360.0 14.382496133799187 0.0 - - - - - - - 240.95454545454547 6 22 RAB11FIP2 RAB11 family interacting protein 2 (class I) 437 56 C20140605_SFK031_02 C20140605_SFK031_02 TB399628.[MT7]-YSTSVAEK[MT7].2y5_1.heavy 586.824 / 677.395 3029.0 21.135950565338135 41 15 10 6 10 3.6295952328459835 27.551281502425134 0.03380012512207031 3 0.957800982167364 5.986486536182575 3029.0 11.138198064035741 1.0 - - - - - - - 220.85714285714286 12 21 RAB11FIP2 RAB11 family interacting protein 2 (class I) 439 56 C20140605_SFK031_02 C20140605_SFK031_02 TB399628.[MT7]-YSTSVAEK[MT7].2b4_1.heavy 586.824 / 583.284 3218.0 21.135950565338135 41 15 10 6 10 3.6295952328459835 27.551281502425134 0.03380012512207031 3 0.957800982167364 5.986486536182575 3218.0 5.342270732091231 1.0 - - - - - - - 737.5833333333334 6 12 RAB11FIP2 RAB11 family interacting protein 2 (class I) 441 56 C20140605_SFK031_02 C20140605_SFK031_02 TB399628.[MT7]-YSTSVAEK[MT7].2y7_1.heavy 586.824 / 865.475 10317.0 21.135950565338135 41 15 10 6 10 3.6295952328459835 27.551281502425134 0.03380012512207031 3 0.957800982167364 5.986486536182575 10317.0 41.327889928740206 0.0 - - - - - - - 156.89473684210526 20 19 RAB11FIP2 RAB11 family interacting protein 2 (class I) 443 57 C20140605_SFK031_02 C20140605_SFK031_02 TB294982.[MT7]-EELNIIQGALELR.2b3_1.heavy 821.468 / 516.279 51229.0 46.07109832763672 47 17 10 10 10 4.160715890423901 24.034325494359052 0.0 3 0.9757569587582469 7.910200812009732 51229.0 221.5091912625808 0.0 - - - - - - - 265.8888888888889 102 9 CNNM1;CNNM2 cyclin M1;cyclin M2 445 57 C20140605_SFK031_02 C20140605_SFK031_02 TB294982.[MT7]-EELNIIQGALELR.2y8_1.heavy 821.468 / 899.531 60181.0 46.07109832763672 47 17 10 10 10 4.160715890423901 24.034325494359052 0.0 3 0.9757569587582469 7.910200812009732 60181.0 130.38096084644417 0.0 - - - - - - - 683.7142857142857 120 7 CNNM1;CNNM2 cyclin M1;cyclin M2 447 57 C20140605_SFK031_02 C20140605_SFK031_02 TB294982.[MT7]-EELNIIQGALELR.2b4_1.heavy 821.468 / 630.321 81719.0 46.07109832763672 47 17 10 10 10 4.160715890423901 24.034325494359052 0.0 3 0.9757569587582469 7.910200812009732 81719.0 165.06828477460067 0.0 - - - - - - - 228.14285714285714 163 7 CNNM1;CNNM2 cyclin M1;cyclin M2 449 57 C20140605_SFK031_02 C20140605_SFK031_02 TB294982.[MT7]-EELNIIQGALELR.2y10_1.heavy 821.468 / 1126.66 56902.0 46.07109832763672 47 17 10 10 10 4.160715890423901 24.034325494359052 0.0 3 0.9757569587582469 7.910200812009732 56902.0 140.71227845922292 0.0 - - - - - - - 696.2857142857143 113 7 CNNM1;CNNM2 cyclin M1;cyclin M2 451 58 C20140605_SFK031_02 C20140605_SFK031_02 TB556369.[MT7]-EVVSALR.2y5_1.heavy 459.28 / 545.341 64339.0 25.850099563598633 47 17 10 10 10 4.957493097486889 20.171485473311737 0.0 3 0.9765839042215935 8.049223905361899 64339.0 7.8452932248212015 0.0 - - - - - - - 1839.3333333333333 128 3 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 453 58 C20140605_SFK031_02 C20140605_SFK031_02 TB556369.[MT7]-EVVSALR.2b4_1.heavy 459.28 / 559.321 17317.0 25.850099563598633 47 17 10 10 10 4.957493097486889 20.171485473311737 0.0 3 0.9765839042215935 8.049223905361899 17317.0 12.415761864767346 2.0 - - - - - - - 1364.75 115 4 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 455 58 C20140605_SFK031_02 C20140605_SFK031_02 TB556369.[MT7]-EVVSALR.2y6_1.heavy 459.28 / 644.409 114588.0 25.850099563598633 47 17 10 10 10 4.957493097486889 20.171485473311737 0.0 3 0.9765839042215935 8.049223905361899 114588.0 28.070494142641223 0.0 - - - - - - - 919.6666666666666 229 3 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 457 58 C20140605_SFK031_02 C20140605_SFK031_02 TB556369.[MT7]-EVVSALR.2b5_1.heavy 459.28 / 630.358 42912.0 25.850099563598633 47 17 10 10 10 4.957493097486889 20.171485473311737 0.0 3 0.9765839042215935 8.049223905361899 42912.0 19.960625397166496 1.0 - - - - - - - 881.0 85 1 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 459 59 C20140605_SFK031_02 C20140605_SFK031_02 TB561792.[MT7]-GTLAYLPEEY[MT7]IK[MT7].4b4_1.heavy 458.016 / 487.3 108172.0 35.57609939575195 38 8 10 10 10 0.617260810958863 77.21483661352195 0.0 3 0.7765170667113069 2.560345962088654 108172.0 30.28509474581753 0.0 - - - - - - - 344.0 216 1 IRAK1 interleukin-1 receptor-associated kinase 1 461 59 C20140605_SFK031_02 C20140605_SFK031_02 TB561792.[MT7]-GTLAYLPEEY[MT7]IK[MT7].4y6_2.heavy 458.016 / 533.805 116193.0 35.57609939575195 38 8 10 10 10 0.617260810958863 77.21483661352195 0.0 3 0.7765170667113069 2.560345962088654 116193.0 116.931284714732 0.0 - - - - - - - 229.0 232 2 IRAK1 interleukin-1 receptor-associated kinase 1 463 59 C20140605_SFK031_02 C20140605_SFK031_02 TB561792.[MT7]-GTLAYLPEEY[MT7]IK[MT7].4b5_1.heavy 458.016 / 650.363 46294.0 35.57609939575195 38 8 10 10 10 0.617260810958863 77.21483661352195 0.0 3 0.7765170667113069 2.560345962088654 46294.0 60.16870299543866 0.0 - - - - - - - 366.6 92 5 IRAK1 interleukin-1 receptor-associated kinase 1 465 59 C20140605_SFK031_02 C20140605_SFK031_02 TB561792.[MT7]-GTLAYLPEEY[MT7]IK[MT7].4b3_1.heavy 458.016 / 416.263 32772.0 35.57609939575195 38 8 10 10 10 0.617260810958863 77.21483661352195 0.0 3 0.7765170667113069 2.560345962088654 32772.0 18.598371335933166 0.0 - - - - - - - 343.5 65 2 IRAK1 interleukin-1 receptor-associated kinase 1 467 60 C20140605_SFK031_02 C20140605_SFK031_02 TB295053.[MT7]-GPNQPVESDESLGGLSAALR.3y7_1.heavy 714.37 / 687.415 24337.0 37.08340072631836 48 18 10 10 10 4.1746028577411955 23.95437444176624 0.0 3 0.9805641136353419 8.838005470377958 24337.0 32.512025669705906 0.0 - - - - - - - 326.0 48 2 IRAK1 interleukin-1 receptor-associated kinase 1 469 60 C20140605_SFK031_02 C20140605_SFK031_02 TB295053.[MT7]-GPNQPVESDESLGGLSAALR.3b6_1.heavy 714.37 / 737.406 19448.0 37.08340072631836 48 18 10 10 10 4.1746028577411955 23.95437444176624 0.0 3 0.9805641136353419 8.838005470377958 19448.0 18.648580147868493 0.0 - - - - - - - 651.875 38 8 IRAK1 interleukin-1 receptor-associated kinase 1 471 60 C20140605_SFK031_02 C20140605_SFK031_02 TB295053.[MT7]-GPNQPVESDESLGGLSAALR.3y8_1.heavy 714.37 / 744.436 67360.0 37.08340072631836 48 18 10 10 10 4.1746028577411955 23.95437444176624 0.0 3 0.9805641136353419 8.838005470377958 67360.0 30.50835178186914 1.0 - - - - - - - 1691.857142857143 159 7 IRAK1 interleukin-1 receptor-associated kinase 1 473 60 C20140605_SFK031_02 C20140605_SFK031_02 TB295053.[MT7]-GPNQPVESDESLGGLSAALR.3y5_1.heavy 714.37 / 517.309 29226.0 37.08340072631836 48 18 10 10 10 4.1746028577411955 23.95437444176624 0.0 3 0.9805641136353419 8.838005470377958 29226.0 23.55514921580204 0.0 - - - - - - - 435.0 58 1 IRAK1 interleukin-1 receptor-associated kinase 1 475 61 C20140605_SFK031_02 C20140605_SFK031_02 TB294988.[MT7]-GDLDLELVLLC[CAM]K[MT7].2y4_1.heavy 838.481 / 677.414 16461.0 46.03129959106445 46 16 10 10 10 1.4076783591355426 45.80771634422828 0.0 3 0.9664936717211503 6.723242826470551 16461.0 63.87114606741574 0.0 - - - - - - - 864.5714285714286 32 7 ILF3 interleukin enhancer binding factor 3, 90kDa 477 61 C20140605_SFK031_02 C20140605_SFK031_02 TB294988.[MT7]-GDLDLELVLLC[CAM]K[MT7].2b4_1.heavy 838.481 / 545.269 34612.0 46.03129959106445 46 16 10 10 10 1.4076783591355426 45.80771634422828 0.0 3 0.9664936717211503 6.723242826470551 34612.0 62.87198501872659 0.0 - - - - - - - 778.75 69 8 ILF3 interleukin enhancer binding factor 3, 90kDa 479 61 C20140605_SFK031_02 C20140605_SFK031_02 TB294988.[MT7]-GDLDLELVLLC[CAM]K[MT7].2b6_1.heavy 838.481 / 787.395 13702.0 46.03129959106445 46 16 10 10 10 1.4076783591355426 45.80771634422828 0.0 3 0.9664936717211503 6.723242826470551 13702.0 39.00194756554308 0.0 - - - - - - - 745.375 27 8 ILF3 interleukin enhancer binding factor 3, 90kDa 481 61 C20140605_SFK031_02 C20140605_SFK031_02 TB294988.[MT7]-GDLDLELVLLC[CAM]K[MT7].2b7_1.heavy 838.481 / 900.479 10499.0 46.03129959106445 46 16 10 10 10 1.4076783591355426 45.80771634422828 0.0 3 0.9664936717211503 6.723242826470551 10499.0 18.874606741573036 0.0 - - - - - - - 672.4444444444445 20 9 ILF3 interleukin enhancer binding factor 3, 90kDa 483 62 C20140605_SFK031_02 C20140605_SFK031_02 TB295050.[MT7]-FLGQVAINLNDIFEDK[MT7].3b6_1.heavy 708.724 / 760.447 64273.0 51.29992389678955 41 15 10 6 10 1.3143820757930056 45.24037937821908 0.036296844482421875 3 0.9547919262208817 5.782351676353995 64273.0 78.19177168045636 0.0 - - - - - - - 321.1666666666667 128 6 RAB11FIP2 RAB11 family interacting protein 2 (class I) 485 62 C20140605_SFK031_02 C20140605_SFK031_02 TB295050.[MT7]-FLGQVAINLNDIFEDK[MT7].3b4_1.heavy 708.724 / 590.342 83197.0 51.29992389678955 41 15 10 6 10 1.3143820757930056 45.24037937821908 0.036296844482421875 3 0.9547919262208817 5.782351676353995 83197.0 111.3967815727774 0.0 - - - - - - - 252.33333333333334 166 3 RAB11FIP2 RAB11 family interacting protein 2 (class I) 487 62 C20140605_SFK031_02 C20140605_SFK031_02 TB295050.[MT7]-FLGQVAINLNDIFEDK[MT7].3b5_1.heavy 708.724 / 689.41 60557.0 51.29992389678955 41 15 10 6 10 1.3143820757930056 45.24037937821908 0.036296844482421875 3 0.9547919262208817 5.782351676353995 60557.0 191.42511332282223 0.0 - - - - - - - 834.375 121 8 RAB11FIP2 RAB11 family interacting protein 2 (class I) 489 62 C20140605_SFK031_02 C20140605_SFK031_02 TB295050.[MT7]-FLGQVAINLNDIFEDK[MT7].3y4_1.heavy 708.724 / 682.353 83265.0 51.29992389678955 41 15 10 6 10 1.3143820757930056 45.24037937821908 0.036296844482421875 3 0.9547919262208817 5.782351676353995 83265.0 163.25804675391265 0.0 - - - - - - - 295.0 166 7 RAB11FIP2 RAB11 family interacting protein 2 (class I) 491 63 C20140605_SFK031_02 C20140605_SFK031_02 TB557497.[MT7]-VEVEVGK[MT7].2y4_1.heavy 524.318 / 576.347 19382.0 24.854000091552734 36 18 0 10 8 4.603516161427655 21.722526106867782 0.0 4 0.9879838576482305 11.247189112940072 19382.0 22.883786411944406 1.0 - - - - - - - 793.375 457 8 CNNM1 cyclin M1 493 63 C20140605_SFK031_02 C20140605_SFK031_02 TB557497.[MT7]-VEVEVGK[MT7].2b4_1.heavy 524.318 / 601.331 13665.0 24.854000091552734 36 18 0 10 8 4.603516161427655 21.722526106867782 0.0 4 0.9879838576482305 11.247189112940072 13665.0 19.626595119824707 0.0 - - - - - - - 1293.375 27 8 CNNM1 cyclin M1 495 63 C20140605_SFK031_02 C20140605_SFK031_02 TB557497.[MT7]-VEVEVGK[MT7].2y3_1.heavy 524.318 / 447.305 19439.0 24.854000091552734 36 18 0 10 8 4.603516161427655 21.722526106867782 0.0 4 0.9879838576482305 11.247189112940072 19439.0 17.923995322933592 0.0 - - - - - - - 1701.125 38 8 CNNM1 cyclin M1 497 63 C20140605_SFK031_02 C20140605_SFK031_02 TB557497.[MT7]-VEVEVGK[MT7].2y6_1.heavy 524.318 / 804.458 16466.0 24.854000091552734 36 18 0 10 8 4.603516161427655 21.722526106867782 0.0 4 0.9879838576482305 11.247189112940072 16466.0 37.565516693163744 0.0 - - - - - - - 686.125 32 8 CNNM1 cyclin M1 499 64 C20140605_SFK031_02 C20140605_SFK031_02 TB561230.[MT7]-ELDEEESIRK[MT7].3y6_1.heavy 512.61 / 905.517 2219.0 23.402700424194336 42 12 10 10 10 3.1807489113802934 31.43913675242123 0.0 3 0.8978246976832441 3.827544685690939 2219.0 30.758415841584156 0.0 - - - - - - - 139.72727272727272 4 22 KIAA1279 KIAA1279 501 64 C20140605_SFK031_02 C20140605_SFK031_02 TB561230.[MT7]-ELDEEESIRK[MT7].3b4_1.heavy 512.61 / 631.305 13467.0 23.402700424194336 42 12 10 10 10 3.1807489113802934 31.43913675242123 0.0 3 0.8978246976832441 3.827544685690939 13467.0 36.69988443185208 0.0 - - - - - - - 692.3636363636364 26 11 KIAA1279 KIAA1279 503 64 C20140605_SFK031_02 C20140605_SFK031_02 TB561230.[MT7]-ELDEEESIRK[MT7].3b5_1.heavy 512.61 / 760.348 8726.0 23.402700424194336 42 12 10 10 10 3.1807489113802934 31.43913675242123 0.0 3 0.8978246976832441 3.827544685690939 8726.0 54.645495049504945 0.0 - - - - - - - 260.7083333333333 17 24 KIAA1279 KIAA1279 505 64 C20140605_SFK031_02 C20140605_SFK031_02 TB561230.[MT7]-ELDEEESIRK[MT7].3b3_1.heavy 512.61 / 502.263 36821.0 23.402700424194336 42 12 10 10 10 3.1807489113802934 31.43913675242123 0.0 3 0.8978246976832441 3.827544685690939 36821.0 47.871586733562474 0.0 - - - - - - - 1737.2222222222222 73 9 KIAA1279 KIAA1279 507 65 C20140605_SFK031_02 C20140605_SFK031_02 TB399793.[MT7]-SDAVLDFATVSEILR.3y7_1.heavy 593.992 / 817.478 57473.0 49.730098724365234 50 20 10 10 10 27.009694535372354 3.7023743407774683 0.0 3 0.99951969035481 56.30984492372271 57473.0 204.58992763772176 0.0 - - - - - - - 340.0 114 15 CNNM1 cyclin M1 509 65 C20140605_SFK031_02 C20140605_SFK031_02 TB399793.[MT7]-SDAVLDFATVSEILR.3b6_1.heavy 593.992 / 745.385 118414.0 49.730098724365234 50 20 10 10 10 27.009694535372354 3.7023743407774683 0.0 3 0.99951969035481 56.30984492372271 118414.0 337.63468954248367 0.0 - - - - - - - 324.8888888888889 236 9 CNNM1 cyclin M1 511 65 C20140605_SFK031_02 C20140605_SFK031_02 TB399793.[MT7]-SDAVLDFATVSEILR.3b4_1.heavy 593.992 / 517.274 96105.0 49.730098724365234 50 20 10 10 10 27.009694535372354 3.7023743407774683 0.0 3 0.99951969035481 56.30984492372271 96105.0 152.63153514537245 0.0 - - - - - - - 720.8 192 10 CNNM1 cyclin M1 513 65 C20140605_SFK031_02 C20140605_SFK031_02 TB399793.[MT7]-SDAVLDFATVSEILR.3y5_1.heavy 593.992 / 617.362 126440.0 49.730098724365234 50 20 10 10 10 27.009694535372354 3.7023743407774683 0.0 3 0.99951969035481 56.30984492372271 126440.0 333.76441176470587 0.0 - - - - - - - 266.7692307692308 252 13 CNNM1 cyclin M1 515 66 C20140605_SFK031_02 C20140605_SFK031_02 TB399794.[MT7]-C[CAM]PVVLAPLLYPEK[MT7].3b6_1.heavy 596.351 / 784.451 38830.0 43.498199462890625 48 18 10 10 10 10.000337863505761 9.999662147909028 0.0 3 0.9855743936637698 10.262941778650184 38830.0 40.60088987764182 0.0 - - - - - - - 210.0 77 3 CNOT1 CCR4-NOT transcription complex, subunit 1 517 66 C20140605_SFK031_02 C20140605_SFK031_02 TB399794.[MT7]-C[CAM]PVVLAPLLYPEK[MT7].3y3_1.heavy 596.351 / 517.31 76311.0 43.498199462890625 48 18 10 10 10 10.000337863505761 9.999662147909028 0.0 3 0.9855743936637698 10.262941778650184 76311.0 32.34897542399893 1.0 - - - - - - - 873.2857142857143 153 7 CNOT1 CCR4-NOT transcription complex, subunit 1 519 66 C20140605_SFK031_02 C20140605_SFK031_02 TB399794.[MT7]-C[CAM]PVVLAPLLYPEK[MT7].3b4_1.heavy 596.351 / 600.33 31549.0 43.498199462890625 48 18 10 10 10 10.000337863505761 9.999662147909028 0.0 3 0.9855743936637698 10.262941778650184 31549.0 25.390462328767125 0.0 - - - - - - - 269.75 63 4 CNOT1 CCR4-NOT transcription complex, subunit 1 521 66 C20140605_SFK031_02 C20140605_SFK031_02 TB399794.[MT7]-C[CAM]PVVLAPLLYPEK[MT7].3b5_1.heavy 596.351 / 713.414 24898.0 43.498199462890625 48 18 10 10 10 10.000337863505761 9.999662147909028 0.0 3 0.9855743936637698 10.262941778650184 24898.0 16.275465924895688 0.0 - - - - - - - 404.5 49 2 CNOT1 CCR4-NOT transcription complex, subunit 1 523 67 C20140605_SFK031_02 C20140605_SFK031_02 TB294857.[MT7]-ELDEEESIR.2b3_1.heavy 632.313 / 502.263 9892.0 25.248600006103516 44 14 10 10 10 3.0946148062304917 25.881745842261104 0.0 3 0.9386619859964977 4.957380153350424 9892.0 20.6342378451008 0.0 - - - - - - - 1276.5714285714287 19 7 KIAA1279 KIAA1279 525 67 C20140605_SFK031_02 C20140605_SFK031_02 TB294857.[MT7]-ELDEEESIR.2y8_1.heavy 632.313 / 990.474 10791.0 25.248600006103516 44 14 10 10 10 3.0946148062304917 25.881745842261104 0.0 3 0.9386619859964977 4.957380153350424 10791.0 64.34123921560345 0.0 - - - - - - - 224.75 21 20 KIAA1279 KIAA1279 527 67 C20140605_SFK031_02 C20140605_SFK031_02 TB294857.[MT7]-ELDEEESIR.2y6_1.heavy 632.313 / 762.363 7082.0 25.248600006103516 44 14 10 10 10 3.0946148062304917 25.881745842261104 0.0 3 0.9386619859964977 4.957380153350424 7082.0 25.407557846764096 0.0 - - - - - - - 252.83333333333334 14 18 KIAA1279 KIAA1279 529 67 C20140605_SFK031_02 C20140605_SFK031_02 TB294857.[MT7]-ELDEEESIR.2y7_1.heavy 632.313 / 877.39 3934.0 25.248600006103516 44 14 10 10 10 3.0946148062304917 25.881745842261104 0.0 3 0.9386619859964977 4.957380153350424 3934.0 22.743124681933843 0.0 - - - - - - - 246.7826086956522 7 23 KIAA1279 KIAA1279 531 68 C20140605_SFK031_02 C20140605_SFK031_02 TB399796.[MT7]-SFLEFAEDVIQVPR.3y11_2.heavy 598.657 / 651.838 173.0 51.78239822387695 44 14 10 10 10 2.970782674329927 26.330778095363044 0.0 3 0.9426488065619354 5.128535377408468 173.0 0.9008695652173913 22.0 - - - - - - - 0.0 0 0 FMR1 fragile X mental retardation 1 533 68 C20140605_SFK031_02 C20140605_SFK031_02 TB399796.[MT7]-SFLEFAEDVIQVPR.3b4_1.heavy 598.657 / 621.336 157781.0 51.78239822387695 44 14 10 10 10 2.970782674329927 26.330778095363044 0.0 3 0.9426488065619354 5.128535377408468 157781.0 600.2117181915178 0.0 - - - - - - - 208.75 315 8 FMR1 fragile X mental retardation 1 535 68 C20140605_SFK031_02 C20140605_SFK031_02 TB399796.[MT7]-SFLEFAEDVIQVPR.3b8_1.heavy 598.657 / 1083.51 60743.0 51.78239822387695 44 14 10 10 10 2.970782674329927 26.330778095363044 0.0 3 0.9426488065619354 5.128535377408468 60743.0 216.562 0.0 - - - - - - - 230.0 121 8 FMR1 fragile X mental retardation 1 537 68 C20140605_SFK031_02 C20140605_SFK031_02 TB399796.[MT7]-SFLEFAEDVIQVPR.3y5_1.heavy 598.657 / 612.383 112684.0 51.78239822387695 44 14 10 10 10 2.970782674329927 26.330778095363044 0.0 3 0.9426488065619354 5.128535377408468 112684.0 325.6248279287175 0.0 - - - - - - - 335.6666666666667 225 6 FMR1 fragile X mental retardation 1 539 69 C20140605_SFK031_02 C20140605_SFK031_02 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 5028.0 38.628466288248696 19 -3 10 6 6 null 0.0 0.0355987548828125 5 0.0 0.0 5028.0 1.486840808279941 0.0 - - - - - - - 309.0 10 2 541 69 C20140605_SFK031_02 C20140605_SFK031_02 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 2117.0 38.628466288248696 19 -3 10 6 6 null 0.0 0.0355987548828125 5 0.0 0.0 2117.0 0.5332493702770781 3.0 - - - - - - - 771.875 5 8 543 69 C20140605_SFK031_02 C20140605_SFK031_02 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 3970.0 38.628466288248696 19 -3 10 6 6 null 0.0 0.0355987548828125 5 0.0 0.0 3970.0 2.1173333333333333 0.0 - - - - - - - 1279.0 7 8 545 70 C20140605_SFK031_02 C20140605_SFK031_02 TB561882.[MT7]-WFPTHVQVTVLQAK[MT7].3y6_1.heavy 648.043 / 803.511 33683.0 38.56400108337402 36 10 10 6 10 1.342090844466405 50.7158322494973 0.034000396728515625 3 0.8284531653528554 2.93600970059491 33683.0 79.25923593422645 0.0 - - - - - - - 774.8888888888889 67 9 RAB11FIP2 RAB11 family interacting protein 2 (class I) 547 70 C20140605_SFK031_02 C20140605_SFK031_02 TB561882.[MT7]-WFPTHVQVTVLQAK[MT7].3b4_1.heavy 648.043 / 676.357 18723.0 38.56400108337402 36 10 10 6 10 1.342090844466405 50.7158322494973 0.034000396728515625 3 0.8284531653528554 2.93600970059491 18723.0 18.794434367954295 2.0 - - - - - - - 1274.6666666666667 96 9 RAB11FIP2 RAB11 family interacting protein 2 (class I) 549 70 C20140605_SFK031_02 C20140605_SFK031_02 TB561882.[MT7]-WFPTHVQVTVLQAK[MT7].3y4_1.heavy 648.043 / 603.395 47542.0 38.56400108337402 36 10 10 6 10 1.342090844466405 50.7158322494973 0.034000396728515625 3 0.8284531653528554 2.93600970059491 47542.0 29.27035740066351 0.0 - - - - - - - 1757.0 95 7 RAB11FIP2 RAB11 family interacting protein 2 (class I) 551 70 C20140605_SFK031_02 C20140605_SFK031_02 TB561882.[MT7]-WFPTHVQVTVLQAK[MT7].3b7_2.heavy 648.043 / 520.775 62410.0 38.56400108337402 36 10 10 6 10 1.342090844466405 50.7158322494973 0.034000396728515625 3 0.8284531653528554 2.93600970059491 62410.0 112.89821656485785 0.0 - - - - - - - 786.5714285714286 124 7 RAB11FIP2 RAB11 family interacting protein 2 (class I) 553 71 C20140605_SFK031_02 C20140605_SFK031_02 TB561933.[MT7]-FC[CAM]IDASQPDVGSWLK[MT7].3b4_1.heavy 671.011 / 680.319 44989.0 41.588401794433594 44 14 10 10 10 2.0070643270952386 49.82401343594546 0.0 3 0.9318582384922048 4.700652629513228 44989.0 77.08489704658618 0.0 - - - - - - - 804.5555555555555 89 9 MECOM MDS1 and EVI1 complex locus 555 71 C20140605_SFK031_02 C20140605_SFK031_02 TB561933.[MT7]-FC[CAM]IDASQPDVGSWLK[MT7].3b5_1.heavy 671.011 / 751.357 25708.0 41.588401794433594 44 14 10 10 10 2.0070643270952386 49.82401343594546 0.0 3 0.9318582384922048 4.700652629513228 25708.0 12.7352964693958 0.0 - - - - - - - 871.375 51 8 MECOM MDS1 and EVI1 complex locus 557 71 C20140605_SFK031_02 C20140605_SFK031_02 TB561933.[MT7]-FC[CAM]IDASQPDVGSWLK[MT7].3y8_1.heavy 671.011 / 1045.58 38562.0 41.588401794433594 44 14 10 10 10 2.0070643270952386 49.82401343594546 0.0 3 0.9318582384922048 4.700652629513228 38562.0 47.66689092670158 0.0 - - - - - - - 778.7 77 10 MECOM MDS1 and EVI1 complex locus 559 71 C20140605_SFK031_02 C20140605_SFK031_02 TB561933.[MT7]-FC[CAM]IDASQPDVGSWLK[MT7].3y5_1.heavy 671.011 / 734.432 42545.0 41.588401794433594 44 14 10 10 10 2.0070643270952386 49.82401343594546 0.0 3 0.9318582384922048 4.700652629513228 42545.0 49.39353643474681 0.0 - - - - - - - 850.9 85 10 MECOM MDS1 and EVI1 complex locus 561 72 C20140605_SFK031_02 C20140605_SFK031_02 TB561884.[MT7]-NRPVDYFVLLLQGK[MT7].4b8_1.heavy 488.291 / 1135.6 N/A 48.001949310302734 34 8 10 6 10 0.4296907206822152 106.83587333465158 0.035400390625 3 0.7594513787489124 2.464016518855752 0.0 -0.0 0.0 - - - - - - - 0.0 0 0 CNNM1 cyclin M1 563 72 C20140605_SFK031_02 C20140605_SFK031_02 TB561884.[MT7]-NRPVDYFVLLLQGK[MT7].4b5_1.heavy 488.291 / 726.401 8263.0 48.001949310302734 34 8 10 6 10 0.4296907206822152 106.83587333465158 0.035400390625 3 0.7594513787489124 2.464016518855752 8263.0 51.55280503144654 0.0 - - - - - - - 208.5 16 8 CNNM1 cyclin M1 565 72 C20140605_SFK031_02 C20140605_SFK031_02 TB561884.[MT7]-NRPVDYFVLLLQGK[MT7].4b7_1.heavy 488.291 / 1036.53 238.0 48.001949310302734 34 8 10 6 10 0.4296907206822152 106.83587333465158 0.035400390625 3 0.7594513787489124 2.464016518855752 238.0 -1.4968553459119496 0.0 - - - - - - - 0.0 0 0 CNNM1 cyclin M1 567 72 C20140605_SFK031_02 C20140605_SFK031_02 TB561884.[MT7]-NRPVDYFVLLLQGK[MT7].4b6_1.heavy 488.291 / 889.465 8581.0 48.001949310302734 34 8 10 6 10 0.4296907206822152 106.83587333465158 0.035400390625 3 0.7594513787489124 2.464016518855752 8581.0 121.98847878072887 0.0 - - - - - - - 204.14285714285714 17 7 CNNM1 cyclin M1 569 73 C20140605_SFK031_02 C20140605_SFK031_02 TB561461.[MT7]-AVSDWIDEQEK[MT7].2y4_1.heavy 804.411 / 677.359 13178.0 33.42390060424805 48 18 10 10 10 3.770362743569226 26.522646970921073 0.0 3 0.9888726434299757 11.688608989167989 13178.0 32.05651564185545 0.0 - - - - - - - 706.2857142857143 26 7 ILF3 interleukin enhancer binding factor 3, 90kDa 571 73 C20140605_SFK031_02 C20140605_SFK031_02 TB561461.[MT7]-AVSDWIDEQEK[MT7].2y5_1.heavy 804.411 / 792.386 13384.0 33.42390060424805 48 18 10 10 10 3.770362743569226 26.522646970921073 0.0 3 0.9888726434299757 11.688608989167989 13384.0 50.9371650485437 0.0 - - - - - - - 206.0 26 10 ILF3 interleukin enhancer binding factor 3, 90kDa 573 73 C20140605_SFK031_02 C20140605_SFK031_02 TB561461.[MT7]-AVSDWIDEQEK[MT7].2b4_1.heavy 804.411 / 517.274 49726.0 33.42390060424805 48 18 10 10 10 3.770362743569226 26.522646970921073 0.0 3 0.9888726434299757 11.688608989167989 49726.0 85.58807786206867 0.0 - - - - - - - 231.75 99 8 ILF3 interleukin enhancer binding factor 3, 90kDa 575 73 C20140605_SFK031_02 C20140605_SFK031_02 TB561461.[MT7]-AVSDWIDEQEK[MT7].2y7_1.heavy 804.411 / 1091.55 24194.0 33.42390060424805 48 18 10 10 10 3.770362743569226 26.522646970921073 0.0 3 0.9888726434299757 11.688608989167989 24194.0 51.41551240560949 0.0 - - - - - - - 274.6666666666667 48 12 ILF3 interleukin enhancer binding factor 3, 90kDa 577 74 C20140605_SFK031_02 C20140605_SFK031_02 TB556970.[MT7]-ASPAPSGPR.2y8_1.heavy 492.273 / 768.4 16648.0 15.906749963760376 41 18 10 3 10 4.500828348423398 22.21813236557425 0.06479930877685547 3 0.9890378188424817 11.776503026890298 16648.0 99.34660162601625 0.0 - - - - - - - 161.0 33 21 RBM20 RNA binding motif protein 20 579 74 C20140605_SFK031_02 C20140605_SFK031_02 TB556970.[MT7]-ASPAPSGPR.2y5_1.heavy 492.273 / 513.278 4149.0 15.906749963760376 41 18 10 3 10 4.500828348423398 22.21813236557425 0.06479930877685547 3 0.9890378188424817 11.776503026890298 4149.0 16.704242136014674 0.0 - - - - - - - 230.55555555555554 8 18 RBM20 RNA binding motif protein 20 581 74 C20140605_SFK031_02 C20140605_SFK031_02 TB556970.[MT7]-ASPAPSGPR.2y6_1.heavy 492.273 / 584.315 1793.0 15.906749963760376 41 18 10 3 10 4.500828348423398 22.21813236557425 0.06479930877685547 3 0.9890378188424817 11.776503026890298 1793.0 5.545572009923399 1.0 - - - - - - - 243.95238095238096 9 21 RBM20 RNA binding motif protein 20 583 74 C20140605_SFK031_02 C20140605_SFK031_02 TB556970.[MT7]-ASPAPSGPR.2y7_1.heavy 492.273 / 681.368 16802.0 15.906749963760376 41 18 10 3 10 4.500828348423398 22.21813236557425 0.06479930877685547 3 0.9890378188424817 11.776503026890298 16802.0 68.37513057103064 0.0 - - - - - - - 194.55 33 20 RBM20 RNA binding motif protein 20 585 75 C20140605_SFK031_02 C20140605_SFK031_02 TB562209.[MT7]-LLPGAVATIVK[MT7]PLSAIPQPTITK[MT7].4y5_1.heavy 690.939 / 703.447 127840.0 46.11090087890625 50 20 10 10 10 8.171140695412214 12.238193384204756 0.0 3 0.996059503525033 19.6536937125817 127840.0 227.7673251727448 0.0 - - - - - - - 311.75 255 4 HNF4A hepatocyte nuclear factor 4, alpha 587 75 C20140605_SFK031_02 C20140605_SFK031_02 TB562209.[MT7]-LLPGAVATIVK[MT7]PLSAIPQPTITK[MT7].4b5_1.heavy 690.939 / 596.389 34790.0 46.11090087890625 50 20 10 10 10 8.171140695412214 12.238193384204756 0.0 3 0.996059503525033 19.6536937125817 34790.0 34.852614626361486 0.0 - - - - - - - 332.75 69 4 HNF4A hepatocyte nuclear factor 4, alpha 589 75 C20140605_SFK031_02 C20140605_SFK031_02 TB562209.[MT7]-LLPGAVATIVK[MT7]PLSAIPQPTITK[MT7].4y3_1.heavy 690.939 / 505.347 27882.0 46.11090087890625 50 20 10 10 10 8.171140695412214 12.238193384204756 0.0 3 0.996059503525033 19.6536937125817 27882.0 30.099675307162308 0.0 - - - - - - - 1695.875 55 8 HNF4A hepatocyte nuclear factor 4, alpha 591 75 C20140605_SFK031_02 C20140605_SFK031_02 TB562209.[MT7]-LLPGAVATIVK[MT7]PLSAIPQPTITK[MT7].4b6_1.heavy 690.939 / 695.457 22222.0 46.11090087890625 50 20 10 10 10 8.171140695412214 12.238193384204756 0.0 3 0.996059503525033 19.6536937125817 22222.0 46.52548196740953 0.0 - - - - - - - 286.55555555555554 44 9 HNF4A hepatocyte nuclear factor 4, alpha 593 76 C20140605_SFK031_02 C20140605_SFK031_02 TB556973.[MT7]-NNPEPGGR.2y5_1.heavy 492.753 / 515.257 1650.0 13.780399799346924 42 16 10 6 10 1.9271047466710534 40.324529082183886 0.034399986267089844 3 0.9629704401890784 6.393501312976469 1650.0 45.48625518672199 0.0 - - - - - - - 129.55555555555554 3 18 GBX1 gastrulation brain homeobox 1 595 76 C20140605_SFK031_02 C20140605_SFK031_02 TB556973.[MT7]-NNPEPGGR.2b4_1.heavy 492.753 / 599.291 12032.0 13.780399799346924 42 16 10 6 10 1.9271047466710534 40.324529082183886 0.034399986267089844 3 0.9629704401890784 6.393501312976469 12032.0 36.683506968468905 0.0 - - - - - - - 145.94736842105263 24 19 GBX1 gastrulation brain homeobox 1 597 76 C20140605_SFK031_02 C20140605_SFK031_02 TB556973.[MT7]-NNPEPGGR.2y6_1.heavy 492.753 / 612.31 18913.0 13.780399799346924 42 16 10 6 10 1.9271047466710534 40.324529082183886 0.034399986267089844 3 0.9629704401890784 6.393501312976469 18913.0 233.6695925414365 0.0 - - - - - - - 149.66666666666666 37 18 GBX1 gastrulation brain homeobox 1 599 76 C20140605_SFK031_02 C20140605_SFK031_02 TB556973.[MT7]-NNPEPGGR.2y7_1.heavy 492.753 / 726.353 8772.0 13.780399799346924 42 16 10 6 10 1.9271047466710534 40.324529082183886 0.034399986267089844 3 0.9629704401890784 6.393501312976469 8772.0 54.11582089552238 0.0 - - - - - - - 212.88235294117646 17 17 GBX1 gastrulation brain homeobox 1 601 77 C20140605_SFK031_02 C20140605_SFK031_02 TB294712.[MT7]-TNTPVK[MT7].2y4_1.heavy 474.292 / 588.384 5622.0 16.275800704956055 46 20 10 10 6 6.000242630275001 16.665992720933826 0.0 6 0.9926872385158763 14.423034830124775 5622.0 12.329455068240106 0.0 - - - - - - - 697.0666666666667 11 15 GTF2I general transcription factor IIi 603 77 C20140605_SFK031_02 C20140605_SFK031_02 TB294712.[MT7]-TNTPVK[MT7].2y5_1.heavy 474.292 / 702.427 5570.0 16.275800704956055 46 20 10 10 6 6.000242630275001 16.665992720933826 0.0 6 0.9926872385158763 14.423034830124775 5570.0 14.38067607316849 3.0 - - - - - - - 221.5 20 14 GTF2I general transcription factor IIi 605 77 C20140605_SFK031_02 C20140605_SFK031_02 TB294712.[MT7]-TNTPVK[MT7].2y3_1.heavy 474.292 / 487.336 17865.0 16.275800704956055 46 20 10 10 6 6.000242630275001 16.665992720933826 0.0 6 0.9926872385158763 14.423034830124775 17865.0 24.927906976744186 0.0 - - - - - - - 728.6 35 15 GTF2I general transcription factor IIi 607 78 C20140605_SFK031_02 C20140605_SFK031_02 TB562109.[MT7]-Y[MT7]IPAFC[CAM]ELPLDDQVALLR.3y6_1.heavy 807.775 / 699.451 13391.0 45.083449363708496 37 11 10 6 10 0.9823722985390786 67.4186632390738 0.036998748779296875 3 0.8551327869219086 3.2025012925211507 13391.0 14.893856613102596 1.0 - - - - - - - 719.0 26 7 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 609 78 C20140605_SFK031_02 C20140605_SFK031_02 TB562109.[MT7]-Y[MT7]IPAFC[CAM]ELPLDDQVALLR.3y8_1.heavy 807.775 / 929.505 23457.0 45.083449363708496 37 11 10 6 10 0.9823722985390786 67.4186632390738 0.036998748779296875 3 0.8551327869219086 3.2025012925211507 23457.0 69.83514748116973 0.0 - - - - - - - 679.0 46 9 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 611 78 C20140605_SFK031_02 C20140605_SFK031_02 TB562109.[MT7]-Y[MT7]IPAFC[CAM]ELPLDDQVALLR.3b7_2.heavy 807.775 / 585.299 97871.0 45.083449363708496 37 11 10 6 10 0.9823722985390786 67.4186632390738 0.036998748779296875 3 0.8551327869219086 3.2025012925211507 97871.0 54.22194533250582 0.0 - - - - - - - 449.0 195 3 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 613 78 C20140605_SFK031_02 C20140605_SFK031_02 TB562109.[MT7]-Y[MT7]IPAFC[CAM]ELPLDDQVALLR.3y10_1.heavy 807.775 / 1139.64 97961.0 45.083449363708496 37 11 10 6 10 0.9823722985390786 67.4186632390738 0.036998748779296875 3 0.8551327869219086 3.2025012925211507 97961.0 92.46256068717003 0.0 - - - - - - - 180.0 195 1 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 615 79 C20140605_SFK031_02 C20140605_SFK031_02 TB399538.[MT7]-AAAESAEAQTIR.3b6_1.heavy 454.576 / 645.332 58475.0 21.39620018005371 46 16 10 10 10 1.9532769696059686 35.07246307796957 0.0 3 0.9623972671008 6.344279333783305 58475.0 98.75394451303667 0.0 - - - - - - - 682.6666666666666 116 9 TOX3 TOX high mobility group box family member 3 617 79 C20140605_SFK031_02 C20140605_SFK031_02 TB399538.[MT7]-AAAESAEAQTIR.3b5_1.heavy 454.576 / 574.295 122249.0 21.39620018005371 46 16 10 10 10 1.9532769696059686 35.07246307796957 0.0 3 0.9623972671008 6.344279333783305 122249.0 54.361221320956616 0.0 - - - - - - - 758.1666666666666 244 6 TOX3 TOX high mobility group box family member 3 619 79 C20140605_SFK031_02 C20140605_SFK031_02 TB399538.[MT7]-AAAESAEAQTIR.3y4_1.heavy 454.576 / 517.309 149962.0 21.39620018005371 46 16 10 10 10 1.9532769696059686 35.07246307796957 0.0 3 0.9623972671008 6.344279333783305 149962.0 100.51740609612236 0.0 - - - - - - - 750.0 299 1 TOX3 TOX high mobility group box family member 3 621 79 C20140605_SFK031_02 C20140605_SFK031_02 TB399538.[MT7]-AAAESAEAQTIR.3y5_1.heavy 454.576 / 588.346 187335.0 21.39620018005371 46 16 10 10 10 1.9532769696059686 35.07246307796957 0.0 3 0.9623972671008 6.344279333783305 187335.0 190.2868301599391 0.0 - - - - - - - 1266.125 374 8 TOX3 TOX high mobility group box family member 3 623 80 C20140605_SFK031_02 C20140605_SFK031_02 TB561469.[MT7]-EQLLVLVEWAK[MT7].3y3_1.heavy 539.327 / 548.331 203037.0 48.301998138427734 43 13 10 10 10 2.7318718646030735 36.60493791663595 0.0 3 0.9207478108418015 4.354576203378854 203037.0 574.4471789500664 0.0 - - - - - - - 740.1428571428571 406 7 HNF4A hepatocyte nuclear factor 4, alpha 625 80 C20140605_SFK031_02 C20140605_SFK031_02 TB561469.[MT7]-EQLLVLVEWAK[MT7].3b4_1.heavy 539.327 / 628.379 224385.0 48.301998138427734 43 13 10 10 10 2.7318718646030735 36.60493791663595 0.0 3 0.9207478108418015 4.354576203378854 224385.0 490.6106124724367 0.0 - - - - - - - 707.0 448 7 HNF4A hepatocyte nuclear factor 4, alpha 627 80 C20140605_SFK031_02 C20140605_SFK031_02 TB561469.[MT7]-EQLLVLVEWAK[MT7].3b5_1.heavy 539.327 / 727.447 203733.0 48.301998138427734 43 13 10 10 10 2.7318718646030735 36.60493791663595 0.0 3 0.9207478108418015 4.354576203378854 203733.0 684.238372242061 0.0 - - - - - - - 275.0 407 9 HNF4A hepatocyte nuclear factor 4, alpha 629 80 C20140605_SFK031_02 C20140605_SFK031_02 TB561469.[MT7]-EQLLVLVEWAK[MT7].3b3_1.heavy 539.327 / 515.295 119192.0 48.301998138427734 43 13 10 10 10 2.7318718646030735 36.60493791663595 0.0 3 0.9207478108418015 4.354576203378854 119192.0 159.25765104445992 0.0 - - - - - - - 721.7777777777778 238 9 HNF4A hepatocyte nuclear factor 4, alpha 631 81 C20140605_SFK031_02 C20140605_SFK031_02 TB294912.[MT7]-EAAGAAGSGK[MT7]K[MT7].3y6_1.heavy 460.272 / 835.524 3766.0 14.01140022277832 38 18 2 10 8 6.417207323564042 15.583102579964827 0.0 4 0.9815834831878777 9.080083556505178 3766.0 54.25593220338983 0.0 - - - - - - - 96.0909090909091 7 11 FOXA2 forkhead box A2 633 81 C20140605_SFK031_02 C20140605_SFK031_02 TB294912.[MT7]-EAAGAAGSGK[MT7]K[MT7].3y3_1.heavy 460.272 / 620.433 6629.0 14.01140022277832 38 18 2 10 8 6.417207323564042 15.583102579964827 0.0 4 0.9815834831878777 9.080083556505178 6629.0 19.42254777070064 1.0 - - - - - - - 176.5 54 18 FOXA2 forkhead box A2 635 81 C20140605_SFK031_02 C20140605_SFK031_02 TB294912.[MT7]-EAAGAAGSGK[MT7]K[MT7].3b5_1.heavy 460.272 / 544.285 6826.0 14.01140022277832 38 18 2 10 8 6.417207323564042 15.583102579964827 0.0 4 0.9815834831878777 9.080083556505178 6826.0 15.197411487347189 0.0 - - - - - - - 666.8333333333334 13 12 FOXA2 forkhead box A2 637 81 C20140605_SFK031_02 C20140605_SFK031_02 TB294912.[MT7]-EAAGAAGSGK[MT7]K[MT7].3y5_1.heavy 460.272 / 764.487 9415.0 14.01140022277832 38 18 2 10 8 6.417207323564042 15.583102579964827 0.0 4 0.9815834831878777 9.080083556505178 9415.0 47.76900753361019 0.0 - - - - - - - 162.06666666666666 18 15 FOXA2 forkhead box A2 639 82 C20140605_SFK031_02 C20140605_SFK031_02 TB561546.[MT7]-YFGSTGLVGLQDK[MT7].3b6_1.heavy 558.31 / 757.364 39057.0 37.376399993896484 44 14 10 10 10 1.9556534471219125 40.58318349180767 0.0 3 0.9321252519523401 4.7099970276707435 39057.0 37.684895284825274 0.0 - - - - - - - 775.4285714285714 78 7 MECOM MDS1 and EVI1 complex locus 641 82 C20140605_SFK031_02 C20140605_SFK031_02 TB561546.[MT7]-YFGSTGLVGLQDK[MT7].3b3_1.heavy 558.31 / 512.263 9190.0 37.376399993896484 44 14 10 10 10 1.9556534471219125 40.58318349180767 0.0 3 0.9321252519523401 4.7099970276707435 9190.0 5.7873828269978596 1.0 - - - - - - - 731.0 18 2 MECOM MDS1 and EVI1 complex locus 643 82 C20140605_SFK031_02 C20140605_SFK031_02 TB561546.[MT7]-YFGSTGLVGLQDK[MT7].3b7_1.heavy 558.31 / 870.448 32478.0 37.376399993896484 44 14 10 10 10 1.9556534471219125 40.58318349180767 0.0 3 0.9321252519523401 4.7099970276707435 32478.0 65.30151063829786 0.0 - - - - - - - 769.0 64 11 MECOM MDS1 and EVI1 complex locus 645 82 C20140605_SFK031_02 C20140605_SFK031_02 TB561546.[MT7]-YFGSTGLVGLQDK[MT7].3y5_1.heavy 558.31 / 704.406 55349.0 37.376399993896484 44 14 10 10 10 1.9556534471219125 40.58318349180767 0.0 3 0.9321252519523401 4.7099970276707435 55349.0 68.19955094459458 0.0 - - - - - - - 793.6 110 10 MECOM MDS1 and EVI1 complex locus 647 83 C20140605_SFK031_02 C20140605_SFK031_02 TB294911.[MT7]-VRIEAENEK[MT7].3b6_1.heavy 459.264 / 842.485 13652.0 20.760924816131592 40 14 10 6 10 1.9630369538144514 40.33716933648435 0.030500411987304688 3 0.9307033792566198 4.660858611996622 13652.0 172.60028571428575 0.0 - - - - - - - 159.15 27 20 FMR1 fragile X mental retardation 1 649 83 C20140605_SFK031_02 C20140605_SFK031_02 TB294911.[MT7]-VRIEAENEK[MT7].3y3_1.heavy 459.264 / 534.3 70970.0 20.760924816131592 40 14 10 6 10 1.9630369538144514 40.33716933648435 0.030500411987304688 3 0.9307033792566198 4.660858611996622 70970.0 66.9751816018052 0.0 - - - - - - - 1268.125 141 8 FMR1 fragile X mental retardation 1 651 83 C20140605_SFK031_02 C20140605_SFK031_02 TB294911.[MT7]-VRIEAENEK[MT7].3b4_1.heavy 459.264 / 642.406 25480.0 20.760924816131592 40 14 10 6 10 1.9630369538144514 40.33716933648435 0.030500411987304688 3 0.9307033792566198 4.660858611996622 25480.0 17.99200827112127 0.0 - - - - - - - 1295.857142857143 50 7 FMR1 fragile X mental retardation 1 653 83 C20140605_SFK031_02 C20140605_SFK031_02 TB294911.[MT7]-VRIEAENEK[MT7].3b4_2.heavy 459.264 / 321.706 55588.0 20.760924816131592 40 14 10 6 10 1.9630369538144514 40.33716933648435 0.030500411987304688 3 0.9307033792566198 4.660858611996622 55588.0 155.00473298289825 0.0 - - - - - - - 685.6666666666666 111 9 FMR1 fragile X mental retardation 1 655 84 C20140605_SFK031_02 C20140605_SFK031_02 TB561465.[MT7]-AVSDWIDEQEK[MT7].3b4_1.heavy 536.61 / 517.274 349876.0 33.42390060424805 50 20 10 10 10 11.135021260056712 8.980674366443974 0.0 3 0.997163686756793 23.167681303106484 349876.0 151.93210441446783 0.0 - - - - - - - 1705.0 699 3 ILF3 interleukin enhancer binding factor 3, 90kDa 657 84 C20140605_SFK031_02 C20140605_SFK031_02 TB561465.[MT7]-AVSDWIDEQEK[MT7].3b5_1.heavy 536.61 / 703.353 143224.0 33.42390060424805 50 20 10 10 10 11.135021260056712 8.980674366443974 0.0 3 0.997163686756793 23.167681303106484 143224.0 174.64381441110282 0.0 - - - - - - - 1198.4285714285713 286 7 ILF3 interleukin enhancer binding factor 3, 90kDa 659 84 C20140605_SFK031_02 C20140605_SFK031_02 TB561465.[MT7]-AVSDWIDEQEK[MT7].3b10_2.heavy 536.61 / 659.308 41535.0 33.42390060424805 50 20 10 10 10 11.135021260056712 8.980674366443974 0.0 3 0.997163686756793 23.167681303106484 41535.0 48.711737247656515 0.0 - - - - - - - 699.1666666666666 83 6 ILF3 interleukin enhancer binding factor 3, 90kDa 661 84 C20140605_SFK031_02 C20140605_SFK031_02 TB561465.[MT7]-AVSDWIDEQEK[MT7].3y5_1.heavy 536.61 / 792.386 120104.0 33.42390060424805 50 20 10 10 10 11.135021260056712 8.980674366443974 0.0 3 0.997163686756793 23.167681303106484 120104.0 244.24595383349168 0.0 - - - - - - - 284.0 240 9 ILF3 interleukin enhancer binding factor 3, 90kDa 663 85 C20140605_SFK031_02 C20140605_SFK031_02 TB558783.[MT7]-SLTYEEVLQELVK[MT7].3y3_1.heavy 613.683 / 503.367 81262.0 47.33110046386719 44 14 10 10 10 2.857417023629056 34.99664178279278 0.0 3 0.9306608368749285 4.659411629139605 81262.0 166.74880147227975 0.0 - - - - - - - 698.625 162 8 RAB11FIP2 RAB11 family interacting protein 2 (class I) 665 85 C20140605_SFK031_02 C20140605_SFK031_02 TB558783.[MT7]-SLTYEEVLQELVK[MT7].3b6_1.heavy 613.683 / 867.422 129954.0 47.33110046386719 44 14 10 10 10 2.857417023629056 34.99664178279278 0.0 3 0.9306608368749285 4.659411629139605 129954.0 246.29516049382715 0.0 - - - - - - - 211.84615384615384 259 13 RAB11FIP2 RAB11 family interacting protein 2 (class I) 667 85 C20140605_SFK031_02 C20140605_SFK031_02 TB558783.[MT7]-SLTYEEVLQELVK[MT7].3b5_1.heavy 613.683 / 738.379 40347.0 47.33110046386719 44 14 10 10 10 2.857417023629056 34.99664178279278 0.0 3 0.9306608368749285 4.659411629139605 40347.0 103.25131746031747 0.0 - - - - - - - 708.75 80 8 RAB11FIP2 RAB11 family interacting protein 2 (class I) 669 85 C20140605_SFK031_02 C20140605_SFK031_02 TB558783.[MT7]-SLTYEEVLQELVK[MT7].3b7_1.heavy 613.683 / 966.49 75104.0 47.33110046386719 44 14 10 10 10 2.857417023629056 34.99664178279278 0.0 3 0.9306608368749285 4.659411629139605 75104.0 191.6233744855967 0.0 - - - - - - - 682.7142857142857 150 7 RAB11FIP2 RAB11 family interacting protein 2 (class I) 671 86 C20140605_SFK031_02 C20140605_SFK031_02 TB556838.[MT7]-LFGMAK[MT7].2y4_1.heavy 477.788 / 550.314 49352.0 33.354201316833496 46 20 10 6 10 6.940452498436258 14.408282460333938 0.038799285888671875 3 0.9957113023786879 18.838413308692864 49352.0 41.747360768642125 0.0 - - - - - - - 317.5 98 4 HNF4A hepatocyte nuclear factor 4, alpha 673 86 C20140605_SFK031_02 C20140605_SFK031_02 TB556838.[MT7]-LFGMAK[MT7].2y5_1.heavy 477.788 / 697.382 74273.0 33.354201316833496 46 20 10 6 10 6.940452498436258 14.408282460333938 0.038799285888671875 3 0.9957113023786879 18.838413308692864 74273.0 144.81698463404197 0.0 - - - - - - - 358.3333333333333 148 6 HNF4A hepatocyte nuclear factor 4, alpha 675 86 C20140605_SFK031_02 C20140605_SFK031_02 TB556838.[MT7]-LFGMAK[MT7].2b4_1.heavy 477.788 / 593.324 10750.0 33.354201316833496 46 20 10 6 10 6.940452498436258 14.408282460333938 0.038799285888671875 3 0.9957113023786879 18.838413308692864 10750.0 20.191209651425154 1.0 - - - - - - - 713.3 21 10 HNF4A hepatocyte nuclear factor 4, alpha 677 86 C20140605_SFK031_02 C20140605_SFK031_02 TB556838.[MT7]-LFGMAK[MT7].2y3_1.heavy 477.788 / 493.293 11336.0 33.354201316833496 46 20 10 6 10 6.940452498436258 14.408282460333938 0.038799285888671875 3 0.9957113023786879 18.838413308692864 11336.0 9.944117277110198 1.0 - - - - - - - 757.375 22 8 HNF4A hepatocyte nuclear factor 4, alpha 679 87 C20140605_SFK031_02 C20140605_SFK031_02 TB560896.[MT7]-HNIVDILFVK[MT7].3b6_1.heavy 495.973 / 836.475 23493.0 41.69894981384277 39 13 10 6 10 1.8707828314981891 41.227144518417745 0.03459930419921875 3 0.9115130504713976 4.117817088063391 23493.0 249.20751381215467 0.0 - - - - - - - 259.625 46 16 CNNM1 cyclin M1 681 87 C20140605_SFK031_02 C20140605_SFK031_02 TB560896.[MT7]-HNIVDILFVK[MT7].3y3_1.heavy 495.973 / 537.352 160021.0 41.69894981384277 39 13 10 6 10 1.8707828314981891 41.227144518417745 0.03459930419921875 3 0.9115130504713976 4.117817088063391 160021.0 220.06997607447443 0.0 - - - - - - - 722.625 320 8 CNNM1 cyclin M1 683 87 C20140605_SFK031_02 C20140605_SFK031_02 TB560896.[MT7]-HNIVDILFVK[MT7].3b5_1.heavy 495.973 / 723.391 92977.0 41.69894981384277 39 13 10 6 10 1.8707828314981891 41.227144518417745 0.03459930419921875 3 0.9115130504713976 4.117817088063391 92977.0 375.6074446232419 0.0 - - - - - - - 198.66666666666666 185 15 CNNM1 cyclin M1 685 87 C20140605_SFK031_02 C20140605_SFK031_02 TB560896.[MT7]-HNIVDILFVK[MT7].3b3_1.heavy 495.973 / 509.295 39124.0 41.69894981384277 39 13 10 6 10 1.8707828314981891 41.227144518417745 0.03459930419921875 3 0.9115130504713976 4.117817088063391 39124.0 168.28186955055145 0.0 - - - - - - - 711.5 78 8 CNNM1 cyclin M1 687 88 C20140605_SFK031_02 C20140605_SFK031_02 TB561944.[MT7]-DLK[MT7]PANILVMGEGPER.3y7_1.heavy 676.378 / 775.34 114528.0 35.90700149536133 48 18 10 10 10 15.247473354273492 6.558463666504618 0.0 3 0.9820635745829682 9.201171714093155 114528.0 118.17940249231268 0.0 - - - - - - - 284.75 229 4 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 689 88 C20140605_SFK031_02 C20140605_SFK031_02 TB561944.[MT7]-DLK[MT7]PANILVMGEGPER.3b6_1.heavy 676.378 / 927.55 38707.0 35.90700149536133 48 18 10 10 10 15.247473354273492 6.558463666504618 0.0 3 0.9820635745829682 9.201171714093155 38707.0 73.68024132309847 0.0 - - - - - - - 782.75 77 8 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 691 88 C20140605_SFK031_02 C20140605_SFK031_02 TB561944.[MT7]-DLK[MT7]PANILVMGEGPER.3y6_1.heavy 676.378 / 644.3 86181.0 35.90700149536133 48 18 10 10 10 15.247473354273492 6.558463666504618 0.0 3 0.9820635745829682 9.201171714093155 86181.0 67.57291707494102 0.0 - - - - - - - 398.5 172 2 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 693 88 C20140605_SFK031_02 C20140605_SFK031_02 TB561944.[MT7]-DLK[MT7]PANILVMGEGPER.3y8_1.heavy 676.378 / 874.409 105876.0 35.90700149536133 48 18 10 10 10 15.247473354273492 6.558463666504618 0.0 3 0.9820635745829682 9.201171714093155 105876.0 137.4973686185528 0.0 - - - - - - - 304.0 211 6 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 695 89 C20140605_SFK031_02 C20140605_SFK031_02 TB561874.[MT7]-QIGASSRPPPNRTDK[MT7].4y8_2.heavy 478.771 / 534.799 11474.0 16.596200942993164 44 14 10 10 10 2.259219723932666 36.26966235231722 0.0 3 0.9386602102621052 4.95730764637522 11474.0 19.376277879883798 0.0 - - - - - - - 692.5714285714286 22 7 FMR1 fragile X mental retardation 1 697 89 C20140605_SFK031_02 C20140605_SFK031_02 TB561874.[MT7]-QIGASSRPPPNRTDK[MT7].4y6_1.heavy 478.771 / 874.486 1885.0 16.596200942993164 44 14 10 10 10 2.259219723932666 36.26966235231722 0.0 3 0.9386602102621052 4.95730764637522 1885.0 11.63148148148148 0.0 - - - - - - - 167.3684210526316 3 19 FMR1 fragile X mental retardation 1 699 89 C20140605_SFK031_02 C20140605_SFK031_02 TB561874.[MT7]-QIGASSRPPPNRTDK[MT7].4y3_1.heavy 478.771 / 507.289 3178.0 16.596200942993164 44 14 10 10 10 2.259219723932666 36.26966235231722 0.0 3 0.9386602102621052 4.95730764637522 3178.0 4.277617425735748 0.0 - - - - - - - 1274.888888888889 6 9 FMR1 fragile X mental retardation 1 701 89 C20140605_SFK031_02 C20140605_SFK031_02 TB561874.[MT7]-QIGASSRPPPNRTDK[MT7].4y7_2.heavy 478.771 / 486.273 7541.0 16.596200942993164 44 14 10 10 10 2.259219723932666 36.26966235231722 0.0 3 0.9386602102621052 4.95730764637522 7541.0 6.69499596448749 0.0 - - - - - - - 1177.2857142857142 15 7 FMR1 fragile X mental retardation 1 703 90 C20140605_SFK031_02 C20140605_SFK031_02 TB560898.[MT7]-TASVLWPWINR.3b4_1.heavy 496.281 / 503.295 131198.0 45.94969940185547 43 13 10 10 10 1.1608841630365947 50.428583789328385 0.0 3 0.9146130020515583 4.1930176625797175 131198.0 175.18425306635177 0.0 - - - - - - - 287.0 262 8 IRAK1 interleukin-1 receptor-associated kinase 1 705 90 C20140605_SFK031_02 C20140605_SFK031_02 TB560898.[MT7]-TASVLWPWINR.3b5_1.heavy 496.281 / 616.379 119713.0 45.94969940185547 43 13 10 10 10 1.1608841630365947 50.428583789328385 0.0 3 0.9146130020515583 4.1930176625797175 119713.0 209.3095220125786 0.0 - - - - - - - 276.25 239 8 IRAK1 interleukin-1 receptor-associated kinase 1 707 90 C20140605_SFK031_02 C20140605_SFK031_02 TB560898.[MT7]-TASVLWPWINR.3y4_1.heavy 496.281 / 588.325 65555.0 45.94969940185547 43 13 10 10 10 1.1608841630365947 50.428583789328385 0.0 3 0.9146130020515583 4.1930176625797175 65555.0 237.48226415094337 0.0 - - - - - - - 247.2 131 5 IRAK1 interleukin-1 receptor-associated kinase 1 709 90 C20140605_SFK031_02 C20140605_SFK031_02 TB560898.[MT7]-TASVLWPWINR.3y5_1.heavy 496.281 / 685.378 116974.0 45.94969940185547 43 13 10 10 10 1.1608841630365947 50.428583789328385 0.0 3 0.9146130020515583 4.1930176625797175 116974.0 457.44884858980527 0.0 - - - - - - - 220.8 233 10 IRAK1 interleukin-1 receptor-associated kinase 1 711 91 C20140605_SFK031_02 C20140605_SFK031_02 TB556106.[MT7]-LLETLR.2y4_1.heavy 444.785 / 518.293 80438.0 33.549800872802734 50 20 10 10 10 2.879148644034085 25.926222357341693 0.0 3 0.9941219754966947 16.089172621011844 80438.0 61.58062951249083 0.0 - - - - - - - 409.0 160 2 B3GALTL;CNNM1;PPFIA3 beta 1,3-galactosyltransferase-like;cyclin M1;protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 713 91 C20140605_SFK031_02 C20140605_SFK031_02 TB556106.[MT7]-LLETLR.2b3_1.heavy 444.785 / 500.32 93622.0 33.549800872802734 50 20 10 10 10 2.879148644034085 25.926222357341693 0.0 3 0.9941219754966947 16.089172621011844 93622.0 110.70929817792991 0.0 - - - - - - - 306.6 187 5 B3GALTL;CNNM1;PPFIA3 beta 1,3-galactosyltransferase-like;cyclin M1;protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 715 91 C20140605_SFK031_02 C20140605_SFK031_02 TB556106.[MT7]-LLETLR.2y5_1.heavy 444.785 / 631.377 392172.0 33.549800872802734 50 20 10 10 10 2.879148644034085 25.926222357341693 0.0 3 0.9941219754966947 16.089172621011844 392172.0 272.62392864529704 0.0 - - - - - - - 1197.2857142857142 784 7 B3GALTL;CNNM1;PPFIA3 beta 1,3-galactosyltransferase-like;cyclin M1;protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 717 91 C20140605_SFK031_02 C20140605_SFK031_02 TB556106.[MT7]-LLETLR.2b4_1.heavy 444.785 / 601.368 102310.0 33.549800872802734 50 20 10 10 10 2.879148644034085 25.926222357341693 0.0 3 0.9941219754966947 16.089172621011844 102310.0 148.96324409839985 0.0 - - - - - - - 1136.875 204 8 B3GALTL;CNNM1;PPFIA3 beta 1,3-galactosyltransferase-like;cyclin M1;protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 719 92 C20140605_SFK031_02 C20140605_SFK031_02 TB294927.[MT7]-AIIFFDPDAK[MT7].2y4_1.heavy 712.905 / 574.332 222378.0 41.69029998779297 47 17 10 10 10 3.462749558493197 28.878784997525095 0.0 3 0.9760363300578506 7.956363115047012 222378.0 212.86143248317947 0.0 - - - - - - - 290.6 444 5 HNF4A hepatocyte nuclear factor 4, alpha 721 92 C20140605_SFK031_02 C20140605_SFK031_02 TB294927.[MT7]-AIIFFDPDAK[MT7].2b6_1.heavy 712.905 / 851.478 59997.0 41.69029998779297 47 17 10 10 10 3.462749558493197 28.878784997525095 0.0 3 0.9760363300578506 7.956363115047012 59997.0 124.30668076109937 0.0 - - - - - - - 680.8 119 10 HNF4A hepatocyte nuclear factor 4, alpha 723 92 C20140605_SFK031_02 C20140605_SFK031_02 TB294927.[MT7]-AIIFFDPDAK[MT7].2y6_1.heavy 712.905 / 836.427 32494.0 41.69029998779297 47 17 10 10 10 3.462749558493197 28.878784997525095 0.0 3 0.9760363300578506 7.956363115047012 32494.0 72.55913224305279 0.0 - - - - - - - 321.3076923076923 64 13 HNF4A hepatocyte nuclear factor 4, alpha 725 92 C20140605_SFK031_02 C20140605_SFK031_02 TB294927.[MT7]-AIIFFDPDAK[MT7].2y7_1.heavy 712.905 / 983.495 65080.0 41.69029998779297 47 17 10 10 10 3.462749558493197 28.878784997525095 0.0 3 0.9760363300578506 7.956363115047012 65080.0 120.0272946259829 0.0 - - - - - - - 805.375 130 8 HNF4A hepatocyte nuclear factor 4, alpha 727 93 C20140605_SFK031_02 C20140605_SFK031_02 TB557028.[MT7]-SC[CAM]VIVIR.2y4_1.heavy 495.798 / 500.355 17479.0 29.026100158691406 47 17 10 10 10 3.1307427440626125 31.941302168518284 0.0 3 0.978509487471387 8.403459918496232 17479.0 9.058199579039867 1.0 - - - - - - - 2137.777777777778 52 9 ILF3 interleukin enhancer binding factor 3, 90kDa 729 93 C20140605_SFK031_02 C20140605_SFK031_02 TB557028.[MT7]-SC[CAM]VIVIR.2b4_1.heavy 495.798 / 604.325 31563.0 29.026100158691406 47 17 10 10 10 3.1307427440626125 31.941302168518284 0.0 3 0.978509487471387 8.403459918496232 31563.0 38.991279749103334 0.0 - - - - - - - 1716.0 63 7 ILF3 interleukin enhancer binding factor 3, 90kDa 731 93 C20140605_SFK031_02 C20140605_SFK031_02 TB557028.[MT7]-SC[CAM]VIVIR.2y6_1.heavy 495.798 / 759.455 27476.0 29.026100158691406 47 17 10 10 10 3.1307427440626125 31.941302168518284 0.0 3 0.978509487471387 8.403459918496232 27476.0 52.3208782520004 0.0 - - - - - - - 691.9090909090909 54 11 ILF3 interleukin enhancer binding factor 3, 90kDa 733 93 C20140605_SFK031_02 C20140605_SFK031_02 TB557028.[MT7]-SC[CAM]VIVIR.2b5_1.heavy 495.798 / 703.393 23515.0 29.026100158691406 47 17 10 10 10 3.1307427440626125 31.941302168518284 0.0 3 0.978509487471387 8.403459918496232 23515.0 24.77790758288762 0.0 - - - - - - - 754.6 47 10 ILF3 interleukin enhancer binding factor 3, 90kDa 735 94 C20140605_SFK031_02 C20140605_SFK031_02 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 2849820.0 35.1083984375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2849820.0 2175.1729922594486 0.0 - - - - - - - 2956.0 5699 2 737 94 C20140605_SFK031_02 C20140605_SFK031_02 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 417677.0 35.1083984375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 417677.0 6.165388119937704 1.0 - - - - - - - 1876.0 852 2 739 94 C20140605_SFK031_02 C20140605_SFK031_02 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 702714.0 35.1083984375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 702714.0 360.16377940406704 0.0 - - - - - - - 1478.0 1405 1 741 95 C20140605_SFK031_02 C20140605_SFK031_02 TB555775.[MT7]-EIALLR.2b3_1.heavy 429.78 / 458.273 805304.0 33.306400299072266 48 18 10 10 10 10.219314769624722 9.785391902912513 0.0 2 0.9854512600879253 10.219313756527034 805304.0 208.89484670220742 0.0 - - - - - - - 793.5 1610 2 CDK8;CDK19;BRD1 cyclin-dependent kinase 8;cyclin-dependent kinase 19;bromodomain containing 1 743 95 C20140605_SFK031_02 C20140605_SFK031_02 TB555775.[MT7]-EIALLR.2y5_1.heavy 429.78 / 585.408 N/A 33.306400299072266 48 18 10 10 10 10.219314769624722 9.785391902912513 0.0 2 0.9854512600879253 10.219313756527034 767226.0 1115.2056608837083 0.0 - - - - - - - 1303.7142857142858 1534 7 CDK8;CDK19;BRD1 cyclin-dependent kinase 8;cyclin-dependent kinase 19;bromodomain containing 1 745 95 C20140605_SFK031_02 C20140605_SFK031_02 TB555775.[MT7]-EIALLR.2b4_1.heavy 429.78 / 571.357 N/A 33.306400299072266 48 18 10 10 10 10.219314769624722 9.785391902912513 0.0 2 0.9854512600879253 10.219313756527034 478351.0 540.1046284528409 0.0 - - - - - - - 496.0 956 1 CDK8;CDK19;BRD1 cyclin-dependent kinase 8;cyclin-dependent kinase 19;bromodomain containing 1 747 95 C20140605_SFK031_02 C20140605_SFK031_02 TB555775.[MT7]-EIALLR.2y3_1.heavy 429.78 / 401.287 660281.0 33.306400299072266 48 18 10 10 10 10.219314769624722 9.785391902912513 0.0 2 0.9854512600879253 10.219313756527034 660281.0 293.49125611600755 0.0 - - - - - - - 1290.0 1320 1 CDK8;CDK19;BRD1 cyclin-dependent kinase 8;cyclin-dependent kinase 19;bromodomain containing 1 749 96 C20140605_SFK031_02 C20140605_SFK031_02 TB557275.[MT7]-YLSLTER.2y4_1.heavy 513.291 / 518.293 10128.0 31.48104953765869 40 18 10 6 6 5.303839774371496 18.85426488243604 0.032199859619140625 6 0.9815036510072926 9.060406383573723 10128.0 5.270301675977654 2.0 - - - - - - - 767.0 62 1 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 751 96 C20140605_SFK031_02 C20140605_SFK031_02 TB557275.[MT7]-YLSLTER.2b3_1.heavy 513.291 / 508.289 14348.0 31.48104953765869 40 18 10 6 6 5.303839774371496 18.85426488243604 0.032199859619140625 6 0.9815036510072926 9.060406383573723 14348.0 6.473407918445931 2.0 - - - - - - - 844.0 40 1 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 753 96 C20140605_SFK031_02 C20140605_SFK031_02 TB557275.[MT7]-YLSLTER.2y5_1.heavy 513.291 / 605.325 50870.0 31.48104953765869 40 18 10 6 6 5.303839774371496 18.85426488243604 0.032199859619140625 6 0.9815036510072926 9.060406383573723 50870.0 62.47085744198763 0.0 - - - - - - - 1249.5714285714287 101 7 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 755 96 C20140605_SFK031_02 C20140605_SFK031_02 TB557275.[MT7]-YLSLTER.2b4_1.heavy 513.291 / 621.373 9974.0 31.48104953765869 40 18 10 6 6 5.303839774371496 18.85426488243604 0.032199859619140625 6 0.9815036510072926 9.060406383573723 9974.0 7.614931318670899 2.0 - - - - - - - 800.1428571428571 30 7 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 757 97 C20140605_SFK031_02 C20140605_SFK031_02 TB556233.[MT7]-DQTELR.2y4_1.heavy 453.244 / 518.293 15165.0 17.212400436401367 44 14 10 10 10 2.43489208867516 31.26796028925591 0.0 3 0.9393567266404707 4.985990901190653 15165.0 20.750985739889348 0.0 - - - - - - - 1153.25 30 8 IRAK1 interleukin-1 receptor-associated kinase 1 759 97 C20140605_SFK031_02 C20140605_SFK031_02 TB556233.[MT7]-DQTELR.2b3_1.heavy 453.244 / 489.242 17162.0 17.212400436401367 44 14 10 10 10 2.43489208867516 31.26796028925591 0.0 3 0.9393567266404707 4.985990901190653 17162.0 18.310935290789306 0.0 - - - - - - - 337.5 34 4 IRAK1 interleukin-1 receptor-associated kinase 1 761 97 C20140605_SFK031_02 C20140605_SFK031_02 TB556233.[MT7]-DQTELR.2y5_1.heavy 453.244 / 646.352 68324.0 17.212400436401367 44 14 10 10 10 2.43489208867516 31.26796028925591 0.0 3 0.9393567266404707 4.985990901190653 68324.0 144.6280104931059 0.0 - - - - - - - 301.5 136 12 IRAK1 interleukin-1 receptor-associated kinase 1 763 97 C20140605_SFK031_02 C20140605_SFK031_02 TB556233.[MT7]-DQTELR.2b4_1.heavy 453.244 / 618.285 118947.0 17.212400436401367 44 14 10 10 10 2.43489208867516 31.26796028925591 0.0 3 0.9393567266404707 4.985990901190653 118947.0 162.1207338951317 0.0 - - - - - - - 731.7777777777778 237 9 IRAK1 interleukin-1 receptor-associated kinase 1 765 98 C20140605_SFK031_02 C20140605_SFK031_02 TB294837.[MT7]-ISDLGLAVK[MT7].2y8_1.heavy 602.381 / 946.569 34704.0 35.01750183105469 35 11 4 10 10 1.4204771065452722 48.851096508412354 0.0 3 0.8560395875169439 3.2128281174007185 34704.0 61.349821879186464 0.0 - - - - - - - 262.0 69 3 GRK5 G protein-coupled receptor kinase 5 767 98 C20140605_SFK031_02 C20140605_SFK031_02 TB294837.[MT7]-ISDLGLAVK[MT7].2b4_1.heavy 602.381 / 573.336 19542.0 35.01750183105469 35 11 4 10 10 1.4204771065452722 48.851096508412354 0.0 3 0.8560395875169439 3.2128281174007185 19542.0 10.855324016819194 0.0 - - - - - - - 898.0 39 1 GRK5 G protein-coupled receptor kinase 5 769 98 C20140605_SFK031_02 C20140605_SFK031_02 TB294837.[MT7]-ISDLGLAVK[MT7].2y6_1.heavy 602.381 / 744.51 31896.0 35.01750183105469 35 11 4 10 10 1.4204771065452722 48.851096508412354 0.0 3 0.8560395875169439 3.2128281174007185 31896.0 26.8745119366412 0.0 - - - - - - - 225.0 63 1 GRK5 G protein-coupled receptor kinase 5 771 98 C20140605_SFK031_02 C20140605_SFK031_02 TB294837.[MT7]-ISDLGLAVK[MT7].2b5_1.heavy 602.381 / 630.358 13814.0 35.01750183105469 35 11 4 10 10 1.4204771065452722 48.851096508412354 0.0 3 0.8560395875169439 3.2128281174007185 13814.0 11.219277091297474 1.0 - - - - - - - 411.6666666666667 121 3 GRK5 G protein-coupled receptor kinase 5 773 99 C20140605_SFK031_02 C20140605_SFK031_02 TB561769.[MT7]-REFLNEDDPEEK[MT7].4b8_2.heavy 452.978 / 582.276 126383.0 25.039549350738525 37 11 10 6 10 1.6383891663865016 52.90037312582314 0.03660011291503906 3 0.876842063062866 3.479923790168736 126383.0 123.25613496833554 0.0 - - - - - - - 1842.857142857143 252 7 CDK19 cyclin-dependent kinase 19 775 99 C20140605_SFK031_02 C20140605_SFK031_02 TB561769.[MT7]-REFLNEDDPEEK[MT7].4b7_2.heavy 452.978 / 524.763 43927.0 25.039549350738525 37 11 10 6 10 1.6383891663865016 52.90037312582314 0.03660011291503906 3 0.876842063062866 3.479923790168736 43927.0 38.9398961038961 0.0 - - - - - - - 1221.75 87 8 CDK19 cyclin-dependent kinase 19 777 99 C20140605_SFK031_02 C20140605_SFK031_02 TB561769.[MT7]-REFLNEDDPEEK[MT7].4y3_1.heavy 452.978 / 549.3 31937.0 25.039549350738525 37 11 10 6 10 1.6383891663865016 52.90037312582314 0.03660011291503906 3 0.876842063062866 3.479923790168736 31937.0 9.227208261884876 1.0 - - - - - - - 2444.0 63 1 CDK19 cyclin-dependent kinase 19 779 99 C20140605_SFK031_02 C20140605_SFK031_02 TB561769.[MT7]-REFLNEDDPEEK[MT7].4b3_1.heavy 452.978 / 577.321 10058.0 25.039549350738525 37 11 10 6 10 1.6383891663865016 52.90037312582314 0.03660011291503906 3 0.876842063062866 3.479923790168736 10058.0 8.475289588319646 0.0 - - - - - - - 1218.6666666666667 20 9 CDK19 cyclin-dependent kinase 19 781 100 C20140605_SFK031_02 C20140605_SFK031_02 TB294730.[MT7]-EAVQNER.2y4_1.heavy 495.26 / 546.263 21850.0 14.50059986114502 50 20 10 10 10 10.67076973415447 9.371395174982078 0.0 3 0.997779243574433 26.18372924545481 21850.0 77.22779591325428 0.0 - - - - - - - 263.05555555555554 43 18 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 783 100 C20140605_SFK031_02 C20140605_SFK031_02 TB294730.[MT7]-EAVQNER.2y5_1.heavy 495.26 / 645.331 14834.0 14.50059986114502 50 20 10 10 10 10.67076973415447 9.371395174982078 0.0 3 0.997779243574433 26.18372924545481 14834.0 101.77373959771616 0.0 - - - - - - - 152.2 29 20 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 785 100 C20140605_SFK031_02 C20140605_SFK031_02 TB294730.[MT7]-EAVQNER.2y6_1.heavy 495.26 / 716.369 68381.0 14.50059986114502 50 20 10 10 10 10.67076973415447 9.371395174982078 0.0 3 0.997779243574433 26.18372924545481 68381.0 125.91768624014023 0.0 - - - - - - - 250.30769230769232 136 13 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 787 100 C20140605_SFK031_02 C20140605_SFK031_02 TB294730.[MT7]-EAVQNER.2b5_1.heavy 495.26 / 686.359 11157.0 14.50059986114502 50 20 10 10 10 10.67076973415447 9.371395174982078 0.0 3 0.997779243574433 26.18372924545481 11157.0 21.678802174956022 0.0 - - - - - - - 163.75 22 16 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 789 101 C20140605_SFK031_02 C20140605_SFK031_02 TB561768.[MT7]-REFLNEDDPEEK[MT7].3y3_1.heavy 603.635 / 549.3 43877.0 25.048699378967285 36 10 10 6 10 0.625915835045754 89.57846135563793 0.03660011291503906 3 0.8434001087318127 3.0770105393405145 43877.0 38.793064863746906 0.0 - - - - - - - 1698.857142857143 87 7 CDK19 cyclin-dependent kinase 19 791 101 C20140605_SFK031_02 C20140605_SFK031_02 TB561768.[MT7]-REFLNEDDPEEK[MT7].3y4_1.heavy 603.635 / 646.353 135502.0 25.048699378967285 36 10 10 6 10 0.625915835045754 89.57846135563793 0.03660011291503906 3 0.8434001087318127 3.0770105393405145 135502.0 135.47418224976582 0.0 - - - - - - - 939.0 271 4 CDK19 cyclin-dependent kinase 19 793 101 C20140605_SFK031_02 C20140605_SFK031_02 TB561768.[MT7]-REFLNEDDPEEK[MT7].3b8_1.heavy 603.635 / 1163.54 21398.0 25.048699378967285 36 10 10 6 10 0.625915835045754 89.57846135563793 0.03660011291503906 3 0.8434001087318127 3.0770105393405145 21398.0 94.46350314622967 0.0 - - - - - - - 227.7058823529412 42 17 CDK19 cyclin-dependent kinase 19 795 101 C20140605_SFK031_02 C20140605_SFK031_02 TB561768.[MT7]-REFLNEDDPEEK[MT7].3b8_2.heavy 603.635 / 582.276 133510.0 25.048699378967285 36 10 10 6 10 0.625915835045754 89.57846135563793 0.03660011291503906 3 0.8434001087318127 3.0770105393405145 133510.0 165.97039249656225 0.0 - - - - - - - 1235.7142857142858 267 7 CDK19 cyclin-dependent kinase 19 797 102 C20140605_SFK031_02 C20140605_SFK031_02 TB294733.[MT7]-LSDTEMR.2y4_1.heavy 498.251 / 536.25 23222.0 22.74020004272461 44 14 10 10 10 2.147580608120395 46.56402633823462 0.0 3 0.9342978429379375 4.788125701024581 23222.0 33.44075724953268 0.0 - - - - - - - 1238.125 46 8 CNNM1 cyclin M1 799 102 C20140605_SFK031_02 C20140605_SFK031_02 TB294733.[MT7]-LSDTEMR.2b4_1.heavy 498.251 / 561.3 4834.0 22.74020004272461 44 14 10 10 10 2.147580608120395 46.56402633823462 0.0 3 0.9342978429379375 4.788125701024581 4834.0 6.992642756680732 0.0 - - - - - - - 800.2222222222222 9 18 CNNM1 cyclin M1 801 102 C20140605_SFK031_02 C20140605_SFK031_02 TB294733.[MT7]-LSDTEMR.2y6_1.heavy 498.251 / 738.309 20236.0 22.74020004272461 44 14 10 10 10 2.147580608120395 46.56402633823462 0.0 3 0.9342978429379375 4.788125701024581 20236.0 46.01474687593641 0.0 - - - - - - - 702.3529411764706 40 17 CNNM1 cyclin M1 803 102 C20140605_SFK031_02 C20140605_SFK031_02 TB294733.[MT7]-LSDTEMR.2b5_1.heavy 498.251 / 690.343 19952.0 22.74020004272461 44 14 10 10 10 2.147580608120395 46.56402633823462 0.0 3 0.9342978429379375 4.788125701024581 19952.0 84.27655870525544 0.0 - - - - - - - 677.7 39 10 CNNM1 cyclin M1 805 103 C20140605_SFK031_02 C20140605_SFK031_02 TB558279.[MT7]-TLEPVWK[MT7].2y4_1.heavy 580.849 / 673.415 37333.0 33.76449966430664 40 20 2 10 8 3.870961138979939 18.824458097863896 0.0 4 0.9952355468473277 17.872415693579796 37333.0 37.400968947892345 0.0 - - - - - - - 1273.0 74 7 RAB11FIP2 RAB11 family interacting protein 2 (class I) 807 103 C20140605_SFK031_02 C20140605_SFK031_02 TB558279.[MT7]-TLEPVWK[MT7].2y5_1.heavy 580.849 / 802.458 4985.0 33.76449966430664 40 20 2 10 8 3.870961138979939 18.824458097863896 0.0 4 0.9952355468473277 17.872415693579796 4985.0 19.587287735849056 0.0 - - - - - - - 279.45454545454544 9 11 RAB11FIP2 RAB11 family interacting protein 2 (class I) 809 103 C20140605_SFK031_02 C20140605_SFK031_02 TB558279.[MT7]-TLEPVWK[MT7].2y3_1.heavy 580.849 / 576.363 4561.0 33.76449966430664 40 20 2 10 8 3.870961138979939 18.824458097863896 0.0 4 0.9952355468473277 17.872415693579796 4561.0 0.0597419577621289 30.0 - - - - - - - 1220.0 18 2 RAB11FIP2 RAB11 family interacting protein 2 (class I) 811 103 C20140605_SFK031_02 C20140605_SFK031_02 TB558279.[MT7]-TLEPVWK[MT7].2y6_1.heavy 580.849 / 915.542 8061.0 33.76449966430664 40 20 2 10 8 3.870961138979939 18.824458097863896 0.0 4 0.9952355468473277 17.872415693579796 8061.0 8.264930373191193 2.0 - - - - - - - 754.1111111111111 208 9 RAB11FIP2 RAB11 family interacting protein 2 (class I) 813 104 C20140605_SFK031_02 C20140605_SFK031_02 TB295089.[MT7]-LFNSPLK[MT7]PLADLDPVVVTFWYR.4y5_1.heavy 720.408 / 772.378 19582.0 54.127601623535156 45 15 10 10 10 1.9373485866527682 36.03045857046843 0.0 3 0.9508312649351011 5.542709464239946 19582.0 56.95147762354086 0.0 - - - - - - - 220.21428571428572 39 14 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 815 104 C20140605_SFK031_02 C20140605_SFK031_02 TB295089.[MT7]-LFNSPLK[MT7]PLADLDPVVVTFWYR.4b13_2.heavy 720.408 / 856.995 28509.0 54.127601623535156 45 15 10 10 10 1.9373485866527682 36.03045857046843 0.0 3 0.9508312649351011 5.542709464239946 28509.0 91.07050295277736 0.0 - - - - - - - 269.6923076923077 57 13 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 817 104 C20140605_SFK031_02 C20140605_SFK031_02 TB295089.[MT7]-LFNSPLK[MT7]PLADLDPVVVTFWYR.4y7_1.heavy 720.408 / 970.515 20751.0 54.127601623535156 45 15 10 10 10 1.9373485866527682 36.03045857046843 0.0 3 0.9508312649351011 5.542709464239946 20751.0 67.5527072860009 0.0 - - - - - - - 210.41666666666666 41 12 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 819 104 C20140605_SFK031_02 C20140605_SFK031_02 TB295089.[MT7]-LFNSPLK[MT7]PLADLDPVVVTFWYR.4y6_1.heavy 720.408 / 871.446 13226.0 54.127601623535156 45 15 10 10 10 1.9373485866527682 36.03045857046843 0.0 3 0.9508312649351011 5.542709464239946 13226.0 89.61488747745628 0.0 - - - - - - - 222.0 26 12 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 821 105 C20140605_SFK031_02 C20140605_SFK031_02 TB295086.[MT7]-LVFIEEPPGGGGVAPSAVPTRPPGPQR.4b5_1.heavy 707.39 / 746.457 70006.0 37.416099548339844 42 12 10 10 10 1.6116773838034595 48.66465578062608 0.0 3 0.8955421192529003 3.7847461107511684 70006.0 39.997547966015865 0.0 - - - - - - - 756.0 140 1 CNNM1 cyclin M1 823 105 C20140605_SFK031_02 C20140605_SFK031_02 TB295086.[MT7]-LVFIEEPPGGGGVAPSAVPTRPPGPQR.4y6_1.heavy 707.39 / 651.357 226870.0 37.416099548339844 42 12 10 10 10 1.6116773838034595 48.66465578062608 0.0 3 0.8955421192529003 3.7847461107511684 226870.0 115.33884581043557 0.0 - - - - - - - 1080.0 453 2 CNNM1 cyclin M1 825 105 C20140605_SFK031_02 C20140605_SFK031_02 TB295086.[MT7]-LVFIEEPPGGGGVAPSAVPTRPPGPQR.4y19_2.heavy 707.39 / 879.474 69465.0 37.416099548339844 42 12 10 10 10 1.6116773838034595 48.66465578062608 0.0 3 0.8955421192529003 3.7847461107511684 69465.0 44.599754813703115 0.0 - - - - - - - 162.0 138 2 CNNM1 cyclin M1 827 105 C20140605_SFK031_02 C20140605_SFK031_02 TB295086.[MT7]-LVFIEEPPGGGGVAPSAVPTRPPGPQR.4b3_1.heavy 707.39 / 504.33 147573.0 37.416099548339844 42 12 10 10 10 1.6116773838034595 48.66465578062608 0.0 3 0.8955421192529003 3.7847461107511684 147573.0 53.61775623536125 0.0 - - - - - - - 1269.0 295 4 CNNM1 cyclin M1 829 106 C20140605_SFK031_02 C20140605_SFK031_02 TB295082.[MT7]-LTLLSEQAPGPVVMDLTGDLAVLK[MT7].3b6_1.heavy 923.529 / 801.484 6343.0 52.95309925079346 38 13 10 5 10 1.528575855230239 57.19662231933938 0.043201446533203125 3 0.9017716473884267 3.9050187687271434 6343.0 17.531735941832224 1.0 - - - - - - - 222.33333333333334 12 12 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 831 106 C20140605_SFK031_02 C20140605_SFK031_02 TB295082.[MT7]-LTLLSEQAPGPVVMDLTGDLAVLK[MT7].3b4_1.heavy 923.529 / 585.409 12923.0 52.95309925079346 38 13 10 5 10 1.528575855230239 57.19662231933938 0.043201446533203125 3 0.9017716473884267 3.9050187687271434 12923.0 17.41858267764028 1.0 - - - - - - - 211.71428571428572 25 7 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 833 106 C20140605_SFK031_02 C20140605_SFK031_02 TB295082.[MT7]-LTLLSEQAPGPVVMDLTGDLAVLK[MT7].3b8_1.heavy 923.529 / 1000.58 44343.0 52.95309925079346 38 13 10 5 10 1.528575855230239 57.19662231933938 0.043201446533203125 3 0.9017716473884267 3.9050187687271434 44343.0 94.82774050242305 0.0 - - - - - - - 256.8333333333333 88 6 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 835 106 C20140605_SFK031_02 C20140605_SFK031_02 TB295082.[MT7]-LTLLSEQAPGPVVMDLTGDLAVLK[MT7].3b7_1.heavy 923.529 / 929.542 20986.0 52.95309925079346 38 13 10 5 10 1.528575855230239 57.19662231933938 0.043201446533203125 3 0.9017716473884267 3.9050187687271434 20986.0 33.53036285460839 1.0 - - - - - - - 296.3333333333333 41 6 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 837 107 C20140605_SFK031_02 C20140605_SFK031_02 TB295083.[MT7]-LTLLSEQAPGPVVMDLTGDLAVLK[MT7].4y4_1.heavy 692.898 / 574.404 30083.0 52.942298889160156 44 14 10 10 10 2.53163877869845 26.367935683614203 0.0 3 0.943544737909603 5.169463690520985 30083.0 124.18106511716518 0.0 - - - - - - - 293.42857142857144 60 7 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 839 107 C20140605_SFK031_02 C20140605_SFK031_02 TB295083.[MT7]-LTLLSEQAPGPVVMDLTGDLAVLK[MT7].4b4_1.heavy 692.898 / 585.409 26398.0 52.942298889160156 44 14 10 10 10 2.53163877869845 26.367935683614203 0.0 3 0.943544737909603 5.169463690520985 26398.0 101.1854113156001 0.0 - - - - - - - 442.6666666666667 52 3 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 841 107 C20140605_SFK031_02 C20140605_SFK031_02 TB295083.[MT7]-LTLLSEQAPGPVVMDLTGDLAVLK[MT7].4y3_1.heavy 692.898 / 503.367 30204.0 52.942298889160156 44 14 10 10 10 2.53163877869845 26.367935683614203 0.0 3 0.943544737909603 5.169463690520985 30204.0 33.12454993980068 1.0 - - - - - - - 271.5 67 2 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 843 107 C20140605_SFK031_02 C20140605_SFK031_02 TB295083.[MT7]-LTLLSEQAPGPVVMDLTGDLAVLK[MT7].4b6_1.heavy 692.898 / 801.484 7913.0 52.942298889160156 44 14 10 10 10 2.53163877869845 26.367935683614203 0.0 3 0.943544737909603 5.169463690520985 7913.0 20.71659608202735 1.0 - - - - - - - 191.0 18 6 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 845 108 C20140605_SFK031_02 C20140605_SFK031_02 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 1669680.0 22.41900062561035 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1669680.0 543.951887774976 0.0 - - - - - - - 1889.142857142857 3339 7 847 108 C20140605_SFK031_02 C20140605_SFK031_02 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 2269210.0 22.41900062561035 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2269210.0 6015.861777262281 0.0 - - - - - - - 254.85714285714286 4538 14 849 108 C20140605_SFK031_02 C20140605_SFK031_02 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 7057680.0 22.41900062561035 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 7057680.0 10512.466385823682 0.0 - - - - - - - 323.6 14115 5 851 109 C20140605_SFK031_02 C20140605_SFK031_02 TB556656.[MT7]-VLLADK[MT7].2y4_1.heavy 473.812 / 590.363 238828.0 27.722700119018555 48 18 10 10 10 37.91080884648692 2.6377701516454635 0.0 3 0.9868389424648116 10.745818671994781 238828.0 120.83206441089521 0.0 - - - - - - - 301.0 477 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 853 109 C20140605_SFK031_02 C20140605_SFK031_02 TB556656.[MT7]-VLLADK[MT7].2y5_1.heavy 473.812 / 703.447 306222.0 27.722700119018555 48 18 10 10 10 37.91080884648692 2.6377701516454635 0.0 3 0.9868389424648116 10.745818671994781 306222.0 392.3407550910233 0.0 - - - - - - - 1218.5 612 8 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 855 109 C20140605_SFK031_02 C20140605_SFK031_02 TB556656.[MT7]-VLLADK[MT7].2y3_1.heavy 473.812 / 477.279 277399.0 27.722700119018555 48 18 10 10 10 37.91080884648692 2.6377701516454635 0.0 3 0.9868389424648116 10.745818671994781 277399.0 196.49553225168182 0.0 - - - - - - - 1188.25 554 4 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 857 109 C20140605_SFK031_02 C20140605_SFK031_02 TB556656.[MT7]-VLLADK[MT7].2b5_1.heavy 473.812 / 656.41 143092.0 27.722700119018555 48 18 10 10 10 37.91080884648692 2.6377701516454635 0.0 3 0.9868389424648116 10.745818671994781 143092.0 161.48767324891094 0.0 - - - - - - - 421.0 286 2 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 859 110 C20140605_SFK031_02 C20140605_SFK031_02 TB557904.[MT7]-WILENK[MT7].2y4_1.heavy 545.829 / 647.385 27361.0 33.549800872802734 50 20 10 10 10 10.225184296026109 9.779774828984134 0.0 3 0.9958027676851284 19.042714045880064 27361.0 12.633934999446005 0.0 - - - - - - - 673.5 54 2 GTF2I;GTF2IRD2B;GTF2IRD2 general transcription factor IIi;GTF2I repeat domain containing 2B;GTF2I repeat domain containing 2 861 110 C20140605_SFK031_02 C20140605_SFK031_02 TB557904.[MT7]-WILENK[MT7].2y5_1.heavy 545.829 / 760.469 21868.0 33.549800872802734 50 20 10 10 10 10.225184296026109 9.779774828984134 0.0 3 0.9958027676851284 19.042714045880064 21868.0 30.33920227983362 0.0 - - - - - - - 1258.5714285714287 43 7 GTF2I;GTF2IRD2B;GTF2IRD2 general transcription factor IIi;GTF2I repeat domain containing 2B;GTF2I repeat domain containing 2 863 110 C20140605_SFK031_02 C20140605_SFK031_02 TB557904.[MT7]-WILENK[MT7].2b4_1.heavy 545.829 / 686.399 6840.0 33.549800872802734 50 20 10 10 10 10.225184296026109 9.779774828984134 0.0 3 0.9958027676851284 19.042714045880064 6840.0 4.627098486919877 0.0 - - - - - - - 1301.111111111111 13 9 GTF2I;GTF2IRD2B;GTF2IRD2 general transcription factor IIi;GTF2I repeat domain containing 2B;GTF2I repeat domain containing 2 865 110 C20140605_SFK031_02 C20140605_SFK031_02 TB557904.[MT7]-WILENK[MT7].2y3_1.heavy 545.829 / 534.3 19174.0 33.549800872802734 50 20 10 10 10 10.225184296026109 9.779774828984134 0.0 3 0.9958027676851284 19.042714045880064 19174.0 8.263235081508478 0.0 - - - - - - - 1036.0 38 1 GTF2I;GTF2IRD2B;GTF2IRD2 general transcription factor IIi;GTF2I repeat domain containing 2B;GTF2I repeat domain containing 2 867 111 C20140605_SFK031_02 C20140605_SFK031_02 TB557800.[MT7]-EFLFNK[MT7].2y4_1.heavy 543.315 / 665.41 29333.0 34.71009826660156 50 20 10 10 10 7.506942014833299 13.321003386253093 0.0 3 0.9938734029934017 15.759075426460758 29333.0 22.563846153846157 0.0 - - - - - - - 682.8571428571429 58 7 PDX1 pancreatic and duodenal homeobox 1 869 111 C20140605_SFK031_02 C20140605_SFK031_02 TB557800.[MT7]-EFLFNK[MT7].2b3_1.heavy 543.315 / 534.304 N/A 34.71009826660156 50 20 10 10 10 7.506942014833299 13.321003386253093 0.0 3 0.9938734029934017 15.759075426460758 65777.0 17.934250408815146 0.0 - - - - - - - 2111.0 131 1 PDX1 pancreatic and duodenal homeobox 1 871 111 C20140605_SFK031_02 C20140605_SFK031_02 TB557800.[MT7]-EFLFNK[MT7].2y5_1.heavy 543.315 / 812.479 37111.0 34.71009826660156 50 20 10 10 10 7.506942014833299 13.321003386253093 0.0 3 0.9938734029934017 15.759075426460758 37111.0 47.57957551755175 0.0 - - - - - - - 680.875 74 8 PDX1 pancreatic and duodenal homeobox 1 873 111 C20140605_SFK031_02 C20140605_SFK031_02 TB557800.[MT7]-EFLFNK[MT7].2y3_1.heavy 543.315 / 552.326 58222.0 34.71009826660156 50 20 10 10 10 7.506942014833299 13.321003386253093 0.0 3 0.9938734029934017 15.759075426460758 58222.0 56.84470195478311 0.0 - - - - - - - 222.0 116 3 PDX1 pancreatic and duodenal homeobox 1 875 112 C20140605_SFK031_02 C20140605_SFK031_02 TB559502.[MT7]-AYAALAALEK[MT7].3y3_1.heavy 436.93 / 533.341 153192.0 37.04209899902344 46 16 10 10 10 2.9162176850526573 29.22320622929001 0.0 3 0.9639657690449646 6.481744630759398 153192.0 159.18468411855304 0.0 - - - - - - - 705.3333333333334 306 9 ILF3 interleukin enhancer binding factor 3, 90kDa 877 112 C20140605_SFK031_02 C20140605_SFK031_02 TB559502.[MT7]-AYAALAALEK[MT7].3b4_1.heavy 436.93 / 521.284 259265.0 37.04209899902344 46 16 10 10 10 2.9162176850526573 29.22320622929001 0.0 3 0.9639657690449646 6.481744630759398 259265.0 689.1244423791821 0.0 - - - - - - - 269.0 518 8 ILF3 interleukin enhancer binding factor 3, 90kDa 879 112 C20140605_SFK031_02 C20140605_SFK031_02 TB559502.[MT7]-AYAALAALEK[MT7].3b5_1.heavy 436.93 / 634.368 147060.0 37.04209899902344 46 16 10 10 10 2.9162176850526573 29.22320622929001 0.0 3 0.9639657690449646 6.481744630759398 147060.0 304.49874050722303 0.0 - - - - - - - 737.5714285714286 294 7 ILF3 interleukin enhancer binding factor 3, 90kDa 881 112 C20140605_SFK031_02 C20140605_SFK031_02 TB559502.[MT7]-AYAALAALEK[MT7].3b3_1.heavy 436.93 / 450.247 118337.0 37.04209899902344 46 16 10 10 10 2.9162176850526573 29.22320622929001 0.0 3 0.9639657690449646 6.481744630759398 118337.0 265.78191737183494 0.0 - - - - - - - 726.25 236 8 ILF3 interleukin enhancer binding factor 3, 90kDa 883 113 C20140605_SFK031_02 C20140605_SFK031_02 TB556227.[MT7]-EVDQLR.2y4_1.heavy 452.254 / 531.289 19187.0 21.26259994506836 34 18 0 10 6 5.398580920528603 18.523386325421328 0.0 5 0.9882454849691816 11.37191702238695 19187.0 22.930190967016493 1.0 - - - - - - - 1245.8333333333333 351 12 FMR1 fragile X mental retardation 1 885 113 C20140605_SFK031_02 C20140605_SFK031_02 TB556227.[MT7]-EVDQLR.2b3_1.heavy 452.254 / 488.247 65842.0 21.26259994506836 34 18 0 10 6 5.398580920528603 18.523386325421328 0.0 5 0.9882454849691816 11.37191702238695 65842.0 74.51428388746803 0.0 - - - - - - - 1768.4444444444443 131 9 FMR1 fragile X mental retardation 1 887 113 C20140605_SFK031_02 C20140605_SFK031_02 TB556227.[MT7]-EVDQLR.2y5_1.heavy 452.254 / 630.357 55075.0 21.26259994506836 34 18 0 10 6 5.398580920528603 18.523386325421328 0.0 5 0.9882454849691816 11.37191702238695 55075.0 55.96489334376274 1.0 - - - - - - - 794.5454545454545 757 11 FMR1 fragile X mental retardation 1 889 113 C20140605_SFK031_02 C20140605_SFK031_02 TB556227.[MT7]-EVDQLR.2b4_1.heavy 452.254 / 616.306 37959.0 21.26259994506836 34 18 0 10 6 5.398580920528603 18.523386325421328 0.0 5 0.9882454849691816 11.37191702238695 37959.0 29.474292116334375 1.0 - - - - - - - 1213.6923076923076 278 13 FMR1 fragile X mental retardation 1 891 114 C20140605_SFK031_02 C20140605_SFK031_02 TB294843.[MT7]-QEGDDGPDVR.2b8_1.heavy 616.287 / 958.387 10418.0 16.972774505615234 41 15 10 6 10 1.9365316378555955 35.08289253220225 0.0363006591796875 3 0.9540468962900447 5.7349238487569485 10418.0 24.33984661429106 0.0 - - - - - - - 149.53846153846155 20 13 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 893 114 C20140605_SFK031_02 C20140605_SFK031_02 TB294843.[MT7]-QEGDDGPDVR.2y5_1.heavy 616.287 / 543.289 6909.0 16.972774505615234 41 15 10 6 10 1.9365316378555955 35.08289253220225 0.0363006591796875 3 0.9540468962900447 5.7349238487569485 6909.0 22.847222222222225 0.0 - - - - - - - 681.75 13 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 895 114 C20140605_SFK031_02 C20140605_SFK031_02 TB294843.[MT7]-QEGDDGPDVR.2b4_1.heavy 616.287 / 574.259 3995.0 16.972774505615234 41 15 10 6 10 1.9365316378555955 35.08289253220225 0.0363006591796875 3 0.9540468962900447 5.7349238487569485 3995.0 17.654671717171716 0.0 - - - - - - - 291.0 7 18 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 897 114 C20140605_SFK031_02 C20140605_SFK031_02 TB294843.[MT7]-QEGDDGPDVR.2b5_1.heavy 616.287 / 689.286 6963.0 16.972774505615234 41 15 10 6 10 1.9365316378555955 35.08289253220225 0.0363006591796875 3 0.9540468962900447 5.7349238487569485 6963.0 31.483935185185185 0.0 - - - - - - - 247.76470588235293 13 17 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 899 115 C20140605_SFK031_02 C20140605_SFK031_02 TB561551.[MT7]-GDLDLELVLLC[CAM]K[MT7].3y3_1.heavy 559.323 / 564.33 93028.0 46.03129959106445 42 12 10 10 10 0.8989640455402461 64.83315174256086 0.0 3 0.8843803499808888 3.5939372925957946 93028.0 263.09553000493617 0.0 - - - - - - - 304.5 186 10 ILF3 interleukin enhancer binding factor 3, 90kDa 901 115 C20140605_SFK031_02 C20140605_SFK031_02 TB561551.[MT7]-GDLDLELVLLC[CAM]K[MT7].3b6_1.heavy 559.323 / 787.395 68858.0 46.03129959106445 42 12 10 10 10 0.8989640455402461 64.83315174256086 0.0 3 0.8843803499808888 3.5939372925957946 68858.0 144.03627174306308 0.0 - - - - - - - 782.4285714285714 137 7 ILF3 interleukin enhancer binding factor 3, 90kDa 903 115 C20140605_SFK031_02 C20140605_SFK031_02 TB561551.[MT7]-GDLDLELVLLC[CAM]K[MT7].3b4_1.heavy 559.323 / 545.269 61729.0 46.03129959106445 42 12 10 10 10 0.8989640455402461 64.83315174256086 0.0 3 0.8843803499808888 3.5939372925957946 61729.0 126.71876803227238 0.0 - - - - - - - 782.5714285714286 123 7 ILF3 interleukin enhancer binding factor 3, 90kDa 905 115 C20140605_SFK031_02 C20140605_SFK031_02 TB561551.[MT7]-GDLDLELVLLC[CAM]K[MT7].3b7_1.heavy 559.323 / 900.479 52948.0 46.03129959106445 42 12 10 10 10 0.8989640455402461 64.83315174256086 0.0 3 0.8843803499808888 3.5939372925957946 52948.0 333.2524631643909 0.0 - - - - - - - 152.25 105 4 ILF3 interleukin enhancer binding factor 3, 90kDa 907 116 C20140605_SFK031_02 C20140605_SFK031_02 TB559776.[MT7]-GRTTDGSLQIR.3y7_1.heavy 449.92 / 788.426 3581.0 21.32859992980957 33 17 0 10 6 3.9064810499135456 25.598485880844883 0.0 6 0.9756069787501611 7.885746013612749 3581.0 22.71091892745725 0.0 - - - - - - - 187.8181818181818 7 22 FMR1 fragile X mental retardation 1 909 116 C20140605_SFK031_02 C20140605_SFK031_02 TB559776.[MT7]-GRTTDGSLQIR.3y6_1.heavy 449.92 / 673.399 24147.0 21.32859992980957 33 17 0 10 6 3.9064810499135456 25.598485880844883 0.0 6 0.9756069787501611 7.885746013612749 24147.0 19.41400575236486 1.0 - - - - - - - 373.7142857142857 579 7 FMR1 fragile X mental retardation 1 911 116 C20140605_SFK031_02 C20140605_SFK031_02 TB559776.[MT7]-GRTTDGSLQIR.3b5_1.heavy 449.92 / 675.354 4912.0 21.32859992980957 33 17 0 10 6 3.9064810499135456 25.598485880844883 0.0 6 0.9756069787501611 7.885746013612749 4912.0 2.1346746224451034 2.0 - - - - - - - 308.07142857142856 61 14 FMR1 fragile X mental retardation 1 913 116 C20140605_SFK031_02 C20140605_SFK031_02 TB559776.[MT7]-GRTTDGSLQIR.3y4_1.heavy 449.92 / 529.346 11339.0 21.32859992980957 33 17 0 10 6 3.9064810499135456 25.598485880844883 0.0 6 0.9756069787501611 7.885746013612749 11339.0 1.694997024430508 2.0 - - - - - - - 1738.0 298 7 FMR1 fragile X mental retardation 1 915 117 C20140605_SFK031_02 C20140605_SFK031_02 TB558538.[MT7]-LLTMDPTK[MT7].2y5_1.heavy 603.854 / 735.383 6980.0 32.57224941253662 41 17 10 6 8 2.4495215702387725 31.122568434077856 0.036998748779296875 4 0.973235136281536 7.5267312680648315 6980.0 10.46250107434465 0.0 - - - - - - - 402.5 13 2 CDK19 cyclin-dependent kinase 19 917 117 C20140605_SFK031_02 C20140605_SFK031_02 TB558538.[MT7]-LLTMDPTK[MT7].2y6_1.heavy 603.854 / 836.43 8680.0 32.57224941253662 41 17 10 6 8 2.4495215702387725 31.122568434077856 0.036998748779296875 4 0.973235136281536 7.5267312680648315 8680.0 15.355679702048416 1.0 - - - - - - - 313.0 17 4 CDK19 cyclin-dependent kinase 19 919 117 C20140605_SFK031_02 C20140605_SFK031_02 TB558538.[MT7]-LLTMDPTK[MT7].2b5_1.heavy 603.854 / 718.393 39908.0 32.57224941253662 41 17 10 6 8 2.4495215702387725 31.122568434077856 0.036998748779296875 4 0.973235136281536 7.5267312680648315 39908.0 31.264530759313743 0.0 - - - - - - - 895.0 79 1 CDK19 cyclin-dependent kinase 19 921 117 C20140605_SFK031_02 C20140605_SFK031_02 TB558538.[MT7]-LLTMDPTK[MT7].2y7_1.heavy 603.854 / 949.515 16196.0 32.57224941253662 41 17 10 6 8 2.4495215702387725 31.122568434077856 0.036998748779296875 4 0.973235136281536 7.5267312680648315 16196.0 28.752205188431937 0.0 - - - - - - - 447.0 32 1 CDK19 cyclin-dependent kinase 19 923 118 C20140605_SFK031_02 C20140605_SFK031_02 TB562136.[MT7]-RVLLGPLPPAVDPSLPNVQVTR.3y7_1.heavy 828.159 / 813.458 222267.0 40.192649841308594 44 18 10 6 10 4.52889754973167 17.601569221261393 0.0364990234375 3 0.9812615567537665 9.001504587716168 222267.0 190.42194766672554 0.0 - - - - - - - 385.6666666666667 444 3 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 925 118 C20140605_SFK031_02 C20140605_SFK031_02 TB562136.[MT7]-RVLLGPLPPAVDPSLPNVQVTR.3b5_1.heavy 828.159 / 683.469 53522.0 40.192649841308594 44 18 10 6 10 4.52889754973167 17.601569221261393 0.0364990234375 3 0.9812615567537665 9.001504587716168 53522.0 53.80608897539726 0.0 - - - - - - - 356.0 107 2 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 927 118 C20140605_SFK031_02 C20140605_SFK031_02 TB562136.[MT7]-RVLLGPLPPAVDPSLPNVQVTR.3b7_1.heavy 828.159 / 893.605 281034.0 40.192649841308594 44 18 10 6 10 4.52889754973167 17.601569221261393 0.0364990234375 3 0.9812615567537665 9.001504587716168 281034.0 70.81097977471961 0.0 - - - - - - - 445.0 562 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 929 118 C20140605_SFK031_02 C20140605_SFK031_02 TB562136.[MT7]-RVLLGPLPPAVDPSLPNVQVTR.3y10_1.heavy 828.159 / 1110.63 324865.0 40.192649841308594 44 18 10 6 10 4.52889754973167 17.601569221261393 0.0364990234375 3 0.9812615567537665 9.001504587716168 324865.0 219.93804103784916 0.0 - - - - - - - 400.5 649 2 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 931 119 C20140605_SFK031_02 C20140605_SFK031_02 TB294943.[MT7]-GGFGEVC[CAM]AC[CAM]QVR.2b6_1.heavy 742.349 / 691.353 4426.0 27.64859962463379 50 20 10 10 10 11.159724004257113 8.960795084345534 0.0 3 0.9962609636989431 20.17655965798927 4426.0 20.702998133941527 0.0 - - - - - - - 269.5 8 18 GRK4;GRK5;GRK6 G protein-coupled receptor kinase 4;G protein-coupled receptor kinase 5;G protein-coupled receptor kinase 6 933 119 C20140605_SFK031_02 C20140605_SFK031_02 TB294943.[MT7]-GGFGEVC[CAM]AC[CAM]QVR.2y6_1.heavy 742.349 / 793.344 3880.0 27.64859962463379 50 20 10 10 10 11.159724004257113 8.960795084345534 0.0 3 0.9962609636989431 20.17655965798927 3880.0 14.563696369636963 0.0 - - - - - - - 201.21052631578948 7 19 GRK4;GRK5;GRK6 G protein-coupled receptor kinase 4;G protein-coupled receptor kinase 5;G protein-coupled receptor kinase 6 935 119 C20140605_SFK031_02 C20140605_SFK031_02 TB294943.[MT7]-GGFGEVC[CAM]AC[CAM]QVR.2b5_1.heavy 742.349 / 592.285 7155.0 27.64859962463379 50 20 10 10 10 11.159724004257113 8.960795084345534 0.0 3 0.9962609636989431 20.17655965798927 7155.0 33.37980769230769 0.0 - - - - - - - 209.54545454545453 14 11 GRK4;GRK5;GRK6 G protein-coupled receptor kinase 4;G protein-coupled receptor kinase 5;G protein-coupled receptor kinase 6 937 119 C20140605_SFK031_02 C20140605_SFK031_02 TB294943.[MT7]-GGFGEVC[CAM]AC[CAM]QVR.2y7_1.heavy 742.349 / 892.413 4851.0 27.64859962463379 50 20 10 10 10 11.159724004257113 8.960795084345534 0.0 3 0.9962609636989431 20.17655965798927 4851.0 10.555289452815225 0.0 - - - - - - - 204.31578947368422 9 19 GRK4;GRK5;GRK6 G protein-coupled receptor kinase 4;G protein-coupled receptor kinase 5;G protein-coupled receptor kinase 6 939 120 C20140605_SFK031_02 C20140605_SFK031_02 TB561272.[MT7]-EK[MT7]PTTALLDK[MT7].3b6_1.heavy 516.65 / 916.534 27533.0 26.57990074157715 48 18 10 10 10 8.463270133440576 11.815763696927748 0.0 3 0.9891351606130011 11.829236569760903 27533.0 138.54902432957988 0.0 - - - - - - - 199.35714285714286 55 14 ILF3 interleukin enhancer binding factor 3, 90kDa 941 120 C20140605_SFK031_02 C20140605_SFK031_02 TB561272.[MT7]-EK[MT7]PTTALLDK[MT7].3y3_1.heavy 516.65 / 519.326 218448.0 26.57990074157715 48 18 10 10 10 8.463270133440576 11.815763696927748 0.0 3 0.9891351606130011 11.829236569760903 218448.0 159.43590706040447 0.0 - - - - - - - 1266.125 436 8 ILF3 interleukin enhancer binding factor 3, 90kDa 943 120 C20140605_SFK031_02 C20140605_SFK031_02 TB561272.[MT7]-EK[MT7]PTTALLDK[MT7].3y4_1.heavy 516.65 / 632.41 79568.0 26.57990074157715 48 18 10 10 10 8.463270133440576 11.815763696927748 0.0 3 0.9891351606130011 11.829236569760903 79568.0 86.73782061924405 0.0 - - - - - - - 843.9166666666666 159 12 ILF3 interleukin enhancer binding factor 3, 90kDa 945 120 C20140605_SFK031_02 C20140605_SFK031_02 TB561272.[MT7]-EK[MT7]PTTALLDK[MT7].3y5_1.heavy 516.65 / 703.447 35842.0 26.57990074157715 48 18 10 10 10 8.463270133440576 11.815763696927748 0.0 3 0.9891351606130011 11.829236569760903 35842.0 42.17280022962957 0.0 - - - - - - - 754.6666666666666 71 9 ILF3 interleukin enhancer binding factor 3, 90kDa 947 121 C20140605_SFK031_02 C20140605_SFK031_02 TB294945.[MT7]-TASVLWPWINR.2y5_1.heavy 743.918 / 685.378 71356.0 45.94969940185547 44 14 10 10 10 1.3270041501920076 45.28816862424312 0.0 3 0.9470735760418751 5.340621021657254 71356.0 88.57125874125875 0.0 - - - - - - - 733.3333333333334 142 9 IRAK1 interleukin-1 receptor-associated kinase 1 949 121 C20140605_SFK031_02 C20140605_SFK031_02 TB294945.[MT7]-TASVLWPWINR.2y6_1.heavy 743.918 / 871.457 42233.0 45.94969940185547 44 14 10 10 10 1.3270041501920076 45.28816862424312 0.0 3 0.9470735760418751 5.340621021657254 42233.0 139.6339989177489 0.0 - - - - - - - 234.66666666666666 84 9 IRAK1 interleukin-1 receptor-associated kinase 1 951 121 C20140605_SFK031_02 C20140605_SFK031_02 TB294945.[MT7]-TASVLWPWINR.2b5_1.heavy 743.918 / 616.379 81122.0 45.94969940185547 44 14 10 10 10 1.3270041501920076 45.28816862424312 0.0 3 0.9470735760418751 5.340621021657254 81122.0 78.33023891668104 0.0 - - - - - - - 264.0 162 3 IRAK1 interleukin-1 receptor-associated kinase 1 953 121 C20140605_SFK031_02 C20140605_SFK031_02 TB294945.[MT7]-TASVLWPWINR.2y7_1.heavy 743.918 / 984.541 63701.0 45.94969940185547 44 14 10 10 10 1.3270041501920076 45.28816862424312 0.0 3 0.9470735760418751 5.340621021657254 63701.0 270.19840833333336 0.0 - - - - - - - 234.66666666666666 127 9 IRAK1 interleukin-1 receptor-associated kinase 1 955 122 C20140605_SFK031_02 C20140605_SFK031_02 TB562137.[MT7]-RVLLGPLPPAVDPSLPNVQVTR.4b7_1.heavy 621.371 / 893.605 270707.0 40.192649841308594 40 14 10 6 10 5.879052930261558 17.009542384839698 0.0364990234375 3 0.9418695518246374 5.093706720075902 270707.0 442.9392308487814 0.0 - - - - - - - 5276.0 541 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 957 122 C20140605_SFK031_02 C20140605_SFK031_02 TB562137.[MT7]-RVLLGPLPPAVDPSLPNVQVTR.4b5_1.heavy 621.371 / 683.469 50976.0 40.192649841308594 40 14 10 6 10 5.879052930261558 17.009542384839698 0.0364990234375 3 0.9418695518246374 5.093706720075902 50976.0 31.327374106396768 0.0 - - - - - - - 1520.0 101 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 959 122 C20140605_SFK031_02 C20140605_SFK031_02 TB562137.[MT7]-RVLLGPLPPAVDPSLPNVQVTR.4y7_1.heavy 621.371 / 813.458 517783.0 40.192649841308594 40 14 10 6 10 5.879052930261558 17.009542384839698 0.0364990234375 3 0.9418695518246374 5.093706720075902 517783.0 736.2745928666696 0.0 - - - - - - - 8764.0 1035 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 961 122 C20140605_SFK031_02 C20140605_SFK031_02 TB562137.[MT7]-RVLLGPLPPAVDPSLPNVQVTR.4y6_1.heavy 621.371 / 716.405 81561.0 40.192649841308594 40 14 10 6 10 5.879052930261558 17.009542384839698 0.0364990234375 3 0.9418695518246374 5.093706720075902 81561.0 116.3979616242653 0.0 - - - - - - - 1878.0 163 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 963 123 C20140605_SFK031_02 C20140605_SFK031_02 TB295093.[MT7]-LALYEDGALDSLQLLSSSSLPGLGLEQDR.4b8_1.heavy 801.924 / 977.506 2403.0 53.39477348327637 36 12 10 6 8 1.8736402641406644 43.91339745361921 0.03929901123046875 4 0.8933193238162281 3.7443873960857106 2403.0 12.470812020460357 1.0 - - - - - - - 164.3125 7 16 IRAK1 interleukin-1 receptor-associated kinase 1 965 123 C20140605_SFK031_02 C20140605_SFK031_02 TB295093.[MT7]-LALYEDGALDSLQLLSSSSLPGLGLEQDR.4b7_1.heavy 801.924 / 906.469 1341.0 53.39477348327637 36 12 10 6 8 1.8736402641406644 43.91339745361921 0.03929901123046875 4 0.8933193238162281 3.7443873960857106 1341.0 7.982142857142857 0.0 - - - - - - - 175.45454545454547 2 22 IRAK1 interleukin-1 receptor-associated kinase 1 967 123 C20140605_SFK031_02 C20140605_SFK031_02 TB295093.[MT7]-LALYEDGALDSLQLLSSSSLPGLGLEQDR.4y9_1.heavy 801.924 / 984.511 6594.0 53.39477348327637 36 12 10 6 8 1.8736402641406644 43.91339745361921 0.03929901123046875 4 0.8933193238162281 3.7443873960857106 6594.0 38.303899253731345 0.0 - - - - - - - 186.44444444444446 13 18 IRAK1 interleukin-1 receptor-associated kinase 1 969 123 C20140605_SFK031_02 C20140605_SFK031_02 TB295093.[MT7]-LALYEDGALDSLQLLSSSSLPGLGLEQDR.4y6_1.heavy 801.924 / 717.353 2570.0 53.39477348327637 36 12 10 6 8 1.8736402641406644 43.91339745361921 0.03929901123046875 4 0.8933193238162281 3.7443873960857106 2570.0 60.11964285714286 0.0 - - - - - - - 238.46666666666667 5 15 IRAK1 interleukin-1 receptor-associated kinase 1 971 124 C20140605_SFK031_02 C20140605_SFK031_02 TB294947.[MT7]-SVNPNK[MT7]PATK[MT7].2y4_1.heavy 744.449 / 560.352 1720.0 16.552749156951904 39 13 10 6 10 1.8205573149524983 43.66665150511996 0.03380012512207031 3 0.919321725128258 4.315389993199528 1720.0 0.0 1.0 - - - - - - - 208.46666666666667 3 15 FMR1 fragile X mental retardation 1 973 124 C20140605_SFK031_02 C20140605_SFK031_02 TB294947.[MT7]-SVNPNK[MT7]PATK[MT7].2y8_2.heavy 744.449 / 579.348 886.0 16.552749156951904 39 13 10 6 10 1.8205573149524983 43.66665150511996 0.03380012512207031 3 0.919321725128258 4.315389993199528 886.0 3.733943740873733 0.0 - - - - - - - 0.0 1 0 FMR1 fragile X mental retardation 1 975 124 C20140605_SFK031_02 C20140605_SFK031_02 TB294947.[MT7]-SVNPNK[MT7]PATK[MT7].2b4_1.heavy 744.449 / 542.305 417.0 16.552749156951904 39 13 10 6 10 1.8205573149524983 43.66665150511996 0.03380012512207031 3 0.919321725128258 4.315389993199528 417.0 0.5346153846153845 21.0 - - - - - - - 0.0 1 0 FMR1 fragile X mental retardation 1 977 124 C20140605_SFK031_02 C20140605_SFK031_02 TB294947.[MT7]-SVNPNK[MT7]PATK[MT7].2y7_1.heavy 744.449 / 1043.65 2346.0 16.552749156951904 39 13 10 6 10 1.8205573149524983 43.66665150511996 0.03380012512207031 3 0.919321725128258 4.315389993199528 2346.0 54.13846153846154 0.0 - - - - - - - 153.125 4 16 FMR1 fragile X mental retardation 1 979 125 C20140605_SFK031_02 C20140605_SFK031_02 TB561553.[MT7]-VEDLFEYEGC[CAM]K[MT7].3b6_1.heavy 559.607 / 877.442 57897.0 37.4556999206543 44 14 10 10 10 2.239822115337506 34.624890731071574 0.0 3 0.9440127236195255 5.191230673022094 57897.0 135.86917697929536 0.0 - - - - - - - 282.3333333333333 115 9 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 981 125 C20140605_SFK031_02 C20140605_SFK031_02 TB561553.[MT7]-VEDLFEYEGC[CAM]K[MT7].3y3_1.heavy 559.607 / 508.267 198351.0 37.4556999206543 44 14 10 10 10 2.239822115337506 34.624890731071574 0.0 3 0.9440127236195255 5.191230673022094 198351.0 182.37761849058262 0.0 - - - - - - - 318.0 396 2 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 983 125 C20140605_SFK031_02 C20140605_SFK031_02 TB561553.[MT7]-VEDLFEYEGC[CAM]K[MT7].3b4_1.heavy 559.607 / 601.331 106373.0 37.4556999206543 44 14 10 10 10 2.239822115337506 34.624890731071574 0.0 3 0.9440127236195255 5.191230673022094 106373.0 52.62183615812155 0.0 - - - - - - - 705.6666666666666 212 3 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 985 125 C20140605_SFK031_02 C20140605_SFK031_02 TB561553.[MT7]-VEDLFEYEGC[CAM]K[MT7].3b5_1.heavy 559.607 / 748.4 41808.0 37.4556999206543 44 14 10 10 10 2.239822115337506 34.624890731071574 0.0 3 0.9440127236195255 5.191230673022094 41808.0 59.86971490746033 0.0 - - - - - - - 714.5 83 12 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 987 126 C20140605_SFK031_02 C20140605_SFK031_02 TB556844.[MT7]-GLSDPGK[MT7].2y4_1.heavy 481.281 / 560.316 8912.0 19.045899868011475 40 20 10 6 4 11.713919327891542 8.536852372023258 0.03600120544433594 8 0.9991096882995604 41.35795940510961 8912.0 5.839920952908346 6.0 - - - - - - - 1259.5 30 8 HNF4A hepatocyte nuclear factor 4, alpha 989 126 C20140605_SFK031_02 C20140605_SFK031_02 TB556844.[MT7]-GLSDPGK[MT7].2y5_1.heavy 481.281 / 647.348 15090.0 19.045899868011475 40 20 10 6 4 11.713919327891542 8.536852372023258 0.03600120544433594 8 0.9991096882995604 41.35795940510961 15090.0 33.90592592592593 0.0 - - - - - - - 683.5833333333334 30 12 HNF4A hepatocyte nuclear factor 4, alpha 991 126 C20140605_SFK031_02 C20140605_SFK031_02 TB556844.[MT7]-GLSDPGK[MT7].2b4_1.heavy 481.281 / 517.274 326356.0 19.045899868011475 40 20 10 6 4 11.713919327891542 8.536852372023258 0.03600120544433594 8 0.9991096882995604 41.35795940510961 326356.0 292.6349341363412 0.0 - - - - - - - 1749.888888888889 652 9 HNF4A hepatocyte nuclear factor 4, alpha 993 126 C20140605_SFK031_02 C20140605_SFK031_02 TB556844.[MT7]-GLSDPGK[MT7].2y6_1.heavy 481.281 / 760.432 8304.0 19.045899868011475 40 20 10 6 4 11.713919327891542 8.536852372023258 0.03600120544433594 8 0.9991096882995604 41.35795940510961 8304.0 33.0386148556127 1.0 - - - - - - - 261.6666666666667 21 18 HNF4A hepatocyte nuclear factor 4, alpha 995 127 C20140605_SFK031_02 C20140605_SFK031_02 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 1515090.0 32.188899993896484 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1515090.0 1108.2860057413404 0.0 - - - - - - - 725.75 3030 8 997 127 C20140605_SFK031_02 C20140605_SFK031_02 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 1380950.0 32.188899993896484 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1380950.0 1189.978807218516 0.0 - - - - - - - 1154.0 2761 7 999 127 C20140605_SFK031_02 C20140605_SFK031_02 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 2569280.0 32.188899993896484 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2569280.0 501.46292883577786 0.0 - - - - - - - 673.0 5138 2 1001 128 C20140605_SFK031_02 C20140605_SFK031_02 TB295090.[MT7]-ALFYAAEILC[CAM]GLEDLHRENTVYR.4b7_1.heavy 725.124 / 910.479 19236.0 53.44390106201172 42 12 10 10 10 1.0187482846481366 65.43978298789727 0.0 3 0.8870155044058551 3.6364402835205736 19236.0 40.01419267074931 0.0 - - - - - - - 231.4 38 10 GRK5 G protein-coupled receptor kinase 5 1003 128 C20140605_SFK031_02 C20140605_SFK031_02 TB295090.[MT7]-ALFYAAEILC[CAM]GLEDLHRENTVYR.4b4_1.heavy 725.124 / 639.362 12346.0 53.44390106201172 42 12 10 10 10 1.0187482846481366 65.43978298789727 0.0 3 0.8870155044058551 3.6364402835205736 12346.0 45.34038465466011 0.0 - - - - - - - 283.5 24 14 GRK5 G protein-coupled receptor kinase 5 1005 128 C20140605_SFK031_02 C20140605_SFK031_02 TB295090.[MT7]-ALFYAAEILC[CAM]GLEDLHRENTVYR.4b5_1.heavy 725.124 / 710.399 14937.0 53.44390106201172 42 12 10 10 10 1.0187482846481366 65.43978298789727 0.0 3 0.8870155044058551 3.6364402835205736 14937.0 31.164531397624508 0.0 - - - - - - - 325.1 29 10 GRK5 G protein-coupled receptor kinase 5 1007 128 C20140605_SFK031_02 C20140605_SFK031_02 TB295090.[MT7]-ALFYAAEILC[CAM]GLEDLHRENTVYR.4y14_2.heavy 725.124 / 881.42 23866.0 53.44390106201172 42 12 10 10 10 1.0187482846481366 65.43978298789727 0.0 3 0.8870155044058551 3.6364402835205736 23866.0 70.90330670683277 0.0 - - - - - - - 275.5 47 14 GRK5 G protein-coupled receptor kinase 5 1009 129 C20140605_SFK031_02 C20140605_SFK031_02 TB561651.[MT7]-VSYLRPLDFEEAR.3y8_1.heavy 580.313 / 976.473 45619.0 37.293701171875 43 13 10 10 10 1.3057576867140628 52.5976576735429 0.0 3 0.9137030916088505 4.170527028278614 45619.0 190.13759914756486 0.0 - - - - - - - 665.2857142857143 91 7 KIAA1279 KIAA1279 1011 129 C20140605_SFK031_02 C20140605_SFK031_02 TB561651.[MT7]-VSYLRPLDFEEAR.3y12_2.heavy 580.313 / 748.381 72185.0 37.293701171875 43 13 10 10 10 1.3057576867140628 52.5976576735429 0.0 3 0.9137030916088505 4.170527028278614 72185.0 92.63543614510402 0.0 - - - - - - - 665.2857142857143 144 7 KIAA1279 KIAA1279 1013 129 C20140605_SFK031_02 C20140605_SFK031_02 TB561651.[MT7]-VSYLRPLDFEEAR.3y5_1.heavy 580.313 / 651.31 47418.0 37.293701171875 43 13 10 10 10 1.3057576867140628 52.5976576735429 0.0 3 0.9137030916088505 4.170527028278614 47418.0 44.41270226849174 0.0 - - - - - - - 370.5 94 2 KIAA1279 KIAA1279 1015 129 C20140605_SFK031_02 C20140605_SFK031_02 TB561651.[MT7]-VSYLRPLDFEEAR.3b8_2.heavy 580.313 / 544.815 42338.0 37.293701171875 43 13 10 10 10 1.3057576867140628 52.5976576735429 0.0 3 0.9137030916088505 4.170527028278614 42338.0 32.32415533818834 0.0 - - - - - - - 741.0 84 3 KIAA1279 KIAA1279 1017 130 C20140605_SFK031_02 C20140605_SFK031_02 TB556229.[MT7]-GAALC[CAM]LR.2y5_1.heavy 452.761 / 632.355 24029.0 26.257700443267822 43 17 10 6 10 2.2959692254489363 30.162460150860802 0.03520011901855469 3 0.9759292184163063 7.938569531315371 24029.0 16.08903271654722 0.0 - - - - - - - 267.0 48 2 FLT4 fms-related tyrosine kinase 4 1019 130 C20140605_SFK031_02 C20140605_SFK031_02 TB556229.[MT7]-GAALC[CAM]LR.2b4_1.heavy 452.761 / 457.289 34174.0 26.257700443267822 43 17 10 6 10 2.2959692254489363 30.162460150860802 0.03520011901855469 3 0.9759292184163063 7.938569531315371 34174.0 6.36189066173813 0.0 - - - - - - - 811.0 68 3 FLT4 fms-related tyrosine kinase 4 1021 130 C20140605_SFK031_02 C20140605_SFK031_02 TB556229.[MT7]-GAALC[CAM]LR.2y6_1.heavy 452.761 / 703.392 38031.0 26.257700443267822 43 17 10 6 10 2.2959692254489363 30.162460150860802 0.03520011901855469 3 0.9759292184163063 7.938569531315371 38031.0 82.26754082629631 0.0 - - - - - - - 704.5 76 8 FLT4 fms-related tyrosine kinase 4 1023 130 C20140605_SFK031_02 C20140605_SFK031_02 TB556229.[MT7]-GAALC[CAM]LR.2b5_1.heavy 452.761 / 617.32 37437.0 26.257700443267822 43 17 10 6 10 2.2959692254489363 30.162460150860802 0.03520011901855469 3 0.9759292184163063 7.938569531315371 37437.0 9.229488642795612 1.0 - - - - - - - 1351.4444444444443 74 9 FLT4 fms-related tyrosine kinase 4 1025 131 C20140605_SFK031_02 C20140605_SFK031_02 TB399668.[MT7]-RQHQNNSK[MT7].3y3_1.heavy 433.909 / 492.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - GRK5 G protein-coupled receptor kinase 5 1027 131 C20140605_SFK031_02 C20140605_SFK031_02 TB399668.[MT7]-RQHQNNSK[MT7].3y4_1.heavy 433.909 / 606.333 N/A N/A - - - - - - - - - 0.0 - - - - - - - GRK5 G protein-coupled receptor kinase 5 1029 131 C20140605_SFK031_02 C20140605_SFK031_02 TB399668.[MT7]-RQHQNNSK[MT7].3b3_1.heavy 433.909 / 566.328 N/A N/A - - - - - - - - - 0.0 - - - - - - - GRK5 G protein-coupled receptor kinase 5 1031 131 C20140605_SFK031_02 C20140605_SFK031_02 TB399668.[MT7]-RQHQNNSK[MT7].3y5_1.heavy 433.909 / 734.391 N/A N/A - - - - - - - - - 0.0 - - - - - - - GRK5 G protein-coupled receptor kinase 5 1033 132 C20140605_SFK031_02 C20140605_SFK031_02 TB556849.[MT7]-TESSPGSR.2y5_1.heavy 482.744 / 503.257 N/A N/A - - - - - - - - - 0.0 - - - - - - - ETV3 ets variant 3 1035 132 C20140605_SFK031_02 C20140605_SFK031_02 TB556849.[MT7]-TESSPGSR.2b4_1.heavy 482.744 / 549.264 N/A N/A - - - - - - - - - 0.0 - - - - - - - ETV3 ets variant 3 1037 132 C20140605_SFK031_02 C20140605_SFK031_02 TB556849.[MT7]-TESSPGSR.2y6_1.heavy 482.744 / 590.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - ETV3 ets variant 3 1039 132 C20140605_SFK031_02 C20140605_SFK031_02 TB556849.[MT7]-TESSPGSR.2y7_1.heavy 482.744 / 719.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - ETV3 ets variant 3 1041 133 C20140605_SFK031_02 C20140605_SFK031_02 TB562047.[MT7]-DLAFVDPDDC[CAM]TPLLTVTR.3y7_1.heavy 731.372 / 799.504 121776.0 43.622501373291016 50 20 10 10 10 7.91647238308845 12.631888947610658 0.0 3 0.9947880684854986 17.087330241149942 121776.0 93.63736645144058 1.0 - - - - - - - 375.0 256 1 CNNM1 cyclin M1 1043 133 C20140605_SFK031_02 C20140605_SFK031_02 TB562047.[MT7]-DLAFVDPDDC[CAM]TPLLTVTR.3b4_1.heavy 731.372 / 591.326 68112.0 43.622501373291016 50 20 10 10 10 7.91647238308845 12.631888947610658 0.0 3 0.9947880684854986 17.087330241149942 68112.0 85.00107300323614 0.0 - - - - - - - 406.3333333333333 136 3 CNNM1 cyclin M1 1045 133 C20140605_SFK031_02 C20140605_SFK031_02 TB562047.[MT7]-DLAFVDPDDC[CAM]TPLLTVTR.3b5_1.heavy 731.372 / 690.394 34525.0 43.622501373291016 50 20 10 10 10 7.91647238308845 12.631888947610658 0.0 3 0.9947880684854986 17.087330241149942 34525.0 45.909026606919056 0.0 - - - - - - - 398.75 69 4 CNNM1 cyclin M1 1047 133 C20140605_SFK031_02 C20140605_SFK031_02 TB562047.[MT7]-DLAFVDPDDC[CAM]TPLLTVTR.3y5_1.heavy 731.372 / 589.367 44001.0 43.622501373291016 50 20 10 10 10 7.91647238308845 12.631888947610658 0.0 3 0.9947880684854986 17.087330241149942 44001.0 60.22926461313173 0.0 - - - - - - - 188.0 88 2 CNNM1 cyclin M1 1049 134 C20140605_SFK031_02 C20140605_SFK031_02 TB562048.[MT7]-SATPSPSSSINEEDADEANR.3y7_1.heavy 741.004 / 790.333 13289.0 22.857099533081055 50 20 10 10 10 14.591208572147638 6.853441886293405 0.0 3 0.9930063929211688 14.748855583608012 13289.0 64.65886571411272 0.0 - - - - - - - 230.25 26 16 TOX3 TOX high mobility group box family member 3 1051 134 C20140605_SFK031_02 C20140605_SFK031_02 TB562048.[MT7]-SATPSPSSSINEEDADEANR.3y6_1.heavy 741.004 / 675.306 11298.0 22.857099533081055 50 20 10 10 10 14.591208572147638 6.853441886293405 0.0 3 0.9930063929211688 14.748855583608012 11298.0 42.45555815813528 0.0 - - - - - - - 732.0 22 7 TOX3 TOX high mobility group box family member 3 1053 134 C20140605_SFK031_02 C20140605_SFK031_02 TB562048.[MT7]-SATPSPSSSINEEDADEANR.3b5_1.heavy 741.004 / 588.311 30560.0 22.857099533081055 50 20 10 10 10 14.591208572147638 6.853441886293405 0.0 3 0.9930063929211688 14.748855583608012 30560.0 48.53542166358899 0.0 - - - - - - - 403.77777777777777 61 9 TOX3 TOX high mobility group box family member 3 1055 134 C20140605_SFK031_02 C20140605_SFK031_02 TB562048.[MT7]-SATPSPSSSINEEDADEANR.3y10_1.heavy 741.004 / 1162.46 20954.0 22.857099533081055 50 20 10 10 10 14.591208572147638 6.853441886293405 0.0 3 0.9930063929211688 14.748855583608012 20954.0 54.93339890944082 0.0 - - - - - - - 718.8888888888889 41 9 TOX3 TOX high mobility group box family member 3 1057 135 C20140605_SFK031_02 C20140605_SFK031_02 TB561579.[MT7]-DVLDIEQFSTVK[MT7].3b6_1.heavy 561.313 / 829.442 75090.0 40.136199951171875 46 16 10 10 10 3.402205704092676 29.392696590833765 0.0 3 0.9671000637852589 6.785266436438416 75090.0 94.8260263338341 0.0 - - - - - - - 299.0 150 8 GRK5;GRK6 G protein-coupled receptor kinase 5;G protein-coupled receptor kinase 6 1059 135 C20140605_SFK031_02 C20140605_SFK031_02 TB561579.[MT7]-DVLDIEQFSTVK[MT7].3b4_1.heavy 561.313 / 587.316 310631.0 40.136199951171875 46 16 10 10 10 3.402205704092676 29.392696590833765 0.0 3 0.9671000637852589 6.785266436438416 310631.0 116.6421331688841 0.0 - - - - - - - 177.0 621 1 GRK5;GRK6 G protein-coupled receptor kinase 5;G protein-coupled receptor kinase 6 1061 135 C20140605_SFK031_02 C20140605_SFK031_02 TB561579.[MT7]-DVLDIEQFSTVK[MT7].3b5_1.heavy 561.313 / 700.4 104843.0 40.136199951171875 46 16 10 10 10 3.402205704092676 29.392696590833765 0.0 3 0.9671000637852589 6.785266436438416 104843.0 120.04256568473696 0.0 - - - - - - - 1239.7777777777778 209 9 GRK5;GRK6 G protein-coupled receptor kinase 5;G protein-coupled receptor kinase 6 1063 135 C20140605_SFK031_02 C20140605_SFK031_02 TB561579.[MT7]-DVLDIEQFSTVK[MT7].3y4_1.heavy 561.313 / 578.363 176479.0 40.136199951171875 46 16 10 10 10 3.402205704092676 29.392696590833765 0.0 3 0.9671000637852589 6.785266436438416 176479.0 248.29159069533952 0.0 - - - - - - - 796.7777777777778 352 9 GRK5;GRK6 G protein-coupled receptor kinase 5;G protein-coupled receptor kinase 6 1065 136 C20140605_SFK031_02 C20140605_SFK031_02 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 1616140.0 26.37190055847168 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1616140.0 883.1694749214603 0.0 - - - - - - - 11218.0 3232 1 1067 136 C20140605_SFK031_02 C20140605_SFK031_02 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 1988760.0 26.37190055847168 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1988760.0 2248.4046591706465 0.0 - - - - - - - 13738.0 3977 1 1069 136 C20140605_SFK031_02 C20140605_SFK031_02 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 2638530.0 26.37190055847168 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2638530.0 2316.9897192420603 0.0 - - - - - - - 18837.0 5277 1 1071 137 C20140605_SFK031_02 C20140605_SFK031_02 TB561411.[MT7]-YNC[CAM]PSFLAAALAR.3y7_1.heavy 533.281 / 685.435 26681.0 42.20197582244873 40 18 8 6 8 3.7403046144925294 26.735790345131456 0.036502838134765625 4 0.9828975090794926 9.423490038095153 26681.0 35.1125766117838 1.0 - - - - - - - 242.33333333333334 78 3 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1073 137 C20140605_SFK031_02 C20140605_SFK031_02 TB561411.[MT7]-YNC[CAM]PSFLAAALAR.3y6_1.heavy 533.281 / 572.352 72146.0 42.20197582244873 40 18 8 6 8 3.7403046144925294 26.735790345131456 0.036502838134765625 4 0.9828975090794926 9.423490038095153 72146.0 118.96708156038844 1.0 - - - - - - - 363.0 190 4 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1075 137 C20140605_SFK031_02 C20140605_SFK031_02 TB561411.[MT7]-YNC[CAM]PSFLAAALAR.3b3_1.heavy 533.281 / 582.246 31853.0 42.20197582244873 40 18 8 6 8 3.7403046144925294 26.735790345131456 0.036502838134765625 4 0.9828975090794926 9.423490038095153 31853.0 41.18092286501378 1.0 - - - - - - - 735.3 63 10 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1077 137 C20140605_SFK031_02 C20140605_SFK031_02 TB561411.[MT7]-YNC[CAM]PSFLAAALAR.3y5_1.heavy 533.281 / 501.314 62890.0 42.20197582244873 40 18 8 6 8 3.7403046144925294 26.735790345131456 0.036502838134765625 4 0.9828975090794926 9.423490038095153 62890.0 62.530049810008805 0.0 - - - - - - - 454.0 125 1 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1079 138 C20140605_SFK031_02 C20140605_SFK031_02 TB559136.[MT7]-QEASESPVK[MT7].3y3_1.heavy 421.566 / 487.336 39796.0 17.667800903320312 41 11 10 10 10 0.6817970938623493 78.9853574109768 0.0 3 0.8759391071336129 3.466963298970021 39796.0 38.89480003547415 0.0 - - - - - - - 1754.8 79 10 FOXK2 forkhead box K2 1081 138 C20140605_SFK031_02 C20140605_SFK031_02 TB559136.[MT7]-QEASESPVK[MT7].3b5_1.heavy 421.566 / 689.322 12900.0 17.667800903320312 41 11 10 10 10 0.6817970938623493 78.9853574109768 0.0 3 0.8759391071336129 3.466963298970021 12900.0 49.206540124036835 0.0 - - - - - - - 727.1538461538462 25 13 FOXK2 forkhead box K2 1083 138 C20140605_SFK031_02 C20140605_SFK031_02 TB559136.[MT7]-QEASESPVK[MT7].3b3_1.heavy 421.566 / 473.248 18644.0 17.667800903320312 41 11 10 10 10 0.6817970938623493 78.9853574109768 0.0 3 0.8759391071336129 3.466963298970021 18644.0 21.434009876809128 0.0 - - - - - - - 1862.888888888889 37 9 FOXK2 forkhead box K2 1085 138 C20140605_SFK031_02 C20140605_SFK031_02 TB559136.[MT7]-QEASESPVK[MT7].3y3_2.heavy 421.566 / 244.172 40527.0 17.667800903320312 41 11 10 10 10 0.6817970938623493 78.9853574109768 0.0 3 0.8759391071336129 3.466963298970021 40527.0 52.1679228224381 0.0 - - - - - - - 2126.1428571428573 81 7 FOXK2 forkhead box K2 1087 139 C20140605_SFK031_02 C20140605_SFK031_02 TB561577.[MT7]-LAQTAVTNNTAAATVLNQVLSK[MT7].3y7_1.heavy 839.481 / 945.585 21228.0 44.17599868774414 43 13 10 10 10 0.8674667199662343 61.24364833735337 0.0 3 0.9105637321144597 4.095569581036785 21228.0 31.668922136159804 1.0 - - - - - - - 727.7142857142857 49 7 RBM20 RNA binding motif protein 20 1089 139 C20140605_SFK031_02 C20140605_SFK031_02 TB561577.[MT7]-LAQTAVTNNTAAATVLNQVLSK[MT7].3b6_1.heavy 839.481 / 728.442 37549.0 44.17599868774414 43 13 10 10 10 0.8674667199662343 61.24364833735337 0.0 3 0.9105637321144597 4.095569581036785 37549.0 22.894032399165727 0.0 - - - - - - - 472.0 75 1 RBM20 RNA binding motif protein 20 1091 139 C20140605_SFK031_02 C20140605_SFK031_02 TB561577.[MT7]-LAQTAVTNNTAAATVLNQVLSK[MT7].3b4_1.heavy 839.481 / 558.337 7265.0 44.17599868774414 43 13 10 10 10 0.8674667199662343 61.24364833735337 0.0 3 0.9105637321144597 4.095569581036785 7265.0 8.014840989399294 1.0 - - - - - - - 358.6 14 5 RBM20 RNA binding motif protein 20 1093 139 C20140605_SFK031_02 C20140605_SFK031_02 TB561577.[MT7]-LAQTAVTNNTAAATVLNQVLSK[MT7].3b5_1.heavy 839.481 / 629.374 16227.0 44.17599868774414 43 13 10 10 10 0.8674667199662343 61.24364833735337 0.0 3 0.9105637321144597 4.095569581036785 16227.0 14.587881612259002 0.0 - - - - - - - 141.5 32 2 RBM20 RNA binding motif protein 20 1095 140 C20140605_SFK031_02 C20140605_SFK031_02 TB560079.[MT7]-VLAGETLSVNDPPDVLDR.3y7_1.heavy 685.368 / 811.431 198354.0 38.12839889526367 50 20 10 10 10 12.523324294291092 7.9851002537390325 0.0 3 0.9954703345743121 18.330116994841656 198354.0 82.14620082008506 0.0 - - - - - - - 754.0 396 1 ILF3 interleukin enhancer binding factor 3, 90kDa 1097 140 C20140605_SFK031_02 C20140605_SFK031_02 TB560079.[MT7]-VLAGETLSVNDPPDVLDR.3b6_1.heavy 685.368 / 715.411 77777.0 38.12839889526367 50 20 10 10 10 12.523324294291092 7.9851002537390325 0.0 3 0.9954703345743121 18.330116994841656 77777.0 80.01968368605782 0.0 - - - - - - - 722.6666666666666 155 3 ILF3 interleukin enhancer binding factor 3, 90kDa 1099 140 C20140605_SFK031_02 C20140605_SFK031_02 TB560079.[MT7]-VLAGETLSVNDPPDVLDR.3b5_1.heavy 685.368 / 614.363 74383.0 38.12839889526367 50 20 10 10 10 12.523324294291092 7.9851002537390325 0.0 3 0.9954703345743121 18.330116994841656 74383.0 18.632594451957704 0.0 - - - - - - - 2168.0 148 1 ILF3 interleukin enhancer binding factor 3, 90kDa 1101 140 C20140605_SFK031_02 C20140605_SFK031_02 TB560079.[MT7]-VLAGETLSVNDPPDVLDR.3y4_1.heavy 685.368 / 502.298 36390.0 38.12839889526367 50 20 10 10 10 12.523324294291092 7.9851002537390325 0.0 3 0.9954703345743121 18.330116994841656 36390.0 33.65737393582187 0.0 - - - - - - - 848.5 72 2 ILF3 interleukin enhancer binding factor 3, 90kDa 1103 141 C20140605_SFK031_02 C20140605_SFK031_02 TB561844.[MT7]-LAAYPPPEFQWYK[MT7].3y7_1.heavy 633.341 / 1141.58 6443.0 41.70759963989258 42 18 10 6 8 2.221459375415398 33.77301997719566 0.03459930419921875 4 0.9828027903565615 9.397428229097006 6443.0 22.49092818428184 2.0 - - - - - - - 233.28571428571428 16 14 FLT4 fms-related tyrosine kinase 4 1105 141 C20140605_SFK031_02 C20140605_SFK031_02 TB561844.[MT7]-LAAYPPPEFQWYK[MT7].3y3_1.heavy 633.341 / 640.357 15427.0 41.70759963989258 42 18 10 6 8 2.221459375415398 33.77301997719566 0.03459930419921875 4 0.9828027903565615 9.397428229097006 15427.0 13.457897153351698 2.0 - - - - - - - 317.5 34 2 FLT4 fms-related tyrosine kinase 4 1107 141 C20140605_SFK031_02 C20140605_SFK031_02 TB561844.[MT7]-LAAYPPPEFQWYK[MT7].3b4_1.heavy 633.341 / 563.331 42196.0 41.70759963989258 42 18 10 6 8 2.221459375415398 33.77301997719566 0.03459930419921875 4 0.9828027903565615 9.397428229097006 42196.0 27.83937860488581 0.0 - - - - - - - 1234.2 84 5 FLT4 fms-related tyrosine kinase 4 1109 141 C20140605_SFK031_02 C20140605_SFK031_02 TB561844.[MT7]-LAAYPPPEFQWYK[MT7].3b5_1.heavy 633.341 / 660.384 6987.0 41.70759963989258 42 18 10 6 8 2.221459375415398 33.77301997719566 0.03459930419921875 4 0.9828027903565615 9.397428229097006 6987.0 3.4680088108506313 0.0 - - - - - - - 2268.5714285714284 13 7 FLT4 fms-related tyrosine kinase 4 1111 142 C20140605_SFK031_02 C20140605_SFK031_02 TB560078.[MT7]-FQGAGSNK[MT7]K[MT7].3y7_1.heavy 456.937 / 949.567 N/A 16.963699340820312 42 12 10 10 10 0.9314452278114146 72.90027184183835 0.0 3 0.880741870143215 3.5375670623154307 0.0 0.0 1.0 - - - - - - - 0.0 0 0 ILF3 interleukin enhancer binding factor 3, 90kDa 1113 142 C20140605_SFK031_02 C20140605_SFK031_02 TB560078.[MT7]-FQGAGSNK[MT7]K[MT7].3y3_1.heavy 456.937 / 677.455 2806.0 16.963699340820312 42 12 10 10 10 0.9314452278114146 72.90027184183835 0.0 3 0.880741870143215 3.5375670623154307 2806.0 8.416425364758698 0.0 - - - - - - - 225.0 5 18 ILF3 interleukin enhancer binding factor 3, 90kDa 1115 142 C20140605_SFK031_02 C20140605_SFK031_02 TB560078.[MT7]-FQGAGSNK[MT7]K[MT7].3y7_2.heavy 456.937 / 475.287 15597.0 16.963699340820312 42 12 10 10 10 0.9314452278114146 72.90027184183835 0.0 3 0.880741870143215 3.5375670623154307 15597.0 23.983374913374913 0.0 - - - - - - - 1125.2857142857142 31 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1117 142 C20140605_SFK031_02 C20140605_SFK031_02 TB560078.[MT7]-FQGAGSNK[MT7]K[MT7].3y8_2.heavy 456.937 / 539.316 10470.0 16.963699340820312 42 12 10 10 10 0.9314452278114146 72.90027184183835 0.0 3 0.880741870143215 3.5375670623154307 10470.0 17.872707948985322 0.0 - - - - - - - 750.3 20 10 ILF3 interleukin enhancer binding factor 3, 90kDa 1119 143 C20140605_SFK031_02 C20140605_SFK031_02 TB560313.[MT7]-ISPQLLLATHR.3b4_1.heavy 464.953 / 570.337 183156.0 35.622798919677734 48 18 10 10 10 3.0274911901602106 26.45676997915229 0.0 3 0.9834243061210437 9.572487000265957 183156.0 312.97480033019616 0.0 - - - - - - - 229.75 366 4 CNNM1 cyclin M1 1121 143 C20140605_SFK031_02 C20140605_SFK031_02 TB560313.[MT7]-ISPQLLLATHR.3b5_1.heavy 464.953 / 683.421 115290.0 35.622798919677734 48 18 10 10 10 3.0274911901602106 26.45676997915229 0.0 3 0.9834243061210437 9.572487000265957 115290.0 268.651521735579 0.0 - - - - - - - 244.0 230 8 CNNM1 cyclin M1 1123 143 C20140605_SFK031_02 C20140605_SFK031_02 TB560313.[MT7]-ISPQLLLATHR.3y4_1.heavy 464.953 / 484.263 201529.0 35.622798919677734 48 18 10 10 10 3.0274911901602106 26.45676997915229 0.0 3 0.9834243061210437 9.572487000265957 201529.0 246.1392334751227 0.0 - - - - - - - 1312.2857142857142 403 7 CNNM1 cyclin M1 1125 143 C20140605_SFK031_02 C20140605_SFK031_02 TB560313.[MT7]-ISPQLLLATHR.3y5_1.heavy 464.953 / 597.347 208763.0 35.622798919677734 48 18 10 10 10 3.0274911901602106 26.45676997915229 0.0 3 0.9834243061210437 9.572487000265957 208763.0 240.15248331606867 0.0 - - - - - - - 267.6666666666667 417 3 CNNM1 cyclin M1 1127 144 C20140605_SFK031_02 C20140605_SFK031_02 TB294655.[MT7]-ALAAYR.2b3_1.heavy 404.743 / 400.268 42791.0 23.05345058441162 40 14 10 6 10 3.6515733006834394 21.628976244683614 0.03190040588378906 3 0.9302973346386153 4.647101770746121 42791.0 18.404524007854615 0.0 - - - - - - - 4171.571428571428 85 7 TOX3;TOX2 TOX high mobility group box family member 3;TOX high mobility group box family member 2 1129 144 C20140605_SFK031_02 C20140605_SFK031_02 TB294655.[MT7]-ALAAYR.2y4_1.heavy 404.743 / 480.257 63000.0 23.05345058441162 40 14 10 6 10 3.6515733006834394 21.628976244683614 0.03190040588378906 3 0.9302973346386153 4.647101770746121 63000.0 101.59919028340082 0.0 - - - - - - - 1334.0 126 7 TOX3;TOX2 TOX high mobility group box family member 3;TOX high mobility group box family member 2 1131 144 C20140605_SFK031_02 C20140605_SFK031_02 TB294655.[MT7]-ALAAYR.2y5_1.heavy 404.743 / 593.341 133708.0 23.05345058441162 40 14 10 6 10 3.6515733006834394 21.628976244683614 0.03190040588378906 3 0.9302973346386153 4.647101770746121 133708.0 244.2884473719907 0.0 - - - - - - - 719.2222222222222 267 9 TOX3;TOX2 TOX high mobility group box family member 3;TOX high mobility group box family member 2 1133 144 C20140605_SFK031_02 C20140605_SFK031_02 TB294655.[MT7]-ALAAYR.2b4_1.heavy 404.743 / 471.305 92548.0 23.05345058441162 40 14 10 6 10 3.6515733006834394 21.628976244683614 0.03190040588378906 3 0.9302973346386153 4.647101770746121 92548.0 94.85231173178764 0.0 - - - - - - - 1792.857142857143 185 7 TOX3;TOX2 TOX high mobility group box family member 3;TOX high mobility group box family member 2 1135 145 C20140605_SFK031_02 C20140605_SFK031_02 TB561975.[MT7]-ASAELQTLLMNQLTVK[MT7].3b6_1.heavy 683.394 / 744.401 5652.0 45.34189987182617 50 20 10 10 10 5.972851507920572 16.742421918139176 0.0 3 0.9923822887410825 14.131037085844545 5652.0 11.24874651810585 0.0 - - - - - - - 710.1666666666666 11 12 ANAPC4 anaphase promoting complex subunit 4 1137 145 C20140605_SFK031_02 C20140605_SFK031_02 TB561975.[MT7]-ASAELQTLLMNQLTVK[MT7].3b4_1.heavy 683.394 / 503.258 11931.0 45.34189987182617 50 20 10 10 10 5.972851507920572 16.742421918139176 0.0 3 0.9923822887410825 14.131037085844545 11931.0 6.7830373052096675 0.0 - - - - - - - 840.875 23 8 ANAPC4 anaphase promoting complex subunit 4 1139 145 C20140605_SFK031_02 C20140605_SFK031_02 TB561975.[MT7]-ASAELQTLLMNQLTVK[MT7].3b5_1.heavy 683.394 / 616.342 6728.0 45.34189987182617 50 20 10 10 10 5.972851507920572 16.742421918139176 0.0 3 0.9923822887410825 14.131037085844545 6728.0 10.962843019709304 0.0 - - - - - - - 697.7777777777778 13 9 ANAPC4 anaphase promoting complex subunit 4 1141 145 C20140605_SFK031_02 C20140605_SFK031_02 TB561975.[MT7]-ASAELQTLLMNQLTVK[MT7].3b7_1.heavy 683.394 / 845.448 6100.0 45.34189987182617 50 20 10 10 10 5.972851507920572 16.742421918139176 0.0 3 0.9923822887410825 14.131037085844545 6100.0 14.777431742467012 0.0 - - - - - - - 314.125 12 8 ANAPC4 anaphase promoting complex subunit 4 1143 146 C20140605_SFK031_02 C20140605_SFK031_02 TB399762.[MT7]-DVLLLGNDYIVPR.2y8_1.heavy 815.968 / 933.479 156617.0 43.10649871826172 43 13 10 10 10 4.299103931899502 23.260661194533235 0.0 3 0.9278217625607749 4.565745976017555 156617.0 89.05823369105215 0.0 - - - - - - - 430.3333333333333 313 3 HNF4A hepatocyte nuclear factor 4, alpha 1145 146 C20140605_SFK031_02 C20140605_SFK031_02 TB399762.[MT7]-DVLLLGNDYIVPR.2y5_1.heavy 815.968 / 647.388 56633.0 43.10649871826172 43 13 10 10 10 4.299103931899502 23.260661194533235 0.0 3 0.9278217625607749 4.565745976017555 56633.0 114.86302603036876 0.0 - - - - - - - 809.5555555555555 113 9 HNF4A hepatocyte nuclear factor 4, alpha 1147 146 C20140605_SFK031_02 C20140605_SFK031_02 TB399762.[MT7]-DVLLLGNDYIVPR.2y9_1.heavy 815.968 / 1046.56 194065.0 43.10649871826172 43 13 10 10 10 4.299103931899502 23.260661194533235 0.0 3 0.9278217625607749 4.565745976017555 194065.0 184.95484925097742 0.0 - - - - - - - 645.6666666666666 388 3 HNF4A hepatocyte nuclear factor 4, alpha 1149 146 C20140605_SFK031_02 C20140605_SFK031_02 TB399762.[MT7]-DVLLLGNDYIVPR.2y10_1.heavy 815.968 / 1159.65 71668.0 43.10649871826172 43 13 10 10 10 4.299103931899502 23.260661194533235 0.0 3 0.9278217625607749 4.565745976017555 71668.0 34.21028713952417 1.0 - - - - - - - 784.0 143 4 HNF4A hepatocyte nuclear factor 4, alpha 1151 147 C20140605_SFK031_02 C20140605_SFK031_02 TB561021.[MT7]-NILLSESDVVK[MT7].3b4_1.heavy 502.299 / 598.404 17242.0 35.52840042114258 40 12 10 10 8 0.840624348687974 77.5039262079155 0.0 4 0.8887958533290814 3.6660012188941913 17242.0 15.15914714611709 0.0 - - - - - - - 258.75 34 4 FLT4 fms-related tyrosine kinase 4 1153 147 C20140605_SFK031_02 C20140605_SFK031_02 TB561021.[MT7]-NILLSESDVVK[MT7].3y4_1.heavy 502.299 / 604.379 7931.0 35.52840042114258 40 12 10 10 8 0.840624348687974 77.5039262079155 0.0 4 0.8887958533290814 3.6660012188941913 7931.0 10.907304773388184 1.0 - - - - - - - 736.0 36 5 FLT4 fms-related tyrosine kinase 4 1155 147 C20140605_SFK031_02 C20140605_SFK031_02 TB561021.[MT7]-NILLSESDVVK[MT7].3b8_1.heavy 502.299 / 1016.54 920.0 35.52840042114258 40 12 10 10 8 0.840624348687974 77.5039262079155 0.0 4 0.8887958533290814 3.6660012188941913 920.0 4.1066666666666665 0.0 - - - - - - - 0.0 1 0 FLT4 fms-related tyrosine kinase 4 1157 147 C20140605_SFK031_02 C20140605_SFK031_02 TB561021.[MT7]-NILLSESDVVK[MT7].3y5_1.heavy 502.299 / 691.411 N/A 35.52840042114258 40 12 10 10 8 0.840624348687974 77.5039262079155 0.0 4 0.8887958533290814 3.6660012188941913 7242.0 4.992004644305128 1.0 - - - - - - - 706.4285714285714 30 7 FLT4 fms-related tyrosine kinase 4 1159 148 C20140605_SFK031_02 C20140605_SFK031_02 TB399759.[MT7]-LVMPNYPFINIR.3y6_1.heavy 540.973 / 759.451 75167.0 45.94969940185547 45 15 10 10 10 2.7615868260724854 36.21106497752942 0.0 3 0.9576805020679516 5.977897982290303 75167.0 333.0342067244075 0.0 - - - - - - - 244.77777777777777 150 9 ETV3 ets variant 3 1161 148 C20140605_SFK031_02 C20140605_SFK031_02 TB399759.[MT7]-LVMPNYPFINIR.3b5_1.heavy 540.973 / 699.398 52829.0 45.94969940185547 45 15 10 10 10 2.7615868260724854 36.21106497752942 0.0 3 0.9576805020679516 5.977897982290303 52829.0 208.5070961145194 0.0 - - - - - - - 207.72727272727272 105 11 ETV3 ets variant 3 1163 148 C20140605_SFK031_02 C20140605_SFK031_02 TB399759.[MT7]-LVMPNYPFINIR.3y4_1.heavy 540.973 / 515.33 38970.0 45.94969940185547 45 15 10 10 10 2.7615868260724854 36.21106497752942 0.0 3 0.9576805020679516 5.977897982290303 38970.0 51.89337664016856 0.0 - - - - - - - 407.75 77 4 ETV3 ets variant 3 1165 148 C20140605_SFK031_02 C20140605_SFK031_02 TB399759.[MT7]-LVMPNYPFINIR.3y5_1.heavy 540.973 / 662.398 37013.0 45.94969940185547 45 15 10 10 10 2.7615868260724854 36.21106497752942 0.0 3 0.9576805020679516 5.977897982290303 37013.0 157.4047107203156 0.0 - - - - - - - 275.25 74 8 ETV3 ets variant 3 1167 149 C20140605_SFK031_02 C20140605_SFK031_02 TB556556.[MT7]-AMVELAR.2y4_1.heavy 467.269 / 488.283 4950.0 27.667099952697754 29 17 0 6 6 4.246556226609739 19.43967070947268 0.03700065612792969 6 0.9799619227780387 8.70375115157147 4950.0 -0.5 4.0 - - - - - - - 2216.285714285714 100 7 FLT4 fms-related tyrosine kinase 4 1169 149 C20140605_SFK031_02 C20140605_SFK031_02 TB556556.[MT7]-AMVELAR.2y5_1.heavy 467.269 / 587.351 6157.0 27.667099952697754 29 17 0 6 6 4.246556226609739 19.43967070947268 0.03700065612792969 6 0.9799619227780387 8.70375115157147 6157.0 1.7247018072289155 3.0 - - - - - - - 1224.5714285714287 50 7 FLT4 fms-related tyrosine kinase 4 1171 149 C20140605_SFK031_02 C20140605_SFK031_02 TB556556.[MT7]-AMVELAR.2b4_1.heavy 467.269 / 575.298 11831.0 27.667099952697754 29 17 0 6 6 4.246556226609739 19.43967070947268 0.03700065612792969 6 0.9799619227780387 8.70375115157147 11831.0 12.656823885079351 0.0 - - - - - - - 1776.2857142857142 23 7 FLT4 fms-related tyrosine kinase 4 1173 149 C20140605_SFK031_02 C20140605_SFK031_02 TB556556.[MT7]-AMVELAR.2y6_1.heavy 467.269 / 718.392 14969.0 27.667099952697754 29 17 0 6 6 4.246556226609739 19.43967070947268 0.03700065612792969 6 0.9799619227780387 8.70375115157147 14969.0 23.48308093164189 1.0 - - - - - - - 682.1 38 10 FLT4 fms-related tyrosine kinase 4 1175 150 C20140605_SFK031_02 C20140605_SFK031_02 TB555961.[MT7]-GVPC[CAM]FR.2y4_1.heavy 440.235 / 579.271 N/A 26.46506627400716 34 20 4 6 4 5.97364089854483 16.740209480010734 0.034900665283203125 7 0.9940286370427198 15.962807893405515 72002.0 15.367626893594853 1.0 - - - - - - - 3164.0 281 1 FOXK2 forkhead box K2 1177 150 C20140605_SFK031_02 C20140605_SFK031_02 TB555961.[MT7]-GVPC[CAM]FR.2y5_1.heavy 440.235 / 678.339 11463.0 26.46506627400716 34 20 4 6 4 5.97364089854483 16.740209480010734 0.034900665283203125 7 0.9940286370427198 15.962807893405515 11463.0 22.962671590186634 0.0 - - - - - - - 204.78571428571428 22 14 FOXK2 forkhead box K2 1179 150 C20140605_SFK031_02 C20140605_SFK031_02 TB555961.[MT7]-GVPC[CAM]FR.2b4_1.heavy 440.235 / 558.283 11403.0 26.46506627400716 34 20 4 6 4 5.97364089854483 16.740209480010734 0.034900665283203125 7 0.9940286370427198 15.962807893405515 11403.0 6.607290335171001 2.0 - - - - - - - 776.0 177 2 FOXK2 forkhead box K2 1181 150 C20140605_SFK031_02 C20140605_SFK031_02 TB555961.[MT7]-GVPC[CAM]FR.2y3_1.heavy 440.235 / 482.218 5552.0 26.46506627400716 34 20 4 6 4 5.97364089854483 16.740209480010734 0.034900665283203125 7 0.9940286370427198 15.962807893405515 5552.0 4.013338332915981 4.0 - - - - - - - 2789.0 52 7 FOXK2 forkhead box K2 1183 151 C20140605_SFK031_02 C20140605_SFK031_02 TB561296.[MT7]-ENADLEWTAVK[MT7].3b6_1.heavy 521.947 / 816.386 104897.0 33.465301513671875 46 16 10 10 10 2.323219060742218 35.93468556029768 0.0 3 0.968826135032668 6.9715977495597325 104897.0 189.36795711005612 0.0 - - - - - - - 602.3333333333334 209 9 IRAK1 interleukin-1 receptor-associated kinase 1 1185 151 C20140605_SFK031_02 C20140605_SFK031_02 TB561296.[MT7]-ENADLEWTAVK[MT7].3b4_1.heavy 521.947 / 574.259 194050.0 33.465301513671875 46 16 10 10 10 2.323219060742218 35.93468556029768 0.0 3 0.968826135032668 6.9715977495597325 194050.0 105.55635381082408 0.0 - - - - - - - 625.3333333333334 388 3 IRAK1 interleukin-1 receptor-associated kinase 1 1187 151 C20140605_SFK031_02 C20140605_SFK031_02 TB561296.[MT7]-ENADLEWTAVK[MT7].3b5_1.heavy 521.947 / 687.343 74971.0 33.465301513671875 46 16 10 10 10 2.323219060742218 35.93468556029768 0.0 3 0.968826135032668 6.9715977495597325 74971.0 90.02739237530508 0.0 - - - - - - - 677.7 149 10 IRAK1 interleukin-1 receptor-associated kinase 1 1189 151 C20140605_SFK031_02 C20140605_SFK031_02 TB561296.[MT7]-ENADLEWTAVK[MT7].3y4_1.heavy 521.947 / 562.368 124813.0 33.465301513671875 46 16 10 10 10 2.323219060742218 35.93468556029768 0.0 3 0.968826135032668 6.9715977495597325 124813.0 20.132253676894088 0.0 - - - - - - - 209.0 249 1 IRAK1 interleukin-1 receptor-associated kinase 1 1191 152 C20140605_SFK031_02 C20140605_SFK031_02 TB399579.[MT7]-SQEEPGK[MT7].2y4_1.heavy 531.787 / 574.332 1062.0 14.445549964904785 40 16 10 6 8 3.23924051835572 30.87143403934737 0.03669929504394531 4 0.9661238837557667 6.6862384205874585 1062.0 4.548547859659486 1.0 - - - - - - - 199.8421052631579 2 19 FOXK1;FOXK2 forkhead box K1;forkhead box K2 1193 152 C20140605_SFK031_02 C20140605_SFK031_02 TB399579.[MT7]-SQEEPGK[MT7].2y5_1.heavy 531.787 / 703.374 1442.0 14.445549964904785 40 16 10 6 8 3.23924051835572 30.87143403934737 0.03669929504394531 4 0.9661238837557667 6.6862384205874585 1442.0 16.69684210526316 0.0 - - - - - - - 132.95 2 20 FOXK1;FOXK2 forkhead box K1;forkhead box K2 1195 152 C20140605_SFK031_02 C20140605_SFK031_02 TB399579.[MT7]-SQEEPGK[MT7].2b4_1.heavy 531.787 / 618.285 2808.0 14.445549964904785 40 16 10 6 8 3.23924051835572 30.87143403934737 0.03669929504394531 4 0.9661238837557667 6.6862384205874585 2808.0 8.621052631578946 1.0 - - - - - - - 216.58823529411765 6 17 FOXK1;FOXK2 forkhead box K1;forkhead box K2 1197 152 C20140605_SFK031_02 C20140605_SFK031_02 TB399579.[MT7]-SQEEPGK[MT7].2y3_1.heavy 531.787 / 445.289 5388.0 14.445549964904785 40 16 10 6 8 3.23924051835572 30.87143403934737 0.03669929504394531 4 0.9661238837557667 6.6862384205874585 5388.0 7.488797364085667 1.0 - - - - - - - 289.25 10 16 FOXK1;FOXK2 forkhead box K1;forkhead box K2 1199 153 C20140605_SFK031_02 C20140605_SFK031_02 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 854679.0 37.56003443400065 23 -3 10 6 10 null 0.0 0.03890228271484375 3 0.0 0.0 854679.0 349.91396740664237 0.0 - - - - - - - 483.0 1709 2 1201 153 C20140605_SFK031_02 C20140605_SFK031_02 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 2073470.0 37.56003443400065 23 -3 10 6 10 null 0.0 0.03890228271484375 3 0.0 0.0 2073470.0 195.83420810072752 0.0 - - - - - - - 354.3333333333333 4146 3 1203 153 C20140605_SFK031_02 C20140605_SFK031_02 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 2059280.0 37.56003443400065 23 -3 10 6 10 null 0.0 0.03890228271484375 3 0.0 0.0 2059280.0 545.1589359858544 0.0 - - - - - - - 290.0 4118 1 1205 154 C20140605_SFK031_02 C20140605_SFK031_02 TB558694.[MT7]-FHEQFIVR.3b4_1.heavy 407.228 / 686.338 22784.0 29.625824451446533 46 20 10 6 10 7.18174652736824 13.924189557361768 0.03370094299316406 3 0.9954236841479516 18.236379132889304 22784.0 50.510773819358825 0.0 - - - - - - - 203.46666666666667 45 15 FMR1 fragile X mental retardation 1 1207 154 C20140605_SFK031_02 C20140605_SFK031_02 TB558694.[MT7]-FHEQFIVR.3b3_1.heavy 407.228 / 558.279 53488.0 29.625824451446533 46 20 10 6 10 7.18174652736824 13.924189557361768 0.03370094299316406 3 0.9954236841479516 18.236379132889304 53488.0 89.39963173895151 0.0 - - - - - - - 779.0 106 10 FMR1 fragile X mental retardation 1 1209 154 C20140605_SFK031_02 C20140605_SFK031_02 TB558694.[MT7]-FHEQFIVR.3y4_1.heavy 407.228 / 534.34 204344.0 29.625824451446533 46 20 10 6 10 7.18174652736824 13.924189557361768 0.03370094299316406 3 0.9954236841479516 18.236379132889304 204344.0 196.4236292223095 0.0 - - - - - - - 1159.142857142857 408 7 FMR1 fragile X mental retardation 1 1211 154 C20140605_SFK031_02 C20140605_SFK031_02 TB558694.[MT7]-FHEQFIVR.3y5_1.heavy 407.228 / 662.398 41803.0 29.625824451446533 46 20 10 6 10 7.18174652736824 13.924189557361768 0.03370094299316406 3 0.9954236841479516 18.236379132889304 41803.0 172.2954315816197 0.0 - - - - - - - 198.3684210526316 83 19 FMR1 fragile X mental retardation 1 1213 155 C20140605_SFK031_02 C20140605_SFK031_02 TB399577.[MT7]-VDC[CAM]NNER.2y6_1.heavy 525.741 / 807.305 4409.0 14.279800415039062 41 11 10 10 10 1.5579472792474556 50.34549756511686 0.0 3 0.873150129360876 3.4278029389561517 4409.0 45.27237120677488 0.0 - - - - - - - 88.83333333333333 8 18 FMR1 fragile X mental retardation 1 1215 155 C20140605_SFK031_02 C20140605_SFK031_02 TB399577.[MT7]-VDC[CAM]NNER.2y4_1.heavy 525.741 / 532.247 146.0 14.279800415039062 41 11 10 10 10 1.5579472792474556 50.34549756511686 0.0 3 0.873150129360876 3.4278029389561517 146.0 0.8824175824175825 23.0 - - - - - - - 0.0 0 0 FMR1 fragile X mental retardation 1 1217 155 C20140605_SFK031_02 C20140605_SFK031_02 TB399577.[MT7]-VDC[CAM]NNER.2y5_1.heavy 525.741 / 692.278 2842.0 14.279800415039062 41 11 10 10 10 1.5579472792474556 50.34549756511686 0.0 3 0.873150129360876 3.4278029389561517 2842.0 11.95889406982305 0.0 - - - - - - - 148.0 5 17 FMR1 fragile X mental retardation 1 1219 155 C20140605_SFK031_02 C20140605_SFK031_02 TB399577.[MT7]-VDC[CAM]NNER.2b4_1.heavy 525.741 / 633.278 401.0 14.279800415039062 41 11 10 10 10 1.5579472792474556 50.34549756511686 0.0 3 0.873150129360876 3.4278029389561517 401.0 5.894271413517989 2.0 - - - - - - - 0.0 0 0 FMR1 fragile X mental retardation 1 1221 156 C20140605_SFK031_02 C20140605_SFK031_02 TB561585.[MT7]-GTLAYLPEEYIK[MT7].3y3_1.heavy 562.318 / 567.362 125545.0 39.75490188598633 48 18 10 10 10 4.679907191088458 21.367945114471787 0.0 3 0.9814493605497367 9.047097327060138 125545.0 106.08213171359698 0.0 - - - - - - - 781.2222222222222 251 9 IRAK1 interleukin-1 receptor-associated kinase 1 1223 156 C20140605_SFK031_02 C20140605_SFK031_02 TB561585.[MT7]-GTLAYLPEEYIK[MT7].3y6_1.heavy 562.318 / 922.5 108717.0 39.75490188598633 48 18 10 10 10 4.679907191088458 21.367945114471787 0.0 3 0.9814493605497367 9.047097327060138 108717.0 457.429090130921 0.0 - - - - - - - 239.6153846153846 217 13 IRAK1 interleukin-1 receptor-associated kinase 1 1225 156 C20140605_SFK031_02 C20140605_SFK031_02 TB561585.[MT7]-GTLAYLPEEYIK[MT7].3b5_1.heavy 562.318 / 650.363 302288.0 39.75490188598633 48 18 10 10 10 4.679907191088458 21.367945114471787 0.0 3 0.9814493605497367 9.047097327060138 302288.0 241.34075254396137 0.0 - - - - - - - 400.5 604 4 IRAK1 interleukin-1 receptor-associated kinase 1 1227 156 C20140605_SFK031_02 C20140605_SFK031_02 TB561585.[MT7]-GTLAYLPEEYIK[MT7].3y4_1.heavy 562.318 / 696.405 98032.0 39.75490188598633 48 18 10 10 10 4.679907191088458 21.367945114471787 0.0 3 0.9814493605497367 9.047097327060138 98032.0 111.71498468197532 0.0 - - - - - - - 756.5 196 10 IRAK1 interleukin-1 receptor-associated kinase 1 1229 157 C20140605_SFK031_02 C20140605_SFK031_02 TB561293.[MT7]-SILSPGGSC[CAM]GPIK[MT7].3y3_1.heavy 520.96 / 501.352 47418.0 30.60859966278076 45 18 10 7 10 6.424865253350145 15.564528757681973 0.029201507568359375 3 0.989492202833938 12.028888650346694 47418.0 17.492867455028964 0.0 - - - - - - - 1419.0 94 3 GTF2I general transcription factor IIi 1231 157 C20140605_SFK031_02 C20140605_SFK031_02 TB561293.[MT7]-SILSPGGSC[CAM]GPIK[MT7].3b4_1.heavy 520.96 / 545.341 40778.0 30.60859966278076 45 18 10 7 10 6.424865253350145 15.564528757681973 0.029201507568359375 3 0.989492202833938 12.028888650346694 40778.0 21.00490185075084 0.0 - - - - - - - 433.0 81 1 GTF2I general transcription factor IIi 1233 157 C20140605_SFK031_02 C20140605_SFK031_02 TB561293.[MT7]-SILSPGGSC[CAM]GPIK[MT7].3y4_1.heavy 520.96 / 558.373 61853.0 30.60859966278076 45 18 10 7 10 6.424865253350145 15.564528757681973 0.029201507568359375 3 0.989492202833938 12.028888650346694 61853.0 35.63524086406222 0.0 - - - - - - - 1280.75 123 8 GTF2I general transcription factor IIi 1235 157 C20140605_SFK031_02 C20140605_SFK031_02 TB561293.[MT7]-SILSPGGSC[CAM]GPIK[MT7].3b7_1.heavy 520.96 / 756.437 6423.0 30.60859966278076 45 18 10 7 10 6.424865253350145 15.564528757681973 0.029201507568359375 3 0.989492202833938 12.028888650346694 6423.0 2.3782878590968166 1.0 - - - - - - - 1723.25 14 8 GTF2I general transcription factor IIi 1237 158 C20140605_SFK031_02 C20140605_SFK031_02 TB559754.[MT7]-VLGMDPLPSK[MT7].3b6_1.heavy 448.931 / 757.404 5394.0 35.385398864746094 43 15 10 10 8 3.1908603178748325 22.69810829165219 0.0 4 0.9552952395841681 5.815059175755526 5394.0 30.83184578094228 0.0 - - - - - - - 244.125 10 8 ILF3 interleukin enhancer binding factor 3, 90kDa 1239 158 C20140605_SFK031_02 C20140605_SFK031_02 TB559754.[MT7]-VLGMDPLPSK[MT7].3y3_1.heavy 448.931 / 475.3 111906.0 35.385398864746094 43 15 10 10 8 3.1908603178748325 22.69810829165219 0.0 4 0.9552952395841681 5.815059175755526 111906.0 189.1094425087108 0.0 - - - - - - - 306.0 223 3 ILF3 interleukin enhancer binding factor 3, 90kDa 1241 158 C20140605_SFK031_02 C20140605_SFK031_02 TB559754.[MT7]-VLGMDPLPSK[MT7].3b4_1.heavy 448.931 / 545.324 14806.0 35.385398864746094 43 15 10 10 8 3.1908603178748325 22.69810829165219 0.0 4 0.9552952395841681 5.815059175755526 14806.0 20.859332365747463 2.0 - - - - - - - 275.4 29 5 ILF3 interleukin enhancer binding factor 3, 90kDa 1243 158 C20140605_SFK031_02 C20140605_SFK031_02 TB559754.[MT7]-VLGMDPLPSK[MT7].3b5_1.heavy 448.931 / 660.351 72997.0 35.385398864746094 43 15 10 10 8 3.1908603178748325 22.69810829165219 0.0 4 0.9552952395841681 5.815059175755526 72997.0 433.1096354794728 0.0 - - - - - - - 178.66666666666666 145 9 ILF3 interleukin enhancer binding factor 3, 90kDa 1245 159 C20140605_SFK031_02 C20140605_SFK031_02 TB561837.[MT7]-ETDGTEGTVEIETVK[MT7].3b6_1.heavy 632.661 / 777.338 19679.0 28.22480010986328 42 12 10 10 10 1.7648156607031313 47.89861575360464 0.0 3 0.8938270883586233 3.7534956568152187 19679.0 38.5808529476335 0.0 - - - - - - - 775.5384615384615 39 13 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1247 159 C20140605_SFK031_02 C20140605_SFK031_02 TB561837.[MT7]-ETDGTEGTVEIETVK[MT7].3y4_1.heavy 632.661 / 620.374 81935.0 28.22480010986328 42 12 10 10 10 1.7648156607031313 47.89861575360464 0.0 3 0.8938270883586233 3.7534956568152187 81935.0 101.20821282051892 0.0 - - - - - - - 874.6 163 5 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1249 159 C20140605_SFK031_02 C20140605_SFK031_02 TB561837.[MT7]-ETDGTEGTVEIETVK[MT7].3b8_1.heavy 632.661 / 935.407 32069.0 28.22480010986328 42 12 10 10 10 1.7648156607031313 47.89861575360464 0.0 3 0.8938270883586233 3.7534956568152187 32069.0 53.32257254901961 0.0 - - - - - - - 704.4 64 10 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1251 159 C20140605_SFK031_02 C20140605_SFK031_02 TB561837.[MT7]-ETDGTEGTVEIETVK[MT7].3b7_1.heavy 632.661 / 834.36 14759.0 28.22480010986328 42 12 10 10 10 1.7648156607031313 47.89861575360464 0.0 3 0.8938270883586233 3.7534956568152187 14759.0 33.530706394486536 0.0 - - - - - - - 749.0833333333334 29 12 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1253 160 C20140605_SFK031_02 C20140605_SFK031_02 TB294764.[MT7]-LAVIQEAR.2y5_1.heavy 522.32 / 616.341 45936.0 29.32469940185547 50 20 10 10 10 22.36859854244652 4.470552762178667 0.0 3 0.9982772155189963 29.72928914441567 45936.0 31.604794453418513 0.0 - - - - - - - 1773.0 91 9 FOXK2 forkhead box K2 1255 160 C20140605_SFK031_02 C20140605_SFK031_02 TB294764.[MT7]-LAVIQEAR.2b4_1.heavy 522.32 / 541.383 24059.0 29.32469940185547 50 20 10 10 10 22.36859854244652 4.470552762178667 0.0 3 0.9982772155189963 29.72928914441567 24059.0 20.35165430376028 0.0 - - - - - - - 2234.5714285714284 48 7 FOXK2 forkhead box K2 1257 160 C20140605_SFK031_02 C20140605_SFK031_02 TB294764.[MT7]-LAVIQEAR.2y6_1.heavy 522.32 / 715.41 28297.0 29.32469940185547 50 20 10 10 10 22.36859854244652 4.470552762178667 0.0 3 0.9982772155189963 29.72928914441567 28297.0 33.1489507582142 0.0 - - - - - - - 1239.7777777777778 56 9 FOXK2 forkhead box K2 1259 160 C20140605_SFK031_02 C20140605_SFK031_02 TB294764.[MT7]-LAVIQEAR.2y7_1.heavy 522.32 / 786.447 85202.0 29.32469940185547 50 20 10 10 10 22.36859854244652 4.470552762178667 0.0 3 0.9982772155189963 29.72928914441567 85202.0 57.23119354355684 0.0 - - - - - - - 1760.875 170 8 FOXK2 forkhead box K2 1261 161 C20140605_SFK031_02 C20140605_SFK031_02 TB294763.[MT7]-QQQDAPGR.2b3_1.heavy 522.271 / 529.285 N/A N/A - - - - - - - - - 0.0 - - - - - - - RBM20 RNA binding motif protein 20 1263 161 C20140605_SFK031_02 C20140605_SFK031_02 TB294763.[MT7]-QQQDAPGR.2y6_1.heavy 522.271 / 643.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - RBM20 RNA binding motif protein 20 1265 161 C20140605_SFK031_02 C20140605_SFK031_02 TB294763.[MT7]-QQQDAPGR.2b5_1.heavy 522.271 / 715.349 N/A N/A - - - - - - - - - 0.0 - - - - - - - RBM20 RNA binding motif protein 20 1267 161 C20140605_SFK031_02 C20140605_SFK031_02 TB294763.[MT7]-QQQDAPGR.2y7_1.heavy 522.271 / 771.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - RBM20 RNA binding motif protein 20 1269 162 C20140605_SFK031_02 C20140605_SFK031_02 TB562050.[MT7]-LYFDDTC[CAM]VVPERLEGK[MT7].3y7_1.heavy 743.72 / 972.56 97658.0 37.611900329589844 40 10 10 10 10 0.7546295810801897 71.27381565932922 0.0 3 0.8350177667070952 2.995598408172488 97658.0 48.26382022748439 0.0 - - - - - - - 705.6 195 5 ETV5 ets variant 5 1271 162 C20140605_SFK031_02 C20140605_SFK031_02 TB562050.[MT7]-LYFDDTC[CAM]VVPERLEGK[MT7].3y15_2.heavy 743.72 / 986.484 119427.0 37.611900329589844 40 10 10 10 10 0.7546295810801897 71.27381565932922 0.0 3 0.8350177667070952 2.995598408172488 119427.0 124.80056503593985 0.0 - - - - - - - 647.7142857142857 238 7 ETV5 ets variant 5 1273 162 C20140605_SFK031_02 C20140605_SFK031_02 TB562050.[MT7]-LYFDDTC[CAM]VVPERLEGK[MT7].3b5_1.heavy 743.72 / 798.379 30336.0 37.611900329589844 40 10 10 10 10 0.7546295810801897 71.27381565932922 0.0 3 0.8350177667070952 2.995598408172488 30336.0 62.841545551222964 0.0 - - - - - - - 648.0 60 7 ETV5 ets variant 5 1275 162 C20140605_SFK031_02 C20140605_SFK031_02 TB562050.[MT7]-LYFDDTC[CAM]VVPERLEGK[MT7].3y8_1.heavy 743.72 / 1071.63 50089.0 37.611900329589844 40 10 10 10 10 0.7546295810801897 71.27381565932922 0.0 3 0.8350177667070952 2.995598408172488 50089.0 139.1361111111111 0.0 - - - - - - - 633.4285714285714 100 7 ETV5 ets variant 5 1277 163 C20140605_SFK031_02 C20140605_SFK031_02 TB562056.[MT7]-GSLGTGAEEGAPVTAGVTAPGGK[MT7].3b11_1.heavy 758.072 / 1074.52 111331.0 28.148825645446777 39 13 10 6 10 2.4135114617512614 41.43340588382343 0.033901214599609375 3 0.9293008460337019 4.613842313803051 111331.0 199.3583100426658 0.0 - - - - - - - 287.9166666666667 222 12 GBX1 gastrulation brain homeobox 1 1279 163 C20140605_SFK031_02 C20140605_SFK031_02 TB562056.[MT7]-GSLGTGAEEGAPVTAGVTAPGGK[MT7].3b6_1.heavy 758.072 / 617.338 10368.0 28.148825645446777 39 13 10 6 10 2.4135114617512614 41.43340588382343 0.033901214599609375 3 0.9293008460337019 4.613842313803051 10368.0 27.073198619069483 0.0 - - - - - - - 297.6470588235294 20 17 GBX1 gastrulation brain homeobox 1 1281 163 C20140605_SFK031_02 C20140605_SFK031_02 TB562056.[MT7]-GSLGTGAEEGAPVTAGVTAPGGK[MT7].3b10_1.heavy 758.072 / 1003.48 31659.0 28.148825645446777 39 13 10 6 10 2.4135114617512614 41.43340588382343 0.033901214599609375 3 0.9293008460337019 4.613842313803051 31659.0 182.213841091577 0.0 - - - - - - - 257.22222222222223 63 18 GBX1 gastrulation brain homeobox 1 1283 163 C20140605_SFK031_02 C20140605_SFK031_02 TB562056.[MT7]-GSLGTGAEEGAPVTAGVTAPGGK[MT7].3b8_1.heavy 758.072 / 817.417 14811.0 28.148825645446777 39 13 10 6 10 2.4135114617512614 41.43340588382343 0.033901214599609375 3 0.9293008460337019 4.613842313803051 14811.0 73.6547027027027 0.0 - - - - - - - 221.47058823529412 29 17 GBX1 gastrulation brain homeobox 1 1285 164 C20140605_SFK031_02 C20140605_SFK031_02 TB399751.[MT7]-IEIPEVLLWAK[MT7].3b6_1.heavy 533.664 / 825.484 20223.0 50.00550079345703 43 13 10 10 10 1.0077388791001942 60.56663162813949 0.0 3 0.9115457482686502 4.11858970946436 20223.0 166.26194999999998 0.0 - - - - - - - 133.28571428571428 40 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1287 164 C20140605_SFK031_02 C20140605_SFK031_02 TB399751.[MT7]-IEIPEVLLWAK[MT7].3y3_1.heavy 533.664 / 548.331 68452.0 50.00550079345703 43 13 10 10 10 1.0077388791001942 60.56663162813949 0.0 3 0.9115457482686502 4.11858970946436 68452.0 396.8719781420765 0.0 - - - - - - - 160.91666666666666 136 12 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1289 164 C20140605_SFK031_02 C20140605_SFK031_02 TB399751.[MT7]-IEIPEVLLWAK[MT7].3b5_1.heavy 533.664 / 726.415 26343.0 50.00550079345703 43 13 10 10 10 1.0077388791001942 60.56663162813949 0.0 3 0.9115457482686502 4.11858970946436 26343.0 155.4712124248497 0.0 - - - - - - - 228.28571428571428 52 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1291 164 C20140605_SFK031_02 C20140605_SFK031_02 TB399751.[MT7]-IEIPEVLLWAK[MT7].3b3_1.heavy 533.664 / 500.32 45169.0 50.00550079345703 43 13 10 10 10 1.0077388791001942 60.56663162813949 0.0 3 0.9115457482686502 4.11858970946436 45169.0 152.82744360902257 0.0 - - - - - - - 237.85714285714286 90 14 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1293 165 C20140605_SFK031_02 C20140605_SFK031_02 TB399750.[MT7]-YNC[CAM]PSFLAAALAR.2b3_1.heavy 799.417 / 582.246 12864.0 42.211100578308105 41 18 10 3 10 5.215959708656994 19.171927235946384 0.07300186157226562 3 0.9838451375752226 9.696708373139739 12864.0 64.58819243414837 0.0 - - - - - - - 751.0 25 7 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1295 165 C20140605_SFK031_02 C20140605_SFK031_02 TB399750.[MT7]-YNC[CAM]PSFLAAALAR.2y5_1.heavy 799.417 / 501.314 1878.0 42.211100578308105 41 18 10 3 10 5.215959708656994 19.171927235946384 0.07300186157226562 3 0.9838451375752226 9.696708373139739 1878.0 0.8 7.0 - - - - - - - 807.4 6 10 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1297 165 C20140605_SFK031_02 C20140605_SFK031_02 TB399750.[MT7]-YNC[CAM]PSFLAAALAR.2y10_1.heavy 799.417 / 1016.59 37842.0 42.211100578308105 41 18 10 3 10 5.215959708656994 19.171927235946384 0.07300186157226562 3 0.9838451375752226 9.696708373139739 37842.0 100.63353392634569 0.0 - - - - - - - 1234.142857142857 75 7 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1299 165 C20140605_SFK031_02 C20140605_SFK031_02 TB399750.[MT7]-YNC[CAM]PSFLAAALAR.2y11_1.heavy 799.417 / 1176.62 6855.0 42.211100578308105 41 18 10 3 10 5.215959708656994 19.171927235946384 0.07300186157226562 3 0.9838451375752226 9.696708373139739 6855.0 11.948861099691902 0.0 - - - - - - - 688.3333333333334 13 9 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1301 166 C20140605_SFK031_02 C20140605_SFK031_02 TB561990.[MT7]-ISDLGLAVK[MT7]IPEGDLIR.3b9_2.heavy 699.756 / 593.376 32205.0 42.28409957885742 42 12 10 10 10 1.9759462235746557 50.60866475358396 0.0 3 0.8883273199598714 3.6581536542281627 32205.0 36.76427568583162 0.0 - - - - - - - 803.4285714285714 64 7 GRK5 G protein-coupled receptor kinase 5 1303 166 C20140605_SFK031_02 C20140605_SFK031_02 TB561990.[MT7]-ISDLGLAVK[MT7]IPEGDLIR.3y7_1.heavy 699.756 / 799.431 38102.0 42.28409957885742 42 12 10 10 10 1.9759462235746557 50.60866475358396 0.0 3 0.8883273199598714 3.6581536542281627 38102.0 105.00551181102362 0.0 - - - - - - - 712.5714285714286 76 14 GRK5 G protein-coupled receptor kinase 5 1305 166 C20140605_SFK031_02 C20140605_SFK031_02 TB561990.[MT7]-ISDLGLAVK[MT7]IPEGDLIR.3b5_1.heavy 699.756 / 630.358 9888.0 42.28409957885742 42 12 10 10 10 1.9759462235746557 50.60866475358396 0.0 3 0.8883273199598714 3.6581536542281627 9888.0 9.412728212088599 0.0 - - - - - - - 1257.0 19 7 GRK5 G protein-coupled receptor kinase 5 1307 166 C20140605_SFK031_02 C20140605_SFK031_02 TB561990.[MT7]-ISDLGLAVK[MT7]IPEGDLIR.3y8_1.heavy 699.756 / 912.515 13426.0 42.28409957885742 42 12 10 10 10 1.9759462235746557 50.60866475358396 0.0 3 0.8883273199598714 3.6581536542281627 13426.0 10.915624815386822 0.0 - - - - - - - 668.875 26 8 GRK5 G protein-coupled receptor kinase 5 1309 167 C20140605_SFK031_02 C20140605_SFK031_02 TB557523.[MT7]-VMVTDADR.2y5_1.heavy 525.772 / 577.258 23000.0 22.725549697875977 47 20 10 7 10 8.565249716177608 11.675082842141203 0.029300689697265625 3 0.992998224410009 14.740239753309105 23000.0 32.64895324837008 0.0 - - - - - - - 1224.111111111111 46 9 GTF2I general transcription factor IIi 1311 167 C20140605_SFK031_02 C20140605_SFK031_02 TB557523.[MT7]-VMVTDADR.2y6_1.heavy 525.772 / 676.326 17226.0 22.725549697875977 47 20 10 7 10 8.565249716177608 11.675082842141203 0.029300689697265625 3 0.992998224410009 14.740239753309105 17226.0 39.574232185340435 0.0 - - - - - - - 675.25 34 12 GTF2I general transcription factor IIi 1313 167 C20140605_SFK031_02 C20140605_SFK031_02 TB557523.[MT7]-VMVTDADR.2b5_1.heavy 525.772 / 690.361 17711.0 22.725549697875977 47 20 10 7 10 8.565249716177608 11.675082842141203 0.029300689697265625 3 0.992998224410009 14.740239753309105 17711.0 29.96804207796461 0.0 - - - - - - - 776.1666666666666 35 12 GTF2I general transcription factor IIi 1315 167 C20140605_SFK031_02 C20140605_SFK031_02 TB557523.[MT7]-VMVTDADR.2y7_1.heavy 525.772 / 807.367 54104.0 22.725549697875977 47 20 10 7 10 8.565249716177608 11.675082842141203 0.029300689697265625 3 0.992998224410009 14.740239753309105 54104.0 257.9701030927835 0.0 - - - - - - - 248.11111111111111 108 18 GTF2I general transcription factor IIi 1317 168 C20140605_SFK031_02 C20140605_SFK031_02 TB559339.[MT7]-LTDPLEALK[MT7].2y4_1.heavy 644.392 / 604.379 5745.0 40.25642395019531 42 18 10 6 8 1.6773815001214791 43.83323643909229 0.0364990234375 4 0.9870628217639292 10.838601835503416 5745.0 2.7373436569386542 2.0 - - - - - - - 309.5 14 2 MECOM MDS1 and EVI1 complex locus 1319 168 C20140605_SFK031_02 C20140605_SFK031_02 TB559339.[MT7]-LTDPLEALK[MT7].2y8_1.heavy 644.392 / 1030.59 11578.0 40.25642395019531 42 18 10 6 8 1.6773815001214791 43.83323643909229 0.0364990234375 4 0.9870628217639292 10.838601835503416 11578.0 14.99993334258406 1.0 - - - - - - - 673.625 23 8 MECOM MDS1 and EVI1 complex locus 1321 168 C20140605_SFK031_02 C20140605_SFK031_02 TB559339.[MT7]-LTDPLEALK[MT7].2y6_1.heavy 644.392 / 814.516 45251.0 40.25642395019531 42 18 10 6 8 1.6773815001214791 43.83323643909229 0.0364990234375 4 0.9870628217639292 10.838601835503416 45251.0 50.84986187746159 0.0 - - - - - - - 206.33333333333334 90 3 MECOM MDS1 and EVI1 complex locus 1323 168 C20140605_SFK031_02 C20140605_SFK031_02 TB559339.[MT7]-LTDPLEALK[MT7].2y7_1.heavy 644.392 / 929.542 3447.0 40.25642395019531 42 18 10 6 8 1.6773815001214791 43.83323643909229 0.0364990234375 4 0.9870628217639292 10.838601835503416 3447.0 0.5511208421843767 2.0 - - - - - - - 333.2307692307692 8 13 MECOM MDS1 and EVI1 complex locus 1325 169 C20140605_SFK031_02 C20140605_SFK031_02 TB294903.[MT7]-LLAFALADTK[MT7].2b4_1.heavy 675.915 / 589.383 27969.0 43.7056999206543 50 20 10 10 10 19.229693052077682 5.200291015003771 0.0 3 0.9975259562801981 24.80670633901442 27969.0 32.841650162753275 0.0 - - - - - - - 330.5 55 4 ANAPC4 anaphase promoting complex subunit 4 1327 169 C20140605_SFK031_02 C20140605_SFK031_02 TB294903.[MT7]-LLAFALADTK[MT7].2y6_1.heavy 675.915 / 762.448 23528.0 43.7056999206543 50 20 10 10 10 19.229693052077682 5.200291015003771 0.0 3 0.9975259562801981 24.80670633901442 23528.0 31.67110699192402 0.0 - - - - - - - 271.375 47 8 ANAPC4 anaphase promoting complex subunit 4 1329 169 C20140605_SFK031_02 C20140605_SFK031_02 TB294903.[MT7]-LLAFALADTK[MT7].2b5_1.heavy 675.915 / 660.42 26552.0 43.7056999206543 50 20 10 10 10 19.229693052077682 5.200291015003771 0.0 3 0.9975259562801981 24.80670633901442 26552.0 37.696902607586644 0.0 - - - - - - - 94.0 53 1 ANAPC4 anaphase promoting complex subunit 4 1331 169 C20140605_SFK031_02 C20140605_SFK031_02 TB294903.[MT7]-LLAFALADTK[MT7].2y7_1.heavy 675.915 / 909.516 27024.0 43.7056999206543 50 20 10 10 10 19.229693052077682 5.200291015003771 0.0 3 0.9975259562801981 24.80670633901442 27024.0 36.338979620075506 0.0 - - - - - - - 283.2857142857143 54 7 ANAPC4 anaphase promoting complex subunit 4 1333 170 C20140605_SFK031_02 C20140605_SFK031_02 TB559234.[MT7]-SLELLVGEK[MT7].2y4_1.heavy 638.392 / 576.347 27394.0 37.04209899902344 48 18 10 10 10 5.635554461833746 17.744482939032963 0.0 3 0.9859846717095879 10.412432336778398 27394.0 25.63334174936009 0.0 - - - - - - - 349.25 54 4 FLT4 fms-related tyrosine kinase 4 1335 170 C20140605_SFK031_02 C20140605_SFK031_02 TB559234.[MT7]-SLELLVGEK[MT7].2y5_1.heavy 638.392 / 689.431 22882.0 37.04209899902344 48 18 10 10 10 5.635554461833746 17.744482939032963 0.0 3 0.9859846717095879 10.412432336778398 22882.0 20.140831496168467 0.0 - - - - - - - 215.0 45 1 FLT4 fms-related tyrosine kinase 4 1337 170 C20140605_SFK031_02 C20140605_SFK031_02 TB559234.[MT7]-SLELLVGEK[MT7].2b4_1.heavy 638.392 / 587.352 32873.0 37.04209899902344 48 18 10 10 10 5.635554461833746 17.744482939032963 0.0 3 0.9859846717095879 10.412432336778398 32873.0 21.272255696822683 0.0 - - - - - - - 2220.1111111111113 65 9 FLT4 fms-related tyrosine kinase 4 1339 170 C20140605_SFK031_02 C20140605_SFK031_02 TB559234.[MT7]-SLELLVGEK[MT7].2b5_1.heavy 638.392 / 700.436 22237.0 37.04209899902344 48 18 10 10 10 5.635554461833746 17.744482939032963 0.0 3 0.9859846717095879 10.412432336778398 22237.0 17.150877659574466 0.0 - - - - - - - 215.0 44 1 FLT4 fms-related tyrosine kinase 4 1341 171 C20140605_SFK031_02 C20140605_SFK031_02 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 1342130.0 40.56169891357422 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1342130.0 213.9567870051154 0.0 - - - - - - - 265.0 2684 1 1343 171 C20140605_SFK031_02 C20140605_SFK031_02 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 2071400.0 40.56169891357422 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2071400.0 232.86156856597898 0.0 - - - - - - - 441.0 4142 1 1345 171 C20140605_SFK031_02 C20140605_SFK031_02 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 2458640.0 40.56169891357422 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2458640.0 192.9087921087921 0.0 - - - - - - - 265.0 4917 1 1347 172 C20140605_SFK031_02 C20140605_SFK031_02 TB399569.[MT7]-AREGGGGK[MT7].2b3_1.heavy 510.295 / 501.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - GRK5 G protein-coupled receptor kinase 5 1349 172 C20140605_SFK031_02 C20140605_SFK031_02 TB399569.[MT7]-AREGGGGK[MT7].2y5_1.heavy 510.295 / 519.301 N/A N/A - - - - - - - - - 0.0 - - - - - - - GRK5 G protein-coupled receptor kinase 5 1351 172 C20140605_SFK031_02 C20140605_SFK031_02 TB399569.[MT7]-AREGGGGK[MT7].2y6_1.heavy 510.295 / 648.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - GRK5 G protein-coupled receptor kinase 5 1353 172 C20140605_SFK031_02 C20140605_SFK031_02 TB399569.[MT7]-AREGGGGK[MT7].2b7_1.heavy 510.295 / 729.376 N/A N/A - - - - - - - - - 0.0 - - - - - - - GRK5 G protein-coupled receptor kinase 5 1355 173 C20140605_SFK031_02 C20140605_SFK031_02 TB561723.[MT7]-DLVEEEAEEAGVALR.3y6_1.heavy 591.971 / 586.367 264781.0 39.88640022277832 40 14 10 6 10 1.9149411103741891 44.39814384063027 0.037197113037109375 3 0.9359825066940772 4.851415651231079 264781.0 87.24758202076355 0.0 - - - - - - - 1336.0 529 2 IRAK1 interleukin-1 receptor-associated kinase 1 1357 173 C20140605_SFK031_02 C20140605_SFK031_02 TB561723.[MT7]-DLVEEEAEEAGVALR.3b4_1.heavy 591.971 / 601.331 154574.0 39.88640022277832 40 14 10 6 10 1.9149411103741891 44.39814384063027 0.037197113037109375 3 0.9359825066940772 4.851415651231079 154574.0 95.27501907548661 0.0 - - - - - - - 445.0 309 1 IRAK1 interleukin-1 receptor-associated kinase 1 1359 173 C20140605_SFK031_02 C20140605_SFK031_02 TB561723.[MT7]-DLVEEEAEEAGVALR.3b5_1.heavy 591.971 / 730.374 146645.0 39.88640022277832 40 14 10 6 10 1.9149411103741891 44.39814384063027 0.037197113037109375 3 0.9359825066940772 4.851415651231079 146645.0 174.65503727239397 0.0 - - - - - - - 687.5714285714286 293 7 IRAK1 interleukin-1 receptor-associated kinase 1 1361 173 C20140605_SFK031_02 C20140605_SFK031_02 TB561723.[MT7]-DLVEEEAEEAGVALR.3y5_1.heavy 591.971 / 515.33 416148.0 39.88640022277832 40 14 10 6 10 1.9149411103741891 44.39814384063027 0.037197113037109375 3 0.9359825066940772 4.851415651231079 416148.0 350.0944519192683 0.0 - - - - - - - 802.0 832 3 IRAK1 interleukin-1 receptor-associated kinase 1 1363 174 C20140605_SFK031_02 C20140605_SFK031_02 TB562162.[MT7]-LAQTAVTNNTAAATVLNQVLSK[MT7].4b4_1.heavy 629.863 / 558.337 7174.0 44.17599868774414 48 18 10 10 10 4.40874137400143 22.682210526048326 0.0 3 0.9828878496429307 9.420822353878934 7174.0 6.306028472127787 0.0 - - - - - - - 1159.7142857142858 14 7 RBM20 RNA binding motif protein 20 1365 174 C20140605_SFK031_02 C20140605_SFK031_02 TB562162.[MT7]-LAQTAVTNNTAAATVLNQVLSK[MT7].4y7_1.heavy 629.863 / 945.585 5381.0 44.17599868774414 48 18 10 10 10 4.40874137400143 22.682210526048326 0.0 3 0.9828878496429307 9.420822353878934 5381.0 18.2542899960241 0.0 - - - - - - - 348.53846153846155 10 13 RBM20 RNA binding motif protein 20 1367 174 C20140605_SFK031_02 C20140605_SFK031_02 TB562162.[MT7]-LAQTAVTNNTAAATVLNQVLSK[MT7].4y6_1.heavy 629.863 / 832.501 6230.0 44.17599868774414 48 18 10 10 10 4.40874137400143 22.682210526048326 0.0 3 0.9828878496429307 9.420822353878934 6230.0 8.97542372881356 0.0 - - - - - - - 320.8 12 5 RBM20 RNA binding motif protein 20 1369 174 C20140605_SFK031_02 C20140605_SFK031_02 TB562162.[MT7]-LAQTAVTNNTAAATVLNQVLSK[MT7].4b6_1.heavy 629.863 / 728.442 15199.0 44.17599868774414 48 18 10 10 10 4.40874137400143 22.682210526048326 0.0 3 0.9828878496429307 9.420822353878934 15199.0 20.77123733138344 0.0 - - - - - - - 1213.7142857142858 30 7 RBM20 RNA binding motif protein 20 1371 175 C20140605_SFK031_02 C20140605_SFK031_02 TB294874.[MT7]-NLSWLEEK[MT7].2y4_1.heavy 653.866 / 662.384 23252.0 36.291099548339844 47 17 10 10 10 2.4853815644778208 27.64680185802144 0.0 3 0.9783407995330102 8.370553091668606 23252.0 9.150849489583187 0.0 - - - - - - - 712.0 46 5 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1373 175 C20140605_SFK031_02 C20140605_SFK031_02 TB294874.[MT7]-NLSWLEEK[MT7].2y5_1.heavy 653.866 / 848.463 11904.0 36.291099548339844 47 17 10 10 10 2.4853815644778208 27.64680185802144 0.0 3 0.9783407995330102 8.370553091668606 11904.0 16.39310181811767 1.0 - - - - - - - 709.375 26 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1375 175 C20140605_SFK031_02 C20140605_SFK031_02 TB294874.[MT7]-NLSWLEEK[MT7].2y3_1.heavy 653.866 / 549.3 16688.0 36.291099548339844 47 17 10 10 10 2.4853815644778208 27.64680185802144 0.0 3 0.9783407995330102 8.370553091668606 16688.0 14.248554718484073 0.0 - - - - - - - 763.0 33 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1377 175 C20140605_SFK031_02 C20140605_SFK031_02 TB294874.[MT7]-NLSWLEEK[MT7].2y6_1.heavy 653.866 / 935.495 18802.0 36.291099548339844 47 17 10 10 10 2.4853815644778208 27.64680185802144 0.0 3 0.9783407995330102 8.370553091668606 18802.0 42.71011726482113 0.0 - - - - - - - 259.6666666666667 37 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1379 176 C20140605_SFK031_02 C20140605_SFK031_02 TB399882.[MT7]-VADNLAIQLAAVTEDK[MT7]YEILQSVDDAAIVIK[MT7].4b8_1.heavy 941.029 / 969.549 3985.0 54.475351333618164 45 18 10 7 10 4.434208529155547 22.551938940734495 0.029300689697265625 3 0.9863301453396132 10.543491399490618 3985.0 14.559553542426102 0.0 - - - - - - - 726.1428571428571 7 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1381 176 C20140605_SFK031_02 C20140605_SFK031_02 TB399882.[MT7]-VADNLAIQLAAVTEDK[MT7]YEILQSVDDAAIVIK[MT7].4b7_1.heavy 941.029 / 841.49 4254.0 54.475351333618164 45 18 10 7 10 4.434208529155547 22.551938940734495 0.029300689697265625 3 0.9863301453396132 10.543491399490618 4254.0 15.711807068975055 0.0 - - - - - - - 170.8148148148148 8 27 ILF3 interleukin enhancer binding factor 3, 90kDa 1383 176 C20140605_SFK031_02 C20140605_SFK031_02 TB399882.[MT7]-VADNLAIQLAAVTEDK[MT7]YEILQSVDDAAIVIK[MT7].4b5_1.heavy 941.029 / 657.369 5374.0 54.475351333618164 45 18 10 7 10 4.434208529155547 22.551938940734495 0.029300689697265625 3 0.9863301453396132 10.543491399490618 5374.0 61.1290349023375 0.0 - - - - - - - 148.04347826086956 10 23 ILF3 interleukin enhancer binding factor 3, 90kDa 1385 176 C20140605_SFK031_02 C20140605_SFK031_02 TB399882.[MT7]-VADNLAIQLAAVTEDK[MT7]YEILQSVDDAAIVIK[MT7].4b6_1.heavy 941.029 / 728.406 8732.0 54.475351333618164 45 18 10 7 10 4.434208529155547 22.551938940734495 0.029300689697265625 3 0.9863301453396132 10.543491399490618 8732.0 37.92873495270152 0.0 - - - - - - - 167.42857142857142 17 21 ILF3 interleukin enhancer binding factor 3, 90kDa 1387 177 C20140605_SFK031_02 C20140605_SFK031_02 TB399881.[MT7]-ILDELVLPFQELQIDDNEYAYLK[MT7].3b6_1.heavy 1023.88 / 827.5 29808.0 54.722900390625 48 18 10 10 10 11.116004600540526 8.996038018474497 0.0 3 0.9855302574793919 10.247239717539259 29808.0 340.8622366288493 0.0 - - - - - - - 75.21875 59 32 HNF4A hepatocyte nuclear factor 4, alpha 1389 177 C20140605_SFK031_02 C20140605_SFK031_02 TB399881.[MT7]-ILDELVLPFQELQIDDNEYAYLK[MT7].3b4_1.heavy 1023.88 / 615.347 36746.0 54.722900390625 48 18 10 10 10 11.116004600540526 8.996038018474497 0.0 3 0.9855302574793919 10.247239717539259 36746.0 266.5427351067816 0.0 - - - - - - - 94.20689655172414 73 29 HNF4A hepatocyte nuclear factor 4, alpha 1391 177 C20140605_SFK031_02 C20140605_SFK031_02 TB399881.[MT7]-ILDELVLPFQELQIDDNEYAYLK[MT7].3b5_1.heavy 1023.88 / 728.431 36140.0 54.722900390625 48 18 10 10 10 11.116004600540526 8.996038018474497 0.0 3 0.9855302574793919 10.247239717539259 36140.0 514.6010470453241 0.0 - - - - - - - 73.36666666666666 72 30 HNF4A hepatocyte nuclear factor 4, alpha 1393 177 C20140605_SFK031_02 C20140605_SFK031_02 TB399881.[MT7]-ILDELVLPFQELQIDDNEYAYLK[MT7].3y8_1.heavy 1023.88 / 1159.58 3717.0 54.722900390625 48 18 10 10 10 11.116004600540526 8.996038018474497 0.0 3 0.9855302574793919 10.247239717539259 3717.0 38.32948933109566 0.0 - - - - - - - 116.96666666666667 7 30 HNF4A hepatocyte nuclear factor 4, alpha 1395 178 C20140605_SFK031_02 C20140605_SFK031_02 TB294871.[MT7]-SLDLIESLLR.2y8_1.heavy 651.891 / 958.557 9306.0 50.20119857788086 45 15 10 10 10 1.8806617753814576 42.50976439319803 0.0 3 0.9543980861962111 5.757135788759294 9306.0 55.737112161581436 0.0 - - - - - - - 222.0 18 10 CNOT1 CCR4-NOT transcription complex, subunit 1 1397 178 C20140605_SFK031_02 C20140605_SFK031_02 TB294871.[MT7]-SLDLIESLLR.2y9_1.heavy 651.891 / 1071.64 12170.0 50.20119857788086 45 15 10 10 10 1.8806617753814576 42.50976439319803 0.0 3 0.9543980861962111 5.757135788759294 12170.0 96.40603350138234 0.0 - - - - - - - 175.16666666666666 24 18 CNOT1 CCR4-NOT transcription complex, subunit 1 1399 178 C20140605_SFK031_02 C20140605_SFK031_02 TB294871.[MT7]-SLDLIESLLR.2b4_1.heavy 651.891 / 573.336 8519.0 50.20119857788086 45 15 10 10 10 1.8806617753814576 42.50976439319803 0.0 3 0.9543980861962111 5.757135788759294 8519.0 29.77836390915079 0.0 - - - - - - - 264.61538461538464 17 13 CNOT1 CCR4-NOT transcription complex, subunit 1 1401 178 C20140605_SFK031_02 C20140605_SFK031_02 TB294871.[MT7]-SLDLIESLLR.2y7_1.heavy 651.891 / 843.53 9449.0 50.20119857788086 45 15 10 10 10 1.8806617753814576 42.50976439319803 0.0 3 0.9543980861962111 5.757135788759294 9449.0 80.34492844364938 0.0 - - - - - - - 205.875 18 8 CNOT1 CCR4-NOT transcription complex, subunit 1 1403 179 C20140605_SFK031_02 C20140605_SFK031_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 842081.0 35.622798919677734 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 842081.0 324.00192381685264 0.0 - - - - - - - 728.0 1684 7 1405 179 C20140605_SFK031_02 C20140605_SFK031_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 166446.0 35.622798919677734 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 166446.0 120.64872781065088 0.0 - - - - - - - 234.0 332 4 1407 179 C20140605_SFK031_02 C20140605_SFK031_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 167590.0 35.622798919677734 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 167590.0 57.31613822586391 0.0 - - - - - - - 1336.7142857142858 335 7 1409 180 C20140605_SFK031_02 C20140605_SFK031_02 TB399785.[MT7]-DVPDSQQHPAPEK[MT7].3y3_1.heavy 579.3 / 517.31 13761.0 18.429124355316162 43 17 10 6 10 4.052267804366319 24.67753979444547 0.03949928283691406 3 0.9749418451595198 7.779948916429453 13761.0 12.668365393414877 0.0 - - - - - - - 1320.5714285714287 27 7 BRD4 bromodomain containing 4 1411 180 C20140605_SFK031_02 C20140605_SFK031_02 TB399785.[MT7]-DVPDSQQHPAPEK[MT7].3b4_1.heavy 579.3 / 571.284 4569.0 18.429124355316162 43 17 10 6 10 4.052267804366319 24.67753979444547 0.03949928283691406 3 0.9749418451595198 7.779948916429453 4569.0 5.661432577205893 1.0 - - - - - - - 1173.0 9 13 BRD4 bromodomain containing 4 1413 180 C20140605_SFK031_02 C20140605_SFK031_02 TB399785.[MT7]-DVPDSQQHPAPEK[MT7].3b7_1.heavy 579.3 / 914.434 4516.0 18.429124355316162 43 17 10 6 10 4.052267804366319 24.67753979444547 0.03949928283691406 3 0.9749418451595198 7.779948916429453 4516.0 17.284209295001574 0.0 - - - - - - - 215.31578947368422 9 19 BRD4 bromodomain containing 4 1415 180 C20140605_SFK031_02 C20140605_SFK031_02 TB399785.[MT7]-DVPDSQQHPAPEK[MT7].3y5_1.heavy 579.3 / 685.4 11954.0 18.429124355316162 43 17 10 6 10 4.052267804366319 24.67753979444547 0.03949928283691406 3 0.9749418451595198 7.779948916429453 11954.0 79.75275669704502 0.0 - - - - - - - 209.25 23 16 BRD4 bromodomain containing 4 1417 181 C20140605_SFK031_02 C20140605_SFK031_02 TB294877.[MT7]-AYAALAALEK[MT7].2y4_1.heavy 654.892 / 604.379 33814.0 37.04209899902344 48 18 10 10 10 4.657588375274516 21.470338712382684 0.0 3 0.9829455365066226 9.43678755892865 33814.0 26.263879519203044 0.0 - - - - - - - 2242.0 67 8 ILF3 interleukin enhancer binding factor 3, 90kDa 1419 181 C20140605_SFK031_02 C20140605_SFK031_02 TB294877.[MT7]-AYAALAALEK[MT7].2y5_1.heavy 654.892 / 675.416 46454.0 37.04209899902344 48 18 10 10 10 4.657588375274516 21.470338712382684 0.0 3 0.9829455365066226 9.43678755892865 46454.0 82.87598671904229 0.0 - - - - - - - 774.0 92 12 ILF3 interleukin enhancer binding factor 3, 90kDa 1421 181 C20140605_SFK031_02 C20140605_SFK031_02 TB294877.[MT7]-AYAALAALEK[MT7].2b4_1.heavy 654.892 / 521.284 46994.0 37.04209899902344 48 18 10 10 10 4.657588375274516 21.470338712382684 0.0 3 0.9829455365066226 9.43678755892865 46994.0 55.32763157779097 0.0 - - - - - - - 756.0 93 9 ILF3 interleukin enhancer binding factor 3, 90kDa 1423 181 C20140605_SFK031_02 C20140605_SFK031_02 TB294877.[MT7]-AYAALAALEK[MT7].2y6_1.heavy 654.892 / 788.5 21499.0 37.04209899902344 48 18 10 10 10 4.657588375274516 21.470338712382684 0.0 3 0.9829455365066226 9.43678755892865 21499.0 21.87660581774338 0.0 - - - - - - - 729.0 42 8 ILF3 interleukin enhancer binding factor 3, 90kDa 1425 182 C20140605_SFK031_02 C20140605_SFK031_02 TB559847.[MT7]-IPEK[MT7]PVNK[MT7].3y6_2.heavy 452.957 / 501.813 12637.0 21.83245038986206 41 14 10 7 10 3.707067696940373 26.97549874326141 0.027799606323242188 3 0.9338269653859662 4.7708676236917995 12637.0 7.390058479532165 0.0 - - - - - - - 1263.8 25 10 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1427 182 C20140605_SFK031_02 C20140605_SFK031_02 TB559847.[MT7]-IPEK[MT7]PVNK[MT7].3y3_1.heavy 452.957 / 504.326 15389.0 21.83245038986206 41 14 10 7 10 3.707067696940373 26.97549874326141 0.027799606323242188 3 0.9338269653859662 4.7708676236917995 15389.0 12.041024600807788 0.0 - - - - - - - 1756.5555555555557 30 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1429 182 C20140605_SFK031_02 C20140605_SFK031_02 TB559847.[MT7]-IPEK[MT7]PVNK[MT7].3y7_2.heavy 452.957 / 550.339 383687.0 21.83245038986206 41 14 10 7 10 3.707067696940373 26.97549874326141 0.027799606323242188 3 0.9338269653859662 4.7708676236917995 383687.0 170.42086343149305 0.0 - - - - - - - 2698.0 767 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1431 182 C20140605_SFK031_02 C20140605_SFK031_02 TB559847.[MT7]-IPEK[MT7]PVNK[MT7].3y4_1.heavy 452.957 / 601.379 72979.0 21.83245038986206 41 14 10 7 10 3.707067696940373 26.97549874326141 0.027799606323242188 3 0.9338269653859662 4.7708676236917995 72979.0 50.60153283276972 0.0 - - - - - - - 769.5 145 2 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1433 183 C20140605_SFK031_02 C20140605_SFK031_02 TB399699.[MT7]-EAAGAAGSGK[MT7]K[MT7].2y8_1.heavy 689.904 / 963.583 N/A N/A - - - - - - - - - 0.0 - - - - - - - FOXA2 forkhead box A2 1435 183 C20140605_SFK031_02 C20140605_SFK031_02 TB399699.[MT7]-EAAGAAGSGK[MT7]K[MT7].2y5_1.heavy 689.904 / 764.487 N/A N/A - - - - - - - - - 0.0 - - - - - - - FOXA2 forkhead box A2 1437 183 C20140605_SFK031_02 C20140605_SFK031_02 TB399699.[MT7]-EAAGAAGSGK[MT7]K[MT7].2y6_1.heavy 689.904 / 835.524 N/A N/A - - - - - - - - - 0.0 - - - - - - - FOXA2 forkhead box A2 1439 183 C20140605_SFK031_02 C20140605_SFK031_02 TB399699.[MT7]-EAAGAAGSGK[MT7]K[MT7].2y10_1.heavy 689.904 / 1105.66 N/A N/A - - - - - - - - - 0.0 - - - - - - - FOXA2 forkhead box A2 1441 184 C20140605_SFK031_02 C20140605_SFK031_02 TB561305.[MT7]-QSFLTEVEQLSR.3b6_1.heavy 527.618 / 850.443 44711.0 44.0447998046875 50 20 10 10 10 10.283191244031777 9.724607626843333 0.0 3 0.9982430636069277 29.43884345695035 44711.0 522.774036601258 0.0 - - - - - - - 200.5 89 8 IRAK1 interleukin-1 receptor-associated kinase 1 1443 184 C20140605_SFK031_02 C20140605_SFK031_02 TB561305.[MT7]-QSFLTEVEQLSR.3y6_1.heavy 527.618 / 731.405 64709.0 44.0447998046875 50 20 10 10 10 10.283191244031777 9.724607626843333 0.0 3 0.9982430636069277 29.43884345695035 64709.0 274.7809616209481 0.0 - - - - - - - 273.7 129 10 IRAK1 interleukin-1 receptor-associated kinase 1 1445 184 C20140605_SFK031_02 C20140605_SFK031_02 TB561305.[MT7]-QSFLTEVEQLSR.3b4_1.heavy 527.618 / 620.352 77726.0 44.0447998046875 50 20 10 10 10 10.283191244031777 9.724607626843333 0.0 3 0.9982430636069277 29.43884345695035 77726.0 242.15420255405576 0.0 - - - - - - - 272.6666666666667 155 9 IRAK1 interleukin-1 receptor-associated kinase 1 1447 184 C20140605_SFK031_02 C20140605_SFK031_02 TB561305.[MT7]-QSFLTEVEQLSR.3y5_1.heavy 527.618 / 632.336 127531.0 44.0447998046875 50 20 10 10 10 10.283191244031777 9.724607626843333 0.0 3 0.9982430636069277 29.43884345695035 127531.0 199.34736348491748 0.0 - - - - - - - 220.16666666666666 255 6 IRAK1 interleukin-1 receptor-associated kinase 1 1449 185 C20140605_SFK031_02 C20140605_SFK031_02 TB562037.[MT7]-EGGPPAVDEVLDEAVPEYR.3b9_1.heavy 729.363 / 996.476 34580.0 41.92259979248047 36 13 10 3 10 1.5645073144714743 50.87924275268704 0.06819915771484375 3 0.9197330226466599 4.326584967785595 34580.0 61.239669421487605 0.0 - - - - - - - 847.1666666666666 69 6 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1451 185 C20140605_SFK031_02 C20140605_SFK031_02 TB562037.[MT7]-EGGPPAVDEVLDEAVPEYR.3b6_1.heavy 729.363 / 653.338 37303.0 41.92259979248047 36 13 10 3 10 1.5645073144714743 50.87924275268704 0.06819915771484375 3 0.9197330226466599 4.326584967785595 37303.0 1.1364204112718965 2.0 - - - - - - - 908.0 74 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1453 185 C20140605_SFK031_02 C20140605_SFK031_02 TB562037.[MT7]-EGGPPAVDEVLDEAVPEYR.3y4_1.heavy 729.363 / 564.278 71792.0 41.92259979248047 36 13 10 3 10 1.5645073144714743 50.87924275268704 0.06819915771484375 3 0.9197330226466599 4.326584967785595 71792.0 5.271831164230273 1.0 - - - - - - - 726.0 143 1 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1455 185 C20140605_SFK031_02 C20140605_SFK031_02 TB562037.[MT7]-EGGPPAVDEVLDEAVPEYR.3b7_1.heavy 729.363 / 752.406 23779.0 41.92259979248047 36 13 10 3 10 1.5645073144714743 50.87924275268704 0.06819915771484375 3 0.9197330226466599 4.326584967785595 23779.0 12.101589716684154 1.0 - - - - - - - 726.0 47 3 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1457 186 C20140605_SFK031_02 C20140605_SFK031_02 TB399875.[MT7]-LVFIEEPPGGGGVAPSAVPTRPPGPQR.3y6_1.heavy 942.851 / 651.357 15128.0 37.416099548339844 39 9 10 10 10 1.1922179128784975 51.65880948068224 0.0 3 0.8017792072390613 2.7248210022786057 15128.0 61.55223301686791 0.0 - - - - - - - 237.625 30 8 CNNM1 cyclin M1 1459 186 C20140605_SFK031_02 C20140605_SFK031_02 TB399875.[MT7]-LVFIEEPPGGGGVAPSAVPTRPPGPQR.3b5_1.heavy 942.851 / 746.457 27497.0 37.416099548339844 39 9 10 10 10 1.1922179128784975 51.65880948068224 0.0 3 0.8017792072390613 2.7248210022786057 27497.0 98.69889994185138 0.0 - - - - - - - 244.42857142857142 54 7 CNNM1 cyclin M1 1461 186 C20140605_SFK031_02 C20140605_SFK031_02 TB399875.[MT7]-LVFIEEPPGGGGVAPSAVPTRPPGPQR.3b3_1.heavy 942.851 / 504.33 64605.0 37.416099548339844 39 9 10 10 10 1.1922179128784975 51.65880948068224 0.0 3 0.8017792072390613 2.7248210022786057 64605.0 98.11805661765241 0.0 - - - - - - - 333.0 129 4 CNNM1 cyclin M1 1463 186 C20140605_SFK031_02 C20140605_SFK031_02 TB399875.[MT7]-LVFIEEPPGGGGVAPSAVPTRPPGPQR.3y21_2.heavy 942.851 / 976.527 183538.0 37.416099548339844 39 9 10 10 10 1.1922179128784975 51.65880948068224 0.0 3 0.8017792072390613 2.7248210022786057 183538.0 166.59393441602725 0.0 - - - - - - - 285.0 367 1 CNNM1 cyclin M1 1465 187 C20140605_SFK031_02 C20140605_SFK031_02 TB557410.[MT7]-QC[CAM]VVDK[MT7].2b3_1.heavy 518.789 / 532.267 8892.0 18.70870018005371 48 18 10 10 10 2.494208271802905 28.477182275172133 0.0 3 0.9812852965359975 9.00722996852192 8892.0 20.694020113073496 0.0 - - - - - - - 720.0909090909091 17 11 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 1467 187 C20140605_SFK031_02 C20140605_SFK031_02 TB557410.[MT7]-QC[CAM]VVDK[MT7].2y5_1.heavy 518.789 / 764.409 21514.0 18.70870018005371 48 18 10 10 10 2.494208271802905 28.477182275172133 0.0 3 0.9812852965359975 9.00722996852192 21514.0 89.74007715565568 0.0 - - - - - - - 689.75 43 8 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 1469 187 C20140605_SFK031_02 C20140605_SFK031_02 TB557410.[MT7]-QC[CAM]VVDK[MT7].2y3_1.heavy 518.789 / 505.31 14718.0 18.70870018005371 48 18 10 10 10 2.494208271802905 28.477182275172133 0.0 3 0.9812852965359975 9.00722996852192 14718.0 23.86503985507246 0.0 - - - - - - - 762.0 29 11 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 1471 187 C20140605_SFK031_02 C20140605_SFK031_02 TB557410.[MT7]-QC[CAM]VVDK[MT7].2b5_1.heavy 518.789 / 746.362 21668.0 18.70870018005371 48 18 10 10 10 2.494208271802905 28.477182275172133 0.0 3 0.9812852965359975 9.00722996852192 21668.0 45.885533669629275 0.0 - - - - - - - 337.4 43 10 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 1473 188 C20140605_SFK031_02 C20140605_SFK031_02 TB399879.[MT7]-AVTTQDAVNPIESLDTWTEFVEGK[MT7].4y5_1.heavy 735.379 / 723.416 7147.0 52.848201751708984 39 11 10 10 8 2.395659719918919 41.74215526877269 0.0 4 0.8714759199650356 3.404905179680163 7147.0 32.86797002798106 0.0 - - - - - - - 132.58823529411765 14 17 FLT4 fms-related tyrosine kinase 4 1475 188 C20140605_SFK031_02 C20140605_SFK031_02 TB399879.[MT7]-AVTTQDAVNPIESLDTWTEFVEGK[MT7].4b7_1.heavy 735.379 / 831.433 8533.0 52.848201751708984 39 11 10 10 8 2.395659719918919 41.74215526877269 0.0 4 0.8714759199650356 3.404905179680163 8533.0 48.523720106626044 0.0 - - - - - - - 166.6153846153846 17 13 FLT4 fms-related tyrosine kinase 4 1477 188 C20140605_SFK031_02 C20140605_SFK031_02 TB399879.[MT7]-AVTTQDAVNPIESLDTWTEFVEGK[MT7].4b9_1.heavy 735.379 / 1044.54 7320.0 52.848201751708984 39 11 10 10 8 2.395659719918919 41.74215526877269 0.0 4 0.8714759199650356 3.404905179680163 7320.0 46.56107346164272 1.0 - - - - - - - 153.63636363636363 14 11 FLT4 fms-related tyrosine kinase 4 1479 188 C20140605_SFK031_02 C20140605_SFK031_02 TB399879.[MT7]-AVTTQDAVNPIESLDTWTEFVEGK[MT7].4b6_1.heavy 735.379 / 760.396 6930.0 52.848201751708984 39 11 10 10 8 2.395659719918919 41.74215526877269 0.0 4 0.8714759199650356 3.404905179680163 6930.0 21.785303405016386 1.0 - - - - - - - 163.30769230769232 16 13 FLT4 fms-related tyrosine kinase 4 1481 189 C20140605_SFK031_02 C20140605_SFK031_02 TB561710.[MT7]-DC[CAM]EGTDARPYC[CAM]K[MT7].3y3_1.heavy 587.271 / 614.309 1531.0 18.587300300598145 34 12 10 6 6 2.4575924938879723 40.69022844458542 0.039600372314453125 6 0.898776135807296 3.8458076006040116 1531.0 8.505555555555556 3.0 - - - - - - - 194.4375 3 16 FLT4 fms-related tyrosine kinase 4 1483 189 C20140605_SFK031_02 C20140605_SFK031_02 TB561710.[MT7]-DC[CAM]EGTDARPYC[CAM]K[MT7].3b6_1.heavy 587.271 / 822.306 21081.0 18.587300300598145 34 12 10 6 6 2.4575924938879723 40.69022844458542 0.039600372314453125 6 0.898776135807296 3.8458076006040116 21081.0 310.0147058823529 0.0 - - - - - - - 117.9375 42 16 FLT4 fms-related tyrosine kinase 4 1485 189 C20140605_SFK031_02 C20140605_SFK031_02 TB561710.[MT7]-DC[CAM]EGTDARPYC[CAM]K[MT7].3b3_1.heavy 587.271 / 549.209 3726.0 18.587300300598145 34 12 10 6 6 2.4575924938879723 40.69022844458542 0.039600372314453125 6 0.898776135807296 3.8458076006040116 3726.0 5.776975024975025 4.0 - - - - - - - 1129.375 11 8 FLT4 fms-related tyrosine kinase 4 1487 189 C20140605_SFK031_02 C20140605_SFK031_02 TB561710.[MT7]-DC[CAM]EGTDARPYC[CAM]K[MT7].3y4_1.heavy 587.271 / 711.362 7095.0 18.587300300598145 34 12 10 6 6 2.4575924938879723 40.69022844458542 0.039600372314453125 6 0.898776135807296 3.8458076006040116 7095.0 32.29516806722689 0.0 - - - - - - - 189.83333333333334 14 18 FLT4 fms-related tyrosine kinase 4 1489 190 C20140605_SFK031_02 C20140605_SFK031_02 TB294789.[MT7]-IC[CAM]DFGLAR.2b3_1.heavy 548.291 / 533.251 36828.0 34.02730178833008 47 17 10 10 10 5.43666458830041 18.39363057548151 0.0 3 0.9772540205430872 8.167391795528097 36828.0 9.579573325429756 0.0 - - - - - - - 1184.6666666666667 73 3 FLT1;FLT3;FLT4;KDR;KIT;PDGFRA;PDGFRB;NLK;MAPK1;MAPK3 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor);fms-related tyrosine kinase 3;fms-related tyrosine kinase 4;kinase insert domain receptor (a type III receptor tyrosine kinase);v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog;platelet-derived growth factor receptor, alpha polypeptide;platelet-derived growth factor receptor, beta polypeptide;nemo-like kinase;mitogen-activated protein kinase 1;mitogen-activated protein kinase 3 1491 190 C20140605_SFK031_02 C20140605_SFK031_02 TB294789.[MT7]-IC[CAM]DFGLAR.2y5_1.heavy 548.291 / 563.33 36828.0 34.02730178833008 47 17 10 10 10 5.43666458830041 18.39363057548151 0.0 3 0.9772540205430872 8.167391795528097 36828.0 18.855232198142417 0.0 - - - - - - - 269.0 73 2 FLT1;FLT3;FLT4;KDR;KIT;PDGFRA;PDGFRB;NLK;MAPK1;MAPK3 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor);fms-related tyrosine kinase 3;fms-related tyrosine kinase 4;kinase insert domain receptor (a type III receptor tyrosine kinase);v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog;platelet-derived growth factor receptor, alpha polypeptide;platelet-derived growth factor receptor, beta polypeptide;nemo-like kinase;mitogen-activated protein kinase 1;mitogen-activated protein kinase 3 1493 190 C20140605_SFK031_02 C20140605_SFK031_02 TB294789.[MT7]-IC[CAM]DFGLAR.2b5_1.heavy 548.291 / 737.341 9476.0 34.02730178833008 47 17 10 10 10 5.43666458830041 18.39363057548151 0.0 3 0.9772540205430872 8.167391795528097 9476.0 16.605099321721987 4.0 - - - - - - - 323.2 47 5 FLT1;FLT3;FLT4;KDR;KIT;PDGFRA;PDGFRB;NLK;MAPK1;MAPK3 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor);fms-related tyrosine kinase 3;fms-related tyrosine kinase 4;kinase insert domain receptor (a type III receptor tyrosine kinase);v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog;platelet-derived growth factor receptor, alpha polypeptide;platelet-derived growth factor receptor, beta polypeptide;nemo-like kinase;mitogen-activated protein kinase 1;mitogen-activated protein kinase 3 1495 190 C20140605_SFK031_02 C20140605_SFK031_02 TB294789.[MT7]-IC[CAM]DFGLAR.2y7_1.heavy 548.291 / 838.388 29936.0 34.02730178833008 47 17 10 10 10 5.43666458830041 18.39363057548151 0.0 3 0.9772540205430872 8.167391795528097 29936.0 41.67207454551507 0.0 - - - - - - - 897.2222222222222 59 9 FLT1;FLT3;FLT4;KDR;KIT;PDGFRA;PDGFRB;NLK;MAPK1;MAPK3 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor);fms-related tyrosine kinase 3;fms-related tyrosine kinase 4;kinase insert domain receptor (a type III receptor tyrosine kinase);v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog;platelet-derived growth factor receptor, alpha polypeptide;platelet-derived growth factor receptor, beta polypeptide;nemo-like kinase;mitogen-activated protein kinase 1;mitogen-activated protein kinase 3 1497 191 C20140605_SFK031_02 C20140605_SFK031_02 TB559447.[MT7]-ILDVAQDLK[MT7].2y8_1.heavy 651.897 / 1045.6 13933.0 38.21030044555664 44 14 10 10 10 2.600845235328353 30.728263200796285 0.0 3 0.942170162757859 5.107059328960068 13933.0 12.455858603076738 0.0 - - - - - - - 1237.0 27 8 CNOT1 CCR4-NOT transcription complex, subunit 1 1499 191 C20140605_SFK031_02 C20140605_SFK031_02 TB559447.[MT7]-ILDVAQDLK[MT7].2y5_1.heavy 651.897 / 718.422 8744.0 38.21030044555664 44 14 10 10 10 2.600845235328353 30.728263200796285 0.0 3 0.942170162757859 5.107059328960068 8744.0 12.89622519633955 0.0 - - - - - - - 1276.4285714285713 17 7 CNOT1 CCR4-NOT transcription complex, subunit 1 1501 191 C20140605_SFK031_02 C20140605_SFK031_02 TB559447.[MT7]-ILDVAQDLK[MT7].2y3_1.heavy 651.897 / 519.326 4900.0 38.21030044555664 44 14 10 10 10 2.600845235328353 30.728263200796285 0.0 3 0.942170162757859 5.107059328960068 4900.0 2.0522267002585655 2.0 - - - - - - - 1291.6666666666667 9 9 CNOT1 CCR4-NOT transcription complex, subunit 1 1503 191 C20140605_SFK031_02 C20140605_SFK031_02 TB559447.[MT7]-ILDVAQDLK[MT7].2y6_1.heavy 651.897 / 817.49 8360.0 38.21030044555664 44 14 10 10 10 2.600845235328353 30.728263200796285 0.0 3 0.942170162757859 5.107059328960068 8360.0 11.29983223895925 0.0 - - - - - - - 829.0 16 8 CNOT1 CCR4-NOT transcription complex, subunit 1 1505 192 C20140605_SFK031_02 C20140605_SFK031_02 TB294648.[MT7]-TEGGAR.2y4_1.heavy 367.699 / 360.199 N/A N/A - - - - - - - - - 0.0 - - - - - - - FLT4 fms-related tyrosine kinase 4 1507 192 C20140605_SFK031_02 C20140605_SFK031_02 TB294648.[MT7]-TEGGAR.2b5_1.heavy 367.699 / 560.28 N/A N/A - - - - - - - - - 0.0 - - - - - - - FLT4 fms-related tyrosine kinase 4 1509 193 C20140605_SFK031_02 C20140605_SFK031_02 TB399872.[MT7]-LLPGAVATIVK[MT7]PLSAIPQPTITK[MT7].3y7_1.heavy 920.916 / 928.558 17170.0 46.10095024108887 35 11 10 6 8 1.6752021871813736 46.01445736739793 0.03980255126953125 4 0.8786081496340344 3.505686736348944 17170.0 218.20707627118645 0.0 - - - - - - - 202.76470588235293 34 17 HNF4A hepatocyte nuclear factor 4, alpha 1511 193 C20140605_SFK031_02 C20140605_SFK031_02 TB399872.[MT7]-LLPGAVATIVK[MT7]PLSAIPQPTITK[MT7].3y3_1.heavy 920.916 / 505.347 1605.0 46.10095024108887 35 11 10 6 8 1.6752021871813736 46.01445736739793 0.03980255126953125 4 0.8786081496340344 3.505686736348944 1605.0 4.060850891305032 1.0 - - - - - - - 221.58823529411765 3 17 HNF4A hepatocyte nuclear factor 4, alpha 1513 193 C20140605_SFK031_02 C20140605_SFK031_02 TB399872.[MT7]-LLPGAVATIVK[MT7]PLSAIPQPTITK[MT7].3b7_1.heavy 920.916 / 766.494 1845.0 46.10095024108887 35 11 10 6 8 1.6752021871813736 46.01445736739793 0.03980255126953125 4 0.8786081496340344 3.505686736348944 1845.0 1.4751063433415097 1.0 - - - - - - - 221.7058823529412 3 17 HNF4A hepatocyte nuclear factor 4, alpha 1515 193 C20140605_SFK031_02 C20140605_SFK031_02 TB399872.[MT7]-LLPGAVATIVK[MT7]PLSAIPQPTITK[MT7].3y5_1.heavy 920.916 / 703.447 8906.0 46.10095024108887 35 11 10 6 8 1.6752021871813736 46.01445736739793 0.03980255126953125 4 0.8786081496340344 3.505686736348944 8906.0 10.847844498561306 1.0 - - - - - - - 223.6315789473684 17 19 HNF4A hepatocyte nuclear factor 4, alpha 1517 194 C20140605_SFK031_02 C20140605_SFK031_02 TB562177.[MT7]-YLRPSPGFLFHPQFQLPDQR.4y4_1.heavy 647.598 / 515.257 40634.0 41.484500885009766 40 10 10 10 10 1.2563786922276685 52.912510020503575 0.0 3 0.8492939738526181 3.13823560008872 40634.0 42.997499508713986 0.0 - - - - - - - 1260.9 81 10 MECOM MDS1 and EVI1 complex locus 1519 194 C20140605_SFK031_02 C20140605_SFK031_02 TB562177.[MT7]-YLRPSPGFLFHPQFQLPDQR.4b8_1.heavy 647.598 / 1062.59 16054.0 41.484500885009766 40 10 10 10 10 1.2563786922276685 52.912510020503575 0.0 3 0.8492939738526181 3.13823560008872 16054.0 77.05399490504864 0.0 - - - - - - - 705.4444444444445 32 9 MECOM MDS1 and EVI1 complex locus 1521 194 C20140605_SFK031_02 C20140605_SFK031_02 TB562177.[MT7]-YLRPSPGFLFHPQFQLPDQR.4b7_1.heavy 647.598 / 915.517 4082.0 41.484500885009766 40 10 10 10 10 1.2563786922276685 52.912510020503575 0.0 3 0.8492939738526181 3.13823560008872 4082.0 7.87311312989573 0.0 - - - - - - - 725.6666666666666 8 9 MECOM MDS1 and EVI1 complex locus 1523 194 C20140605_SFK031_02 C20140605_SFK031_02 TB562177.[MT7]-YLRPSPGFLFHPQFQLPDQR.4y7_1.heavy 647.598 / 903.468 42538.0 41.484500885009766 40 10 10 10 10 1.2563786922276685 52.912510020503575 0.0 3 0.8492939738526181 3.13823560008872 42538.0 69.45673120626324 0.0 - - - - - - - 758.6363636363636 85 11 MECOM MDS1 and EVI1 complex locus 1525 195 C20140605_SFK031_02 C20140605_SFK031_02 TB557796.[MT7]-APELLLGAR.2y8_1.heavy 542.336 / 868.525 990758.0 35.76359939575195 50 20 10 10 10 7.646386043730977 13.07807367141589 0.0 3 0.9905296811330769 12.671753900647797 990758.0 1616.4980710651023 0.0 - - - - - - - 115.0 1981 1 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1527 195 C20140605_SFK031_02 C20140605_SFK031_02 TB557796.[MT7]-APELLLGAR.2b4_1.heavy 542.336 / 555.326 57627.0 35.76359939575195 50 20 10 10 10 7.646386043730977 13.07807367141589 0.0 3 0.9905296811330769 12.671753900647797 57627.0 42.73652454468176 0.0 - - - - - - - 1211.7777777777778 115 9 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1529 195 C20140605_SFK031_02 C20140605_SFK031_02 TB557796.[MT7]-APELLLGAR.2y6_1.heavy 542.336 / 642.43 110317.0 35.76359939575195 50 20 10 10 10 7.646386043730977 13.07807367141589 0.0 3 0.9905296811330769 12.671753900647797 110317.0 66.59467225045336 0.0 - - - - - - - 1334.5 220 8 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1531 195 C20140605_SFK031_02 C20140605_SFK031_02 TB557796.[MT7]-APELLLGAR.2y7_1.heavy 542.336 / 771.472 50509.0 35.76359939575195 50 20 10 10 10 7.646386043730977 13.07807367141589 0.0 3 0.9905296811330769 12.671753900647797 50509.0 75.36427796812791 0.0 - - - - - - - 278.85714285714283 101 7 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1533 196 C20140605_SFK031_02 C20140605_SFK031_02 TB399771.[MT7]-LYFDDTC[CAM]VVPER.2y9_1.heavy 829.404 / 1090.48 6879.0 37.25230026245117 43 13 10 10 10 1.2640815120832833 53.40760843554863 0.0 3 0.9239407235060607 4.446255226607675 6879.0 9.595605741506475 0.0 - - - - - - - 290.6666666666667 13 12 ETV5 ets variant 5 1535 196 C20140605_SFK031_02 C20140605_SFK031_02 TB399771.[MT7]-LYFDDTC[CAM]VVPER.2y10_1.heavy 829.404 / 1237.55 3390.0 37.25230026245117 43 13 10 10 10 1.2640815120832833 53.40760843554863 0.0 3 0.9239407235060607 4.446255226607675 3390.0 11.9796992481203 0.0 - - - - - - - 685.375 6 8 ETV5 ets variant 5 1537 196 C20140605_SFK031_02 C20140605_SFK031_02 TB399771.[MT7]-LYFDDTC[CAM]VVPER.2b5_1.heavy 829.404 / 798.379 4885.0 37.25230026245117 43 13 10 10 10 1.2640815120832833 53.40760843554863 0.0 3 0.9239407235060607 4.446255226607675 4885.0 11.435143893218116 0.0 - - - - - - - 827.5 9 10 ETV5 ets variant 5 1539 196 C20140605_SFK031_02 C20140605_SFK031_02 TB399771.[MT7]-LYFDDTC[CAM]VVPER.2y7_1.heavy 829.404 / 860.43 5184.0 37.25230026245117 43 13 10 10 10 1.2640815120832833 53.40760843554863 0.0 3 0.9239407235060607 4.446255226607675 5184.0 29.335719399673955 0.0 - - - - - - - 199.27272727272728 10 11 ETV5 ets variant 5 1541 197 C20140605_SFK031_02 C20140605_SFK031_02 TB560874.[MT7]-IK[MT7]LDVPEDLR.3y6_1.heavy 495.967 / 728.394 56682.0 34.113800048828125 40 10 10 10 10 0.7007584857263154 73.92690722776791 0.0 3 0.8468052222471891 3.111955990753055 56682.0 93.31289150893517 0.0 - - - - - - - 245.11111111111111 113 9 FMR1 fragile X mental retardation 1 1543 197 C20140605_SFK031_02 C20140605_SFK031_02 TB560874.[MT7]-IK[MT7]LDVPEDLR.3b4_1.heavy 495.967 / 758.501 52271.0 34.113800048828125 40 10 10 10 10 0.7007584857263154 73.92690722776791 0.0 3 0.8468052222471891 3.111955990753055 52271.0 231.24004705422806 0.0 - - - - - - - 220.66666666666666 104 6 FMR1 fragile X mental retardation 1 1545 197 C20140605_SFK031_02 C20140605_SFK031_02 TB560874.[MT7]-IK[MT7]LDVPEDLR.3y5_1.heavy 495.967 / 629.325 120643.0 34.113800048828125 40 10 10 10 10 0.7007584857263154 73.92690722776791 0.0 3 0.8468052222471891 3.111955990753055 120643.0 159.7961482587135 0.0 - - - - - - - 441.0 241 4 FMR1 fragile X mental retardation 1 1547 197 C20140605_SFK031_02 C20140605_SFK031_02 TB560874.[MT7]-IK[MT7]LDVPEDLR.3b8_2.heavy 495.967 / 599.85 123400.0 34.113800048828125 40 10 10 10 10 0.7007584857263154 73.92690722776791 0.0 3 0.8468052222471891 3.111955990753055 123400.0 669.7187819296453 0.0 - - - - - - - 283.57142857142856 246 7 FMR1 fragile X mental retardation 1 1549 198 C20140605_SFK031_02 C20140605_SFK031_02 TB557793.[MT7]-NTVYAVK[MT7].2y4_1.heavy 541.826 / 624.384 67591.0 23.021550178527832 44 18 10 6 10 5.877439016136143 17.01421311653872 0.03190040588378906 3 0.9875550927989352 11.05134434471333 67591.0 138.50400348297214 0.0 - - - - - - - 756.7058823529412 135 17 IRAK1 interleukin-1 receptor-associated kinase 1 1551 198 C20140605_SFK031_02 C20140605_SFK031_02 TB557793.[MT7]-NTVYAVK[MT7].2b4_1.heavy 541.826 / 622.332 9833.0 23.021550178527832 44 18 10 6 10 5.877439016136143 17.01421311653872 0.03190040588378906 3 0.9875550927989352 11.05134434471333 9833.0 19.590912617363735 0.0 - - - - - - - 762.6428571428571 19 14 IRAK1 interleukin-1 receptor-associated kinase 1 1553 198 C20140605_SFK031_02 C20140605_SFK031_02 TB557793.[MT7]-NTVYAVK[MT7].2y6_1.heavy 541.826 / 824.5 13161.0 23.021550178527832 44 18 10 6 10 5.877439016136143 17.01421311653872 0.03190040588378906 3 0.9875550927989352 11.05134434471333 13161.0 76.73652052716412 0.0 - - - - - - - 688.2857142857143 26 7 IRAK1 interleukin-1 receptor-associated kinase 1 1555 198 C20140605_SFK031_02 C20140605_SFK031_02 TB557793.[MT7]-NTVYAVK[MT7].2b5_1.heavy 541.826 / 693.369 8939.0 23.021550178527832 44 18 10 6 10 5.877439016136143 17.01421311653872 0.03190040588378906 3 0.9875550927989352 11.05134434471333 8939.0 33.23886746754505 0.0 - - - - - - - 711.7777777777778 17 9 IRAK1 interleukin-1 receptor-associated kinase 1 1557 199 C20140605_SFK031_02 C20140605_SFK031_02 TB294887.[MT7]-TLQNTSSEGSR.2y8_1.heavy 662.335 / 837.37 2006.0 16.367799758911133 40 10 10 10 10 1.469451431230942 54.92037976579515 0.0 3 0.8422787168759412 3.065748148932714 2006.0 24.62769296740995 0.0 - - - - - - - 161.8125 4 16 FMR1 fragile X mental retardation 1 1559 199 C20140605_SFK031_02 C20140605_SFK031_02 TB294887.[MT7]-TLQNTSSEGSR.2b4_1.heavy 662.335 / 601.343 1003.0 16.367799758911133 40 10 10 10 10 1.469451431230942 54.92037976579515 0.0 3 0.8422787168759412 3.065748148932714 1003.0 0.6334736842105263 6.0 - - - - - - - 266.5238095238095 2 21 FMR1 fragile X mental retardation 1 1561 199 C20140605_SFK031_02 C20140605_SFK031_02 TB294887.[MT7]-TLQNTSSEGSR.2y9_1.heavy 662.335 / 965.428 2904.0 16.367799758911133 40 10 10 10 10 1.469451431230942 54.92037976579515 0.0 3 0.8422787168759412 3.065748148932714 2904.0 59.34204417419297 0.0 - - - - - - - 149.5 5 12 FMR1 fragile X mental retardation 1 1563 199 C20140605_SFK031_02 C20140605_SFK031_02 TB294887.[MT7]-TLQNTSSEGSR.2y10_1.heavy 662.335 / 1078.51 6124.0 16.367799758911133 40 10 10 10 10 1.469451431230942 54.92037976579515 0.0 3 0.8422787168759412 3.065748148932714 6124.0 44.233283389305086 0.0 - - - - - - - 166.53846153846155 12 13 FMR1 fragile X mental retardation 1 1565 200 C20140605_SFK031_02 C20140605_SFK031_02 TB399868.[MT7]-GQAATPETPQPSPPGGSGSEPYK[MT7].3y3_1.heavy 843.422 / 551.331 4407.0 24.560924530029297 31 5 10 6 10 0.42598660437539776 119.50288982742332 0.032501220703125 3 0.6660933704901927 2.07323755445878 4407.0 14.504334722222222 1.0 - - - - - - - 196.23076923076923 8 13 HNF4A hepatocyte nuclear factor 4, alpha 1567 200 C20140605_SFK031_02 C20140605_SFK031_02 TB399868.[MT7]-GQAATPETPQPSPPGGSGSEPYK[MT7].3y11_2.heavy 843.422 / 610.307 17578.0 24.560924530029297 31 5 10 6 10 0.42598660437539776 119.50288982742332 0.032501220703125 3 0.6660933704901927 2.07323755445878 17578.0 71.07804984509465 0.0 - - - - - - - 209.27272727272728 35 11 HNF4A hepatocyte nuclear factor 4, alpha 1569 200 C20140605_SFK031_02 C20140605_SFK031_02 TB399868.[MT7]-GQAATPETPQPSPPGGSGSEPYK[MT7].3b5_1.heavy 843.422 / 573.311 8914.0 24.560924530029297 31 5 10 6 10 0.42598660437539776 119.50288982742332 0.032501220703125 3 0.6660933704901927 2.07323755445878 8914.0 26.864187231023564 0.0 - - - - - - - 191.0909090909091 17 11 HNF4A hepatocyte nuclear factor 4, alpha 1571 200 C20140605_SFK031_02 C20140605_SFK031_02 TB399868.[MT7]-GQAATPETPQPSPPGGSGSEPYK[MT7].3y10_1.heavy 843.422 / 1122.55 3055.0 24.560924530029297 31 5 10 6 10 0.42598660437539776 119.50288982742332 0.032501220703125 3 0.6660933704901927 2.07323755445878 3055.0 19.348333333333333 1.0 - - - - - - - 181.375 6 16 HNF4A hepatocyte nuclear factor 4, alpha 1573 201 C20140605_SFK031_02 C20140605_SFK031_02 TB560556.[MT7]-EVGSPPLDPTER.2y4_1.heavy 720.876 / 502.262 66002.0 26.546175479888916 37 14 10 3 10 1.6849927806640388 49.533900088114265 0.06830024719238281 3 0.9372294429670269 4.899886625785182 66002.0 129.06201663353687 0.0 - - - - - - - 255.2 132 5 KIAA1279 KIAA1279 1575 201 C20140605_SFK031_02 C20140605_SFK031_02 TB560556.[MT7]-EVGSPPLDPTER.2y8_1.heavy 720.876 / 924.479 29085.0 26.546175479888916 37 14 10 3 10 1.6849927806640388 49.533900088114265 0.06830024719238281 3 0.9372294429670269 4.899886625785182 29085.0 249.17691079718827 0.0 - - - - - - - 194.2 58 5 KIAA1279 KIAA1279 1577 201 C20140605_SFK031_02 C20140605_SFK031_02 TB560556.[MT7]-EVGSPPLDPTER.2b4_1.heavy 720.876 / 517.274 32849.0 26.546175479888916 37 14 10 3 10 1.6849927806640388 49.533900088114265 0.06830024719238281 3 0.9372294429670269 4.899886625785182 32849.0 49.68426661302548 0.0 - - - - - - - 273.125 65 8 KIAA1279 KIAA1279 1579 201 C20140605_SFK031_02 C20140605_SFK031_02 TB560556.[MT7]-EVGSPPLDPTER.2y10_1.heavy 720.876 / 1068.53 13844.0 26.546175479888916 37 14 10 3 10 1.6849927806640388 49.533900088114265 0.06830024719238281 3 0.9372294429670269 4.899886625785182 13844.0 21.053738039215688 0.0 - - - - - - - 204.875 27 8 KIAA1279 KIAA1279 1581 202 C20140605_SFK031_02 C20140605_SFK031_02 TB294993.[MT7]-LFPDTPLALDANK[MT7].3y6_1.heavy 568.325 / 775.443 39580.0 41.01210021972656 41 11 10 10 10 0.8700590024992765 69.16089995016816 0.0 3 0.875985229151479 3.4676219005894477 39580.0 87.51895054838842 0.0 - - - - - - - 749.2222222222222 79 9 ILF3 interleukin enhancer binding factor 3, 90kDa 1583 202 C20140605_SFK031_02 C20140605_SFK031_02 TB294993.[MT7]-LFPDTPLALDANK[MT7].3b4_1.heavy 568.325 / 617.341 40290.0 41.01210021972656 41 11 10 10 10 0.8700590024992765 69.16089995016816 0.0 3 0.875985229151479 3.4676219005894477 40290.0 52.05507110294619 0.0 - - - - - - - 1217.0 80 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1585 202 C20140605_SFK031_02 C20140605_SFK031_02 TB294993.[MT7]-LFPDTPLALDANK[MT7].3b5_1.heavy 568.325 / 718.389 78184.0 41.01210021972656 41 11 10 10 10 0.8700590024992765 69.16089995016816 0.0 3 0.875985229151479 3.4676219005894477 78184.0 138.15786146386517 0.0 - - - - - - - 658.0 156 12 ILF3 interleukin enhancer binding factor 3, 90kDa 1587 202 C20140605_SFK031_02 C20140605_SFK031_02 TB294993.[MT7]-LFPDTPLALDANK[MT7].3y4_1.heavy 568.325 / 591.322 129567.0 41.01210021972656 41 11 10 10 10 0.8700590024992765 69.16089995016816 0.0 3 0.875985229151479 3.4676219005894477 129567.0 105.60808693653763 0.0 - - - - - - - 177.0 259 2 ILF3 interleukin enhancer binding factor 3, 90kDa 1589 203 C20140605_SFK031_02 C20140605_SFK031_02 TB561600.[MT7]-RVELAVMLNLTER.3y6_1.heavy 563.326 / 745.42 34200.0 41.0807991027832 43 13 10 10 10 3.7918992177296333 26.372008921659614 0.0 3 0.9225802372896781 4.406501245079665 34200.0 115.78722665741063 0.0 - - - - - - - 259.1 68 10 PDX1 pancreatic and duodenal homeobox 1 1591 203 C20140605_SFK031_02 C20140605_SFK031_02 TB561600.[MT7]-RVELAVMLNLTER.3b6_1.heavy 563.326 / 812.511 33039.0 41.0807991027832 43 13 10 10 10 3.7918992177296333 26.372008921659614 0.0 3 0.9225802372896781 4.406501245079665 33039.0 89.25355377489029 0.0 - - - - - - - 223.375 66 8 PDX1 pancreatic and duodenal homeobox 1 1593 203 C20140605_SFK031_02 C20140605_SFK031_02 TB561600.[MT7]-RVELAVMLNLTER.3b5_1.heavy 563.326 / 713.443 30092.0 41.0807991027832 43 13 10 10 10 3.7918992177296333 26.372008921659614 0.0 3 0.9225802372896781 4.406501245079665 30092.0 81.84994115444606 0.0 - - - - - - - 854.7142857142857 60 7 PDX1 pancreatic and duodenal homeobox 1 1595 203 C20140605_SFK031_02 C20140605_SFK031_02 TB561600.[MT7]-RVELAVMLNLTER.3y5_1.heavy 563.326 / 632.336 56255.0 41.0807991027832 43 13 10 10 10 3.7918992177296333 26.372008921659614 0.0 3 0.9225802372896781 4.406501245079665 56255.0 41.26814671814671 0.0 - - - - - - - 841.8571428571429 112 7 PDX1 pancreatic and duodenal homeobox 1 1597 204 C20140605_SFK031_02 C20140605_SFK031_02 TB294995.[MT7]-VLEAILPLVQNDPR.2y8_1.heavy 861.008 / 938.505 99467.0 46.698723793029785 33 10 10 3 10 0.7531635124857098 69.61154688756037 0.07670211791992188 3 0.8222404691191416 2.882650716880453 99467.0 130.858445515695 0.0 - - - - - - - 788.7142857142857 198 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1599 204 C20140605_SFK031_02 C20140605_SFK031_02 TB294995.[MT7]-VLEAILPLVQNDPR.2b4_1.heavy 861.008 / 557.341 84456.0 46.698723793029785 33 10 10 3 10 0.7531635124857098 69.61154688756037 0.07670211791992188 3 0.8222404691191416 2.882650716880453 84456.0 88.99473129610116 1.0 - - - - - - - 216.0 168 2 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1601 204 C20140605_SFK031_02 C20140605_SFK031_02 TB294995.[MT7]-VLEAILPLVQNDPR.2b5_1.heavy 861.008 / 670.426 111200.0 46.698723793029785 33 10 10 3 10 0.7531635124857098 69.61154688756037 0.07670211791992188 3 0.8222404691191416 2.882650716880453 111200.0 199.3851540454938 0.0 - - - - - - - 345.0 222 1 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1603 204 C20140605_SFK031_02 C20140605_SFK031_02 TB294995.[MT7]-VLEAILPLVQNDPR.2y11_1.heavy 861.008 / 1235.71 10180.0 46.698723793029785 33 10 10 3 10 0.7531635124857098 69.61154688756037 0.07670211791992188 3 0.8222404691191416 2.882650716880453 10180.0 17.321584125155965 0.0 - - - - - - - 759.2 20 10 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1605 205 C20140605_SFK031_02 C20140605_SFK031_02 TB556064.[MT7]-EGVDYR.2b3_1.heavy 441.726 / 430.242 32715.0 18.597200393676758 47 17 10 10 10 4.477024722211587 22.3362626308218 0.0 3 0.9791531097878104 8.532658332005107 32715.0 21.329362423290995 0.0 - - - - - - - 2679.1428571428573 65 7 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1607 205 C20140605_SFK031_02 C20140605_SFK031_02 TB556064.[MT7]-EGVDYR.2y5_1.heavy 441.726 / 609.299 33275.0 18.597200393676758 47 17 10 10 10 4.477024722211587 22.3362626308218 0.0 3 0.9791531097878104 8.532658332005107 33275.0 59.50863907849829 0.0 - - - - - - - 735.0 66 14 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1609 205 C20140605_SFK031_02 C20140605_SFK031_02 TB556064.[MT7]-EGVDYR.2b4_1.heavy 441.726 / 545.269 365572.0 18.597200393676758 47 17 10 10 10 4.477024722211587 22.3362626308218 0.0 3 0.9791531097878104 8.532658332005107 365572.0 409.7541921998958 0.0 - - - - - - - 718.7777777777778 731 9 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1611 205 C20140605_SFK031_02 C20140605_SFK031_02 TB556064.[MT7]-EGVDYR.2b5_1.heavy 441.726 / 708.332 5351.0 18.597200393676758 47 17 10 10 10 4.477024722211587 22.3362626308218 0.0 3 0.9791531097878104 8.532658332005107 5351.0 5.460533828991701 0.0 - - - - - - - 692.8 10 10 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1613 206 C20140605_SFK031_02 C20140605_SFK031_02 TB559598.[MT7]-VYQSLANLIR.2b3_1.heavy 660.891 / 535.3 40921.0 42.13999938964844 48 18 10 10 10 2.948220265202508 27.716865403531866 0.0 3 0.9818002970956085 9.134175305958122 40921.0 47.853051206036234 0.0 - - - - - - - 756.0 81 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1615 206 C20140605_SFK031_02 C20140605_SFK031_02 TB559598.[MT7]-VYQSLANLIR.2y8_1.heavy 660.891 / 914.542 65238.0 42.13999938964844 48 18 10 10 10 2.948220265202508 27.716865403531866 0.0 3 0.9818002970956085 9.134175305958122 65238.0 86.6381879445106 0.0 - - - - - - - 705.6666666666666 130 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1617 206 C20140605_SFK031_02 C20140605_SFK031_02 TB559598.[MT7]-VYQSLANLIR.2y9_1.heavy 660.891 / 1077.61 242988.0 42.13999938964844 48 18 10 10 10 2.948220265202508 27.716865403531866 0.0 3 0.9818002970956085 9.134175305958122 242988.0 298.4375658588971 0.0 - - - - - - - 215.375 485 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1619 206 C20140605_SFK031_02 C20140605_SFK031_02 TB559598.[MT7]-VYQSLANLIR.2y7_1.heavy 660.891 / 786.483 50993.0 42.13999938964844 48 18 10 10 10 2.948220265202508 27.716865403531866 0.0 3 0.9818002970956085 9.134175305958122 50993.0 69.35008179865946 0.0 - - - - - - - 756.0 101 9 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1621 207 C20140605_SFK031_02 C20140605_SFK031_02 TB557785.[MT7]-VAVVAPMSR.2y8_1.heavy 537.317 / 830.455 34012.0 27.8430495262146 38 18 6 6 8 5.005940828761575 19.976264886203044 0.03700065612792969 4 0.9853627604692059 10.188297387061235 34012.0 102.43559554732907 0.0 - - - - - - - 717.375 68 8 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1623 207 C20140605_SFK031_02 C20140605_SFK031_02 TB557785.[MT7]-VAVVAPMSR.2y5_1.heavy 537.317 / 561.281 14107.0 27.8430495262146 38 18 6 6 8 5.005940828761575 19.976264886203044 0.03700065612792969 4 0.9853627604692059 10.188297387061235 14107.0 9.882312351136783 1.0 - - - - - - - 1233.6363636363637 28 11 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1625 207 C20140605_SFK031_02 C20140605_SFK031_02 TB557785.[MT7]-VAVVAPMSR.2y6_1.heavy 537.317 / 660.35 22894.0 27.8430495262146 38 18 6 6 8 5.005940828761575 19.976264886203044 0.03700065612792969 4 0.9853627604692059 10.188297387061235 22894.0 21.377467654417895 1.0 - - - - - - - 1273.6153846153845 113 13 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1627 207 C20140605_SFK031_02 C20140605_SFK031_02 TB557785.[MT7]-VAVVAPMSR.2y7_1.heavy 537.317 / 759.418 9145.0 27.8430495262146 38 18 6 6 8 5.005940828761575 19.976264886203044 0.03700065612792969 4 0.9853627604692059 10.188297387061235 9145.0 1.5401561628555496 1.0 - - - - - - - 1144.0 18 7 RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 1629 208 C20140605_SFK031_02 C20140605_SFK031_02 TB399860.[MT7]-VMDALEPADWC[CAM]QFAALIVR.3b6_1.heavy 783.733 / 803.409 15223.0 54.46070098876953 48 18 10 10 10 4.641011785627439 21.547025652829827 0.0 3 0.9898399147173064 12.233347162349963 15223.0 134.3419164615237 0.0 - - - - - - - 179.0 30 19 IRAK1 interleukin-1 receptor-associated kinase 1 1631 208 C20140605_SFK031_02 C20140605_SFK031_02 TB399860.[MT7]-VMDALEPADWC[CAM]QFAALIVR.3b4_1.heavy 783.733 / 561.282 15800.0 54.46070098876953 48 18 10 10 10 4.641011785627439 21.547025652829827 0.0 3 0.9898399147173064 12.233347162349963 15800.0 124.95651870463428 0.0 - - - - - - - 130.85 31 20 IRAK1 interleukin-1 receptor-associated kinase 1 1633 208 C20140605_SFK031_02 C20140605_SFK031_02 TB399860.[MT7]-VMDALEPADWC[CAM]QFAALIVR.3b5_1.heavy 783.733 / 674.366 10753.0 54.46070098876953 48 18 10 10 10 4.641011785627439 21.547025652829827 0.0 3 0.9898399147173064 12.233347162349963 10753.0 65.36953331108887 0.0 - - - - - - - 158.5 21 20 IRAK1 interleukin-1 receptor-associated kinase 1 1635 208 C20140605_SFK031_02 C20140605_SFK031_02 TB399860.[MT7]-VMDALEPADWC[CAM]QFAALIVR.3y9_1.heavy 783.733 / 1077.59 9146.0 54.46070098876953 48 18 10 10 10 4.641011785627439 21.547025652829827 0.0 3 0.9898399147173064 12.233347162349963 9146.0 62.543419439540045 0.0 - - - - - - - 156.7 18 20 IRAK1 interleukin-1 receptor-associated kinase 1 1637 209 C20140605_SFK031_02 C20140605_SFK031_02 TB557641.[MT7]-IPEGDLIR.2y5_1.heavy 528.812 / 573.336 31935.0 32.08790111541748 46 20 10 6 10 6.725593150825729 14.868577054459886 0.036800384521484375 3 0.995563401635659 18.521519609729214 31935.0 11.746206896551723 1.0 - - - - - - - 435.0 63 1 GRK5 G protein-coupled receptor kinase 5 1639 209 C20140605_SFK031_02 C20140605_SFK031_02 TB557641.[MT7]-IPEGDLIR.2y6_1.heavy 528.812 / 702.378 13400.0 32.08790111541748 46 20 10 6 10 6.725593150825729 14.868577054459886 0.036800384521484375 3 0.995563401635659 18.521519609729214 13400.0 8.952586206896552 0.0 - - - - - - - 377.0 26 3 GRK5 G protein-coupled receptor kinase 5 1641 209 C20140605_SFK031_02 C20140605_SFK031_02 TB557641.[MT7]-IPEGDLIR.2b5_1.heavy 528.812 / 656.337 17664.0 32.08790111541748 46 20 10 6 10 6.725593150825729 14.868577054459886 0.036800384521484375 3 0.995563401635659 18.521519609729214 17664.0 17.63785360140713 0.0 - - - - - - - 870.0 35 2 GRK5 G protein-coupled receptor kinase 5 1643 209 C20140605_SFK031_02 C20140605_SFK031_02 TB557641.[MT7]-IPEGDLIR.2y7_1.heavy 528.812 / 799.431 298378.0 32.08790111541748 46 20 10 6 10 6.725593150825729 14.868577054459886 0.036800384521484375 3 0.995563401635659 18.521519609729214 298378.0 320.4976830675036 0.0 - - - - - - - 261.0 596 2 GRK5 G protein-coupled receptor kinase 5 1645 210 C20140605_SFK031_02 C20140605_SFK031_02 TB557780.[MT7]-SRSEEC[CAM]R.2y5_1.heavy 534.255 / 680.267 N/A N/A - - - - - - - - - 0.0 - - - - - - - ETV5 ets variant 5 1647 210 C20140605_SFK031_02 C20140605_SFK031_02 TB557780.[MT7]-SRSEEC[CAM]R.2b4_1.heavy 534.255 / 604.317 N/A N/A - - - - - - - - - 0.0 - - - - - - - ETV5 ets variant 5 1649 210 C20140605_SFK031_02 C20140605_SFK031_02 TB557780.[MT7]-SRSEEC[CAM]R.2b6_1.heavy 534.255 / 893.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - ETV5 ets variant 5 1651 210 C20140605_SFK031_02 C20140605_SFK031_02 TB557780.[MT7]-SRSEEC[CAM]R.2b5_1.heavy 534.255 / 733.36 N/A N/A - - - - - - - - - 0.0 - - - - - - - ETV5 ets variant 5 1653 211 C20140605_SFK031_02 C20140605_SFK031_02 TB561803.[MT7]-GAFGVGQEQIDAFLK[MT7].3y3_1.heavy 623.343 / 551.367 62263.0 43.145599365234375 50 20 10 10 10 8.593509035372792 11.636689923566472 0.0 3 0.995911426308055 19.294270965457166 62263.0 83.28142058256296 0.0 - - - - - - - 1135.142857142857 124 7 CNOT1 CCR4-NOT transcription complex, subunit 1 1655 211 C20140605_SFK031_02 C20140605_SFK031_02 TB561803.[MT7]-GAFGVGQEQIDAFLK[MT7].3b5_1.heavy 623.343 / 576.326 109284.0 43.145599365234375 50 20 10 10 10 8.593509035372792 11.636689923566472 0.0 3 0.995911426308055 19.294270965457166 109284.0 185.04879561273992 0.0 - - - - - - - 749.3333333333334 218 9 CNOT1 CCR4-NOT transcription complex, subunit 1 1657 211 C20140605_SFK031_02 C20140605_SFK031_02 TB561803.[MT7]-GAFGVGQEQIDAFLK[MT7].3y4_1.heavy 623.343 / 622.404 44711.0 43.145599365234375 50 20 10 10 10 8.593509035372792 11.636689923566472 0.0 3 0.995911426308055 19.294270965457166 44711.0 42.03893839940244 0.0 - - - - - - - 1253.857142857143 89 7 CNOT1 CCR4-NOT transcription complex, subunit 1 1659 211 C20140605_SFK031_02 C20140605_SFK031_02 TB561803.[MT7]-GAFGVGQEQIDAFLK[MT7].3y5_1.heavy 623.343 / 737.431 67621.0 43.145599365234375 50 20 10 10 10 8.593509035372792 11.636689923566472 0.0 3 0.995911426308055 19.294270965457166 67621.0 117.84309324742505 0.0 - - - - - - - 712.5714285714286 135 7 CNOT1 CCR4-NOT transcription complex, subunit 1 1661 212 C20140605_SFK031_02 C20140605_SFK031_02 TB558348.[MT7]-NIIVQFGVR.2y8_1.heavy 595.362 / 931.572 19762.0 37.71887493133545 46 20 10 6 10 8.232476790829836 12.147012684128075 0.038898468017578125 3 0.9943792331344279 16.453600616573272 19762.0 42.75774412540463 0.0 - - - - - - - 651.4285714285714 39 7 CNOT1 CCR4-NOT transcription complex, subunit 1 1663 212 C20140605_SFK031_02 C20140605_SFK031_02 TB558348.[MT7]-NIIVQFGVR.2y5_1.heavy 595.362 / 606.336 13986.0 37.71887493133545 46 20 10 6 10 8.232476790829836 12.147012684128075 0.038898468017578125 3 0.9943792331344279 16.453600616573272 13986.0 14.299283636830854 0.0 - - - - - - - 1205.9 27 10 CNOT1 CCR4-NOT transcription complex, subunit 1 1665 212 C20140605_SFK031_02 C20140605_SFK031_02 TB558348.[MT7]-NIIVQFGVR.2y6_1.heavy 595.362 / 705.404 21586.0 37.71887493133545 46 20 10 6 10 8.232476790829836 12.147012684128075 0.038898468017578125 3 0.9943792331344279 16.453600616573272 21586.0 24.21754202560774 0.0 - - - - - - - 1165.375 43 8 CNOT1 CCR4-NOT transcription complex, subunit 1 1667 212 C20140605_SFK031_02 C20140605_SFK031_02 TB558348.[MT7]-NIIVQFGVR.2y7_1.heavy 595.362 / 818.488 26046.0 37.71887493133545 46 20 10 6 10 8.232476790829836 12.147012684128075 0.038898468017578125 3 0.9943792331344279 16.453600616573272 26046.0 49.216082016266164 0.0 - - - - - - - 646.0 52 8 CNOT1 CCR4-NOT transcription complex, subunit 1 1669 213 C20140605_SFK031_02 C20140605_SFK031_02 TB295026.[MT7]-ERVEDLFEYEGC[CAM]K[MT7].3b6_1.heavy 654.655 / 886.475 78803.0 34.328399658203125 38 8 10 10 10 0.5715286438061413 90.55531363387729 0.0 3 0.7697692423343584 2.520998120490415 78803.0 132.86603955696853 0.0 - - - - - - - 803.0 157 7 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1671 213 C20140605_SFK031_02 C20140605_SFK031_02 TB295026.[MT7]-ERVEDLFEYEGC[CAM]K[MT7].3y3_1.heavy 654.655 / 508.267 378955.0 34.328399658203125 38 8 10 10 10 0.5715286438061413 90.55531363387729 0.0 3 0.7697692423343584 2.520998120490415 378955.0 185.74533807873274 0.0 - - - - - - - 742.0 757 1 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1673 213 C20140605_SFK031_02 C20140605_SFK031_02 TB295026.[MT7]-ERVEDLFEYEGC[CAM]K[MT7].3b5_1.heavy 654.655 / 773.391 81242.0 34.328399658203125 38 8 10 10 10 0.5715286438061413 90.55531363387729 0.0 3 0.7697692423343584 2.520998120490415 81242.0 116.63581067568667 0.0 - - - - - - - 1242.7142857142858 162 7 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1675 213 C20140605_SFK031_02 C20140605_SFK031_02 TB295026.[MT7]-ERVEDLFEYEGC[CAM]K[MT7].3y4_1.heavy 654.655 / 637.31 160364.0 34.328399658203125 38 8 10 10 10 0.5715286438061413 90.55531363387729 0.0 3 0.7697692423343584 2.520998120490415 160364.0 105.06544658795772 0.0 - - - - - - - 848.0 320 2 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1677 214 C20140605_SFK031_02 C20140605_SFK031_02 TB399856.[MT7]-YIPAFC[CAM]ELPLDDQVALLR.2y8_1.heavy 1139.11 / 929.505 19922.0 48.994300842285156 37 7 10 10 10 0.44507889488103897 102.71354405526546 0.0 3 0.733991377758855 2.3376533317479287 19922.0 67.50879978340328 0.0 - - - - - - - 223.46153846153845 39 13 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 1679 214 C20140605_SFK031_02 C20140605_SFK031_02 TB399856.[MT7]-YIPAFC[CAM]ELPLDDQVALLR.2y6_1.heavy 1139.11 / 699.451 12520.0 48.994300842285156 37 7 10 10 10 0.44507889488103897 102.71354405526546 0.0 3 0.733991377758855 2.3376533317479287 12520.0 40.58559394603206 0.0 - - - - - - - 182.71428571428572 25 14 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 1681 214 C20140605_SFK031_02 C20140605_SFK031_02 TB399856.[MT7]-YIPAFC[CAM]ELPLDDQVALLR.2y7_1.heavy 1139.11 / 814.478 11345.0 48.994300842285156 37 7 10 10 10 0.44507889488103897 102.71354405526546 0.0 3 0.733991377758855 2.3376533317479287 11345.0 93.12527501309586 0.0 - - - - - - - 157.0 22 11 HNF4A;HNF4G hepatocyte nuclear factor 4, alpha;hepatocyte nuclear factor 4, gamma 1683 215 C20140605_SFK031_02 C20140605_SFK031_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 1660140.0 44.304100036621094 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1660140.0 562.5066077370174 0.0 - - - - - - - 376.5 3320 2 1685 215 C20140605_SFK031_02 C20140605_SFK031_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 2896790.0 44.304100036621094 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2896790.0 333.7000455388767 0.0 - - - - - - - 753.0 5793 1 1687 215 C20140605_SFK031_02 C20140605_SFK031_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 2510760.0 44.304100036621094 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2510760.0 79.7716197436888 1.0 - - - - - - - 621.4 5464 5 1689 216 C20140605_SFK031_02 C20140605_SFK031_02 TB399855.[MT7]-VLVASSVVAGESQK[MT7]PELK[MT7].4y4_1.heavy 569.091 / 630.394 38754.0 31.854700088500977 35 5 10 10 10 0.5050699656098702 99.85505859821521 0.0 3 0.686735721797531 2.144646322562681 38754.0 22.14759247589011 0.0 - - - - - - - 1276.7142857142858 77 7 FMR1 fragile X mental retardation 1 1691 216 C20140605_SFK031_02 C20140605_SFK031_02 TB399855.[MT7]-VLVASSVVAGESQK[MT7]PELK[MT7].4y9_2.heavy 569.091 / 652.377 90101.0 31.854700088500977 35 5 10 10 10 0.5050699656098702 99.85505859821521 0.0 3 0.686735721797531 2.144646322562681 90101.0 69.15357120786221 0.0 - - - - - - - 365.25 180 4 FMR1 fragile X mental retardation 1 1693 216 C20140605_SFK031_02 C20140605_SFK031_02 TB399855.[MT7]-VLVASSVVAGESQK[MT7]PELK[MT7].4b4_1.heavy 569.091 / 527.367 29411.0 31.854700088500977 35 5 10 10 10 0.5050699656098702 99.85505859821521 0.0 3 0.686735721797531 2.144646322562681 29411.0 20.90012454212454 0.0 - - - - - - - 406.0 58 1 FMR1 fragile X mental retardation 1 1695 216 C20140605_SFK031_02 C20140605_SFK031_02 TB399855.[MT7]-VLVASSVVAGESQK[MT7]PELK[MT7].4b5_1.heavy 569.091 / 614.399 18605.0 31.854700088500977 35 5 10 10 10 0.5050699656098702 99.85505859821521 0.0 3 0.686735721797531 2.144646322562681 18605.0 16.398649949691777 0.0 - - - - - - - 1760.2222222222222 37 9 FMR1 fragile X mental retardation 1 1697 217 C20140605_SFK031_02 C20140605_SFK031_02 TB556389.[MT7]-LTEQER.2y4_1.heavy 460.252 / 561.263 17134.0 17.63159942626953 48 20 10 10 8 10.175094212601696 9.827918829110354 0.0 4 0.9978300595968822 26.48865473791352 17134.0 17.051528839849684 0.0 - - - - - - - 786.625 34 8 KIAA1279 KIAA1279 1699 217 C20140605_SFK031_02 C20140605_SFK031_02 TB556389.[MT7]-LTEQER.2b3_1.heavy 460.252 / 488.284 21418.0 17.63159942626953 48 20 10 10 8 10.175094212601696 9.827918829110354 0.0 4 0.9978300595968822 26.48865473791352 21418.0 23.43764176192101 1.0 - - - - - - - 1071.0 103 8 KIAA1279 KIAA1279 1701 217 C20140605_SFK031_02 C20140605_SFK031_02 TB556389.[MT7]-LTEQER.2y5_1.heavy 460.252 / 662.31 118511.0 17.63159942626953 48 20 10 10 8 10.175094212601696 9.827918829110354 0.0 4 0.9978300595968822 26.48865473791352 118511.0 109.6782853815591 1.0 - - - - - - - 423.0 237 2 KIAA1279 KIAA1279 1703 217 C20140605_SFK031_02 C20140605_SFK031_02 TB556389.[MT7]-LTEQER.2b4_1.heavy 460.252 / 616.342 17081.0 17.63159942626953 48 20 10 10 8 10.175094212601696 9.827918829110354 0.0 4 0.9978300595968822 26.48865473791352 17081.0 33.63622557015527 0.0 - - - - - - - 683.7857142857143 34 14 KIAA1279 KIAA1279 1705 218 C20140605_SFK031_02 C20140605_SFK031_02 TB557198.[MT7]-QLDPDDR.2y5_1.heavy 501.752 / 617.253 30455.0 19.000900268554688 46 16 10 10 10 4.176930410190283 23.941026107601452 0.0 3 0.962178601746943 6.325796054924592 30455.0 85.29728902251216 0.0 - - - - - - - 771.2857142857143 60 7 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1707 218 C20140605_SFK031_02 C20140605_SFK031_02 TB557198.[MT7]-QLDPDDR.2b6_1.heavy 501.752 / 828.386 30760.0 19.000900268554688 46 16 10 10 10 4.176930410190283 23.941026107601452 0.0 3 0.962178601746943 6.325796054924592 30760.0 146.83246962588717 0.0 - - - - - - - 662.0 61 7 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1709 218 C20140605_SFK031_02 C20140605_SFK031_02 TB557198.[MT7]-QLDPDDR.2y6_1.heavy 501.752 / 730.337 62233.0 19.000900268554688 46 16 10 10 10 4.176930410190283 23.941026107601452 0.0 3 0.962178601746943 6.325796054924592 62233.0 69.36673844205193 0.0 - - - - - - - 769.6666666666666 124 9 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1711 218 C20140605_SFK031_02 C20140605_SFK031_02 TB557198.[MT7]-QLDPDDR.2b5_1.heavy 501.752 / 713.359 181710.0 19.000900268554688 46 16 10 10 10 4.176930410190283 23.941026107601452 0.0 3 0.962178601746943 6.325796054924592 181710.0 234.58554152237173 0.0 - - - - - - - 719.375 363 8 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma 1713 219 C20140605_SFK031_02 C20140605_SFK031_02 TB560548.[MT7]-QRIEALGGC[CAM]VVWFGAWR.3y7_1.heavy 717.046 / 921.473 17929.0 44.72999954223633 48 18 10 10 10 4.662648103618036 17.128738840853224 0.0 3 0.9838373876369559 9.69437702061812 17929.0 38.3702940212045 0.0 - - - - - - - 747.0 35 8 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1715 219 C20140605_SFK031_02 C20140605_SFK031_02 TB560548.[MT7]-QRIEALGGC[CAM]VVWFGAWR.3y6_1.heavy 717.046 / 822.405 24746.0 44.72999954223633 48 18 10 10 10 4.662648103618036 17.128738840853224 0.0 3 0.9838373876369559 9.69437702061812 24746.0 106.52930977882878 0.0 - - - - - - - 280.1111111111111 49 9 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1717 219 C20140605_SFK031_02 C20140605_SFK031_02 TB560548.[MT7]-QRIEALGGC[CAM]VVWFGAWR.3b5_1.heavy 717.046 / 742.433 3175.0 44.72999954223633 48 18 10 10 10 4.662648103618036 17.128738840853224 0.0 3 0.9838373876369559 9.69437702061812 3175.0 4.236820428336079 0.0 - - - - - - - 696.2727272727273 6 11 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1719 219 C20140605_SFK031_02 C20140605_SFK031_02 TB560548.[MT7]-QRIEALGGC[CAM]VVWFGAWR.3y5_1.heavy 717.046 / 636.325 23065.0 44.72999954223633 48 18 10 10 10 4.662648103618036 17.128738840853224 0.0 3 0.9838373876369559 9.69437702061812 23065.0 26.86101459177977 0.0 - - - - - - - 747.0 46 9 PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 1721 220 C20140605_SFK031_02 C20140605_SFK031_02 TB560811.[MT7]-GAAAAAGSPGPGAAAAR.3y6_1.heavy 489.931 / 516.289 19612.0 18.597200393676758 48 18 10 10 10 3.007280061151049 27.670866264300905 0.0 3 0.9804075091762864 8.802497431969215 19612.0 34.89484509466437 0.0 - - - - - - - 631.5454545454545 39 11 FOXD2 forkhead box D2 1723 220 C20140605_SFK031_02 C20140605_SFK031_02 TB560811.[MT7]-GAAAAAGSPGPGAAAAR.3y8_1.heavy 489.931 / 670.363 25741.0 18.597200393676758 48 18 10 10 10 3.007280061151049 27.670866264300905 0.0 3 0.9804075091762864 8.802497431969215 25741.0 56.71211750305998 0.0 - - - - - - - 292.54545454545456 51 11 FOXD2 forkhead box D2 1725 220 C20140605_SFK031_02 C20140605_SFK031_02 TB560811.[MT7]-GAAAAAGSPGPGAAAAR.3b7_1.heavy 489.931 / 614.338 24617.0 18.597200393676758 48 18 10 10 10 3.007280061151049 27.670866264300905 0.0 3 0.9804075091762864 8.802497431969215 24617.0 98.02872720479007 0.0 - - - - - - - 270.3529411764706 49 17 FOXD2 forkhead box D2 1727 220 C20140605_SFK031_02 C20140605_SFK031_02 TB560811.[MT7]-GAAAAAGSPGPGAAAAR.3y9_1.heavy 489.931 / 767.416 19663.0 18.597200393676758 48 18 10 10 10 3.007280061151049 27.670866264300905 0.0 3 0.9804075091762864 8.802497431969215 19663.0 227.8462733112805 0.0 - - - - - - - 170.13333333333333 39 15 FOXD2 forkhead box D2 1729 221 C20140605_SFK031_02 C20140605_SFK031_02 TB559713.[MT7]-EATDAIGHLDR.3b4_1.heavy 447.901 / 561.264 350326.0 25.140399932861328 46 16 10 10 10 2.889136456872757 27.488617273636002 0.0 3 0.9675439882638869 6.831768148188352 350326.0 262.29374414795217 0.0 - - - - - - - 1287.6 700 10 ILF3 interleukin enhancer binding factor 3, 90kDa 1731 221 C20140605_SFK031_02 C20140605_SFK031_02 TB559713.[MT7]-EATDAIGHLDR.3b5_1.heavy 447.901 / 632.301 282791.0 25.140399932861328 46 16 10 10 10 2.889136456872757 27.488617273636002 0.0 3 0.9675439882638869 6.831768148188352 282791.0 567.533028422472 0.0 - - - - - - - 708.625 565 8 ILF3 interleukin enhancer binding factor 3, 90kDa 1733 221 C20140605_SFK031_02 C20140605_SFK031_02 TB559713.[MT7]-EATDAIGHLDR.3y4_1.heavy 447.901 / 540.289 88712.0 25.140399932861328 46 16 10 10 10 2.889136456872757 27.488617273636002 0.0 3 0.9675439882638869 6.831768148188352 88712.0 97.63988209949053 0.0 - - - - - - - 1741.5714285714287 177 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1735 221 C20140605_SFK031_02 C20140605_SFK031_02 TB559713.[MT7]-EATDAIGHLDR.3y5_1.heavy 447.901 / 597.31 355649.0 25.140399932861328 46 16 10 10 10 2.889136456872757 27.488617273636002 0.0 3 0.9675439882638869 6.831768148188352 355649.0 630.5035018608377 0.0 - - - - - - - 776.0 711 9 ILF3 interleukin enhancer binding factor 3, 90kDa 1737 222 C20140605_SFK031_02 C20140605_SFK031_02 TB295033.[MT7]-QLPQEIIFLVWSPK[MT7].2y4_1.heavy 993.587 / 661.379 2193.0 52.26029968261719 30 11 8 5 6 0.7710948397339122 77.50989563670298 0.0449981689453125 5 0.8576857733393435 3.2318245537622463 2193.0 10.32825679475164 1.0 - - - - - - - 166.14285714285714 5 7 ANAPC4 anaphase promoting complex subunit 4 1739 222 C20140605_SFK031_02 C20140605_SFK031_02 TB295033.[MT7]-QLPQEIIFLVWSPK[MT7].2b6_1.heavy 993.587 / 853.49 2193.0 52.26029968261719 30 11 8 5 6 0.7710948397339122 77.50989563670298 0.0449981689453125 5 0.8576857733393435 3.2318245537622463 2193.0 37.6022564102564 0.0 - - - - - - - 176.36363636363637 4 11 ANAPC4 anaphase promoting complex subunit 4 1741 222 C20140605_SFK031_02 C20140605_SFK031_02 TB295033.[MT7]-QLPQEIIFLVWSPK[MT7].2b5_1.heavy 993.587 / 740.406 1032.0 52.26029968261719 30 11 8 5 6 0.7710948397339122 77.50989563670298 0.0449981689453125 5 0.8576857733393435 3.2318245537622463 1032.0 1.6941176470588233 1.0 - - - - - - - 188.41666666666666 4 12 ANAPC4 anaphase promoting complex subunit 4 1743 222 C20140605_SFK031_02 C20140605_SFK031_02 TB295033.[MT7]-QLPQEIIFLVWSPK[MT7].2y7_1.heavy 993.587 / 1020.6 N/A 52.26029968261719 30 11 8 5 6 0.7710948397339122 77.50989563670298 0.0449981689453125 5 0.8576857733393435 3.2318245537622463 0.0 0.0 38.0 - - - - - - - 766.25 4 8 ANAPC4 anaphase promoting complex subunit 4 1745 223 C20140605_SFK031_02 C20140605_SFK031_02 TB558354.[MT7]-QVEELFER.2y4_1.heavy 597.318 / 564.314 13364.0 34.45719909667969 48 18 10 10 10 5.907244497775957 16.92836652311402 0.0 3 0.982740611604234 9.380436431844746 13364.0 6.141151977108992 0.0 - - - - - - - 221.0 26 1 GTF2I general transcription factor IIi 1747 223 C20140605_SFK031_02 C20140605_SFK031_02 TB558354.[MT7]-QVEELFER.2b4_1.heavy 597.318 / 630.321 18224.0 34.45719909667969 48 18 10 10 10 5.907244497775957 16.92836652311402 0.0 3 0.982740611604234 9.380436431844746 18224.0 10.516307490349904 0.0 - - - - - - - 663.0 36 1 GTF2I general transcription factor IIi 1749 223 C20140605_SFK031_02 C20140605_SFK031_02 TB558354.[MT7]-QVEELFER.2y6_1.heavy 597.318 / 822.399 12039.0 34.45719909667969 48 18 10 10 10 5.907244497775957 16.92836652311402 0.0 3 0.982740611604234 9.380436431844746 12039.0 18.391654716981133 0.0 - - - - - - - 309.2 24 5 GTF2I general transcription factor IIi 1751 223 C20140605_SFK031_02 C20140605_SFK031_02 TB558354.[MT7]-QVEELFER.2y7_1.heavy 597.318 / 921.468 35674.0 34.45719909667969 48 18 10 10 10 5.907244497775957 16.92836652311402 0.0 3 0.982740611604234 9.380436431844746 35674.0 61.28595268405198 0.0 - - - - - - - 731.75 71 8 GTF2I general transcription factor IIi 1753 224 C20140605_SFK031_02 C20140605_SFK031_02 TB557224.[MT7]-IADMGFAR.2y5_1.heavy 512.772 / 581.286 198002.0 32.33580017089844 50 20 10 10 10 10.7416674334697 9.309541616268293 0.0 3 0.9984494878901552 31.33781104756874 198002.0 191.90206190506842 0.0 - - - - - - - 1703.0 396 9 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1755 224 C20140605_SFK031_02 C20140605_SFK031_02 TB557224.[MT7]-IADMGFAR.2y6_1.heavy 512.772 / 696.313 41667.0 32.33580017089844 50 20 10 10 10 10.7416674334697 9.309541616268293 0.0 3 0.9984494878901552 31.33781104756874 41667.0 16.21588643191504 0.0 - - - - - - - 1185.6 83 5 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1757 224 C20140605_SFK031_02 C20140605_SFK031_02 TB557224.[MT7]-IADMGFAR.2b5_1.heavy 512.772 / 632.319 44800.0 32.33580017089844 50 20 10 10 10 10.7416674334697 9.309541616268293 0.0 3 0.9984494878901552 31.33781104756874 44800.0 67.15987969314995 0.0 - - - - - - - 423.0 89 2 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1759 224 C20140605_SFK031_02 C20140605_SFK031_02 TB557224.[MT7]-IADMGFAR.2y7_1.heavy 512.772 / 767.351 159384.0 32.33580017089844 50 20 10 10 10 10.7416674334697 9.309541616268293 0.0 3 0.9984494878901552 31.33781104756874 159384.0 103.78566645591928 0.0 - - - - - - - 1279.6666666666667 318 9 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1761 225 C20140605_SFK031_02 C20140605_SFK031_02 TB557221.[MT7]-IFVNDDR.2y4_1.heavy 511.773 / 519.216 21625.0 27.37534999847412 34 14 6 6 8 2.176587866632208 45.943470297263055 0.035800933837890625 4 0.9312406136568078 4.679246355836868 21625.0 21.219743246165596 1.0 - - - - - - - 1709.4285714285713 116 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1763 225 C20140605_SFK031_02 C20140605_SFK031_02 TB557221.[MT7]-IFVNDDR.2b3_1.heavy 511.773 / 504.33 26606.0 27.37534999847412 34 14 6 6 8 2.176587866632208 45.943470297263055 0.035800933837890625 4 0.9312406136568078 4.679246355836868 26606.0 20.115617906637134 4.0 - - - - - - - 2273.5714285714284 387 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1765 225 C20140605_SFK031_02 C20140605_SFK031_02 TB557221.[MT7]-IFVNDDR.2y6_1.heavy 511.773 / 765.353 129263.0 27.37534999847412 34 14 6 6 8 2.176587866632208 45.943470297263055 0.035800933837890625 4 0.9312406136568078 4.679246355836868 129263.0 296.7814351406095 0.0 - - - - - - - 1245.125 258 8 ILF3 interleukin enhancer binding factor 3, 90kDa 1767 225 C20140605_SFK031_02 C20140605_SFK031_02 TB557221.[MT7]-IFVNDDR.2b5_1.heavy 511.773 / 733.4 88990.0 27.37534999847412 34 14 6 6 8 2.176587866632208 45.943470297263055 0.035800933837890625 4 0.9312406136568078 4.679246355836868 88990.0 110.45480630574664 0.0 - - - - - - - 338.2857142857143 177 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1769 226 C20140605_SFK031_02 C20140605_SFK031_02 TB295038.[MT7]-VVEEVLTPLGDC[CAM]FMLR.2y5_1.heavy 1011.53 / 726.343 3535.0 48.9208984375 38 8 10 10 10 0.670155416600917 80.13471592832403 0.0 3 0.7733029072048625 2.5413878122564997 3535.0 30.749500701716507 0.0 - - - - - - - 162.25 7 16 CNNM1 cyclin M1 1771 226 C20140605_SFK031_02 C20140605_SFK031_02 TB295038.[MT7]-VVEEVLTPLGDC[CAM]FMLR.2y9_1.heavy 1011.53 / 1108.53 42102.0 48.9208984375 38 8 10 10 10 0.670155416600917 80.13471592832403 0.0 3 0.7733029072048625 2.5413878122564997 42102.0 229.42147517868432 0.0 - - - - - - - 218.92857142857142 84 14 CNNM1 cyclin M1 1773 226 C20140605_SFK031_02 C20140605_SFK031_02 TB295038.[MT7]-VVEEVLTPLGDC[CAM]FMLR.2b4_1.heavy 1011.53 / 601.331 19323.0 48.9208984375 38 8 10 10 10 0.670155416600917 80.13471592832403 0.0 3 0.7733029072048625 2.5413878122564997 19323.0 88.93726832657788 0.0 - - - - - - - 221.88235294117646 38 17 CNNM1 cyclin M1 1775 226 C20140605_SFK031_02 C20140605_SFK031_02 TB295038.[MT7]-VVEEVLTPLGDC[CAM]FMLR.2b5_1.heavy 1011.53 / 700.4 22857.0 48.9208984375 38 8 10 10 10 0.670155416600917 80.13471592832403 0.0 3 0.7733029072048625 2.5413878122564997 22857.0 121.37923243009824 0.0 - - - - - - - 118.1 45 10 CNNM1 cyclin M1 1777 227 C20140605_SFK031_02 C20140605_SFK031_02 TB295039.[MT7]-VVEEVLTPLGDC[CAM]FMLR.3y7_1.heavy 674.689 / 898.391 35521.0 48.9208984375 48 18 10 10 10 2.95204541990873 28.802492143576174 0.0 3 0.9808745415774587 8.90967432639658 35521.0 156.53774310213456 0.0 - - - - - - - 259.0 71 14 CNNM1 cyclin M1 1779 227 C20140605_SFK031_02 C20140605_SFK031_02 TB295039.[MT7]-VVEEVLTPLGDC[CAM]FMLR.3b4_1.heavy 674.689 / 601.331 64347.0 48.9208984375 48 18 10 10 10 2.95204541990873 28.802492143576174 0.0 3 0.9808745415774587 8.90967432639658 64347.0 76.26937242944771 0.0 - - - - - - - 252.3 128 10 CNNM1 cyclin M1 1781 227 C20140605_SFK031_02 C20140605_SFK031_02 TB295039.[MT7]-VVEEVLTPLGDC[CAM]FMLR.3b5_1.heavy 674.689 / 700.4 43318.0 48.9208984375 48 18 10 10 10 2.95204541990873 28.802492143576174 0.0 3 0.9808745415774587 8.90967432639658 43318.0 108.00579567990951 0.0 - - - - - - - 726.5555555555555 86 9 CNNM1 cyclin M1 1783 227 C20140605_SFK031_02 C20140605_SFK031_02 TB295039.[MT7]-VVEEVLTPLGDC[CAM]FMLR.3y9_1.heavy 674.689 / 1108.53 47020.0 48.9208984375 48 18 10 10 10 2.95204541990873 28.802492143576174 0.0 3 0.9808745415774587 8.90967432639658 47020.0 126.86887240961138 0.0 - - - - - - - 275.9166666666667 94 12 CNNM1 cyclin M1 1785 228 C20140605_SFK031_02 C20140605_SFK031_02 TB562194.[MT7]-DFEQPFINK[MT7]PDTLLVNRK[MT7].4y9_1.heavy 652.372 / 1199.72 25383.0 35.291099548339844 48 18 10 10 10 4.490411728986059 22.269672812960547 0.0 3 0.9813747874577468 9.028910926137922 25383.0 56.47725160227167 0.0 - - - - - - - 240.36363636363637 50 11 FLT4 fms-related tyrosine kinase 4 1787 228 C20140605_SFK031_02 C20140605_SFK031_02 TB562194.[MT7]-DFEQPFINK[MT7]PDTLLVNRK[MT7].4b4_1.heavy 652.372 / 664.306 68568.0 35.291099548339844 48 18 10 10 10 4.490411728986059 22.269672812960547 0.0 3 0.9813747874577468 9.028910926137922 68568.0 29.906638977913424 0.0 - - - - - - - 345.0 137 1 FLT4 fms-related tyrosine kinase 4 1789 228 C20140605_SFK031_02 C20140605_SFK031_02 TB562194.[MT7]-DFEQPFINK[MT7]PDTLLVNRK[MT7].4y7_1.heavy 652.372 / 987.643 15161.0 35.291099548339844 48 18 10 10 10 4.490411728986059 22.269672812960547 0.0 3 0.9813747874577468 9.028910926137922 15161.0 38.78659109442711 0.0 - - - - - - - 778.4444444444445 30 9 FLT4 fms-related tyrosine kinase 4 1791 228 C20140605_SFK031_02 C20140605_SFK031_02 TB562194.[MT7]-DFEQPFINK[MT7]PDTLLVNRK[MT7].4b3_1.heavy 652.372 / 536.247 35605.0 35.291099548339844 48 18 10 10 10 4.490411728986059 22.269672812960547 0.0 3 0.9813747874577468 9.028910926137922 35605.0 13.222366246664143 0.0 - - - - - - - 1401.2 71 5 FLT4 fms-related tyrosine kinase 4 1793 229 C20140605_SFK031_02 C20140605_SFK031_02 TB399842.[MT7]-ALFYAAEILC[CAM]GLEDLHR.3b4_1.heavy 712.374 / 639.362 21166.0 54.722900390625 43 13 10 10 10 1.489301434357762 46.23788545748994 0.0 3 0.9238658075184276 4.444038588789399 21166.0 -7.839259259259258 0.0 - - - - - - - 121.29032258064517 42 31 GRK5 G protein-coupled receptor kinase 5 1795 229 C20140605_SFK031_02 C20140605_SFK031_02 TB399842.[MT7]-ALFYAAEILC[CAM]GLEDLHR.3b5_1.heavy 712.374 / 710.399 41793.0 54.722900390625 43 13 10 10 10 1.489301434357762 46.23788545748994 0.0 3 0.9238658075184276 4.444038588789399 41793.0 29.53568904593639 0.0 - - - - - - - 111.17857142857143 83 28 GRK5 G protein-coupled receptor kinase 5 1797 229 C20140605_SFK031_02 C20140605_SFK031_02 TB399842.[MT7]-ALFYAAEILC[CAM]GLEDLHR.3y8_1.heavy 712.374 / 999.468 56741.0 54.722900390625 43 13 10 10 10 1.489301434357762 46.23788545748994 0.0 3 0.9238658075184276 4.444038588789399 56741.0 1073.5257098765433 0.0 - - - - - - - 99.25925925925925 113 27 GRK5 G protein-coupled receptor kinase 5 1799 229 C20140605_SFK031_02 C20140605_SFK031_02 TB399842.[MT7]-ALFYAAEILC[CAM]GLEDLHR.3b7_1.heavy 712.374 / 910.479 48107.0 54.722900390625 43 13 10 10 10 1.489301434357762 46.23788545748994 0.0 3 0.9238658075184276 4.444038588789399 48107.0 321.5951264219095 0.0 - - - - - - - 121.81481481481481 96 27 GRK5 G protein-coupled receptor kinase 5 1801 230 C20140605_SFK031_02 C20140605_SFK031_02 TB559888.[MT7]-AAAESAEAQTIR.2y8_1.heavy 681.361 / 875.458 38878.0 21.39620018005371 47 17 10 10 10 2.513240897924182 31.850430336336075 0.0 3 0.973598857054184 7.578632667583725 38878.0 256.61154599431245 0.0 - - - - - - - 165.66666666666666 77 18 TOX3 TOX high mobility group box family member 3 1803 230 C20140605_SFK031_02 C20140605_SFK031_02 TB559888.[MT7]-AAAESAEAQTIR.2y9_1.heavy 681.361 / 1004.5 46397.0 21.39620018005371 47 17 10 10 10 2.513240897924182 31.850430336336075 0.0 3 0.973598857054184 7.578632667583725 46397.0 298.07608768054376 0.0 - - - - - - - 159.52380952380952 92 21 TOX3 TOX high mobility group box family member 3 1805 230 C20140605_SFK031_02 C20140605_SFK031_02 TB559888.[MT7]-AAAESAEAQTIR.2y10_1.heavy 681.361 / 1075.54 40574.0 21.39620018005371 47 17 10 10 10 2.513240897924182 31.850430336336075 0.0 3 0.973598857054184 7.578632667583725 40574.0 538.5276363636365 0.0 - - - - - - - 141.58333333333334 81 12 TOX3 TOX high mobility group box family member 3 1807 230 C20140605_SFK031_02 C20140605_SFK031_02 TB559888.[MT7]-AAAESAEAQTIR.2y11_1.heavy 681.361 / 1146.57 43783.0 21.39620018005371 47 17 10 10 10 2.513240897924182 31.850430336336075 0.0 3 0.973598857054184 7.578632667583725 43783.0 309.971562507457 0.0 - - - - - - - 216.1904761904762 87 21 TOX3 TOX high mobility group box family member 3 1809 231 C20140605_SFK031_02 C20140605_SFK031_02 TB559194.[MT7]-LAAFGQLHK[MT7].3y3_1.heavy 424.927 / 541.358 63805.0 31.086599349975586 46 18 10 10 8 9.202853561840861 10.86619485228415 0.0 4 0.9858388835144984 10.358569362155505 63805.0 101.62446853029795 1.0 - - - - - - - 1153.0 153 10 ILF3 interleukin enhancer binding factor 3, 90kDa 1811 231 C20140605_SFK031_02 C20140605_SFK031_02 TB559194.[MT7]-LAAFGQLHK[MT7].3b6_1.heavy 424.927 / 732.416 62906.0 31.086599349975586 46 18 10 10 8 9.202853561840861 10.86619485228415 0.0 4 0.9858388835144984 10.358569362155505 62906.0 253.61509000989122 0.0 - - - - - - - 192.125 125 16 ILF3 interleukin enhancer binding factor 3, 90kDa 1813 231 C20140605_SFK031_02 C20140605_SFK031_02 TB559194.[MT7]-LAAFGQLHK[MT7].3b4_1.heavy 424.927 / 547.336 97055.0 31.086599349975586 46 18 10 10 8 9.202853561840861 10.86619485228415 0.0 4 0.9858388835144984 10.358569362155505 97055.0 177.89041060893226 0.0 - - - - - - - 1173.0 194 9 ILF3 interleukin enhancer binding factor 3, 90kDa 1815 231 C20140605_SFK031_02 C20140605_SFK031_02 TB559194.[MT7]-LAAFGQLHK[MT7].3b5_1.heavy 424.927 / 604.357 76311.0 31.086599349975586 46 18 10 10 8 9.202853561840861 10.86619485228415 0.0 4 0.9858388835144984 10.358569362155505 76311.0 78.28193046759196 0.0 - - - - - - - 732.9285714285714 152 14 ILF3 interleukin enhancer binding factor 3, 90kDa 1817 232 C20140605_SFK031_02 C20140605_SFK031_02 TB555629.[MT7]-ALLSLR.2b3_1.heavy 408.775 / 442.315 7415.0 33.27910041809082 34 20 2 6 6 8.548690597216963 11.697697894523767 0.03639984130859375 5 0.9955578767784178 18.509989490021646 7415.0 13.137526372514628 2.0 - - - - - - - 355.8 14 5 PKDREJ;MAGED2;GRIK5 polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin);melanoma antigen family D, 2;glutamate receptor, ionotropic, kainate 5 1819 232 C20140605_SFK031_02 C20140605_SFK031_02 TB555629.[MT7]-ALLSLR.2y4_1.heavy 408.775 / 488.319 10677.0 33.27910041809082 34 20 2 6 6 8.548690597216963 11.697697894523767 0.03639984130859375 5 0.9955578767784178 18.509989490021646 10677.0 9.50032035054284 0.0 - - - - - - - 815.75 21 8 PKDREJ;MAGED2;GRIK5 polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin);melanoma antigen family D, 2;glutamate receptor, ionotropic, kainate 5 1821 232 C20140605_SFK031_02 C20140605_SFK031_02 TB555629.[MT7]-ALLSLR.2y5_1.heavy 408.775 / 601.403 20168.0 33.27910041809082 34 20 2 6 6 8.548690597216963 11.697697894523767 0.03639984130859375 5 0.9955578767784178 18.509989490021646 20168.0 97.52121518987342 1.0 - - - - - - - 214.25 133 12 PKDREJ;MAGED2;GRIK5 polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin);melanoma antigen family D, 2;glutamate receptor, ionotropic, kainate 5 1823 232 C20140605_SFK031_02 C20140605_SFK031_02 TB555629.[MT7]-ALLSLR.2b4_1.heavy 408.775 / 529.347 8898.0 33.27910041809082 34 20 2 6 6 8.548690597216963 11.697697894523767 0.03639984130859375 5 0.9955578767784178 18.509989490021646 8898.0 18.07500705513457 1.0 - - - - - - - 737.0 25 11 PKDREJ;MAGED2;GRIK5 polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin);melanoma antigen family D, 2;glutamate receptor, ionotropic, kainate 5 1825 233 C20140605_SFK031_02 C20140605_SFK031_02 TB558066.[MT7]-VK[MT7]PDSK[MT7].2y4_1.heavy 553.351 / 590.327 7301.0 15.100500106811523 29 13 0 10 6 2.032546817111638 38.330710398256386 0.0 5 0.9287620806000835 4.596150290251476 7301.0 22.181387014496497 0.0 - - - - - - - 206.53846153846155 14 13 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1827 233 C20140605_SFK031_02 C20140605_SFK031_02 TB558066.[MT7]-VK[MT7]PDSK[MT7].2y5_1.heavy 553.351 / 862.524 2968.0 15.100500106811523 29 13 0 10 6 2.032546817111638 38.330710398256386 0.0 5 0.9287620806000835 4.596150290251476 2968.0 40.36715470609448 2.0 - - - - - - - 156.0 63 16 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1829 233 C20140605_SFK031_02 C20140605_SFK031_02 TB558066.[MT7]-VK[MT7]PDSK[MT7].2b4_1.heavy 553.351 / 728.455 8714.0 15.100500106811523 29 13 0 10 6 2.032546817111638 38.330710398256386 0.0 5 0.9287620806000835 4.596150290251476 8714.0 51.96411400642813 0.0 - - - - - - - 188.35714285714286 17 14 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1831 233 C20140605_SFK031_02 C20140605_SFK031_02 TB558066.[MT7]-VK[MT7]PDSK[MT7].2y3_1.heavy 553.351 / 493.274 801.0 15.100500106811523 29 13 0 10 6 2.032546817111638 38.330710398256386 0.0 5 0.9287620806000835 4.596150290251476 801.0 0.9916789700215204 38.0 - - - - - - - 724.9444444444445 4 18 CDK8;CDK19 cyclin-dependent kinase 8;cyclin-dependent kinase 19 1833 234 C20140605_SFK031_02 C20140605_SFK031_02 TB560623.[MT7]-GTHNFSEELK[MT7].3y3_1.heavy 483.924 / 533.341 61703.0 24.26020050048828 46 16 10 10 10 1.870894263848975 39.11425267466638 0.0 3 0.9608740941054812 6.218761265877675 61703.0 48.482024617328804 0.0 - - - - - - - 2197.0 123 8 IRAK1 interleukin-1 receptor-associated kinase 1 1835 234 C20140605_SFK031_02 C20140605_SFK031_02 TB560623.[MT7]-GTHNFSEELK[MT7].3b4_1.heavy 483.924 / 554.28 42524.0 24.26020050048828 46 16 10 10 10 1.870894263848975 39.11425267466638 0.0 3 0.9608740941054812 6.218761265877675 42524.0 21.98959103131378 0.0 - - - - - - - 801.3333333333334 85 3 IRAK1 interleukin-1 receptor-associated kinase 1 1837 234 C20140605_SFK031_02 C20140605_SFK031_02 TB560623.[MT7]-GTHNFSEELK[MT7].3y4_1.heavy 483.924 / 662.384 47065.0 24.26020050048828 46 16 10 10 10 1.870894263848975 39.11425267466638 0.0 3 0.9608740941054812 6.218761265877675 47065.0 51.7077113901258 0.0 - - - - - - - 1255.5 94 10 IRAK1 interleukin-1 receptor-associated kinase 1 1839 234 C20140605_SFK031_02 C20140605_SFK031_02 TB560623.[MT7]-GTHNFSEELK[MT7].3y5_1.heavy 483.924 / 749.416 53743.0 24.26020050048828 46 16 10 10 10 1.870894263848975 39.11425267466638 0.0 3 0.9608740941054812 6.218761265877675 53743.0 119.09629404311755 0.0 - - - - - - - 656.4285714285714 107 7 IRAK1 interleukin-1 receptor-associated kinase 1 1841 235 C20140605_SFK031_02 C20140605_SFK031_02 TB562069.[MT7]-SPVFIAQVGQDLVSQTEEK[MT7].3b6_1.heavy 788.428 / 759.452 35962.0 45.00019836425781 47 17 10 10 10 3.6314524900249245 27.53719077275155 0.0 3 0.9789505537022385 8.491360314634516 35962.0 96.01361369863014 0.0 - - - - - - - 740.3333333333334 71 9 GRK5 G protein-coupled receptor kinase 5 1843 235 C20140605_SFK031_02 C20140605_SFK031_02 TB562069.[MT7]-SPVFIAQVGQDLVSQTEEK[MT7].3y6_1.heavy 788.428 / 865.438 92643.0 45.00019836425781 47 17 10 10 10 3.6314524900249245 27.53719077275155 0.0 3 0.9789505537022385 8.491360314634516 92643.0 253.71272137494068 0.0 - - - - - - - 289.1666666666667 185 6 GRK5 G protein-coupled receptor kinase 5 1845 235 C20140605_SFK031_02 C20140605_SFK031_02 TB562069.[MT7]-SPVFIAQVGQDLVSQTEEK[MT7].3b4_1.heavy 788.428 / 575.331 96385.0 45.00019836425781 47 17 10 10 10 3.6314524900249245 27.53719077275155 0.0 3 0.9789505537022385 8.491360314634516 96385.0 117.99710051546391 0.0 - - - - - - - 183.0 192 1 GRK5 G protein-coupled receptor kinase 5 1847 235 C20140605_SFK031_02 C20140605_SFK031_02 TB562069.[MT7]-SPVFIAQVGQDLVSQTEEK[MT7].3b5_1.heavy 788.428 / 688.415 81051.0 45.00019836425781 47 17 10 10 10 3.6314524900249245 27.53719077275155 0.0 3 0.9789505537022385 8.491360314634516 81051.0 273.50404224629784 0.0 - - - - - - - 775.625 162 8 GRK5 G protein-coupled receptor kinase 5 1849 236 C20140605_SFK031_02 C20140605_SFK031_02 TB562065.[MT7]-AVQFGTGELC[CAM]DAISAVEEK[MT7].3y3_1.heavy 771.394 / 549.3 21191.0 43.7056999206543 48 18 10 10 10 4.471347292683026 22.364623782107323 0.0 3 0.9872221895088685 10.906128661592167 21191.0 32.2954108333502 0.0 - - - - - - - 743.0 42 9 KIAA1279 KIAA1279 1851 236 C20140605_SFK031_02 C20140605_SFK031_02 TB562065.[MT7]-AVQFGTGELC[CAM]DAISAVEEK[MT7].3y6_1.heavy 771.394 / 806.438 37673.0 43.7056999206543 48 18 10 10 10 4.471347292683026 22.364623782107323 0.0 3 0.9872221895088685 10.906128661592167 37673.0 58.60282161222848 0.0 - - - - - - - 339.2 75 5 KIAA1279 KIAA1279 1853 236 C20140605_SFK031_02 C20140605_SFK031_02 TB562065.[MT7]-AVQFGTGELC[CAM]DAISAVEEK[MT7].3y4_1.heavy 771.394 / 648.369 21191.0 43.7056999206543 48 18 10 10 10 4.471347292683026 22.364623782107323 0.0 3 0.9872221895088685 10.906128661592167 21191.0 83.99147148096455 0.0 - - - - - - - 239.8181818181818 42 11 KIAA1279 KIAA1279 1855 236 C20140605_SFK031_02 C20140605_SFK031_02 TB562065.[MT7]-AVQFGTGELC[CAM]DAISAVEEK[MT7].3b8_1.heavy 771.394 / 934.475 26466.0 43.7056999206543 48 18 10 10 10 4.471347292683026 22.364623782107323 0.0 3 0.9872221895088685 10.906128661592167 26466.0 50.94658174097665 0.0 - - - - - - - 303.44444444444446 52 9 KIAA1279 KIAA1279 1857 237 C20140605_SFK031_02 C20140605_SFK031_02 TB399741.[MT7]-ASQQEIQHIVNR.3b4_1.heavy 522.954 / 559.296 46082.0 25.736799240112305 45 15 10 10 10 2.0499847064048136 39.83978826845248 0.0 3 0.9550307011515926 5.797800028032957 46082.0 44.59734093511742 0.0 - - - - - - - 770.0 92 1 CNOT1 CCR4-NOT transcription complex, subunit 1 1859 237 C20140605_SFK031_02 C20140605_SFK031_02 TB399741.[MT7]-ASQQEIQHIVNR.3b5_1.heavy 522.954 / 688.338 81550.0 25.736799240112305 45 15 10 10 10 2.0499847064048136 39.83978826845248 0.0 3 0.9550307011515926 5.797800028032957 81550.0 77.68944281524927 0.0 - - - - - - - 1233.5714285714287 163 7 CNOT1 CCR4-NOT transcription complex, subunit 1 1861 237 C20140605_SFK031_02 C20140605_SFK031_02 TB399741.[MT7]-ASQQEIQHIVNR.3y4_1.heavy 522.954 / 501.314 71212.0 25.736799240112305 45 15 10 10 10 2.0499847064048136 39.83978826845248 0.0 3 0.9550307011515926 5.797800028032957 71212.0 24.63415752985946 0.0 - - - - - - - 1870.0 142 1 CNOT1 CCR4-NOT transcription complex, subunit 1 1863 237 C20140605_SFK031_02 C20140605_SFK031_02 TB399741.[MT7]-ASQQEIQHIVNR.3y5_1.heavy 522.954 / 638.373 79570.0 25.736799240112305 45 15 10 10 10 2.0499847064048136 39.83978826845248 0.0 3 0.9550307011515926 5.797800028032957 79570.0 83.6488503785424 0.0 - - - - - - - 1265.0 159 7 CNOT1 CCR4-NOT transcription complex, subunit 1 1865 238 C20140605_SFK031_02 C20140605_SFK031_02 TB295008.[MT7]-SFLEFAEDVIQVPR.2y9_1.heavy 897.481 / 1026.56 23306.0 51.78239822387695 43 13 10 10 10 1.37297509486437 42.40110380810876 0.0 3 0.9012755720756366 3.895028264718598 23306.0 127.83514925373134 0.0 - - - - - - - 256.8333333333333 46 12 FMR1 fragile X mental retardation 1 1867 238 C20140605_SFK031_02 C20140605_SFK031_02 TB295008.[MT7]-SFLEFAEDVIQVPR.2b4_1.heavy 897.481 / 621.336 38710.0 51.78239822387695 43 13 10 10 10 1.37297509486437 42.40110380810876 0.0 3 0.9012755720756366 3.895028264718598 38710.0 171.40248756218904 0.0 - - - - - - - 228.91666666666666 77 12 FMR1 fragile X mental retardation 1 1869 238 C20140605_SFK031_02 C20140605_SFK031_02 TB295008.[MT7]-SFLEFAEDVIQVPR.2y6_1.heavy 897.481 / 711.451 7501.0 51.78239822387695 43 13 10 10 10 1.37297509486437 42.40110380810876 0.0 3 0.9012755720756366 3.895028264718598 7501.0 10.58883248904266 1.0 - - - - - - - 256.8333333333333 18 12 FMR1 fragile X mental retardation 1 1871 238 C20140605_SFK031_02 C20140605_SFK031_02 TB295008.[MT7]-SFLEFAEDVIQVPR.2y10_1.heavy 897.481 / 1173.63 19221.0 51.78239822387695 43 13 10 10 10 1.37297509486437 42.40110380810876 0.0 3 0.9012755720756366 3.895028264718598 19221.0 38.36823070362473 0.0 - - - - - - - 775.2857142857143 38 7 FMR1 fragile X mental retardation 1 1873 239 C20140605_SFK031_02 C20140605_SFK031_02 TB295006.[MT7]-SDAVLDFATVSEILR.2b4_1.heavy 890.484 / 517.274 38691.0 49.720699310302734 42 16 10 6 10 2.6912397613613463 29.567353974754514 0.03759765625 3 0.9637381571919076 6.461245781356095 38691.0 146.87835454755844 0.0 - - - - - - - 298.09090909090907 77 11 CNNM1 cyclin M1 1875 239 C20140605_SFK031_02 C20140605_SFK031_02 TB295006.[MT7]-SDAVLDFATVSEILR.2y9_1.heavy 890.484 / 1035.58 23408.0 49.720699310302734 42 16 10 6 10 2.6912397613613463 29.567353974754514 0.03759765625 3 0.9637381571919076 6.461245781356095 23408.0 72.65010358846556 0.0 - - - - - - - 244.0909090909091 46 11 CNNM1 cyclin M1 1877 239 C20140605_SFK031_02 C20140605_SFK031_02 TB295006.[MT7]-SDAVLDFATVSEILR.2b6_1.heavy 890.484 / 745.385 19606.0 49.720699310302734 42 16 10 6 10 2.6912397613613463 29.567353974754514 0.03759765625 3 0.9637381571919076 6.461245781356095 19606.0 39.837684422016636 0.0 - - - - - - - 657.3636363636364 39 11 CNNM1 cyclin M1 1879 239 C20140605_SFK031_02 C20140605_SFK031_02 TB295006.[MT7]-SDAVLDFATVSEILR.2y10_1.heavy 890.484 / 1150.61 19532.0 49.720699310302734 42 16 10 6 10 2.6912397613613463 29.567353974754514 0.03759765625 3 0.9637381571919076 6.461245781356095 19532.0 56.71234202410989 0.0 - - - - - - - 681.5714285714286 39 7 CNNM1 cyclin M1 1881 240 C20140605_SFK031_02 C20140605_SFK031_02 TB558327.[MT7]-FLPEEEK[MT7].2y4_1.heavy 590.329 / 678.343 5314.0 29.30840015411377 44 18 10 6 10 1.5664519683107914 37.70390004010079 0.03259849548339844 3 0.9880443852943885 11.275680845954529 5314.0 10.190054203818248 0.0 - - - - - - - 674.8888888888889 10 9 KIAA1279 KIAA1279 1883 240 C20140605_SFK031_02 C20140605_SFK031_02 TB558327.[MT7]-FLPEEEK[MT7].2y5_1.heavy 590.329 / 775.395 72748.0 29.30840015411377 44 18 10 6 10 1.5664519683107914 37.70390004010079 0.03259849548339844 3 0.9880443852943885 11.275680845954529 72748.0 124.64924110671936 0.0 - - - - - - - 759.1 145 10 KIAA1279 KIAA1279 1885 240 C20140605_SFK031_02 C20140605_SFK031_02 TB558327.[MT7]-FLPEEEK[MT7].2y3_1.heavy 590.329 / 549.3 8097.0 29.30840015411377 44 18 10 6 10 1.5664519683107914 37.70390004010079 0.03259849548339844 3 0.9880443852943885 11.275680845954529 8097.0 4.041257913172017 0.0 - - - - - - - 2177.8571428571427 16 7 KIAA1279 KIAA1279 1887 240 C20140605_SFK031_02 C20140605_SFK031_02 TB558327.[MT7]-FLPEEEK[MT7].2y6_1.heavy 590.329 / 888.479 23406.0 29.30840015411377 44 18 10 6 10 1.5664519683107914 37.70390004010079 0.03259849548339844 3 0.9880443852943885 11.275680845954529 23406.0 55.96942114173563 0.0 - - - - - - - 680.0 46 12 KIAA1279 KIAA1279 1889 241 C20140605_SFK031_02 C20140605_SFK031_02 TB560238.[MT7]-YLSVQALEAPR.3y6_1.heavy 464.265 / 656.373 18753.0 36.69850158691406 48 20 10 10 8 5.113024974346479 19.55789390854315 0.0 4 0.9924853356585339 14.227717590951027 18753.0 44.540764525993886 0.0 - - - - - - - 716.2857142857143 37 7 FLT4 fms-related tyrosine kinase 4 1891 241 C20140605_SFK031_02 C20140605_SFK031_02 TB560238.[MT7]-YLSVQALEAPR.3b3_1.heavy 464.265 / 508.289 19516.0 36.69850158691406 48 20 10 10 8 5.113024974346479 19.55789390854315 0.0 4 0.9924853356585339 14.227717590951027 19516.0 35.311824668705405 2.0 - - - - - - - 763.0 40 10 FLT4 fms-related tyrosine kinase 4 1893 241 C20140605_SFK031_02 C20140605_SFK031_02 TB560238.[MT7]-YLSVQALEAPR.3y4_1.heavy 464.265 / 472.251 34888.0 36.69850158691406 48 20 10 10 8 5.113024974346479 19.55789390854315 0.0 4 0.9924853356585339 14.227717590951027 34888.0 48.171045871559635 0.0 - - - - - - - 290.6666666666667 69 3 FLT4 fms-related tyrosine kinase 4 1895 241 C20140605_SFK031_02 C20140605_SFK031_02 TB560238.[MT7]-YLSVQALEAPR.3y5_1.heavy 464.265 / 585.336 19080.0 36.69850158691406 48 20 10 10 8 5.113024974346479 19.55789390854315 0.0 4 0.9924853356585339 14.227717590951027 19080.0 15.416550724670348 0.0 - - - - - - - 835.6666666666666 38 9 FLT4 fms-related tyrosine kinase 4 1897 242 C20140605_SFK031_02 C20140605_SFK031_02 TB295004.[MT7]-DLVEEEAEEAGVALR.2b4_1.heavy 887.453 / 601.331 79082.0 39.88640022277832 43 17 10 6 10 2.4192044338440004 33.11824980232798 0.037197113037109375 3 0.9740367069211728 7.642550797900572 79082.0 118.77011192704245 0.0 - - - - - - - 704.5 158 8 IRAK1 interleukin-1 receptor-associated kinase 1 1899 242 C20140605_SFK031_02 C20140605_SFK031_02 TB295004.[MT7]-DLVEEEAEEAGVALR.2y9_1.heavy 887.453 / 915.489 49292.0 39.88640022277832 43 17 10 6 10 2.4192044338440004 33.11824980232798 0.037197113037109375 3 0.9740367069211728 7.642550797900572 49292.0 88.68545599895077 0.0 - - - - - - - 666.1111111111111 98 9 IRAK1 interleukin-1 receptor-associated kinase 1 1901 242 C20140605_SFK031_02 C20140605_SFK031_02 TB295004.[MT7]-DLVEEEAEEAGVALR.2y10_1.heavy 887.453 / 1044.53 63606.0 39.88640022277832 43 17 10 6 10 2.4192044338440004 33.11824980232798 0.037197113037109375 3 0.9740367069211728 7.642550797900572 63606.0 117.48180201692195 0.0 - - - - - - - 339.8 127 5 IRAK1 interleukin-1 receptor-associated kinase 1 1903 242 C20140605_SFK031_02 C20140605_SFK031_02 TB295004.[MT7]-DLVEEEAEEAGVALR.2y11_1.heavy 887.453 / 1173.57 51976.0 39.88640022277832 43 17 10 6 10 2.4192044338440004 33.11824980232798 0.037197113037109375 3 0.9740367069211728 7.642550797900572 51976.0 52.80040017954001 0.0 - - - - - - - 258.22222222222223 103 9 IRAK1 interleukin-1 receptor-associated kinase 1 1905 243 C20140605_SFK031_02 C20140605_SFK031_02 TB558324.[MT7]-SSNVLLDER.2y8_1.heavy 588.821 / 945.5 26909.0 27.192774772644043 36 10 10 6 10 1.1237546410784194 59.687374443529364 0.036098480224609375 3 0.830385226138046 2.9531916521319346 26909.0 72.00210384411128 0.0 - - - - - - - 807.0 53 7 IRAK1 interleukin-1 receptor-associated kinase 1 1907 243 C20140605_SFK031_02 C20140605_SFK031_02 TB558324.[MT7]-SSNVLLDER.2y6_1.heavy 588.821 / 744.425 6135.0 27.192774772644043 36 10 10 6 10 1.1237546410784194 59.687374443529364 0.036098480224609375 3 0.830385226138046 2.9531916521319346 6135.0 5.807726229945778 1.0 - - - - - - - 402.90909090909093 12 11 IRAK1 interleukin-1 receptor-associated kinase 1 1909 243 C20140605_SFK031_02 C20140605_SFK031_02 TB558324.[MT7]-SSNVLLDER.2b7_1.heavy 588.821 / 873.48 89415.0 27.192774772644043 36 10 10 6 10 1.1237546410784194 59.687374443529364 0.036098480224609375 3 0.830385226138046 2.9531916521319346 89415.0 191.32339231912113 0.0 - - - - - - - 327.9 178 10 IRAK1 interleukin-1 receptor-associated kinase 1 1911 243 C20140605_SFK031_02 C20140605_SFK031_02 TB558324.[MT7]-SSNVLLDER.2y7_1.heavy 588.821 / 858.468 5588.0 27.192774772644043 36 10 10 6 10 1.1237546410784194 59.687374443529364 0.036098480224609375 3 0.830385226138046 2.9531916521319346 5588.0 18.566767206328084 0.0 - - - - - - - 746.2857142857143 11 7 IRAK1 interleukin-1 receptor-associated kinase 1 1913 244 C20140605_SFK031_02 C20140605_SFK031_02 TB399840.[MT7]-FLGQVAINLNDIFEDK[MT7].2y4_1.heavy 1062.58 / 682.353 2977.0 51.28177547454834 42 16 10 6 10 2.8792651158691207 34.73108448709646 0.036296844482421875 3 0.9694996779851046 7.048554940351124 2977.0 8.002688172043012 0.0 - - - - - - - 159.42857142857142 5 14 RAB11FIP2 RAB11 family interacting protein 2 (class I) 1915 244 C20140605_SFK031_02 C20140605_SFK031_02 TB399840.[MT7]-FLGQVAINLNDIFEDK[MT7].2y8_1.heavy 1062.58 / 1137.59 1737.0 51.28177547454834 42 16 10 6 10 2.8792651158691207 34.73108448709646 0.036296844482421875 3 0.9694996779851046 7.048554940351124 1737.0 7.844516129032258 0.0 - - - - - - - 232.5 3 16 RAB11FIP2 RAB11 family interacting protein 2 (class I) 1917 244 C20140605_SFK031_02 C20140605_SFK031_02 TB399840.[MT7]-FLGQVAINLNDIFEDK[MT7].2b4_1.heavy 1062.58 / 590.342 6760.0 51.28177547454834 42 16 10 6 10 2.8792651158691207 34.73108448709646 0.036296844482421875 3 0.9694996779851046 7.048554940351124 6760.0 32.618817204301074 0.0 - - - - - - - 233.69230769230768 13 13 RAB11FIP2 RAB11 family interacting protein 2 (class I) 1919 244 C20140605_SFK031_02 C20140605_SFK031_02 TB399840.[MT7]-FLGQVAINLNDIFEDK[MT7].2b6_1.heavy 1062.58 / 760.447 6140.0 51.28177547454834 42 16 10 6 10 2.8792651158691207 34.73108448709646 0.036296844482421875 3 0.9694996779851046 7.048554940351124 6140.0 62.39032258064516 0.0 - - - - - - - 168.28571428571428 12 14 RAB11FIP2 RAB11 family interacting protein 2 (class I) 1921 245 C20140605_SFK031_02 C20140605_SFK031_02 TB399832.[MT7]-VLAGETLSVNDPPDVLDR.2y4_1.heavy 1027.55 / 502.298 9363.0 38.14859962463379 43 18 10 5 10 1.6667477392805208 35.52165353421725 0.040401458740234375 3 0.9843885530512261 9.8644793907331 9363.0 127.73807142857142 0.0 - - - - - - - 182.0 18 13 ILF3 interleukin enhancer binding factor 3, 90kDa 1923 245 C20140605_SFK031_02 C20140605_SFK031_02 TB399832.[MT7]-VLAGETLSVNDPPDVLDR.2b6_1.heavy 1027.55 / 715.411 11545.0 38.14859962463379 43 18 10 5 10 1.6667477392805208 35.52165353421725 0.040401458740234375 3 0.9843885530512261 9.8644793907331 11545.0 35.03435534591195 0.0 - - - - - - - 239.9090909090909 23 11 ILF3 interleukin enhancer binding factor 3, 90kDa 1925 245 C20140605_SFK031_02 C20140605_SFK031_02 TB399832.[MT7]-VLAGETLSVNDPPDVLDR.2y11_1.heavy 1027.55 / 1226.6 7727.0 38.14859962463379 43 18 10 5 10 1.6667477392805208 35.52165353421725 0.040401458740234375 3 0.9843885530512261 9.8644793907331 7727.0 25.24933029234916 0.0 - - - - - - - 306.09090909090907 15 11 ILF3 interleukin enhancer binding factor 3, 90kDa 1927 245 C20140605_SFK031_02 C20140605_SFK031_02 TB399832.[MT7]-VLAGETLSVNDPPDVLDR.2y7_1.heavy 1027.55 / 811.431 88266.0 38.14859962463379 43 18 10 5 10 1.6667477392805208 35.52165353421725 0.040401458740234375 3 0.9843885530512261 9.8644793907331 88266.0 55.56084588501065 0.0 - - - - - - - 318.5 176 2 ILF3 interleukin enhancer binding factor 3, 90kDa 1929 246 C20140605_SFK031_02 C20140605_SFK031_02 TB295010.[MT7]-TAFTSEQLLELEK[MT7].2b8_1.heavy 898.998 / 1022.53 11705.0 38.40840148925781 44 14 10 10 10 1.8386109992833934 43.3354088175818 0.0 3 0.9373111599160969 4.90311334408609 11705.0 122.94254643206256 0.0 - - - - - - - 247.92857142857142 23 14 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 1931 246 C20140605_SFK031_02 C20140605_SFK031_02 TB295010.[MT7]-TAFTSEQLLELEK[MT7].2y5_1.heavy 898.998 / 775.468 8233.0 38.40840148925781 44 14 10 10 10 1.8386109992833934 43.3354088175818 0.0 3 0.9373111599160969 4.90311334408609 8233.0 31.229773504032483 0.0 - - - - - - - 808.0 16 7 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 1933 246 C20140605_SFK031_02 C20140605_SFK031_02 TB295010.[MT7]-TAFTSEQLLELEK[MT7].2y3_1.heavy 898.998 / 533.341 12400.0 38.40840148925781 44 14 10 10 10 1.8386109992833934 43.3354088175818 0.0 3 0.9373111599160969 4.90311334408609 12400.0 23.615827231331746 0.0 - - - - - - - 779.4285714285714 24 7 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 1935 246 C20140605_SFK031_02 C20140605_SFK031_02 TB295010.[MT7]-TAFTSEQLLELEK[MT7].2b7_1.heavy 898.998 / 909.443 9424.0 38.40840148925781 44 14 10 10 10 1.8386109992833934 43.3354088175818 0.0 3 0.9373111599160969 4.90311334408609 9424.0 22.48705882352941 0.0 - - - - - - - 297.72727272727275 18 11 GBX1;GBX2 gastrulation brain homeobox 1;gastrulation brain homeobox 2 1937 247 C20140605_SFK031_02 C20140605_SFK031_02 TB399830.[MT7]-VVADIAPGEELLLFMK[MT7].3y3_1.heavy 678.391 / 569.324 98903.0 51.78239822387695 40 10 10 10 10 0.7514394496527148 79.36537950504956 0.0 3 0.8260414944753761 2.91496114121505 98903.0 207.9561023095452 0.0 - - - - - - - 650.0 197 7 MECOM MDS1 and EVI1 complex locus 1939 247 C20140605_SFK031_02 C20140605_SFK031_02 TB399830.[MT7]-VVADIAPGEELLLFMK[MT7].3b6_1.heavy 678.391 / 713.431 120058.0 51.78239822387695 40 10 10 10 10 0.7514394496527148 79.36537950504956 0.0 3 0.8260414944753761 2.91496114121505 120058.0 112.10068183143314 1.0 - - - - - - - 729.8 249 10 MECOM MDS1 and EVI1 complex locus 1941 247 C20140605_SFK031_02 C20140605_SFK031_02 TB399830.[MT7]-VVADIAPGEELLLFMK[MT7].3b4_1.heavy 678.391 / 529.31 74045.0 51.78239822387695 40 10 10 10 10 0.7514394496527148 79.36537950504956 0.0 3 0.8260414944753761 2.91496114121505 74045.0 116.32950110613898 0.0 - - - - - - - 694.25 148 8 MECOM MDS1 and EVI1 complex locus 1943 247 C20140605_SFK031_02 C20140605_SFK031_02 TB399830.[MT7]-VVADIAPGEELLLFMK[MT7].3b5_1.heavy 678.391 / 642.394 51038.0 51.78239822387695 40 10 10 10 10 0.7514394496527148 79.36537950504956 0.0 3 0.8260414944753761 2.91496114121505 51038.0 137.93482537593525 0.0 - - - - - - - 299.6190476190476 102 21 MECOM MDS1 and EVI1 complex locus 1945 248 C20140605_SFK031_02 C20140605_SFK031_02 TB560142.[MT7]-ITFTALSSEK[MT7].3y3_1.heavy 462.269 / 507.289 56820.0 35.291099548339844 50 20 10 10 10 13.270632175102095 7.535436042573508 0.0 3 0.9973680244022015 24.050612449773514 56820.0 48.44944039778325 0.0 - - - - - - - 457.0 113 1 FOXK2 forkhead box K2 1947 248 C20140605_SFK031_02 C20140605_SFK031_02 TB560142.[MT7]-ITFTALSSEK[MT7].3b4_1.heavy 462.269 / 607.357 22865.0 35.291099548339844 50 20 10 10 10 13.270632175102095 7.535436042573508 0.0 3 0.9973680244022015 24.050612449773514 22865.0 29.290498778662045 0.0 - - - - - - - 737.0 45 9 FOXK2 forkhead box K2 1949 248 C20140605_SFK031_02 C20140605_SFK031_02 TB560142.[MT7]-ITFTALSSEK[MT7].3b5_1.heavy 462.269 / 678.394 36470.0 35.291099548339844 50 20 10 10 10 13.270632175102095 7.535436042573508 0.0 3 0.9973680244022015 24.050612449773514 36470.0 93.25499828040813 0.0 - - - - - - - 767.7142857142857 72 7 FOXK2 forkhead box K2 1951 248 C20140605_SFK031_02 C20140605_SFK031_02 TB560142.[MT7]-ITFTALSSEK[MT7].3y4_1.heavy 462.269 / 594.321 87802.0 35.291099548339844 50 20 10 10 10 13.270632175102095 7.535436042573508 0.0 3 0.9973680244022015 24.050612449773514 87802.0 215.2366643998018 0.0 - - - - - - - 323.6666666666667 175 6 FOXK2 forkhead box K2 1953 249 C20140605_SFK031_02 C20140605_SFK031_02 TB558079.[MT7]-LDILLGTAR.2y8_1.heavy 558.349 / 858.504 129727.0 40.47654914855957 43 17 10 6 10 3.5296954471535593 23.96584910299118 0.034099578857421875 3 0.9781264736184079 8.32929309437061 129727.0 212.23043201133146 0.0 - - - - - - - 264.55555555555554 259 9 IRAK1 interleukin-1 receptor-associated kinase 1 1955 249 C20140605_SFK031_02 C20140605_SFK031_02 TB558079.[MT7]-LDILLGTAR.2y5_1.heavy 558.349 / 517.309 71394.0 40.47654914855957 43 17 10 6 10 3.5296954471535593 23.96584910299118 0.034099578857421875 3 0.9781264736184079 8.32929309437061 71394.0 38.3087871323159 0.0 - - - - - - - 926.5 142 2 IRAK1 interleukin-1 receptor-associated kinase 1 1957 249 C20140605_SFK031_02 C20140605_SFK031_02 TB558079.[MT7]-LDILLGTAR.2y6_1.heavy 558.349 / 630.393 86485.0 40.47654914855957 43 17 10 6 10 3.5296954471535593 23.96584910299118 0.034099578857421875 3 0.9781264736184079 8.32929309437061 86485.0 117.47020620782726 0.0 - - - - - - - 1147.111111111111 172 9 IRAK1 interleukin-1 receptor-associated kinase 1 1959 249 C20140605_SFK031_02 C20140605_SFK031_02 TB558079.[MT7]-LDILLGTAR.2y7_1.heavy 558.349 / 743.477 82778.0 40.47654914855957 43 17 10 6 10 3.5296954471535593 23.96584910299118 0.034099578857421875 3 0.9781264736184079 8.32929309437061 82778.0 90.6066595967259 0.0 - - - - - - - 686.2222222222222 165 9 IRAK1 interleukin-1 receptor-associated kinase 1 1961 250 C20140605_SFK031_02 C20140605_SFK031_02 TB399734.[MT7]-GAAGPGPGPPSGGAATR.2y14_1.heavy 761.398 / 1178.59 519.0 18.57740020751953 35 11 10 6 8 2.6862213716874725 26.317152526571846 0.039600372314453125 4 0.8579122711160718 3.234463837175705 519.0 0.0 1.0 - - - - - - - 0.0 1 0 FOXD2 forkhead box D2 1963 250 C20140605_SFK031_02 C20140605_SFK031_02 TB399734.[MT7]-GAAGPGPGPPSGGAATR.2b6_1.heavy 761.398 / 555.301 2126.0 18.57740020751953 35 11 10 6 8 2.6862213716874725 26.317152526571846 0.039600372314453125 4 0.8579122711160718 3.234463837175705 2126.0 48.85711538461538 0.0 - - - - - - - 168.75 4 12 FOXD2 forkhead box D2 1965 250 C20140605_SFK031_02 C20140605_SFK031_02 TB399734.[MT7]-GAAGPGPGPPSGGAATR.2y13_1.heavy 761.398 / 1121.57 1608.0 18.57740020751953 35 11 10 6 8 2.6862213716874725 26.317152526571846 0.039600372314453125 4 0.8579122711160718 3.234463837175705 1608.0 12.36923076923077 1.0 - - - - - - - 147.69230769230768 4 13 FOXD2 forkhead box D2 1967 250 C20140605_SFK031_02 C20140605_SFK031_02 TB399734.[MT7]-GAAGPGPGPPSGGAATR.2y11_1.heavy 761.398 / 967.496 2489.0 18.57740020751953 35 11 10 6 8 2.6862213716874725 26.317152526571846 0.039600372314453125 4 0.8579122711160718 3.234463837175705 2489.0 22.776523597175768 0.0 - - - - - - - 129.71428571428572 4 14 FOXD2 forkhead box D2 1969 251 C20140605_SFK031_02 C20140605_SFK031_02 TB558081.[MT7]-C[CAM]LAALASLR.2y8_1.heavy 559.827 / 814.515 48135.0 37.46560001373291 46 20 10 6 10 21.377232266120593 4.677874046327484 0.039600372314453125 3 0.9990399500792637 39.82728576848771 48135.0 80.76497596153847 0.0 - - - - - - - 668.5714285714286 96 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1971 251 C20140605_SFK031_02 C20140605_SFK031_02 TB558081.[MT7]-C[CAM]LAALASLR.2y6_1.heavy 559.827 / 630.393 20585.0 37.46560001373291 46 20 10 6 10 21.377232266120593 4.677874046327484 0.039600372314453125 3 0.9990399500792637 39.82728576848771 20585.0 25.42890799070765 0.0 - - - - - - - 1781.857142857143 41 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1973 251 C20140605_SFK031_02 C20140605_SFK031_02 TB558081.[MT7]-C[CAM]LAALASLR.2b5_1.heavy 559.827 / 673.382 12684.0 37.46560001373291 46 20 10 6 10 21.377232266120593 4.677874046327484 0.039600372314453125 3 0.9990399500792637 39.82728576848771 12684.0 18.06285422319321 0.0 - - - - - - - 390.0 25 4 ILF3 interleukin enhancer binding factor 3, 90kDa 1975 251 C20140605_SFK031_02 C20140605_SFK031_02 TB558081.[MT7]-C[CAM]LAALASLR.2y7_1.heavy 559.827 / 701.43 41378.0 37.46560001373291 46 20 10 6 10 21.377232266120593 4.677874046327484 0.039600372314453125 3 0.9990399500792637 39.82728576848771 41378.0 48.77762476705216 0.0 - - - - - - - 713.1428571428571 82 7 ILF3 interleukin enhancer binding factor 3, 90kDa 1977 252 C20140605_SFK031_02 C20140605_SFK031_02 TB555904.[MT7]-AHAC[CAM]PEC[CAM]GK[MT7].3y3_1.heavy 439.881 / 508.267 96582.0 14.50059986114502 50 20 10 10 10 2.7912480838946454 26.985361225937652 0.0 3 0.9933764037636259 15.155680346203283 96582.0 32.37998844576967 0.0 - - - - - - - 704.0 193 8 MECOM MDS1 and EVI1 complex locus 1979 252 C20140605_SFK031_02 C20140605_SFK031_02 TB555904.[MT7]-AHAC[CAM]PEC[CAM]GK[MT7].3b4_1.heavy 439.881 / 584.273 33733.0 14.50059986114502 50 20 10 10 10 2.7912480838946454 26.985361225937652 0.0 3 0.9933764037636259 15.155680346203283 33733.0 165.93169367588933 0.0 - - - - - - - 271.7647058823529 67 17 MECOM MDS1 and EVI1 complex locus 1981 252 C20140605_SFK031_02 C20140605_SFK031_02 TB555904.[MT7]-AHAC[CAM]PEC[CAM]GK[MT7].3y4_1.heavy 439.881 / 637.31 20495.0 14.50059986114502 50 20 10 10 10 2.7912480838946454 26.985361225937652 0.0 3 0.9933764037636259 15.155680346203283 20495.0 84.07607954545455 0.0 - - - - - - - 245.14285714285714 40 21 MECOM MDS1 and EVI1 complex locus 1983 252 C20140605_SFK031_02 C20140605_SFK031_02 TB555904.[MT7]-AHAC[CAM]PEC[CAM]GK[MT7].3y5_1.heavy 439.881 / 734.362 N/A 14.50059986114502 50 20 10 10 10 2.7912480838946454 26.985361225937652 0.0 3 0.9933764037636259 15.155680346203283 29115.0 16.942631300647932 6.0 - - - - - - - 1627.0 212 2 MECOM MDS1 and EVI1 complex locus 1985 253 C20140605_SFK031_02 C20140605_SFK031_02 TB560935.[MT7]-SVNPNK[MT7]PATK[MT7].3b4_1.heavy 496.635 / 542.305 3922.0 16.561199188232422 46 18 10 10 8 7.271249307752764 13.752794845498947 0.0 4 0.9866447312901799 10.667226664830375 3922.0 10.428109235430684 1.0 - - - - - - - 698.4444444444445 12 9 FMR1 fragile X mental retardation 1 1987 253 C20140605_SFK031_02 C20140605_SFK031_02 TB560935.[MT7]-SVNPNK[MT7]PATK[MT7].3y7_2.heavy 496.635 / 522.326 34435.0 16.561199188232422 46 18 10 10 8 7.271249307752764 13.752794845498947 0.0 4 0.9866447312901799 10.667226664830375 34435.0 77.92956511883563 0.0 - - - - - - - 792.375 68 8 FMR1 fragile X mental retardation 1 1989 253 C20140605_SFK031_02 C20140605_SFK031_02 TB560935.[MT7]-SVNPNK[MT7]PATK[MT7].3y4_1.heavy 496.635 / 560.352 76069.0 16.561199188232422 46 18 10 10 8 7.271249307752764 13.752794845498947 0.0 4 0.9866447312901799 10.667226664830375 76069.0 90.78927294906677 0.0 - - - - - - - 1205.0 152 7 FMR1 fragile X mental retardation 1 1991 253 C20140605_SFK031_02 C20140605_SFK031_02 TB560935.[MT7]-SVNPNK[MT7]PATK[MT7].3y8_2.heavy 496.635 / 579.348 13538.0 16.561199188232422 46 18 10 10 8 7.271249307752764 13.752794845498947 0.0 4 0.9866447312901799 10.667226664830375 13538.0 36.39968241874318 1.0 - - - - - - - 631.25 27 8 FMR1 fragile X mental retardation 1 1993 254 C20140605_SFK031_02 C20140605_SFK031_02 TB558804.[MT7]-VGPNAPEEK[MT7].3y3_1.heavy 410.231 / 549.3 58253.0 19.71299934387207 48 18 10 10 10 4.389668287493502 22.780764616066225 0.0 3 0.9820035912833054 9.185778617221152 58253.0 114.10455032565186 0.0 - - - - - - - 652.7777777777778 116 9 FMR1 fragile X mental retardation 1 1995 254 C20140605_SFK031_02 C20140605_SFK031_02 TB558804.[MT7]-VGPNAPEEK[MT7].3b4_1.heavy 410.231 / 512.295 102208.0 19.71299934387207 48 18 10 10 10 4.389668287493502 22.780764616066225 0.0 3 0.9820035912833054 9.185778617221152 102208.0 80.45671828401063 0.0 - - - - - - - 1262.3333333333333 204 9 FMR1 fragile X mental retardation 1 1997 254 C20140605_SFK031_02 C20140605_SFK031_02 TB558804.[MT7]-VGPNAPEEK[MT7].3b5_1.heavy 410.231 / 583.332 65137.0 19.71299934387207 48 18 10 10 10 4.389668287493502 22.780764616066225 0.0 3 0.9820035912833054 9.185778617221152 65137.0 93.40084165910301 0.0 - - - - - - - 1183.0 130 7 FMR1 fragile X mental retardation 1 1999 254 C20140605_SFK031_02 C20140605_SFK031_02 TB558804.[MT7]-VGPNAPEEK[MT7].3y4_1.heavy 410.231 / 646.353 42895.0 19.71299934387207 48 18 10 10 10 4.389668287493502 22.780764616066225 0.0 3 0.9820035912833054 9.185778617221152 42895.0 101.73834976063081 0.0 - - - - - - - 722.3 85 10 FMR1 fragile X mental retardation 1 2001 255 C20140605_SFK031_02 C20140605_SFK031_02 TB560001.[MT7]-AADPYSDLVK[MT7].2y5_1.heavy 683.876 / 705.426 3448.0 30.52614974975586 42 16 10 6 10 5.243012710596483 19.07300354200806 0.03070068359375 3 0.9699568082594101 7.10225067604708 3448.0 9.814190628496299 1.0 - - - - - - - 742.0 6 11 CNNM1 cyclin M1 2003 255 C20140605_SFK031_02 C20140605_SFK031_02 TB560001.[MT7]-AADPYSDLVK[MT7].2y3_1.heavy 683.876 / 503.367 14706.0 30.52614974975586 42 16 10 6 10 5.243012710596483 19.07300354200806 0.03070068359375 3 0.9699568082594101 7.10225067604708 14706.0 39.70435806204901 0.0 - - - - - - - 757.6923076923077 29 13 CNNM1 cyclin M1 2005 255 C20140605_SFK031_02 C20140605_SFK031_02 TB560001.[MT7]-AADPYSDLVK[MT7].2b7_1.heavy 683.876 / 864.386 7529.0 30.52614974975586 42 16 10 6 10 5.243012710596483 19.07300354200806 0.03070068359375 3 0.9699568082594101 7.10225067604708 7529.0 14.397221644677048 0.0 - - - - - - - 298.2857142857143 15 21 CNNM1 cyclin M1 2007 255 C20140605_SFK031_02 C20140605_SFK031_02 TB560001.[MT7]-AADPYSDLVK[MT7].2y7_1.heavy 683.876 / 965.542 66987.0 30.52614974975586 42 16 10 6 10 5.243012710596483 19.07300354200806 0.03070068359375 3 0.9699568082594101 7.10225067604708 66987.0 279.97459374423755 0.0 - - - - - - - 309.45 133 20 CNNM1 cyclin M1 2009 256 C20140605_SFK031_02 C20140605_SFK031_02 TB558806.[MT7]-AQLLELEK[MT7].3y3_1.heavy 411.255 / 533.341 292500.0 33.80929946899414 48 18 10 10 10 56.89858164192632 1.757513054179789 0.0 3 0.9895164527483472 12.042817297718816 292500.0 383.05180833615634 0.0 - - - - - - - 286.0 585 6 PDX1 pancreatic and duodenal homeobox 1 2011 256 C20140605_SFK031_02 C20140605_SFK031_02 TB558806.[MT7]-AQLLELEK[MT7].3b4_1.heavy 411.255 / 570.373 156443.0 33.80929946899414 48 18 10 10 10 56.89858164192632 1.757513054179789 0.0 3 0.9895164527483472 12.042817297718816 156443.0 171.2202213991399 0.0 - - - - - - - 357.6666666666667 312 3 PDX1 pancreatic and duodenal homeobox 1 2013 256 C20140605_SFK031_02 C20140605_SFK031_02 TB558806.[MT7]-AQLLELEK[MT7].3b5_1.heavy 411.255 / 699.416 105261.0 33.80929946899414 48 18 10 10 10 56.89858164192632 1.757513054179789 0.0 3 0.9895164527483472 12.042817297718816 105261.0 424.9667701863354 0.0 - - - - - - - 236.3 210 10 PDX1 pancreatic and duodenal homeobox 1 2015 256 C20140605_SFK031_02 C20140605_SFK031_02 TB558806.[MT7]-AQLLELEK[MT7].3b3_1.heavy 411.255 / 457.289 622523.0 33.80929946899414 48 18 10 10 10 56.89858164192632 1.757513054179789 0.0 3 0.9895164527483472 12.042817297718816 622523.0 854.84686541366 0.0 - - - - - - - 268.0 1245 2 PDX1 pancreatic and duodenal homeobox 1 2017 257 C20140605_SFK031_02 C20140605_SFK031_02 TB295016.[MT7]-VADLVHILTHLQLLR.3y7_1.heavy 629.055 / 880.536 67424.0 52.026798248291016 42 12 10 10 10 1.1988712281689133 58.971138727308436 0.0 3 0.8942655352534079 3.7614128901643054 67424.0 580.4419994710395 0.0 - - - - - - - 212.66666666666666 134 15 IRAK1 interleukin-1 receptor-associated kinase 1 2019 257 C20140605_SFK031_02 C20140605_SFK031_02 TB295016.[MT7]-VADLVHILTHLQLLR.3b4_1.heavy 629.055 / 543.326 63439.0 52.026798248291016 42 12 10 10 10 1.1988712281689133 58.971138727308436 0.0 3 0.8942655352534079 3.7614128901643054 63439.0 161.14612232788886 0.0 - - - - - - - 325.7 126 10 IRAK1 interleukin-1 receptor-associated kinase 1 2021 257 C20140605_SFK031_02 C20140605_SFK031_02 TB295016.[MT7]-VADLVHILTHLQLLR.3y4_1.heavy 629.055 / 529.346 24977.0 52.026798248291016 42 12 10 10 10 1.1988712281689133 58.971138727308436 0.0 3 0.8942655352534079 3.7614128901643054 24977.0 83.97603718576703 0.0 - - - - - - - 298.92857142857144 49 14 IRAK1 interleukin-1 receptor-associated kinase 1 2023 257 C20140605_SFK031_02 C20140605_SFK031_02 TB295016.[MT7]-VADLVHILTHLQLLR.3y8_1.heavy 629.055 / 993.62 107082.0 52.026798248291016 42 12 10 10 10 1.1988712281689133 58.971138727308436 0.0 3 0.8942655352534079 3.7614128901643054 107082.0 366.30571748819557 0.0 - - - - - - - 256.14285714285717 214 7 IRAK1 interleukin-1 receptor-associated kinase 1 2025 258 C20140605_SFK031_02 C20140605_SFK031_02 TB562071.[MT7]-SPVFIAQVGQDLVSQTEEK[MT7].4y4_1.heavy 591.573 / 650.348 40447.0 44.990973472595215 40 14 10 6 10 2.220833796955844 45.028133189017865 0.036899566650390625 3 0.9337507266890831 4.768090662045558 40447.0 55.785002530450924 0.0 - - - - - - - 455.0 80 1 GRK5 G protein-coupled receptor kinase 5 2027 258 C20140605_SFK031_02 C20140605_SFK031_02 TB562071.[MT7]-SPVFIAQVGQDLVSQTEEK[MT7].4b4_1.heavy 591.573 / 575.331 60944.0 44.990973472595215 40 14 10 6 10 2.220833796955844 45.028133189017865 0.036899566650390625 3 0.9337507266890831 4.768090662045558 60944.0 90.21834328207152 0.0 - - - - - - - 341.25 121 4 GRK5 G protein-coupled receptor kinase 5 2029 258 C20140605_SFK031_02 C20140605_SFK031_02 TB562071.[MT7]-SPVFIAQVGQDLVSQTEEK[MT7].4b5_1.heavy 591.573 / 688.415 47188.0 44.990973472595215 40 14 10 6 10 2.220833796955844 45.028133189017865 0.036899566650390625 3 0.9337507266890831 4.768090662045558 47188.0 163.610235001485 0.0 - - - - - - - 273.0 94 7 GRK5 G protein-coupled receptor kinase 5 2031 258 C20140605_SFK031_02 C20140605_SFK031_02 TB562071.[MT7]-SPVFIAQVGQDLVSQTEEK[MT7].4y6_1.heavy 591.573 / 865.438 30791.0 44.990973472595215 40 14 10 6 10 2.220833796955844 45.028133189017865 0.036899566650390625 3 0.9337507266890831 4.768090662045558 30791.0 149.6732505765839 0.0 - - - - - - - 273.0 61 7 GRK5 G protein-coupled receptor kinase 5 2033 259 C20140605_SFK031_02 C20140605_SFK031_02 TB295018.[MT7]-VADLVHILTHLQLLR.4y4_1.heavy 472.043 / 529.346 164276.0 52.026798248291016 41 11 10 10 10 1.581638291861809 49.2270284469854 0.0 3 0.8611341605122178 3.2726974339532218 164276.0 814.8842599873177 0.0 - - - - - - - 169.0909090909091 328 11 IRAK1 interleukin-1 receptor-associated kinase 1 2035 259 C20140605_SFK031_02 C20140605_SFK031_02 TB295018.[MT7]-VADLVHILTHLQLLR.4y8_1.heavy 472.043 / 993.62 133.0 52.026798248291016 41 11 10 10 10 1.581638291861809 49.2270284469854 0.0 3 0.8611341605122178 3.2726974339532218 133.0 -0.0 0.0 - - - - - - - 0.0 0 0 IRAK1 interleukin-1 receptor-associated kinase 1 2037 259 C20140605_SFK031_02 C20140605_SFK031_02 TB295018.[MT7]-VADLVHILTHLQLLR.4b4_1.heavy 472.043 / 543.326 112795.0 52.026798248291016 41 11 10 10 10 1.581638291861809 49.2270284469854 0.0 3 0.8611341605122178 3.2726974339532218 112795.0 980.2676228054453 0.0 - - - - - - - 121.5 225 6 IRAK1 interleukin-1 receptor-associated kinase 1 2039 259 C20140605_SFK031_02 C20140605_SFK031_02 TB295018.[MT7]-VADLVHILTHLQLLR.4y7_1.heavy 472.043 / 880.536 18002.0 52.026798248291016 41 11 10 10 10 1.581638291861809 49.2270284469854 0.0 3 0.8611341605122178 3.2726974339532218 18002.0 408.11095921622234 0.0 - - - - - - - 199.0 36 5 IRAK1 interleukin-1 receptor-associated kinase 1 2041 260 C20140605_SFK031_02 C20140605_SFK031_02 TB560145.[MT7]-IVVPIPVHVNR.3y6_1.heavy 462.962 / 721.41 241924.0 35.338199615478516 47 17 10 10 10 4.888773373973309 20.45502876700661 0.0 3 0.9731123736396895 7.509451371009189 241924.0 823.7514953337886 0.0 - - - - - - - 306.3333333333333 483 3 GBX1 gastrulation brain homeobox 1 2043 260 C20140605_SFK031_02 C20140605_SFK031_02 TB560145.[MT7]-IVVPIPVHVNR.3b5_1.heavy 462.962 / 666.467 73634.0 35.338199615478516 47 17 10 10 10 4.888773373973309 20.45502876700661 0.0 3 0.9731123736396895 7.509451371009189 73634.0 153.6554862242313 0.0 - - - - - - - 306.3333333333333 147 3 GBX1 gastrulation brain homeobox 1 2045 260 C20140605_SFK031_02 C20140605_SFK031_02 TB560145.[MT7]-IVVPIPVHVNR.3y4_1.heavy 462.962 / 525.289 228599.0 35.338199615478516 47 17 10 10 10 4.888773373973309 20.45502876700661 0.0 3 0.9731123736396895 7.509451371009189 228599.0 164.71520687724015 0.0 - - - - - - - 306.3333333333333 457 3 GBX1 gastrulation brain homeobox 1 2047 260 C20140605_SFK031_02 C20140605_SFK031_02 TB560145.[MT7]-IVVPIPVHVNR.3y5_1.heavy 462.962 / 624.358 66512.0 35.338199615478516 47 17 10 10 10 4.888773373973309 20.45502876700661 0.0 3 0.9731123736396895 7.509451371009189 66512.0 116.88366785919503 0.0 - - - - - - - 689.0 133 7 GBX1 gastrulation brain homeobox 1 2049 261 C20140605_SFK031_02 C20140605_SFK031_02 TB557202.[MT7]-EGAGEQK[MT7].2y4_1.heavy 503.774 / 605.338 697.0 13.338000297546387 32 20 0 10 2 5.799642357057848 17.242442523771395 0.0 12 0.9927474999122357 14.482904667020206 697.0 4.047096774193548 4.0 - - - - - - - 217.38888888888889 8 18 ILF3 interleukin enhancer binding factor 3, 90kDa 2051 261 C20140605_SFK031_02 C20140605_SFK031_02 TB557202.[MT7]-EGAGEQK[MT7].2b6_1.heavy 503.774 / 716.333 581.0 13.338000297546387 32 20 0 10 2 5.799642357057848 17.242442523771395 0.0 12 0.9927474999122357 14.482904667020206 581.0 1.124516129032258 9.0 - - - - - - - 232.42857142857142 10 14 ILF3 interleukin enhancer binding factor 3, 90kDa 2053 261 C20140605_SFK031_02 C20140605_SFK031_02 TB557202.[MT7]-EGAGEQK[MT7].2y6_1.heavy 503.774 / 733.396 1317.0 13.338000297546387 32 20 0 10 2 5.799642357057848 17.242442523771395 0.0 12 0.9927474999122357 14.482904667020206 1317.0 10.313446112368526 5.0 - - - - - - - 257.47058823529414 24 17 ILF3 interleukin enhancer binding factor 3, 90kDa 2055 261 C20140605_SFK031_02 C20140605_SFK031_02 TB557202.[MT7]-EGAGEQK[MT7].2b5_1.heavy 503.774 / 588.275 658.0 13.338000297546387 32 20 0 10 2 5.799642357057848 17.242442523771395 0.0 12 0.9927474999122357 14.482904667020206 658.0 2.7134020618556702 11.0 - - - - - - - 209.89473684210526 4 19 ILF3 interleukin enhancer binding factor 3, 90kDa